data_2jyo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jyo _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.687 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 13.7 p . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.0 t -52.15 118.72 3.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.787 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.2 mt -84.61 -15.75 44.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.217 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -120.88 108.8 1.43 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.738 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 17.8 m-85 -79.92 -167.49 1.29 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.263 0.554 . . . . 0.0 111.177 -173.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.5 t -125.03 170.74 10.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.973 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -133.98 77.53 1.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.516 0.674 . . . . 0.0 110.311 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.518 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 94.7 mtt180 -133.23 179.09 6.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.743 176.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.565 HD11 ' CD1' ' A' ' 55' ' ' TRP . 3.0 mm -118.29 83.46 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 164.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.594 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.5 mm? -79.42 158.88 27.26 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.691 ' HD1' ' HD2' ' A' ' 18' ' ' LYS . 54.7 m170 -131.81 175.71 3.47 Favored Pre-proline 0 C--N 1.312 -1.052 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.151 -174.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.642 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 32.5 Cg_exo -56.4 -25.51 57.84 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.747 1.631 . . . . 0.0 109.282 164.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.691 ' HD2' ' HD1' ' A' ' 16' ' ' HIS . 64.0 mttm -49.38 -31.55 9.72 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.282 175.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 41' ' ' THR . 91.0 m-85 -124.1 0.32 8.45 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.44 ' CG1' ' HB3' ' A' ' 39' ' ' PHE . 1.4 mp -105.88 130.08 57.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.077 0.465 . . . . 0.0 112.105 -173.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.1 m -123.95 -5.76 7.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.468 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.12 162.6 30.21 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.409 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.659 ' CB ' HD13 ' A' ' 63' ' ' LEU . 1.1 t80 -158.04 133.65 9.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.981 0.42 . . . . 0.0 110.413 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.6 m -135.91 120.37 18.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.938 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -93.0 137.2 32.57 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.131 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.687 ' NE2' ' HB2' ' A' ' 6' ' ' CYS . 12.9 mt-30 -120.72 121.01 37.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.749 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.4 mp -102.45 165.91 10.84 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.026 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.27 18.36 11.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.401 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -139.61 1.98 1.97 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.781 0.324 . . . . 0.0 111.62 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -99.99 -21.73 15.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.107 0.479 . . . . 0.0 110.33 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.21 -53.95 0.1 OUTLIER Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.5 t -69.03 156.89 37.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -89.63 -20.07 24.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.455 0.645 . . . . 0.0 109.788 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.428 HG12 ' SG ' ' A' ' 6' ' ' CYS . 4.6 pt -116.26 -178.68 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -129.7 129.08 43.77 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.115 0.483 . . . . 0.0 110.557 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . -141.95 132.82 25.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.118 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.555 ' HB ' ' HB1' ' A' ' 49' ' ' ALA . 46.7 mm -82.34 125.17 39.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.9 mm -98.8 101.68 12.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 O-C-N 121.969 -0.457 . . . . 0.0 110.757 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.518 ' HE2' HG23 ' A' ' 56' ' ' VAL . 18.6 m-85 -87.99 123.49 32.75 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 173.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -92.88 112.75 24.81 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 36.7 p -75.22 160.52 30.29 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.663 -176.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -71.93 5.62 2.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.476 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.452 ' H ' ' C ' ' A' ' 41' ' ' THR . 0.5 OUTLIER -106.57 12.28 29.62 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.335 176.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 68.14 19.39 9.2 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.079 174.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.8 mt -112.7 136.19 52.57 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.991 0.424 . . . . 0.0 110.925 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.6 p -84.88 115.79 22.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.623 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 83.0 t -89.12 126.6 42.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.625 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 16.5 m -83.09 81.24 8.77 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.616 0.722 . . . . 0.0 109.238 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.555 ' HB1' ' HB ' ' A' ' 37' ' ' ILE . . . -71.85 134.48 46.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.671 -175.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.738 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -80.64 124.29 82.04 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -65.62 -0.44 3.73 Favored 'Trans proline' 0 C--N 1.328 -0.537 0 C-N-CA 121.862 1.708 . . . . 0.0 111.933 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.462 ' H ' ' C ' ' A' ' 50' ' ' ASN . 51.0 mtpt -85.0 -25.46 27.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.874 -175.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.493 HE21 ' CG2' ' A' ' 56' ' ' VAL . 5.4 pt20 -103.37 145.95 29.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.7 -167.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.41 -32.59 68.58 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -171.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.594 ' CZ3' ' HB2' ' A' ' 15' ' ' LEU . 48.3 p-90 -63.48 -32.91 74.49 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.859 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.518 HG23 ' HE2' ' A' ' 39' ' ' PHE . 4.5 t -69.75 -46.95 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.314 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.744 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 65.0 mttm -58.04 -40.6 81.29 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.098 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -62.93 -53.11 59.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.188 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.443 HG22 ' CD1' ' A' ' 63' ' ' LEU . 85.0 mt -63.79 -41.06 91.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.314 -177.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.1 p -68.44 -25.62 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.132 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.744 ' HG2' ' O ' ' A' ' 57' ' ' LYS . 1.3 mmp_? -66.43 -45.19 80.71 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 122.007 -0.433 . . . . 0.0 109.999 174.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.9 mt -68.72 -36.42 78.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.821 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.659 HD13 ' CB ' ' A' ' 23' ' ' PHE . 81.3 mt -72.3 -18.54 61.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.92 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 C--N 1.327 -0.38 0 CA-C-O 120.816 0.341 . . . . 0.0 110.969 173.68 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.737 ' SG ' HG12 ' A' ' 34' ' ' ILE . 20.8 p . . . . . 0 N--CA 1.449 -0.476 0 CA-C-O 120.949 0.404 . . . . 0.0 110.999 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 55.8 m -61.36 117.65 5.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.684 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.3 mt -68.82 -16.55 63.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.292 0.568 . . . . 0.0 110.242 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.1 88.17 0.19 Allowed Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.121 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.445 ' HB2' ' ND2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -74.39 157.31 35.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.111 0.482 . . . . 0.0 110.533 174.583 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 48' ' ' CYS . 15.1 t -82.3 159.34 23.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -164.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -118.54 74.23 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.51 ' HB2' HD23 ' A' ' 15' ' ' LEU . 1.8 mmp_? -131.65 178.53 6.67 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.586 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.544 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.9 mm -121.6 84.46 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.237 161.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.545 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 1.9 mm? -84.59 167.58 16.15 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 175.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 1.011 ' HD1' ' HD2' ' A' ' 18' ' ' LYS . 63.5 m170 -133.04 168.14 19.45 Favored Pre-proline 0 C--N 1.311 -1.088 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.689 -175.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 17.3 Cg_endo -59.49 -23.05 69.1 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.316 2.011 . . . . 0.0 109.207 165.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 1.011 ' HD2' ' HD1' ' A' ' 16' ' ' HIS . 65.1 mttm -49.53 -27.68 4.67 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 113.846 -1.525 . . . . 0.0 111.628 170.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -124.99 -1.46 7.8 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -172.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.531 HD13 HG23 ' A' ' 59' ' ' ILE . 27.7 mt -105.99 124.64 61.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.838 0.351 . . . . 0.0 111.544 -173.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.2 m -121.13 0.69 7.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.002 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.99 158.7 30.0 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.587 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.572 ' CZ ' HG21 ' A' ' 60' ' ' VAL . 2.1 t80 -153.24 134.31 14.05 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.346 0.593 . . . . 0.0 110.93 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.9 m -141.95 112.56 7.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.495 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -80.29 103.08 9.91 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.961 0.41 . . . . 0.0 110.381 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.562 ' NE2' ' HA ' ' A' ' 6' ' ' CYS . 8.5 tt0 -74.27 126.11 29.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.045 -177.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.481 ' HB3' HD21 ' A' ' 29' ' ' ASN . 87.8 mt -100.59 156.39 17.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.499 0.666 . . . . 0.0 112.606 -170.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.57 -30.65 36.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.909 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.481 HD21 ' HB3' ' A' ' 27' ' ' LEU . 44.3 m-80 -49.94 -34.06 19.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.534 -1.212 . . . . 0.0 113.069 -175.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -99.83 27.3 5.55 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -172.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.13 -44.82 1.03 Allowed Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.722 172.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -80.56 -167.1 1.23 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.008 0.432 . . . . 0.0 111.955 -174.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -122.54 -28.54 4.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.718 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.737 HG12 ' SG ' ' A' ' 6' ' ' CYS . 1.4 pt -111.69 169.51 4.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -116.2 123.35 47.55 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.01 121.62 43.69 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.715 0.293 . . . . 0.0 110.847 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.71 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 48.6 mm -69.74 104.94 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.371 176.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.425 HD13 ' NE2' ' A' ' 26' ' ' GLN . 33.4 mm -85.89 97.64 6.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 O-C-N 122.059 -0.401 . . . . 0.0 110.113 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.483 ' HB3' HG12 ' A' ' 20' ' ' ILE . 9.6 m-85 -85.77 122.88 30.48 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -93.45 106.76 18.69 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.8 p -78.09 162.92 26.31 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.073 -173.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -65.9 -7.8 18.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.326 173.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -91.16 2.82 56.06 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.282 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 68.41 17.73 9.12 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.936 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.6 mt -106.69 125.98 51.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.517 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.4 p -76.72 108.35 9.67 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.652 177.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 99.6 t -91.63 131.35 38.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.662 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.438 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 62.8 m -88.7 90.97 8.63 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.71 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . . . -77.95 141.15 39.18 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.958 -176.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.573 ' N ' HD21 ' A' ' 50' ' ' ASN . 0.7 OUTLIER -82.38 130.34 59.66 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.82 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -71.48 2.93 4.01 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.099 1.866 . . . . 0.0 112.041 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -90.32 -21.62 21.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.918 -176.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.509 HE21 HG22 ' A' ' 56' ' ' VAL . 5.0 pt20 -103.14 142.27 34.43 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.437 -168.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 p -74.3 -28.79 61.34 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -171.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.617 ' O ' HG13 ' A' ' 59' ' ' ILE . 47.2 p-90 -62.57 -33.73 75.54 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.387 176.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.521 ' CG2' ' HB1' ' A' ' 49' ' ' ALA . 4.5 t -70.99 -47.92 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.413 174.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -56.98 -36.71 70.65 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 123.761 0.663 . . . . 0.0 110.85 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -65.77 -49.47 68.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.838 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.617 HG13 ' O ' ' A' ' 55' ' ' TRP . 60.0 mt -67.76 -47.86 78.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.039 -175.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.572 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 11.7 p -62.69 -29.84 47.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 120.803 0.335 . . . . 0.0 110.762 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -64.47 -45.26 88.17 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 34.8 mt -70.26 -30.81 67.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.934 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.574 HD22 HG22 ' A' ' 59' ' ' ILE . 2.0 mm? -68.45 -36.65 79.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.539 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.694 -178.777 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.802 ' SG ' HG12 ' A' ' 34' ' ' ILE . 26.2 p . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.652 ' O ' HD12 ' A' ' 34' ' ' ILE . 58.3 m -60.2 130.25 45.72 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.136 174.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.3 mt -84.5 0.13 50.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.209 0.528 . . . . 0.0 110.108 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.54 136.44 6.94 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 174.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.81 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 29.0 m-85 -97.3 176.65 5.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.798 0.332 . . . . 0.0 110.226 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.488 HG21 ' CG1' ' A' ' 47' ' ' VAL . 2.7 t -112.91 137.85 50.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.168 0.509 . . . . 0.0 111.015 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -108.02 68.9 0.72 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.564 0.697 . . . . 0.0 109.363 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.478 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 4.3 mmp_? -129.19 -173.21 2.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.586 -177.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.569 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.4 mm -124.98 89.65 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.208 165.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.594 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.7 mm? -89.12 162.83 15.75 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.787 ' HD1' ' HD2' ' A' ' 18' ' ' LYS . 58.3 m170 -132.05 166.65 26.92 Favored Pre-proline 0 C--N 1.312 -1.051 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.994 -172.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 12.2 Cg_endo -57.57 -27.14 75.53 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.176 1.917 . . . . 0.0 109.149 166.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.787 ' HD2' ' HD1' ' A' ' 16' ' ' HIS . 65.6 mttm -45.0 -35.47 2.93 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.384 171.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -116.89 -13.48 10.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.903 -172.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.663 HG12 ' HB3' ' A' ' 39' ' ' PHE . 21.8 mt -92.39 127.18 44.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.768 0.318 . . . . 0.0 111.327 -172.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 m -122.33 -7.6 8.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.157 0.503 . . . . 0.0 110.995 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -152.21 163.1 30.1 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.656 ' CB ' HD13 ' A' ' 63' ' ' LEU . 2.4 t80 -156.6 134.28 10.91 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 117.325 0.563 . . . . 0.0 110.897 -175.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.545 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 83.5 m -140.41 107.8 5.55 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.112 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 25' ' ' ARG . 14.8 ptp180 -86.5 102.78 14.42 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.776 HE21 ' HB2' ' A' ' 36' ' ' ALA . 19.9 pt20 -93.25 136.04 33.88 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 86.7 mt -119.64 163.72 16.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.214 0.53 . . . . 0.0 111.882 -170.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.58 35.03 0.49 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.824 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -132.73 -52.62 0.93 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.396 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -60.97 -43.21 99.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.799 -173.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -157.16 -65.03 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.279 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.8 t -71.42 169.3 15.64 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.378 0.609 . . . . 0.0 112.384 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -90.1 -24.67 21.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.653 -173.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.802 HG12 ' SG ' ' A' ' 6' ' ' CYS . 2.1 pt -120.41 170.16 10.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -118.86 128.18 54.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.778 0.323 . . . . 0.0 111.178 -176.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.776 ' HB2' HE21 ' A' ' 26' ' ' GLN . . . -131.9 143.6 50.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.958 0.409 . . . . 0.0 110.928 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.599 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 49.9 mm -90.2 101.34 12.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.229 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.545 ' HB ' ' HB ' ' A' ' 24' ' ' THR . 63.9 mt -79.49 104.75 7.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.019 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.663 ' HB3' HG12 ' A' ' 20' ' ' ILE . 12.5 m-85 -95.26 111.35 23.21 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 172.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -82.67 110.25 17.57 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.439 ' C ' ' H ' ' A' ' 43' ' ' LYS . 37.0 p -85.06 163.13 19.01 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.412 0.625 . . . . 0.0 112.008 -174.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -68.75 -2.53 9.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.032 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.439 ' H ' ' C ' ' A' ' 41' ' ' THR . 27.1 tptp -90.58 3.04 55.2 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.769 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt 69.47 22.86 6.24 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.015 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 97.3 mt -114.75 139.6 49.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.144 0.497 . . . . 0.0 110.712 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.0 p -90.07 95.41 10.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.694 174.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.488 ' CG1' HG21 ' A' ' 11' ' ' THR . 59.0 t -76.33 130.2 36.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.834 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.0 m -92.64 81.74 4.78 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.018 0.913 . . . . 0.0 109.591 -175.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -69.87 144.63 52.46 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.794 -176.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.81 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -83.8 129.39 59.49 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.758 -179.126 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -72.01 21.33 0.27 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.406 2.071 . . . . 0.0 111.988 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.502 ' H ' ' C ' ' A' ' 50' ' ' ASN . 35.3 mtmm -119.42 -4.93 10.36 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.99 -173.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.509 HE21 HG23 ' A' ' 56' ' ' VAL . 4.7 pt20 -117.26 146.37 43.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.027 0.441 . . . . 0.0 111.555 -172.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 p -69.86 -36.32 75.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -171.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.594 ' CZ3' ' HB2' ' A' ' 15' ' ' LEU . 47.9 p-90 -61.05 -30.75 70.51 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 60' ' ' VAL . 12.6 t -74.21 -49.04 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.244 174.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 84.1 mttt -57.0 -34.05 67.76 Favored 'General case' 0 C--N 1.334 -0.089 0 O-C-N 123.457 0.473 . . . . 0.0 110.506 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -66.1 -54.73 22.06 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.527 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.66 HG23 HD11 ' A' ' 20' ' ' ILE . 72.7 mt -65.57 -43.82 94.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.477 -174.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.566 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 13.8 p -66.71 -33.83 66.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.092 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -62.89 -43.14 99.59 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.37 0.605 . . . . 0.0 109.494 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.3 tp -66.2 -41.06 90.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.041 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.656 HD13 ' CB ' ' A' ' 23' ' ' PHE . 75.3 mt -76.28 -7.44 54.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.355 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 C--N 1.327 -0.391 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.864 178.092 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.71 ' HA ' ' HB3' ' A' ' 26' ' ' GLN . 7.9 p . . . . . 0 N--CA 1.44 -0.932 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.483 ' O ' HD11 ' A' ' 34' ' ' ILE . 94.8 m -105.91 122.75 46.76 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 166.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.6 mt -67.7 -26.69 66.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.345 0.593 . . . . 0.0 109.536 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -129.06 135.38 8.43 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.206 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.759 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 6.9 m-85 -100.58 -160.12 0.78 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.1 t -129.12 158.7 38.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.214 176.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.492 ' O ' ' HD2' ' A' ' 13' ' ' ARG . 1.5 m-20 -118.55 69.23 0.79 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.858 0.361 . . . . 0.0 110.087 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.492 ' HD2' ' O ' ' A' ' 12' ' ' ASP . 8.4 mmm180 -131.36 175.89 8.75 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.411 0.624 . . . . 0.0 112.122 -177.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.551 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.1 mm -120.18 90.05 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.001 164.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.498 ' O ' ' HD2' ' A' ' 16' ' ' HIS . 1.9 mm? -92.35 163.26 13.94 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.775 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 34.9 m170 -131.24 176.39 2.93 Favored Pre-proline 0 C--N 1.313 -1.013 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.277 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.775 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 13.2 Cg_endo -58.68 -21.28 54.99 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.631 1.554 . . . . 0.0 109.353 167.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.759 ' HD3' ' HD1' ' A' ' 16' ' ' HIS . 28.5 mtpp -45.17 -32.77 1.97 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.844 171.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 41' ' ' THR . 77.9 m-85 -124.27 -5.08 7.82 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -174.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.611 HG12 ' HB3' ' A' ' 39' ' ' PHE . 18.3 mt -100.26 128.45 52.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.777 0.323 . . . . 0.0 111.666 -173.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.6 m -120.68 -11.48 9.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.195 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.3 165.74 31.42 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.709 ' HB2' HD12 ' A' ' 63' ' ' LEU . 2.7 t80 -155.01 133.44 11.87 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.23 0.538 . . . . 0.0 111.666 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.7 m -142.1 121.42 13.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.603 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -98.11 119.16 36.26 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.512 -0.475 . . . . 0.0 112.112 -176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.71 ' HB3' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -76.17 130.09 37.72 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 170.756 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.6 mt -97.9 152.52 19.13 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -169.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.87 5.48 43.39 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.059 173.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -100.26 -64.61 1.03 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.146 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -116.98 86.41 2.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.63 0.728 . . . . 0.0 110.079 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.56 -77.37 0.16 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.444 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.438 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 47.1 t -117.9 176.51 5.17 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -87.38 -23.28 24.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.351 0.596 . . . . 0.0 109.405 171.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.686 HG12 ' SG ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -113.33 162.97 11.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.519 ' HB2' ' O ' ' A' ' 26' ' ' GLN . 7.0 p30 -129.11 138.35 51.77 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.286 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.88 148.56 52.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.017 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.779 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 47.8 mm -95.48 116.81 38.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.715 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.407 HD11 HE22 ' A' ' 26' ' ' GLN . 44.4 mm -90.31 98.38 8.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.085 0.469 . . . . 0.0 110.047 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.611 ' HB3' HG12 ' A' ' 20' ' ' ILE . 8.8 m-85 -87.94 115.01 25.11 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -82.03 108.14 15.28 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 42.0 p -82.55 159.15 22.85 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.195 0.521 . . . . 0.0 111.471 -175.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -67.28 -2.42 5.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.358 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -95.15 3.71 54.42 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.842 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt 70.33 11.92 7.5 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.451 0.7 . . . . 0.0 111.176 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.3 mt -92.85 125.82 37.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.098 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 p -86.06 93.79 9.08 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.3 t -85.64 130.92 35.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.687 -174.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 82.3 m -86.29 84.73 7.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 122.016 0.912 . . . . 0.0 109.506 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.779 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . . . -69.51 143.03 53.58 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.6 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.759 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -88.14 122.52 69.83 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -178.362 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.493 ' HG3' ' OD1' ' A' ' 35' ' ' ASN . 9.5 Cg_endo -57.33 -8.19 3.49 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.889 2.393 . . . . 0.0 112.471 172.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 50' ' ' ASN . 51.5 mttm -77.2 -34.54 56.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.961 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.683 ' CG ' ' HB2' ' A' ' 50' ' ' ASN . 0.4 OUTLIER -85.43 140.53 30.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.719 -169.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.64 -27.68 61.39 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -176.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.551 ' CD1' HD13 ' A' ' 14' ' ' ILE . 47.8 p-90 -62.74 -32.4 73.53 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.592 HG21 HE21 ' A' ' 53' ' ' GLN . 7.4 t -73.03 -48.78 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.494 174.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 66.7 mttm -53.93 -36.5 62.83 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.584 0.552 . . . . 0.0 110.575 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -66.52 -57.28 7.64 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.691 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.564 HG23 HD13 ' A' ' 20' ' ' ILE . 75.2 mt -62.67 -43.3 98.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.201 -175.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.62 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 12.6 p -63.5 -33.42 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 121.309 -0.156 . . . . 0.0 111.328 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -63.75 -41.99 97.91 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.268 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.4 mt -81.48 4.81 19.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.023 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.709 HD12 ' HB2' ' A' ' 23' ' ' PHE . 55.9 mt -117.7 -14.86 10.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.321 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--N 1.325 -0.466 0 CA-C-O 120.761 0.315 . . . . 0.0 110.185 179.064 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.701 ' SG ' HG12 ' A' ' 34' ' ' ILE . 19.3 p . . . . . 0 N--CA 1.451 -0.421 0 CA-C-O 120.963 0.411 . . . . 0.0 111.985 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.9 m -61.6 134.68 57.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.808 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt -86.72 6.62 30.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.592 0.711 . . . . 0.0 109.885 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.67 119.79 0.95 Allowed Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.676 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.402 ' HD1' ' H ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -118.62 161.38 20.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.944 0.402 . . . . 0.0 110.833 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.401 HG22 ' HA ' ' A' ' 49' ' ' ALA . 14.4 t -73.38 -171.52 0.99 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -167.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -147.27 14.19 1.12 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.634 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -88.81 170.43 10.75 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.408 -171.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.56 HD11 ' CD1' ' A' ' 55' ' ' TRP . 8.7 mm -105.3 84.57 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 163.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.571 HD11 ' CH2' ' A' ' 55' ' ' TRP . 1.1 mt -92.14 160.49 15.17 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.741 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 52.1 m170 -132.51 171.5 9.03 Favored Pre-proline 0 C--N 1.313 -1.014 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.005 -173.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.572 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 32.1 Cg_exo -55.83 -24.24 46.09 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.181 1.921 . . . . 0.0 109.255 165.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.741 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 64.9 mttm -44.51 -32.65 1.47 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 114.24 -1.346 . . . . 0.0 112.082 171.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -126.81 -3.48 6.52 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 122.243 -0.286 . . . . 0.0 111.449 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.619 HG13 ' HB3' ' A' ' 39' ' ' PHE . 1.2 mp -92.88 120.12 41.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.02 0.438 . . . . 0.0 110.344 -175.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.3 m -113.63 -5.87 11.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.735 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.19 158.37 29.13 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.36 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.658 ' CZ ' HG21 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -146.97 137.39 23.58 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.139 0.495 . . . . 0.0 110.258 -179.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.2 m -144.38 109.45 5.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.518 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -75.9 118.14 18.37 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.418 ' NE2' HD13 ' A' ' 38' ' ' ILE . 8.4 tt0 -101.88 106.35 17.29 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -177.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.449 ' HA ' HD21 ' A' ' 35' ' ' ASN . 6.6 mp -81.7 164.5 21.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.457 0.646 . . . . 0.0 111.984 -173.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.24 -57.8 3.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.862 175.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -74.62 19.67 0.13 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -170.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -115.19 23.86 12.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.281 0.562 . . . . 0.0 110.494 173.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.25 -12.86 4.36 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.647 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.426 ' HB2' ' H ' ' A' ' 6' ' ' CYS . 2.4 t -120.06 -153.69 0.55 Allowed 'General case' 0 C--N 1.319 -0.742 0 O-C-N 122.454 -0.439 . . . . 0.0 111.563 -177.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -129.61 -27.95 2.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.576 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.701 HG12 ' SG ' ' A' ' 6' ' ' CYS . 2.8 pt -118.61 169.51 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.449 HD21 ' HA ' ' A' ' 27' ' ' LEU . 14.9 m120 -103.39 131.06 50.78 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 174.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.14 126.14 36.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.28 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.666 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 46.7 mm -88.72 98.08 7.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.34 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.418 HD13 ' NE2' ' A' ' 26' ' ' GLN . 70.2 mt -75.49 105.95 4.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.867 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.619 ' HB3' HG13 ' A' ' 20' ' ' ILE . 13.6 m-85 -97.73 116.94 30.93 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 171.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -86.88 106.46 17.77 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 43' ' ' LYS . 42.7 p -74.75 164.1 26.94 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.642 -176.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -74.26 4.79 5.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.963 0.887 . . . . 0.0 108.912 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 14.5 tppt? -87.87 -1.36 57.93 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.004 176.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt 70.6 12.26 7.32 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.828 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.6 mt -109.44 129.2 55.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.598 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.8 p -79.84 107.07 12.33 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.821 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 73.0 t -93.23 127.25 45.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 57.4 m -88.94 100.5 13.24 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.703 0.763 . . . . 0.0 109.493 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.666 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . . . -78.66 143.38 36.38 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.934 -177.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.621 ' N ' HD21 ' A' ' 50' ' ' ASN . 0.7 OUTLIER -80.41 130.98 63.13 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.59 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.53 -10.63 28.54 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.678 2.252 . . . . 0.0 112.044 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -74.93 -27.76 60.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.231 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.601 HE21 HG22 ' A' ' 56' ' ' VAL . 5.1 mt-30 -84.64 139.29 32.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.036 -168.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 p -76.33 -31.1 57.93 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.856 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.571 ' CH2' HD11 ' A' ' 15' ' ' LEU . 51.9 p-90 -60.35 -33.8 72.94 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 174.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.601 HG22 HE21 ' A' ' 53' ' ' GLN . 25.7 t -68.54 -52.06 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.252 173.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 67.6 mttm -54.2 -38.21 65.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.683 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -63.46 -52.45 61.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.787 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 55' ' ' TRP . 72.6 mt -63.52 -47.65 90.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.296 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.658 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 7.5 p -63.99 -36.19 75.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -175.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -68.7 -31.67 70.92 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.303 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 30.2 tp -74.28 -41.88 60.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.828 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.45 HD12 ' HB3' ' A' ' 23' ' ' PHE . 2.4 mm? -66.25 -29.09 69.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.039 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.0 -176.924 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.689 ' SG ' ' HG2' ' A' ' 26' ' ' GLN . 93.8 m . . . . . 0 N--CA 1.452 -0.352 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 67.1 m -49.3 122.29 5.92 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.284 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.7 mt -65.24 -24.82 67.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.087 0.47 . . . . 0.0 110.406 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.72 134.77 7.43 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.11 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.824 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 28.9 m-85 -92.66 178.41 5.8 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.566 0.222 . . . . 0.0 110.445 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.652 HG21 HG13 ' A' ' 47' ' ' VAL . 3.4 t -127.08 130.58 50.18 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.371 0.605 . . . . 0.0 111.758 -177.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.66 72.57 2.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 122.007 0.908 . . . . 0.0 108.6 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.428 ' HB2' HD13 ' A' ' 15' ' ' LEU . 18.2 mmt180 -104.42 -178.9 3.79 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.925 177.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.455 HD13 ' CD1' ' A' ' 55' ' ' TRP . 9.1 mm -126.74 87.68 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 162.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.701 HD12 HG12 ' A' ' 47' ' ' VAL . 1.2 mt -99.82 162.27 13.1 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.273 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.956 ' HD1' ' HD2' ' A' ' 18' ' ' LYS . 63.1 m170 -132.59 167.08 24.41 Favored Pre-proline 0 C--N 1.316 -0.889 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.087 -172.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.602 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 18.3 Cg_endo -61.3 -22.53 74.86 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.315 2.01 . . . . 0.0 108.925 166.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.956 ' HD2' ' HD1' ' A' ' 16' ' ' HIS . 66.4 mttm -52.46 -28.31 19.68 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.718 172.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -124.0 -2.71 8.17 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.426 -175.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.602 ' HB ' ' HA ' ' A' ' 17' ' ' PRO . 0.9 OUTLIER -94.19 124.18 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 120.995 0.426 . . . . 0.0 110.891 -174.078 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.4 m -120.32 -1.96 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.547 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.3 160.22 31.95 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.432 -0.889 . . . . 0.0 111.962 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.54 ' CB ' ' HG ' ' A' ' 63' ' ' LEU . 1.7 t80 -149.3 134.5 18.23 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.5 m -140.95 107.18 5.23 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.381 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.503 ' HD3' HD23 ' A' ' 27' ' ' LEU . 32.4 ttm180 -82.37 107.52 15.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.168 0.509 . . . . 0.0 110.013 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.689 ' HG2' ' SG ' ' A' ' 6' ' ' CYS . 4.1 tt0 -80.14 115.56 19.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.906 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.503 HD23 ' HD3' ' A' ' 25' ' ' ARG . 65.2 mt -103.39 148.18 26.2 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -166.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.62 15.88 0.44 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.272 176.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.445 ' H ' ' C ' ' A' ' 27' ' ' LEU . 34.3 m-80 -116.04 -6.99 11.96 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.783 -177.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -103.69 -1.06 28.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.474 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.99 -48.65 0.68 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.496 -0.859 . . . . 0.0 113.311 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 34' ' ' ILE . 13.4 p -68.16 171.04 7.52 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -112.52 6.76 18.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.553 0.692 . . . . 0.0 111.035 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.415 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 25.0 pt -131.34 -171.81 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 8.9 p30 -142.62 124.08 14.83 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.874 174.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.99 137.89 51.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.729 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 50.0 mm -89.04 98.23 7.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.089 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.682 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 2.6 mp -85.46 99.7 7.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.346 -0.541 . . . . 0.0 110.541 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.534 ' HE2' HG21 ' A' ' 56' ' ' VAL . 20.1 m-85 -86.89 125.93 34.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 171.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -93.32 112.32 24.22 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.4 p -79.13 155.39 28.72 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -65.62 -6.72 11.97 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.283 175.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -99.21 12.32 36.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.989 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.9 mttm 70.68 19.89 5.87 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.372 172.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.8 mt -104.48 124.72 49.77 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.416 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.8 p -80.85 109.56 15.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.302 0.572 . . . . 0.0 109.769 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.701 HG12 HD12 ' A' ' 15' ' ' LEU . 70.0 t -87.1 132.14 33.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.025 -176.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 65.0 m -93.34 76.97 4.51 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.863 0.84 . . . . 0.0 108.832 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.578 ' HB2' ' CG2' ' A' ' 56' ' ' VAL . . . -70.71 141.13 51.56 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.898 -175.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.824 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -79.0 129.63 72.52 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.3 -179.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.54 -3.08 8.44 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 121.794 1.663 . . . . 0.0 111.122 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.46 ' H ' ' C ' ' A' ' 50' ' ' ASN . 53.8 mtmt -88.58 -18.85 27.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.048 -173.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.547 HE21 HG22 ' A' ' 56' ' ' VAL . 5.5 pt20 -104.54 145.21 30.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.953 0.406 . . . . 0.0 111.05 -170.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 p -69.72 -36.06 75.56 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -172.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.643 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 36.1 p-90 -60.14 -30.93 69.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.453 0.644 . . . . 0.0 109.466 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.578 ' CG2' ' HB2' ' A' ' 49' ' ' ALA . 15.1 t -75.27 -49.54 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.198 175.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -56.09 -33.61 65.22 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 123.454 0.471 . . . . 0.0 110.401 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -66.48 -56.96 8.44 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.872 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.452 HG12 ' HD3' ' A' ' 17' ' ' PRO . 72.4 mt -64.65 -43.94 96.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.142 -176.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 56' ' ' VAL . 7.1 p -67.07 -24.46 32.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.586 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 61' ' ' ARG . 8.4 ttp180 -69.61 -33.28 72.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.154 0.502 . . . . 0.0 110.114 174.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.6 mt -73.22 -44.45 59.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.872 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.54 ' HG ' ' CB ' ' A' ' 23' ' ' PHE . 3.7 mm? -61.96 -49.81 74.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.776 176.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.1 t . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 121.479 0.657 . . . . 0.0 109.8 178.882 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.808 ' HA ' ' HG3' ' A' ' 26' ' ' GLN . 82.8 m . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 110.94 -0.022 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.0 t -56.76 118.58 5.04 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 123.396 0.435 . . . . 0.0 110.062 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.33 -24.98 66.83 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.167 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.25 142.41 10.48 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.998 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.827 ' HB2' ' ND2' ' A' ' 50' ' ' ASN . 0.3 OUTLIER -105.24 171.32 7.38 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.027 0.441 . . . . 0.0 111.973 -178.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 t -93.12 154.11 18.27 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -169.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -95.19 59.53 2.25 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.419 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.594 ' HB3' HD23 ' A' ' 15' ' ' LEU . 6.7 mtm180 -129.34 173.66 10.32 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.497 HD11 ' CD1' ' A' ' 55' ' ' TRP . 14.5 mm -120.71 79.74 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 113.979 -1.464 . . . . 0.0 108.528 168.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.594 HD23 ' HB3' ' A' ' 13' ' ' ARG . 2.8 mm? -79.31 159.12 27.33 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.93 ' HD1' ' HD2' ' A' ' 18' ' ' LYS . 52.3 m170 -134.24 172.05 7.99 Favored Pre-proline 0 C--N 1.309 -1.19 0 O-C-N 122.028 -0.42 . . . . 0.0 111.064 -176.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.586 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 14.4 Cg_endo -59.56 -21.64 63.08 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.732 1.622 . . . . 0.0 109.177 165.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.93 ' HD2' ' HD1' ' A' ' 16' ' ' HIS . 67.6 mttm -49.01 -34.28 12.88 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.151 174.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 41' ' ' THR . 12.0 m-85 -122.83 1.79 9.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.745 0.307 . . . . 0.0 111.135 -173.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.48 HD11 ' O ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -95.63 129.57 45.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.666 -174.27 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.35 -8.3 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.061 0.458 . . . . 0.0 110.389 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.02 159.43 30.34 Favored Glycine 0 N--CA 1.453 -0.193 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.564 ' CB ' HD12 ' A' ' 63' ' ' LEU . 1.6 t80 -147.04 131.0 17.16 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.617 0.722 . . . . 0.0 111.281 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.693 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 38.2 m -129.42 144.17 51.14 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.341 -1.3 . . . . 0.0 107.82 174.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -127.73 121.62 30.79 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.434 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.808 ' HG3' ' HA ' ' A' ' 6' ' ' CYS . 1.2 pm0 -97.75 123.92 41.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.301 177.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.458 ' C ' ' H ' ' A' ' 29' ' ' ASN . 82.8 mt -103.72 159.54 15.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.507 -176.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.48 ' C ' HD21 ' A' ' 29' ' ' ASN . . . -78.04 32.82 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.445 0.64 . . . . 0.0 110.662 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.48 HD21 ' C ' ' A' ' 28' ' ' ALA . 0.9 OUTLIER -116.86 -30.37 5.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.167 -174.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -104.24 30.91 4.92 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -170.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.81 -60.06 0.67 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.741 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 0.5 OUTLIER -70.3 139.14 52.02 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 122.198 0.199 . . . . 0.0 111.058 178.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.36 -18.98 47.47 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.362 0.601 . . . . 0.0 109.419 176.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.3 pt -97.53 174.25 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.039 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -143.02 145.62 33.08 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.55 177.11 8.51 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.078 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 1.024 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 42.6 mm -122.31 133.26 69.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.693 ' HB ' ' HB ' ' A' ' 24' ' ' THR . 72.9 mt -101.78 99.13 7.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.844 0.354 . . . . 0.0 110.091 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.4 ' HE2' HG21 ' A' ' 56' ' ' VAL . 10.0 m-85 -91.76 114.06 26.49 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 172.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -86.56 113.49 22.51 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -176.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 41.5 p -79.75 162.08 25.36 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.142 0.496 . . . . 0.0 111.314 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -69.87 -2.66 12.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.829 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -93.67 7.26 45.44 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.777 176.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm 72.63 8.62 5.64 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.444 0.698 . . . . 0.0 111.002 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.77 120.74 36.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.03 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 p -79.94 105.57 11.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.358 0.599 . . . . 0.0 109.769 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 96.5 t -86.01 130.43 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.805 -176.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.9 m -82.1 92.22 6.8 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.855 0.835 . . . . 0.0 109.09 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 1.024 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -70.38 142.7 52.07 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.315 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.827 ' ND2' ' HB2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -81.79 151.79 68.23 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -174.178 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -89.76 39.16 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.562 2.174 . . . . 0.0 112.835 168.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.597 ' O ' ' HE2' ' A' ' 57' ' ' LYS . 64.9 mttm -131.97 -80.79 0.51 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.046 0.451 . . . . 0.0 111.234 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.67 HE22 ' CG2' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -40.1 139.31 0.71 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.664 1.186 . . . . 0.0 113.543 177.387 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.446 HG21 ' HD2' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -75.1 -16.93 60.53 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -172.395 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.586 ' CD1' ' HB2' ' A' ' 53' ' ' GLN . 60.7 p-90 -65.01 -30.82 71.82 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.586 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.67 ' CG2' HE22 ' A' ' 53' ' ' GLN . 0.9 OUTLIER -71.39 -47.94 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.914 174.019 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.597 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 68.3 mttm -54.41 -34.98 62.4 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 123.779 0.674 . . . . 0.0 110.386 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -68.33 -56.27 9.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.128 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.567 HG12 ' HD3' ' A' ' 17' ' ' PRO . 63.5 mt -64.57 -46.59 92.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.641 0.258 . . . . 0.0 111.486 -175.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 56' ' ' VAL . 12.7 p -71.4 -28.5 32.14 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.016 -174.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -68.9 -35.02 76.37 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.4 tp -72.1 -37.53 69.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.323 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.564 HD12 ' CB ' ' A' ' 23' ' ' PHE . 95.9 mt -82.4 -37.62 25.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.819 -177.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 C--N 1.324 -0.519 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.808 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.553 ' SG ' HG12 ' A' ' 34' ' ' ILE . 25.1 p . . . . . 0 N--CA 1.447 -0.578 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 46.8 t -61.7 126.29 26.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.624 177.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -64.21 -24.91 67.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.929 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.27 122.57 1.74 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.565 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.691 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 3.2 m-85 -79.15 -178.42 6.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.561 0.696 . . . . 0.0 110.306 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.2 t -107.38 -166.26 1.14 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.065 175.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -160.22 81.42 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 170.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.439 ' HB2' HD23 ' A' ' 15' ' ' LEU . 23.1 mmm180 -131.59 -173.99 3.28 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.479 -168.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.499 HD11 ' CD1' ' A' ' 55' ' ' TRP . 7.6 mm -126.89 86.3 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 113.647 -1.615 . . . . 0.0 107.872 160.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.626 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 1.9 mm? -91.2 169.92 10.44 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.747 ' HD1' ' HD2' ' A' ' 18' ' ' LYS . 63.1 m170 -134.25 170.21 11.88 Favored Pre-proline 0 C--N 1.311 -1.073 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.879 -175.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 31.6 Cg_exo -55.73 -26.89 58.76 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 121.951 1.767 . . . . 0.0 109.251 164.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.747 ' HD2' ' HD1' ' A' ' 16' ' ' HIS . 62.6 mttm -45.5 -38.25 6.07 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 113.95 -1.477 . . . . 0.0 112.085 172.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 41' ' ' THR . 14.0 m-85 -118.14 2.59 12.02 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -170.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.675 HG12 ' HB3' ' A' ' 39' ' ' PHE . 17.2 mt -106.45 122.53 60.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.874 0.369 . . . . 0.0 111.058 -175.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.57 -0.52 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.822 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -157.42 158.32 28.87 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.537 ' CB ' HD12 ' A' ' 63' ' ' LEU . 2.8 t80 -155.29 133.29 11.49 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.514 0.673 . . . . 0.0 110.545 -176.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.3 m -136.87 108.82 7.12 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.07 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 25' ' ' ARG . 0.4 OUTLIER -80.15 105.28 11.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.967 0.889 . . . . 0.0 110.464 -177.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.642 ' HB3' ' O ' ' A' ' 36' ' ' ALA . 0.7 OUTLIER -84.67 120.15 26.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.449 178.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.453 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 2.8 mm? -114.89 155.12 27.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.494 0.664 . . . . 0.0 112.036 -170.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.2 22.27 1.25 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.909 -175.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.453 ' ND2' ' HB3' ' A' ' 27' ' ' LEU . 7.8 p30 -127.08 -3.17 6.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -103.8 25.19 10.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.029 0.443 . . . . 0.0 110.974 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.14 -64.83 0.6 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.634 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.56 152.8 41.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.772 0.32 . . . . 0.0 111.288 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -90.97 -14.46 31.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.012 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.553 HG12 ' SG ' ' A' ' 6' ' ' CYS . 3.6 pt -111.71 140.31 31.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -110.43 126.97 54.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.314 0.578 . . . . 0.0 110.519 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.642 ' O ' ' HB3' ' A' ' 26' ' ' GLN . . . -127.11 132.01 50.69 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.683 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.424 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 47.0 mm -77.61 112.28 15.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.1 mm -90.21 97.79 7.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 122.044 -0.41 . . . . 0.0 111.087 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.675 ' HB3' HG12 ' A' ' 20' ' ' ILE . 16.7 m-85 -90.52 119.07 30.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 6.6 m-70 -89.31 115.1 26.54 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.435 ' C ' ' H ' ' A' ' 43' ' ' LYS . 15.0 p -84.86 159.47 20.37 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.774 0.797 . . . . 0.0 112.509 -171.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -67.9 -0.7 4.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.055 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 41' ' ' THR . 67.6 mttm -98.61 20.62 12.57 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.68 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt 67.9 22.64 8.6 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.58 175.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.32 173.65 8.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.724 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 40' ' ' HIS . 49.1 m -127.75 122.3 32.47 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 173.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.4 t -92.01 131.51 38.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.439 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 20.6 m -82.87 82.18 8.27 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.471 ' HB2' ' CG2' ' A' ' 56' ' ' VAL . . . -72.16 141.28 49.08 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.155 -173.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.691 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -82.41 131.42 55.68 Favored Pre-proline 0 CA--C 1.508 -0.671 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.733 -175.379 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.69 15.3 1.09 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.025 1.817 . . . . 0.0 111.632 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.43 ' H ' ' C ' ' A' ' 50' ' ' ASN . 1.1 ttpp -89.82 -28.66 19.15 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.664 176.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.581 HE21 HG23 ' A' ' 56' ' ' VAL . 5.3 pt20 -105.95 138.8 41.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.746 -163.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.29 -29.81 66.65 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -173.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.626 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 46.0 p-90 -63.19 -33.76 76.17 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.421 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.581 HG23 HE21 ' A' ' 53' ' ' GLN . 2.7 t -70.17 -46.99 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.918 174.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.465 ' HA ' HG13 ' A' ' 60' ' ' VAL . 91.1 mttt -62.19 -29.06 70.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.855 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -68.19 -51.01 50.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.79 0.329 . . . . 0.0 110.419 173.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 55' ' ' TRP . 58.1 mt -68.53 -43.91 83.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.322 -175.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.532 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 14.9 p -68.22 -33.29 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.08 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -66.04 -40.19 90.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.103 0.478 . . . . 0.0 109.78 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.0 tp -66.69 -47.64 71.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.992 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.537 HD12 ' CB ' ' A' ' 23' ' ' PHE . 83.0 mt -65.5 -36.37 83.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.377 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.5 m . . . . . 0 C--N 1.32 -0.691 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.453 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.704 ' HA ' ' NE2' ' A' ' 26' ' ' GLN . 1.8 p . . . . . 0 CA--C 1.52 -0.18 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.51 ' C ' ' H ' ' A' ' 9' ' ' GLY . 73.4 m -62.84 155.39 27.1 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.609 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 pp -77.34 25.7 0.17 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.428 0.632 . . . . 0.0 110.638 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 7' ' ' CYS . . . 131.15 156.98 8.69 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -175.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.637 ' HB2' ' ND2' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -105.96 172.03 7.03 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.53 178.86 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 t -84.66 -174.96 5.56 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.032 -172.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -135.66 70.99 1.42 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 173.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -131.65 178.51 6.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.541 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.57 HD12 ' CD1' ' A' ' 55' ' ' TRP . 5.2 mm -124.51 94.79 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.374 167.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.511 HD12 ' CH2' ' A' ' 55' ' ' TRP . 1.1 mt -106.75 158.08 17.24 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.877 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.795 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 26.4 m170 -132.19 178.81 1.58 Allowed Pre-proline 0 C--N 1.314 -0.969 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.716 -173.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.795 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 9.4 Cg_endo -55.42 -20.32 25.64 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.281 1.987 . . . . 0.0 110.046 164.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.649 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 22.0 mtpp -47.16 -27.03 1.29 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.308 172.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 41' ' ' THR . 55.2 m-85 -126.15 -10.85 6.47 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.427 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.493 HD12 ' O ' ' A' ' 16' ' ' HIS . 1.5 mp -95.13 128.42 46.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.046 0.45 . . . . 0.0 111.649 -170.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -122.53 -16.96 5.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.591 172.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -145.07 162.37 28.13 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.588 ' CZ ' HG21 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -155.16 136.03 13.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.002 0.429 . . . . 0.0 111.006 -175.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.2 m -134.47 123.25 23.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.501 174.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 25' ' ' ARG . 6.6 ptp85 -91.18 91.89 8.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.612 0.72 . . . . 0.0 110.298 176.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.704 ' NE2' ' HA ' ' A' ' 6' ' ' CYS . 0.9 OUTLIER -68.76 121.61 16.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.95 179.2 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.7 mt -113.82 147.8 37.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.899 -168.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.83 46.84 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.159 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -139.32 -29.49 0.75 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.244 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -90.56 28.62 1.45 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -168.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.32 -37.99 2.7 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.74 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.7 m -91.14 158.56 16.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.856 0.36 . . . . 0.0 110.735 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -110.45 -12.39 14.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.539 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.509 ' O ' HG13 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -105.93 133.42 50.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 174.119 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -108.54 136.84 47.48 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.929 0.395 . . . . 0.0 110.872 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 26' ' ' GLN . . . -140.19 140.19 35.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.94 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 45.8 mm -79.94 101.95 5.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -87.03 98.33 7.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 O-C-N 121.87 -0.519 . . . . 0.0 110.747 -176.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.522 ' HE2' HG21 ' A' ' 56' ' ' VAL . 11.3 m-85 -86.23 135.15 33.67 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -105.96 116.91 32.75 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 41.7 p -79.85 163.63 24.23 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.34 -172.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -63.57 -12.19 30.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.551 170.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -84.04 0.16 49.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.278 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 67.9 mttm 71.27 12.4 6.74 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.778 0.831 . . . . 0.0 111.368 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.7 mt -107.86 141.68 39.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.423 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.8 p -92.47 124.16 36.31 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.102 0.477 . . . . 0.0 110.721 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.4 t -105.16 134.1 47.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.43 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 69.6 m -85.32 86.2 7.39 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.582 0.706 . . . . 0.0 109.634 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.598 ' HB2' ' CG2' ' A' ' 56' ' ' VAL . . . -72.78 149.12 43.92 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.451 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.637 ' ND2' ' HB2' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -83.48 151.76 62.74 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.865 -172.295 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -88.91 32.16 0.39 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.263 1.975 . . . . 0.0 113.771 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.671 ' O ' ' HE3' ' A' ' 57' ' ' LYS . 50.9 mtpt -132.25 -61.43 0.87 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -174.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.655 HE22 ' CG2' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -56.49 143.14 36.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.55 0.691 . . . . 0.0 112.272 -179.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p -74.94 -20.49 59.67 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -172.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.57 ' CD1' HD12 ' A' ' 14' ' ' ILE . 60.4 p-90 -63.22 -32.47 73.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.068 176.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.655 ' CG2' HE22 ' A' ' 53' ' ' GLN . 1.0 OUTLIER -68.92 -46.31 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.922 174.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.671 ' HE3' ' O ' ' A' ' 52' ' ' LYS . 92.6 mttt -63.81 -24.55 67.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.573 -178.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -74.12 -49.83 22.09 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.547 174.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.446 HD11 ' O ' ' A' ' 15' ' ' LEU . 76.8 mt -65.66 -48.15 83.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.06 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.588 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 14.1 p -65.37 -29.14 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 120.579 0.228 . . . . 0.0 110.743 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.534 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 28.3 ttm180 -63.79 -43.92 94.89 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.4 mt -64.75 -43.33 93.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.69 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.493 ' HG ' ' CB ' ' A' ' 23' ' ' PHE . 3.9 mm? -57.48 -49.95 74.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.951 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.8 m . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.989 -176.461 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.829 ' HA ' ' CD ' ' A' ' 26' ' ' GLN . 30.2 p . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 121.452 0.644 . . . . 0.0 112.056 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.438 ' O ' HD11 ' A' ' 34' ' ' ILE . 74.1 m -57.0 143.2 39.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.209 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.3 mt -82.56 10.27 7.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.91 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.22 162.89 34.29 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.172 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.722 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 39.1 m-85 -116.19 -178.89 3.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.913 0.387 . . . . 0.0 110.304 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.8 t -96.0 -178.68 4.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.135 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -144.83 23.37 1.56 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.073 0.463 . . . . 0.0 110.717 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.529 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 40.6 mtt180 -109.65 -174.08 2.41 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.76 0.791 . . . . 0.0 113.001 -173.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.549 HD12 ' CD1' ' A' ' 55' ' ' TRP . 6.2 mm -117.71 77.69 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 113.598 -1.637 . . . . 0.0 107.912 167.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 13' ' ' ARG . 2.8 mm? -75.45 158.33 32.81 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.798 ' HD1' ' HD2' ' A' ' 18' ' ' LYS . 42.1 m170 -132.1 174.59 4.52 Favored Pre-proline 0 C--N 1.306 -1.285 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.857 -176.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.72 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 9.4 Cg_endo -54.52 -26.56 45.85 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.807 1.671 . . . . 0.0 108.954 166.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.798 ' HD2' ' HD1' ' A' ' 16' ' ' HIS . 67.4 mttm -46.27 -34.8 4.71 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 113.676 -1.602 . . . . 0.0 111.726 173.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -124.93 -4.6 7.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.632 0.253 . . . . 0.0 111.626 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.79 HG12 ' HB3' ' A' ' 39' ' ' PHE . 11.6 mt -102.83 114.86 43.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.071 0.462 . . . . 0.0 110.86 -173.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.9 -5.36 11.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.63 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -150.8 159.94 28.38 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.459 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 2.3 t80 -154.66 137.07 14.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.222 0.534 . . . . 0.0 110.483 -176.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.2 m -143.82 104.01 4.12 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.674 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -73.77 104.13 4.56 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.898 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.829 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 11.0 tt0 -90.14 125.88 35.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.216 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.9 mp -105.93 173.97 6.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.46 0.647 . . . . 0.0 112.156 -170.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.43 16.82 21.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.286 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -118.11 7.55 12.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.287 -173.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -119.63 37.49 4.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.174 0.511 . . . . 0.0 110.751 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.68 -62.31 0.29 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.052 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -71.64 143.75 49.66 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -97.27 9.78 41.3 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -170.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.76 HG12 ' SG ' ' A' ' 6' ' ' CYS . 4.5 pt -128.23 156.83 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 172.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -120.23 122.25 40.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.194 0.521 . . . . 0.0 111.524 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 26' ' ' GLN . . . -121.2 137.11 54.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.809 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.619 ' HB ' ' HB1' ' A' ' 49' ' ' ALA . 48.0 mm -82.6 98.56 4.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.158 0.504 . . . . 0.0 109.905 178.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.463 HG22 ' HB2' ' A' ' 46' ' ' SER . 67.0 mt -76.91 105.83 6.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.036 0.446 . . . . 0.0 111.273 -176.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.79 ' HB3' HG12 ' A' ' 20' ' ' ILE . 19.8 m-85 -96.29 119.42 34.75 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -89.01 106.09 18.2 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.429 ' C ' ' H ' ' A' ' 43' ' ' LYS . 21.9 p -72.57 164.0 27.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.645 -175.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -71.47 6.54 1.77 Allowed 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.421 0.629 . . . . 0.0 110.55 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.429 ' H ' ' C ' ' A' ' 41' ' ' THR . 63.1 tttm -101.81 9.41 40.8 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.126 173.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 68.41 14.07 9.09 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.663 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.5 mt -103.05 131.48 50.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.051 0.453 . . . . 0.0 110.699 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.463 ' HB2' HG22 ' A' ' 38' ' ' ILE . 5.7 p -80.58 102.54 9.85 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.541 177.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 77.8 t -84.93 124.03 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.743 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.8 m -88.82 90.58 8.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.739 0.781 . . . . 0.0 109.496 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.619 ' HB1' ' HB ' ' A' ' 37' ' ' ILE . . . -70.87 134.82 47.62 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.818 -174.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.722 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -70.26 129.15 90.8 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.22 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.39 -6.5 13.58 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.387 2.058 . . . . 0.0 112.676 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -76.43 -37.56 56.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.777 0.799 . . . . 0.0 111.254 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.611 HE21 HG23 ' A' ' 56' ' ' VAL . 7.0 mt-30 -72.79 134.96 45.16 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.862 -164.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.22 -26.62 60.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.861 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.549 ' CD1' HD12 ' A' ' 14' ' ' ILE . 55.8 p-90 -65.31 -32.45 74.1 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 173.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.611 HG23 HE21 ' A' ' 53' ' ' GLN . 43.2 t -70.04 -50.5 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.829 173.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 96.5 mttt -59.3 -28.08 66.46 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.696 0.622 . . . . 0.0 111.281 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -71.06 -56.86 5.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.7 0.286 . . . . 0.0 110.309 173.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.656 HG22 HD21 ' A' ' 63' ' ' LEU . 81.9 mt -60.19 -45.95 95.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 -177.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 56' ' ' VAL . 9.8 p -70.3 -26.42 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.362 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -60.55 -43.11 97.6 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 174.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.2 mt -72.78 -41.2 65.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.489 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.656 HD21 HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -62.31 -46.4 88.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.348 -0.387 . . . . 0.0 112.043 -179.017 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 p . . . . . 0 C--N 1.323 -0.586 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -173.21 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.559 ' HB3' ' HG2' ' A' ' 26' ' ' GLN . 30.1 p . . . . . 0 N--CA 1.444 -0.754 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.8 t -50.74 114.14 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.607 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.1 mt -90.45 17.92 6.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.662 -176.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.54 113.39 0.7 Allowed Glycine 0 C--O 1.225 -0.415 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.75 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 33.6 m-85 -85.27 168.68 14.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.126 0.489 . . . . 0.0 111.239 -173.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.569 HG23 ' HA ' ' A' ' 49' ' ' ALA . 11.1 t -86.75 -177.48 6.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.938 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -141.23 16.57 2.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.935 -177.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.534 ' HB3' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -104.76 175.16 5.58 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.213 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.547 HD11 ' CD1' ' A' ' 55' ' ' TRP . 2.8 mm -110.34 90.07 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 113.813 -1.539 . . . . 0.0 108.173 161.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.583 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 2.5 mm? -88.97 167.2 13.39 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.597 ' O ' HD13 ' A' ' 20' ' ' ILE . 63.2 m170 -133.07 167.83 21.01 Favored Pre-proline 0 C--N 1.314 -0.947 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.0 -175.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.638 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 22.8 Cg_endo -63.42 -19.07 67.29 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.121 1.881 . . . . 0.0 109.214 165.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.594 ' HD2' ' HD1' ' A' ' 16' ' ' HIS . 85.6 mttt -55.35 -24.66 30.47 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.417 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 41' ' ' THR . 50.2 m-85 -128.29 2.53 5.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.946 -175.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.638 ' HB ' ' HA ' ' A' ' 17' ' ' PRO . 1.0 OUTLIER -100.85 122.78 53.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.098 0.475 . . . . 0.0 110.587 -175.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.03 -9.96 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.67 175.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -148.43 161.28 28.6 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.41 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.539 ' CE2' HG23 ' A' ' 60' ' ' VAL . 1.8 t80 -156.05 134.01 11.25 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -176.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.498 HG22 ' OE1' ' A' ' 26' ' ' GLN . 22.9 m -141.02 112.69 7.58 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.399 176.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 11.7 ttp180 -101.73 117.65 35.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.936 0.398 . . . . 0.0 111.202 -176.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.559 ' HG2' ' HB3' ' A' ' 6' ' ' CYS . 1.2 mp0 -97.75 139.01 34.26 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.806 174.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.522 HD11 ' HG3' ' A' ' 30' ' ' GLU . 5.2 mp -124.64 159.54 30.53 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 123.628 0.58 . . . . 0.0 109.767 -177.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.719 ' HA ' ' O ' ' A' ' 32' ' ' CYS . . . -77.01 1.08 18.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.818 0.818 . . . . 0.0 110.722 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -116.44 2.77 13.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.619 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.522 ' HG3' HD11 ' A' ' 27' ' ' LEU . 7.1 mm-40 -107.48 -8.75 16.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.849 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.12 -56.74 0.47 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.154 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.719 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 9.5 t -57.99 151.07 19.24 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 122.88 0.472 . . . . 0.0 109.98 174.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -84.39 -21.74 30.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.092 0.472 . . . . 0.0 109.911 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.415 HG13 ' SG ' ' A' ' 6' ' ' CYS . 46.9 pt -110.41 -171.46 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 173.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -138.86 119.29 13.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.445 0.64 . . . . 0.0 110.477 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.74 137.53 53.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.055 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 15.5 mm -96.47 92.32 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.217 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 40.5 mt -79.63 101.16 4.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.852 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.471 ' CE1' ' HD2' ' A' ' 23' ' ' PHE . 20.8 m-85 -85.13 131.2 34.48 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 171.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -100.02 107.89 19.94 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 41.1 p -71.14 159.21 35.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.762 -174.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -3.08 12.28 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.576 0.703 . . . . 0.0 109.642 171.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -90.97 1.22 57.22 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.112 174.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 70.42 16.32 7.13 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.638 -1.164 . . . . 0.0 112.057 173.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.8 mt -107.2 136.56 46.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.825 175.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.8 p -84.47 120.82 26.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.062 0.458 . . . . 0.0 110.477 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 91.0 t -104.2 124.36 58.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.962 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.5 m -85.53 82.79 8.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.661 0.743 . . . . 0.0 109.385 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.575 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -69.64 143.55 53.19 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.034 -173.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.75 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -81.29 128.33 70.72 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.924 -176.046 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -71.19 13.49 0.4 Allowed 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.761 2.308 . . . . 0.0 112.303 173.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 50' ' ' ASN . 55.6 mtpt -99.47 -23.94 14.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.172 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.53 HE21 HG23 ' A' ' 56' ' ' VAL . 5.0 pt20 -102.63 145.77 29.16 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.737 -167.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.3 -30.83 63.66 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.638 -171.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.583 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 42.6 p-90 -63.34 -32.87 74.41 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.368 177.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.575 ' CG2' ' HB1' ' A' ' 49' ' ' ALA . 8.6 t -72.09 -46.14 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.38 174.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.491 ' HA ' HG11 ' A' ' 60' ' ' VAL . 88.6 mttt -60.5 -34.65 74.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.903 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -64.37 -50.07 69.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.395 174.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 55' ' ' TRP . 68.0 mt -68.88 -45.96 79.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.481 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.539 HG23 ' CE2' ' A' ' 23' ' ' PHE . 12.8 p -65.65 -35.35 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.89 -0.141 . . . . 0.0 111.297 -178.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -65.39 -33.84 76.89 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 30.6 tp -74.64 -38.1 62.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.236 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.446 ' HG ' ' CB ' ' A' ' 23' ' ' PHE . 2.8 mm? -69.52 -26.17 64.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.55 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.1 p . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 121.322 0.582 . . . . 0.0 110.25 175.948 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.699 ' SG ' HG12 ' A' ' 34' ' ' ILE . 19.6 p . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.0 t -62.63 152.69 34.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.328 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.9 mt -74.97 2.14 11.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.45 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.13 -153.92 12.31 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.81 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 64.0 m-85 -137.37 -171.47 2.98 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.516 HG22 ' CG1' ' A' ' 47' ' ' VAL . 11.2 t -127.19 136.88 52.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.075 0.464 . . . . 0.0 111.045 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -101.97 56.65 0.81 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.822 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.548 ' NE ' ' HA ' ' A' ' 13' ' ' ARG . 3.3 mmp_? -122.65 -177.16 3.57 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.517 0.675 . . . . 0.0 112.088 -177.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.606 HD11 ' CD1' ' A' ' 55' ' ' TRP . 3.5 mm -125.4 87.2 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 114.228 -1.351 . . . . 0.0 107.789 167.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.588 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.8 mm? -88.14 161.0 17.53 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.714 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 48.4 m170 -131.77 174.8 4.28 Favored Pre-proline 0 C--N 1.31 -1.115 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.275 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.714 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 10.1 Cg_endo -56.05 -23.22 42.83 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.8 1.667 . . . . 0.0 108.99 167.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.659 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 9.5 mmmt -47.35 -26.59 1.32 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 113.541 -1.663 . . . . 0.0 112.245 173.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.443 ' O ' ' HA ' ' A' ' 41' ' ' THR . 86.4 m-85 -126.86 -11.35 6.03 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 122.195 -0.316 . . . . 0.0 111.682 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.564 HG13 ' HB3' ' A' ' 39' ' ' PHE . 1.4 mp -89.65 122.59 41.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.062 0.458 . . . . 0.0 110.988 -171.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.53 -8.07 8.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.769 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -154.19 155.59 26.28 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.709 ' HB2' HD11 ' A' ' 63' ' ' LEU . 2.4 t80 -147.67 137.54 22.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.908 0.385 . . . . 0.0 110.278 -177.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 50.3 m -145.22 110.58 5.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.577 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -83.9 139.3 32.7 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.619 ' NE2' ' HA ' ' A' ' 6' ' ' CYS . 1.9 pt20 -119.26 108.41 14.6 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.784 0.802 . . . . 0.0 110.704 177.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 86.2 mt -98.24 165.04 12.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.958 -175.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.791 ' HA ' ' O ' ' A' ' 32' ' ' CYS . . . -82.7 11.31 6.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.586 -177.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -108.58 -19.87 13.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.839 0.352 . . . . 0.0 111.73 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -134.39 30.77 3.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.118 0.485 . . . . 0.0 111.769 -170.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.72 -86.83 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 119.933 -1.127 . . . . 0.0 113.119 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.791 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 42.2 t -105.64 170.11 8.08 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.572 -0.314 . . . . 0.0 110.904 -175.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.402 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 9.5 m-20 -83.59 -21.87 32.47 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.096 0.247 . . . . 0.0 111.618 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.699 HG12 ' SG ' ' A' ' 6' ' ' CYS . 2.0 pt -100.0 157.33 3.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -115.26 130.54 56.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.367 0.603 . . . . 0.0 111.246 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.59 ' HB1' ' OE1' ' A' ' 26' ' ' GLN . . . -139.08 166.46 24.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.597 175.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 43.5 mm -113.88 106.19 20.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.161 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 66.0 mt -83.64 105.08 12.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 O-C-N 121.734 -0.603 . . . . 0.0 111.238 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.564 ' HB3' HG13 ' A' ' 20' ' ' ILE . 14.0 m-85 -94.96 111.85 23.61 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 171.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -84.45 112.98 20.86 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 28.2 p -76.33 166.01 24.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.128 0.49 . . . . 0.0 111.123 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -71.14 2.97 3.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.617 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.425 ' H ' ' C ' ' A' ' 41' ' ' THR . 36.0 mmtp -98.82 5.64 47.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.568 176.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 67.2 mttm 68.42 12.58 8.77 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.805 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.5 mt -97.82 130.65 44.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.022 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.4 p -86.66 106.64 17.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.298 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.516 ' CG1' HG22 ' A' ' 11' ' ' THR . 66.4 t -86.82 124.93 40.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.9 m -88.61 83.89 6.76 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.718 0.771 . . . . 0.0 109.985 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.556 ' HB2' ' CG2' ' A' ' 56' ' ' VAL . . . -69.82 141.59 53.27 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.397 -175.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.81 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -80.53 130.21 65.72 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.083 -179.075 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -73.2 23.47 0.31 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.831 1.688 . . . . 0.0 111.666 171.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 50' ' ' ASN . 32.2 mtmm -115.24 -17.21 11.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.547 -176.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.526 HE21 HG22 ' A' ' 56' ' ' VAL . 5.8 pt20 -109.5 145.23 36.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 -170.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.679 ' HA ' ' HG2' ' A' ' 57' ' ' LYS . 1.3 p -81.5 -23.1 37.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -170.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.606 ' CD1' HD11 ' A' ' 14' ' ' ILE . 54.9 p-90 -63.19 -32.83 74.33 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 173.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.556 ' CG2' ' HB2' ' A' ' 49' ' ' ALA . 25.3 t -69.16 -46.98 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.792 172.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.679 ' HG2' ' HA ' ' A' ' 54' ' ' THR . 6.9 mmtp -55.89 -38.47 70.22 Favored 'General case' 0 C--O 1.222 -0.383 0 O-C-N 123.426 0.454 . . . . 0.0 110.737 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -65.22 -53.81 38.93 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.707 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.516 HG22 HD12 ' A' ' 63' ' ' LEU . 78.9 mt -62.74 -45.71 98.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.874 -177.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.548 HG11 ' O ' ' A' ' 56' ' ' VAL . 12.5 p -70.02 -24.9 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 120.911 -0.315 . . . . 0.0 110.903 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 49.8 ttp180 -64.45 -35.14 79.95 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.16 0.505 . . . . 0.0 110.256 176.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.6 mt -84.42 -25.22 29.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.968 177.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.709 HD11 ' HB2' ' A' ' 23' ' ' PHE . 77.5 mt -87.68 -31.28 19.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.307 -176.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 121.215 0.531 . . . . 0.0 109.74 178.074 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.791 ' HA ' ' CD ' ' A' ' 26' ' ' GLN . 26.6 p . . . . . 0 C--O 1.231 0.118 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.476 ' O ' HD13 ' A' ' 34' ' ' ILE . 43.1 t -73.03 127.75 33.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.088 171.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.7 mt -81.93 45.34 0.9 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.146 0.498 . . . . 0.0 110.742 -174.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 166.26 157.65 10.37 Favored Glycine 0 N--CA 1.44 -1.048 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.812 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 25.2 m-85 -123.87 162.33 23.5 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 117.159 0.479 . . . . 0.0 110.488 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.5 t -90.18 -175.58 4.58 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.404 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -144.78 31.18 1.17 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.553 0.692 . . . . 0.0 109.813 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.534 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 35.2 mmt180 -87.68 -176.6 5.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.714 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.489 HD11 ' CD1' ' A' ' 55' ' ' TRP . 16.4 mm -124.93 77.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.654 165.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.745 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.2 mm? -74.76 153.7 38.68 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.057 -178.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.706 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 42.9 m170 -132.66 173.63 5.66 Favored Pre-proline 0 C--N 1.317 -0.847 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.622 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.706 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 13.0 Cg_endo -58.86 -23.84 69.33 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 121.718 1.612 . . . . 0.0 108.825 167.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 8.7 mmmt -47.22 -34.4 6.38 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 113.434 -1.712 . . . . 0.0 111.931 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.672 ' HA ' ' HE3' ' A' ' 42' ' ' LYS . 27.0 m-85 -125.44 -0.2 7.59 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.655 0.264 . . . . 0.0 111.338 -175.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.441 HD11 ' O ' ' A' ' 16' ' ' HIS . 1.3 mp -96.46 126.75 49.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.0 0.428 . . . . 0.0 110.635 -175.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.12 -6.8 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.999 174.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -157.73 154.27 25.38 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.542 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.597 ' CZ ' HG22 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -145.02 132.99 21.29 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.477 0.656 . . . . 0.0 110.386 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.7 m -132.93 121.06 22.27 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.469 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -86.68 114.03 23.04 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.508 0.671 . . . . 0.0 110.412 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.791 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 21.6 tt0 -104.27 121.91 44.31 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.876 177.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.5 mp -109.31 178.65 4.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.946 -170.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -111.52 26.58 10.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.922 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -130.7 -12.82 3.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.489 -175.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -115.05 23.51 12.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.462 -174.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.42 -91.79 0.11 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.358 177.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 6' ' ' CYS . 18.5 m -66.16 169.56 6.89 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.997 0.427 . . . . 0.0 111.976 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -99.22 -6.02 28.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.089 176.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.476 HD13 ' O ' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -108.61 153.41 10.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 174.561 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.501 ' OD1' ' HG2' ' A' ' 51' ' ' PRO . 4.8 p30 -127.09 129.64 48.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.801 -0.181 . . . . 0.0 111.28 -173.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.753 ' O ' ' HB3' ' A' ' 26' ' ' GLN . . . -134.68 127.37 30.93 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.244 0.545 . . . . 0.0 111.962 176.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.3 mm -70.05 117.61 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 170.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 55.8 mt -94.42 104.41 15.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 120.834 0.349 . . . . 0.0 111.117 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.672 ' CE2' HG12 ' A' ' 56' ' ' VAL . 12.1 m-85 -93.98 127.73 39.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 173.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -98.03 108.81 21.6 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.1 p -74.0 160.15 31.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.068 -174.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.672 ' HE3' ' HA ' ' A' ' 19' ' ' PHE . 18.0 ptpt -66.07 -3.03 4.71 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.317 172.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -89.66 0.54 56.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.633 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.722 ' HB2' ' HZ2' ' A' ' 44' ' ' LYS . 8.3 mtmp? 71.89 15.6 5.69 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.981 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.0 mt -107.88 136.66 47.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.904 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.1 p -87.16 118.57 26.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.301 0.572 . . . . 0.0 110.007 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 76.5 t -97.24 134.05 36.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.083 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.3 m -89.12 87.44 7.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.429 ' HB1' ' CG1' ' A' ' 56' ' ' VAL . . . -79.49 143.07 35.25 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.409 -174.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.812 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -82.53 122.19 78.6 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.524 -174.2 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.501 ' HG2' ' OD1' ' A' ' 35' ' ' ASN . 19.8 Cg_exo -70.18 9.8 0.62 Allowed 'Trans proline' 0 C--N 1.329 -0.479 0 C-N-CA 122.279 1.986 . . . . 0.0 112.368 175.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.429 ' H ' ' C ' ' A' ' 50' ' ' ASN . 51.3 mttm -104.33 -14.27 15.83 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.406 -176.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.739 ' CG ' ' HB2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -89.53 168.13 12.42 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -176.454 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.23 -33.51 14.65 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.745 ' CZ3' ' HB2' ' A' ' 15' ' ' LEU . 59.3 p-90 -62.19 -28.58 69.77 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.823 -177.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.672 HG12 ' CE2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -71.04 -49.91 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 174.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 93.9 mttt -55.03 -33.85 63.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.687 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -64.37 -52.67 57.12 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.211 0.529 . . . . 0.0 110.486 174.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 15' ' ' LEU . 87.7 mt -65.85 -48.96 80.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.74 -176.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.597 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 7.8 p -65.53 -28.37 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.836 0.35 . . . . 0.0 110.754 -176.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -69.03 -35.43 76.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.212 0.53 . . . . 0.0 109.672 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.4 tp -79.02 -32.63 45.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.995 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.468 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 1.9 mm? -67.63 -42.5 82.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.275 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.7 p . . . . . 0 C--N 1.323 -0.545 0 CA-C-O 120.894 0.378 . . . . 0.0 110.901 -179.969 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.756 ' HB2' HG12 ' A' ' 34' ' ' ILE . 18.7 p . . . . . 0 N--CA 1.441 -0.892 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.1 t -106.54 158.37 16.97 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.927 -0.483 . . . . 0.0 110.425 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.7 mt -77.73 -27.94 50.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.933 0.397 . . . . 0.0 110.828 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.83 136.3 4.08 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.768 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 20.1 m-85 -78.47 173.63 12.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.486 0.66 . . . . 0.0 111.047 -177.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.8 t -89.02 -178.55 5.72 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.94 174.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -140.63 1.86 1.76 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.011 0.434 . . . . 0.0 110.169 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.601 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 32.7 mtt180 -94.23 -172.42 2.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.641 -166.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.606 HD11 ' CD1' ' A' ' 55' ' ' TRP . 3.3 mm -117.64 88.79 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.599 -1.182 . . . . 0.0 107.982 167.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.601 ' CD2' ' HB2' ' A' ' 13' ' ' ARG . 2.9 mm? -88.34 164.77 15.39 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.926 ' HD1' ' HD2' ' A' ' 18' ' ' LYS . 63.2 m170 -132.97 163.63 49.66 Favored Pre-proline 0 C--N 1.311 -1.105 0 C-N-CA 119.831 -0.748 . . . . 0.0 112.151 -174.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.621 ' HD3' HG12 ' A' ' 59' ' ' ILE . 26.7 Cg_endo -64.28 -17.18 58.75 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.213 1.942 . . . . 0.0 109.174 167.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.926 ' HD2' ' HD1' ' A' ' 16' ' ' HIS . 60.8 mttm -51.66 -29.23 17.14 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.361 172.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -128.01 11.37 6.55 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.62 -174.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.624 HG12 ' O ' ' A' ' 16' ' ' HIS . 7.5 mm -106.69 127.64 62.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -173.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.3 m -118.56 -3.49 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.146 0.498 . . . . 0.0 110.934 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -155.29 158.91 28.76 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.004 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.703 ' HB2' HD12 ' A' ' 63' ' ' LEU . 1.4 t80 -155.47 134.68 12.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.239 0.542 . . . . 0.0 110.183 -177.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.427 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 25.5 m -142.06 107.08 4.93 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.867 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 25' ' ' ARG . 14.1 ptp180 -77.02 109.03 10.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.827 0.822 . . . . 0.0 110.112 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.576 ' OE1' ' HB1' ' A' ' 36' ' ' ALA . 2.4 tt0 -99.05 133.11 43.79 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.218 -175.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.0 mt -122.18 158.9 28.36 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -159.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.72 31.24 4.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.737 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -99.41 -73.42 0.63 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.745 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -110.9 23.12 14.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.574 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -129.53 -71.93 0.13 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.345 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 47.3 t -128.63 -172.08 2.62 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.441 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 0.9 OUTLIER -96.85 -23.55 16.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.957 0.408 . . . . 0.0 109.923 178.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.756 HG12 ' HB2' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -109.03 159.75 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 175.352 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -132.56 132.13 42.24 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.915 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.576 ' HB1' ' OE1' ' A' ' 26' ' ' GLN . . . -129.1 145.13 51.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.415 0.626 . . . . 0.0 111.63 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.739 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 47.9 mm -88.79 104.77 15.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.861 177.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 24' ' ' THR . 58.1 mt -79.65 103.05 6.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 O-C-N 122.108 -0.37 . . . . 0.0 111.386 -176.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -91.65 123.82 35.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 171.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -97.66 108.93 21.76 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.2 p -75.84 157.49 33.29 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.116 0.484 . . . . 0.0 111.37 -175.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -68.17 -10.33 53.44 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.426 ' HE2' ' HB2' ' A' ' 43' ' ' LYS . 23.0 ttmm -89.92 14.18 12.77 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.702 -177.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp 71.0 13.55 6.94 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.046 173.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.5 mt -112.66 142.15 45.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.968 0.413 . . . . 0.0 111.042 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.0 p -99.13 112.64 24.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.222 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.2 t -92.48 120.31 41.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.354 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.9 m -83.44 89.21 7.02 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.808 0.813 . . . . 0.0 109.269 177.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.739 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -71.18 140.33 50.47 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.387 -174.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.768 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -79.97 126.06 80.6 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.175 -179.213 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.1 13.98 0.48 Allowed 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.321 2.014 . . . . 0.0 111.613 174.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.503 ' H ' ' C ' ' A' ' 50' ' ' ASN . 74.8 mttt -100.5 -21.51 15.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.136 -175.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.565 HE21 ' CG2' ' A' ' 56' ' ' VAL . 5.8 pt20 -109.57 148.46 31.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.646 -167.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p -75.03 -33.65 61.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -170.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.606 ' CD1' HD11 ' A' ' 14' ' ' ILE . 49.7 p-90 -61.34 -32.58 72.47 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.352 0.596 . . . . 0.0 109.491 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.607 HG21 ' HB2' ' A' ' 49' ' ' ALA . 14.7 t -70.51 -51.29 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.171 174.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 95.2 mttt -58.05 -32.12 67.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.968 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -68.04 -56.37 9.15 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.395 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.621 HG12 ' HD3' ' A' ' 17' ' ' PRO . 72.5 mt -61.02 -43.34 95.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.222 -176.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.633 HG22 ' CE1' ' A' ' 23' ' ' PHE . 13.8 p -65.45 -35.03 74.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.374 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -68.63 -33.08 73.41 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.989 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 29.8 mt -77.66 -33.44 53.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.094 0.473 . . . . 0.0 110.701 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.703 HD12 ' HB2' ' A' ' 23' ' ' PHE . 78.7 mt -79.24 -12.49 59.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.989 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--N 1.32 -0.691 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.526 173.079 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.639 ' HB3' ' HG2' ' A' ' 26' ' ' GLN . 18.5 p . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.2 m -41.26 98.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 -169.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.1 mt -63.65 -37.28 86.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.548 173.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.38 85.58 0.42 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.775 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.511 ' HB2' ' ND2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -88.11 155.03 20.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.994 0.426 . . . . 0.0 111.254 177.504 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.408 HG22 HG13 ' A' ' 47' ' ' VAL . 14.9 t -91.11 141.94 28.28 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -166.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -104.58 74.57 1.16 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.68 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -123.44 -171.8 2.38 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.055 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.542 HD13 ' CD1' ' A' ' 55' ' ' TRP . 8.2 mm -126.54 91.78 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.147 165.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.623 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 1.7 mm? -98.15 162.77 13.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.78 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 34.2 m170 -132.63 175.46 3.69 Favored Pre-proline 0 C--N 1.317 -0.841 0 O-C-N 122.054 -0.404 . . . . 0.0 110.757 -178.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.78 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 18.9 Cg_endo -60.25 -16.95 43.68 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.106 1.871 . . . . 0.0 109.453 166.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 9.1 mtmt -45.91 -35.54 4.69 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 114.111 -1.404 . . . . 0.0 111.779 172.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -126.68 2.22 6.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.024 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.592 ' HB ' ' HA ' ' A' ' 17' ' ' PRO . 1.2 mp -92.44 124.32 44.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.81 0.338 . . . . 0.0 110.116 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.3 m -121.34 -1.18 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.977 0.418 . . . . 0.0 110.333 176.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.92 157.94 29.48 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.676 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.721 ' HB2' HD13 ' A' ' 63' ' ' LEU . 2.8 t80 -151.01 134.29 16.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.193 0.521 . . . . 0.0 110.564 -177.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.405 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 32.2 m -146.15 102.32 3.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.265 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -74.58 126.7 31.37 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.711 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.639 ' HG2' ' HB3' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -101.35 126.87 48.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.689 -177.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.3 mp -125.17 153.42 43.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.335 0.588 . . . . 0.0 111.712 -171.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HA ' ' C ' ' A' ' 32' ' ' CYS . . . -64.57 -23.58 67.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.328 174.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.409 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.9 OUTLIER -67.38 -24.87 65.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.366 -176.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -102.72 -32.62 9.76 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.866 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.38 41.24 0.02 OUTLIER Glycine 0 C--O 1.221 -0.682 0 C-N-CA 119.998 -1.096 . . . . 0.0 112.306 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 53.8 t -133.8 -179.71 5.71 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 173.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -118.23 -32.18 4.77 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.974 169.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.5 pt -95.75 -156.58 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 169.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -150.93 137.36 18.63 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.115 0.483 . . . . 0.0 110.132 174.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.49 145.11 33.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.071 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.783 ' HB ' ' HB1' ' A' ' 49' ' ' ALA . 46.4 mm -93.57 108.25 20.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 24' ' ' THR . 33.6 mm -85.91 99.03 7.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 O-C-N 121.982 -0.449 . . . . 0.0 110.636 -177.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.433 ' HB3' HG13 ' A' ' 20' ' ' ILE . 17.1 m-85 -90.59 122.9 33.8 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 174.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -93.6 107.35 19.22 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.5 p -79.36 164.58 23.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.119 0.485 . . . . 0.0 111.698 -174.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -72.86 -1.63 17.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 122.151 0.976 . . . . 0.0 108.59 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.409 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 12.6 tptt -86.14 9.0 18.71 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.505 173.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.8 pttm 46.89 34.04 2.48 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.455 1.102 . . . . 0.0 111.686 -173.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 43' ' ' LYS . 94.0 mt -119.47 131.13 55.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.072 175.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.9 p -84.9 105.69 15.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.382 0.611 . . . . 0.0 110.651 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.408 HG13 HG22 ' A' ' 11' ' ' THR . 54.3 t -79.62 126.28 39.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.601 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 58.8 m -84.67 88.86 7.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.783 ' HB1' ' HB ' ' A' ' 37' ' ' ILE . . . -76.72 134.67 39.14 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.629 -176.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.587 ' N ' HD21 ' A' ' 50' ' ' ASN . 0.7 OUTLIER -77.35 134.99 66.01 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.106 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -74.25 7.29 2.62 Favored 'Trans proline' 0 C--N 1.33 -0.398 0 C-N-CA 122.502 2.135 . . . . 0.0 110.614 168.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.465 ' H ' ' C ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -90.3 -17.48 27.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.265 -177.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.525 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 6.2 pt20 -118.83 150.72 39.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.859 -168.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.73 ' HA ' ' HG2' ' A' ' 57' ' ' LYS . 1.7 p -91.45 -17.75 25.27 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -170.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.623 ' CZ3' ' HB2' ' A' ' 15' ' ' LEU . 58.1 p-90 -63.62 -32.8 74.38 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 172.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 49' ' ' ALA . 38.9 t -66.52 -47.28 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.839 171.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.73 ' HG2' ' HA ' ' A' ' 54' ' ' THR . 13.4 mmtp -54.45 -39.0 66.98 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.168 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.495 ' HD1' HH21 ' A' ' 61' ' ' ARG . 5.8 t80 -67.41 -53.69 26.94 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.087 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.54 HG21 HD11 ' A' ' 63' ' ' LEU . 71.0 mt -61.34 -45.16 99.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.954 -176.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.539 HG11 ' O ' ' A' ' 56' ' ' VAL . 12.0 p -70.15 -23.47 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 120.784 0.326 . . . . 0.0 110.688 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.495 HH21 ' HD1' ' A' ' 58' ' ' TYR . 43.5 ttp180 -66.46 -29.64 69.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.136 0.493 . . . . 0.0 110.113 175.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.3 mp -87.58 -36.74 17.37 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.599 174.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.721 HD13 ' HB2' ' A' ' 23' ' ' PHE . 91.0 mt -81.8 2.12 31.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.646 -176.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 120.701 0.286 . . . . 0.0 111.054 175.045 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.653 ' HA ' ' CD ' ' A' ' 26' ' ' GLN . 22.0 p . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 37.7 m -74.96 148.26 40.14 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.211 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.6 mt -70.69 -9.26 56.75 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.153 0.501 . . . . 0.0 110.681 176.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.62 160.27 28.53 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.89 ' HB2' HD21 ' A' ' 50' ' ' ASN . 0.3 OUTLIER -113.65 158.62 20.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.716 0.258 . . . . 0.0 110.846 177.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 t -88.94 145.56 25.45 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -168.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -95.12 66.2 2.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.662 0.744 . . . . 0.0 109.46 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.479 ' C ' HD11 ' A' ' 14' ' ' ILE . 36.2 mtp180 -130.85 -178.08 4.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.523 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.56 HG22 ' CD2' ' A' ' 16' ' ' HIS . 2.4 mp -121.89 91.39 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 163.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.527 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 3.5 mm? -72.14 155.87 39.79 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.031 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.717 ' HB2' ' HG2' ' A' ' 18' ' ' LYS . 65.5 m170 -131.64 159.22 72.83 Favored Pre-proline 0 C--N 1.315 -0.898 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.905 -168.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.51 -30.47 74.12 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.553 2.169 . . . . 0.0 109.882 167.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.717 ' HG2' ' HB2' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -62.95 -18.32 63.02 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.226 178.353 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -118.84 -13.3 9.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.582 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.5 HG12 ' HB3' ' A' ' 39' ' ' PHE . 23.4 mt -97.83 127.43 50.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.025 0.44 . . . . 0.0 111.249 -172.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.9 p -111.61 -16.81 8.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.419 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.48 150.89 21.85 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.584 -0.607 . . . . 0.0 111.584 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.549 ' CZ ' HG22 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -134.15 134.79 42.58 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.253 0.549 . . . . 0.0 110.637 -178.461 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.412 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 20.6 m -139.86 112.61 7.99 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.099 175.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 25' ' ' ARG . 9.0 ptp180 -75.78 130.27 38.36 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.014 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.653 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -101.03 127.02 47.74 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.898 179.161 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.2 mp -117.86 169.13 9.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.854 0.359 . . . . 0.0 111.125 -170.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.7 29.72 1.12 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.615 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -127.25 -53.9 1.38 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.251 -174.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -83.82 36.38 0.55 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.189 0.518 . . . . 0.0 111.707 -172.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.88 -96.28 0.16 Allowed Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.312 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 42.2 t -70.77 160.83 31.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.496 -0.352 . . . . 0.0 110.772 -178.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -92.36 0.39 57.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.597 -177.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.452 HG12 ' SG ' ' A' ' 6' ' ' CYS . 3.4 pt -116.2 167.91 8.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -132.79 136.94 46.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.973 0.416 . . . . 0.0 111.556 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.469 ' HA ' ' HG3' ' A' ' 51' ' ' PRO . . . -138.56 164.78 28.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.634 172.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.677 ' HB ' ' HB1' ' A' ' 49' ' ' ALA . 49.9 mm -96.9 112.06 28.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.432 HD13 HE21 ' A' ' 26' ' ' GLN . 60.2 mt -88.78 102.39 12.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 O-C-N 121.707 -0.62 . . . . 0.0 111.152 -178.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.565 ' HE2' HG23 ' A' ' 56' ' ' VAL . 6.9 m-85 -95.58 119.81 34.73 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.406 ' HE2' ' CB ' ' A' ' 24' ' ' THR . 4.8 m-70 -94.27 111.56 23.3 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.2 p -78.77 153.18 30.98 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.299 0.571 . . . . 0.0 111.41 -175.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -58.17 -17.83 21.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.742 173.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -83.94 10.45 9.78 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.214 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 74.62 7.34 4.46 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.416 0.686 . . . . 0.0 111.911 173.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.7 mt -102.9 135.74 44.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.866 0.365 . . . . 0.0 110.524 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.8 p -92.61 110.54 21.97 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.4 HG12 ' HG ' ' A' ' 15' ' ' LEU . 49.0 t -94.67 132.15 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.971 -176.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.8 m -85.85 91.26 8.29 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.759 0.79 . . . . 0.0 108.982 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.677 ' HB1' ' HB ' ' A' ' 37' ' ' ILE . . . -74.47 143.31 44.71 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.473 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.89 HD21 ' HB2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -81.38 142.3 50.27 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -174.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.469 ' HG3' ' HA ' ' A' ' 36' ' ' ALA . 5.1 Cg_exo -82.5 1.5 9.11 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.125 1.883 . . . . 0.0 112.714 176.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -98.03 -48.81 4.99 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -175.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.81 ' OE1' ' HB ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -65.14 166.99 8.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.122 0.487 . . . . 0.0 112.17 -174.647 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.97 -25.59 16.45 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -175.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.68 ' O ' HG13 ' A' ' 59' ' ' ILE . 58.7 p-90 -58.25 -34.75 70.82 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.73 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.81 ' HB ' ' OE1' ' A' ' 53' ' ' GLN . 1.1 t -69.59 -46.21 76.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.959 175.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -58.77 -31.7 68.61 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.482 0.489 . . . . 0.0 110.67 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -64.75 -51.79 60.45 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.918 172.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.68 HG13 ' O ' ' A' ' 55' ' ' TRP . 23.8 mt -61.64 -56.86 15.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.268 -176.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.686 HG11 ' O ' ' A' ' 56' ' ' VAL . 4.4 p -62.1 -25.45 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.337 -175.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -63.43 -47.29 82.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.764 0.316 . . . . 0.0 110.187 172.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.3 mt -78.0 -1.44 32.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.044 0.45 . . . . 0.0 110.872 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 3.4 mm? -96.84 -58.28 2.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.64 176.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.5 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.426 -170.578 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.604 ' SG ' HG12 ' A' ' 34' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 t -43.62 118.54 1.41 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.941 170.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.0 mt -68.25 -26.67 65.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.249 -174.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.87 140.12 12.19 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.716 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 42.6 m-85 -91.79 179.85 5.51 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.071 0.462 . . . . 0.0 110.708 -176.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.58 ' OG1' ' HG2' ' A' ' 13' ' ' ARG . 14.4 t -97.78 -172.02 2.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.931 177.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -147.6 17.38 1.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.005 0.431 . . . . 0.0 110.609 177.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.638 ' HB2' HD22 ' A' ' 15' ' ' LEU . 18.0 mmm180 -88.1 -173.61 4.32 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.379 0.609 . . . . 0.0 112.462 -171.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.554 HD12 ' CD1' ' A' ' 55' ' ' TRP . 5.2 mm -125.31 90.35 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 114.176 -1.374 . . . . 0.0 108.423 167.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.638 HD22 ' HB2' ' A' ' 13' ' ' ARG . 2.8 mm? -93.31 165.07 12.97 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 1.006 ' HD1' ' HD2' ' A' ' 18' ' ' LYS . 63.2 m170 -133.29 168.28 18.71 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.569 -175.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 14.0 Cg_endo -59.02 -24.3 72.78 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.055 1.836 . . . . 0.0 108.94 166.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 1.006 ' HD2' ' HD1' ' A' ' 16' ' ' HIS . 60.7 mttm -49.26 -33.3 12.56 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 114.011 -1.449 . . . . 0.0 111.04 171.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 41' ' ' THR . 76.5 m-85 -120.51 -0.98 10.19 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.744 -171.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.647 HG12 ' HB3' ' A' ' 39' ' ' PHE . 19.5 mt -104.68 118.86 52.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.061 0.457 . . . . 0.0 111.211 -173.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.86 -5.96 11.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.779 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -152.05 151.58 23.44 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.493 ' CZ ' HG22 ' A' ' 60' ' ' VAL . 1.1 t80 -148.99 129.8 14.2 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.137 0.494 . . . . 0.0 110.495 -177.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.5 m -131.4 126.28 34.74 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.033 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 25' ' ' ARG . 10.3 ptp180 -98.41 103.63 15.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.307 0.575 . . . . 0.0 111.09 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.591 ' OE1' ' HA ' ' A' ' 6' ' ' CYS . 13.9 mt-30 -77.77 126.65 31.18 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.254 176.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.697 ' HB3' HD21 ' A' ' 29' ' ' ASN . 34.2 mt -119.94 145.07 47.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.925 -171.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.699 ' HA ' ' O ' ' A' ' 32' ' ' CYS . . . -76.47 63.97 2.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.971 172.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.697 HD21 ' HB3' ' A' ' 27' ' ' LEU . 32.2 m-80 -135.42 -66.13 0.58 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.504 -174.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -105.9 51.48 0.75 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.249 0.547 . . . . 0.0 111.889 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.79 -58.31 0.71 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.9 173.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 1.1 t -60.7 136.46 58.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.716 0.293 . . . . 0.0 110.733 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -87.67 -30.16 20.61 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.238 -175.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.604 HG12 ' SG ' ' A' ' 6' ' ' CYS . 37.3 pt -105.55 -152.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -153.41 121.67 6.2 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 171.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . -132.9 129.11 37.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.581 -177.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 47.1 mm -81.71 113.14 20.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.771 177.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 42.8 mt -91.47 103.66 14.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.558 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.647 ' HB3' HG12 ' A' ' 20' ' ' ILE . 16.5 m-85 -87.81 113.69 23.71 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 172.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -87.95 105.71 17.63 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 58.2 p -75.51 158.49 32.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.462 0.648 . . . . 0.0 111.826 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.538 ' HD3' ' O ' ' A' ' 42' ' ' LYS . 1.9 tmtp? -60.21 -20.99 61.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.423 172.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 82.5 tttt -84.03 11.91 7.15 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.486 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 75.4 mmtt 77.87 -20.92 0.35 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.831 0.852 . . . . 0.0 112.285 174.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.6 mt -73.46 126.57 30.5 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.971 0.415 . . . . 0.0 111.192 -177.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 p -87.18 105.34 17.13 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.843 175.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 62.1 t -82.65 130.54 35.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.804 -174.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.4 m -85.62 76.46 9.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.522 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -69.43 138.12 53.27 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.032 -173.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.716 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -80.44 127.46 75.86 Favored Pre-proline 0 CA--C 1.507 -0.678 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -177.433 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.24 14.52 0.22 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.221 1.947 . . . . 0.0 111.811 172.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.556 ' H ' ' C ' ' A' ' 50' ' ' ASN . 0.4 OUTLIER -106.44 -19.07 13.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.875 -174.239 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.612 HE21 HG21 ' A' ' 56' ' ' VAL . 5.6 pt20 -105.05 140.65 37.92 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.032 -168.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 p -64.83 -36.24 83.7 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -172.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.583 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 43.9 p-90 -60.83 -32.62 72.0 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.726 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.612 HG21 HE21 ' A' ' 53' ' ' GLN . 4.8 t -73.58 -50.42 30.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.324 174.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 94.8 mttt -54.92 -36.95 65.78 Favored 'General case' 0 CA--C 1.522 -0.126 0 O-C-N 123.602 0.564 . . . . 0.0 110.421 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -65.95 -58.64 5.08 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.642 176.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 55' ' ' TRP . 78.6 mt -59.1 -48.0 88.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -175.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 56' ' ' VAL . 11.9 p -65.45 -31.62 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.992 -177.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.0 ttp85 -63.83 -41.57 97.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.847 0.356 . . . . 0.0 110.517 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.37 -29.86 42.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.138 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.453 HD12 ' CB ' ' A' ' 23' ' ' PHE . 28.5 mt -72.4 -46.46 55.13 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.558 177.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.7 t . . . . . 0 C--N 1.323 -0.576 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.373 -174.709 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.673 ' SG ' HG12 ' A' ' 34' ' ' ILE . 3.7 p . . . . . 0 N--CA 1.437 -1.105 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.422 ' O ' HD12 ' A' ' 34' ' ' ILE . 19.3 t -125.99 135.33 51.69 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 166.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 pp -65.87 -13.6 59.91 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.48 0.487 . . . . 0.0 111.873 -176.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.72 166.9 28.75 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.836 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 81.0 m-85 -119.39 -168.56 1.6 Allowed 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 176.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.465 ' H ' ' ND2' ' A' ' 50' ' ' ASN . 14.9 t -129.03 148.29 50.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.493 -178.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -107.15 62.69 0.62 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.449 ' HB3' HD22 ' A' ' 15' ' ' LEU . 15.9 mtm180 -131.25 173.18 11.31 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.1 mm -122.4 91.13 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.428 165.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.451 ' O ' ' HD2' ' A' ' 16' ' ' HIS . 2.9 mm? -88.9 167.19 13.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.521 ' HD1' ' HD2' ' A' ' 18' ' ' LYS . 63.6 m170 -132.56 166.78 26.44 Favored Pre-proline 0 C--N 1.313 -0.994 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.894 -174.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 19.5 Cg_endo -60.39 -21.96 69.52 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.852 1.701 . . . . 0.0 109.213 166.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.521 ' HD2' ' HD1' ' A' ' 16' ' ' HIS . 83.7 mttt -52.94 -27.34 18.4 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 113.938 -1.483 . . . . 0.0 111.01 172.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -125.5 2.0 7.64 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.987 -174.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.677 HG12 ' HB3' ' A' ' 39' ' ' PHE . 13.3 mt -106.93 123.66 62.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.997 0.427 . . . . 0.0 111.275 -174.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.3 m -117.09 -16.19 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.02 177.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.66 160.17 26.51 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.532 ' CZ ' HG21 ' A' ' 60' ' ' VAL . 2.0 t80 -155.7 134.03 11.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.533 0.682 . . . . 0.0 110.606 -175.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.9 m -138.02 135.65 36.11 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.801 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -116.2 117.81 31.08 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.09 0.471 . . . . 0.0 111.847 -175.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.6 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 1.1 mp0 -94.32 135.96 35.14 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 174.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.9 156.07 18.35 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.1 0.476 . . . . 0.0 111.516 -170.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.17 11.93 26.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.278 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -126.83 -58.33 1.31 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.781 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -103.12 89.31 3.38 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.918 177.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.57 -63.11 0.52 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.973 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.564 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 49.1 t -130.76 171.28 13.3 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -86.25 -20.19 28.83 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.673 HG12 ' SG ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -111.35 169.75 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 171.052 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -127.03 144.89 50.91 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 121.961 -0.462 . . . . 0.0 111.39 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.45 146.72 35.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.431 174.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.574 HG12 ' HG3' ' A' ' 51' ' ' PRO . 49.5 mm -106.96 102.4 13.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.882 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.586 HG13 HE22 ' A' ' 26' ' ' GLN . 70.0 mt -78.96 104.99 7.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.978 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.677 ' HB3' HG12 ' A' ' 20' ' ' ILE . 19.5 m-85 -88.91 120.15 30.07 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 170.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -90.25 104.85 17.38 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.4 p -74.38 161.79 29.5 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.779 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -68.18 -3.47 10.68 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.353 172.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 21.6 ttmm -95.47 8.39 43.41 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.245 176.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 31.3 mmmt 76.53 -24.17 0.23 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.244 1.018 . . . . 0.0 112.446 176.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.94 130.55 41.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.066 0.46 . . . . 0.0 111.38 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 p -86.51 108.84 18.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.185 176.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 60.9 t -91.97 128.96 43.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.434 -175.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 79.4 m -85.18 82.21 8.49 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.676 0.75 . . . . 0.0 109.143 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.499 ' HB3' ' CG2' ' A' ' 56' ' ' VAL . . . -72.45 136.79 46.08 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.091 -177.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.836 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -77.59 126.88 83.88 Favored Pre-proline 0 CA--C 1.51 -0.565 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.677 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.574 ' HG3' HG12 ' A' ' 37' ' ' ILE . 27.0 Cg_exo -63.99 -5.95 10.23 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 122.425 2.083 . . . . 0.0 111.903 177.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.469 ' O ' ' HE3' ' A' ' 57' ' ' LYS . 83.2 mttt -82.61 -29.8 29.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.634 -176.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.57 HE21 HG22 ' A' ' 56' ' ' VAL . 12.1 mt-30 -72.71 134.16 44.9 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.289 -175.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.5 -33.18 75.32 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.538 ' O ' HG13 ' A' ' 59' ' ' ILE . 49.0 p-90 -63.42 -33.11 74.83 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 175.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.57 HG22 HE21 ' A' ' 53' ' ' GLN . 8.7 t -72.67 -47.14 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.308 174.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 82.0 mttt -60.65 -28.07 68.29 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -70.1 -52.66 22.02 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.166 173.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.648 HG23 HD13 ' A' ' 20' ' ' ILE . 70.4 mt -68.03 -40.19 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.627 -176.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.532 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 15.0 p -70.44 -30.3 42.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 O-C-N 122.122 -0.361 . . . . 0.0 110.555 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -66.0 -30.66 71.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.789 0.804 . . . . 0.0 108.999 173.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.1 tp -84.12 -20.66 32.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.435 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.525 HD12 ' HB2' ' A' ' 23' ' ' PHE . 65.4 mt -108.89 4.27 23.24 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -175.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.3 t . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.457 -177.993 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.707 ' SG ' HG12 ' A' ' 34' ' ' ILE . 31.8 p . . . . . 0 N--CA 1.442 -0.833 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.427 ' O ' HD12 ' A' ' 34' ' ' ILE . 61.0 m -54.97 128.82 35.29 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.931 -176.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 pp -81.57 -14.53 56.71 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.275 0.56 . . . . 0.0 110.121 174.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.61 140.65 11.99 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.667 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.827 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 5.7 m-85 -107.07 -163.12 0.88 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.59 0.233 . . . . 0.0 110.415 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.487 HG23 ' CG1' ' A' ' 47' ' ' VAL . 4.7 t -137.46 149.99 47.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.974 0.416 . . . . 0.0 111.354 177.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -116.6 73.51 0.86 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.228 0.537 . . . . 0.0 109.783 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.521 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 57.5 mtt180 -129.23 -171.39 2.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.294 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.575 HD12 ' CD1' ' A' ' 55' ' ' TRP . 13.7 mm -125.59 78.58 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.344 168.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.555 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.6 mm? -81.7 161.86 23.21 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.834 ' HD1' ' HD3' ' A' ' 18' ' ' LYS . 65.5 m170 -133.82 162.17 59.31 Favored Pre-proline 0 C--N 1.31 -1.125 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.938 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.826 ' HD3' HG12 ' A' ' 59' ' ' ILE . 27.7 Cg_endo -64.55 -16.87 57.48 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.341 2.027 . . . . 0.0 108.746 166.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.834 ' HD3' ' HD1' ' A' ' 16' ' ' HIS . 28.8 mtpp -53.43 -21.58 6.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 113.38 -1.736 . . . . 0.0 110.966 170.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -130.31 3.74 4.72 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.642 ' HB ' ' HA ' ' A' ' 17' ' ' PRO . 3.9 mm -100.37 122.9 52.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -170.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.3 m -114.49 -10.13 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.483 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.52 158.46 27.67 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.668 ' CB ' HD13 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -156.52 134.7 11.29 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.065 0.46 . . . . 0.0 109.867 -175.686 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.409 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 30.7 m -138.4 103.23 4.84 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.495 178.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.429 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 11.5 ptm180 -78.36 89.76 4.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.785 0.802 . . . . 0.0 109.787 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.649 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 4.0 tt0 -72.46 114.92 11.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.842 -175.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 25' ' ' ARG . 97.7 mt -116.71 164.07 15.18 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.225 -171.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.62 -37.44 65.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.826 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -62.14 -19.96 63.58 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -174.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -94.1 13.89 21.67 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.76 -30.17 2.79 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.092 -1.051 . . . . 0.0 113.658 174.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 3.7 t -86.08 -168.6 2.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.18 0.514 . . . . 0.0 111.659 -177.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -120.12 -36.2 3.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.216 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.707 HG12 ' SG ' ' A' ' 6' ' ' CYS . 6.8 pt -104.75 -175.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -138.16 112.16 8.46 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.345 0.593 . . . . 0.0 111.922 -173.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.5 119.88 39.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.527 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.457 ' O ' ' HB1' ' A' ' 49' ' ' ALA . 41.3 mm -80.38 98.05 3.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.051 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.491 ' CG2' ' HB3' ' A' ' 46' ' ' SER . 23.7 mt -80.37 111.74 17.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 O-C-N 121.832 -0.542 . . . . 0.0 111.495 -174.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.437 ' HE2' HG22 ' A' ' 56' ' ' VAL . 30.3 m-85 -97.28 122.45 40.32 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 9.2 m-70 -97.66 111.36 23.67 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -176.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.5 p -71.17 163.63 27.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.099 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -66.92 -3.08 6.13 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.846 171.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -94.36 0.5 55.54 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.691 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm 78.64 -1.31 2.43 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.25 1.02 . . . . 0.0 111.496 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.4 mt -83.78 119.81 25.27 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.491 ' HB3' ' CG2' ' A' ' 38' ' ' ILE . 3.4 m -88.87 106.99 18.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.19 0.519 . . . . 0.0 109.901 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.487 ' CG1' HG23 ' A' ' 11' ' ' THR . 24.4 t -91.08 132.9 34.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.597 -175.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.8 m -88.19 91.6 8.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.749 0.785 . . . . 0.0 109.515 -178.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.634 ' HB3' HG22 ' A' ' 56' ' ' VAL . . . -76.52 146.0 38.73 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.077 -174.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.827 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -84.16 128.68 61.39 Favored Pre-proline 0 CA--C 1.512 -0.495 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.293 -177.578 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.79 6.55 1.28 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.248 1.965 . . . . 0.0 112.65 176.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 50' ' ' ASN . 49.0 mtpt -92.34 -24.7 18.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.863 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.503 HE21 HG23 ' A' ' 56' ' ' VAL . 4.8 pt20 -103.61 142.7 33.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.056 -165.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 p -65.6 -37.2 85.95 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -172.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.575 ' CD1' HD12 ' A' ' 14' ' ' ILE . 49.9 p-90 -60.49 -33.84 73.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.221 0.534 . . . . 0.0 109.752 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.634 HG22 ' HB3' ' A' ' 49' ' ' ALA . 14.2 t -70.72 -50.62 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.154 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 95.7 mttt -54.82 -37.38 66.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.378 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -67.77 -54.39 19.61 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.836 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.826 HG12 ' HD3' ' A' ' 17' ' ' PRO . 75.0 mt -62.82 -45.52 98.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.634 0.254 . . . . 0.0 111.038 -176.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.556 HG23 ' CE1' ' A' ' 23' ' ' PHE . 10.2 p -64.4 -29.22 46.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.807 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -67.59 -43.95 79.29 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.988 0.423 . . . . 0.0 110.194 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.6 mt -75.07 -32.36 61.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.816 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.668 HD13 ' CB ' ' A' ' 23' ' ' PHE . 82.7 mt -71.73 -35.95 70.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.858 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 C--N 1.326 -0.44 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 172.897 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.5 ' HA ' ' NE2' ' A' ' 26' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.4 t -66.35 128.63 36.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.467 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.6 mt -75.21 -17.94 60.25 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.196 0.31 . . . . 0.0 111.436 -176.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.31 117.58 1.39 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.285 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.733 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 1.6 m-85 -75.63 168.51 19.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.274 0.559 . . . . 0.0 109.709 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.431 ' OG1' ' HG3' ' A' ' 13' ' ' ARG . 4.8 t -94.7 -176.42 3.88 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.762 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -150.3 72.63 1.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.494 ' HB2' HD22 ' A' ' 15' ' ' LEU . 2.2 mtp180 -132.68 -179.56 5.54 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.121 -175.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.558 HD11 ' CD1' ' A' ' 55' ' ' TRP . 19.1 mm -126.4 84.33 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.014 167.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.529 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.3 mm? -89.32 161.57 16.29 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.996 ' HD1' ' HD2' ' A' ' 18' ' ' LYS . 55.3 m170 -133.95 177.96 2.0 Allowed Pre-proline 0 C--N 1.312 -1.053 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.185 -177.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.645 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 51.8 Cg_exo -53.26 -30.7 52.73 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.676 1.584 . . . . 0.0 109.272 161.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.996 ' HD2' ' HD1' ' A' ' 16' ' ' HIS . 64.6 mttm -44.42 -34.0 1.88 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.582 169.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 41' ' ' THR . 98.7 m-85 -127.16 2.15 6.45 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -173.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 16' ' ' HIS . 1.2 mp -98.12 130.47 46.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.811 0.338 . . . . 0.0 110.46 -175.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 p -124.27 -7.2 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.492 0.663 . . . . 0.0 110.199 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.02 156.9 26.5 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.803 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.928 ' HB3' HD11 ' A' ' 63' ' ' LEU . 1.9 t80 -140.7 138.08 33.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.256 0.551 . . . . 0.0 110.769 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.6 m -143.59 105.26 4.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.697 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.506 ' H ' ' NE ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -77.68 115.6 17.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.394 0.616 . . . . 0.0 111.117 -178.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.531 ' NE2' HD11 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -86.18 117.12 24.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.247 -179.174 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.778 ' HB3' HD21 ' A' ' 29' ' ' ASN . 98.2 mt -103.85 145.95 29.36 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -167.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.88 50.29 1.94 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.42 176.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.778 HD21 ' HB3' ' A' ' 27' ' ' LEU . 52.9 m-80 -127.23 -64.42 1.0 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.201 -175.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -85.55 53.4 2.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.653 0.739 . . . . 0.0 111.902 -174.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.55 -61.5 0.51 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.809 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -55.06 152.13 8.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.842 -0.679 . . . . 0.0 111.63 175.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -120.35 -5.86 9.86 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.439 ' O ' HG13 ' A' ' 34' ' ' ILE . 26.1 pt -127.85 115.75 40.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 CA-C-O 121.911 0.862 . . . . 0.0 111.069 176.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -83.55 118.2 23.64 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 121.475 -0.766 . . . . 0.0 111.442 -172.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.1 139.06 53.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.767 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.587 HG12 ' HG3' ' A' ' 51' ' ' PRO . 43.5 mm -85.48 109.89 18.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.249 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.531 HD11 ' NE2' ' A' ' 26' ' ' GLN . 42.3 mm -90.4 100.17 10.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.989 0.423 . . . . 0.0 110.814 -177.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.564 ' HE2' HG21 ' A' ' 56' ' ' VAL . 11.7 m-85 -92.22 118.53 30.96 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.882 173.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -89.03 115.19 26.4 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.465 ' C ' ' H ' ' A' ' 43' ' ' LYS . 33.1 p -82.21 162.24 22.45 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.468 0.652 . . . . 0.0 112.249 -172.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -60.32 -4.43 0.84 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.313 170.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.465 ' H ' ' C ' ' A' ' 41' ' ' THR . 75.2 mmtt -109.74 16.56 22.0 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.944 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 59.7 mttp 75.17 -21.44 0.3 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.87 0.868 . . . . 0.0 112.525 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.3 mt -68.5 118.29 11.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.868 0.366 . . . . 0.0 111.159 -173.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.2 p -79.24 101.64 8.11 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 175.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 76.3 t -83.16 132.63 30.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.456 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.0 m -85.41 74.38 10.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.863 0.839 . . . . 0.0 109.094 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HA ' HG22 ' A' ' 11' ' ' THR . . . -69.71 142.45 53.32 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.657 -175.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.733 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -84.02 127.8 65.41 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.197 -177.114 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.587 ' HG3' HG12 ' A' ' 37' ' ' ILE . 24.1 Cg_exo -64.75 3.18 0.97 Allowed 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.728 2.285 . . . . 0.0 111.824 174.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.513 ' H ' ' C ' ' A' ' 50' ' ' ASN . 57.7 mtpt -92.67 -22.7 19.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.627 -176.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.648 ' CG ' ' HB2' ' A' ' 50' ' ' ASN . 0.6 OUTLIER -93.27 134.31 35.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.536 -169.585 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 p -64.34 -32.42 74.02 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.558 ' CD1' HD11 ' A' ' 14' ' ' ILE . 47.3 p-90 -61.94 -33.32 74.05 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.638 HG22 HE21 ' A' ' 53' ' ' GLN . 14.0 t -70.34 -49.77 51.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.99 173.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.444 ' HA ' HG13 ' A' ' 60' ' ' VAL . 96.4 mttt -56.72 -35.05 68.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.26 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -66.09 -56.43 11.52 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.012 175.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 16' ' ' HIS . 86.6 mt -60.84 -48.07 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.121 -176.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.648 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 14.4 p -62.55 -31.68 52.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -177.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -62.45 -47.78 82.51 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.066 0.46 . . . . 0.0 110.039 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.86 -40.54 75.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.304 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.928 HD11 ' HB3' ' A' ' 23' ' ' PHE . 3.6 mm? -70.11 -7.62 42.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.55 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.95 178.451 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.895 0 CA-C-O 120.589 0.233 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.3 m -80.0 129.25 34.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.918 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -62.26 -55.06 32.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.072 0.463 . . . . 0.0 110.353 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.665 ' CE2' ' HG2' ' A' ' 26' ' ' GLN . 48.7 p90 -131.68 175.52 9.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.699 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -131.92 103.92 6.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.593 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.687 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 13.7 p -50.86 157.58 0.79 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 123.983 0.913 . . . . 0.0 113.379 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.0 t -52.15 118.72 3.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.787 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.2 mt -84.61 -15.75 44.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.217 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -120.88 108.8 1.43 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.738 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 17.8 m-85 -79.92 -167.49 1.29 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.263 0.554 . . . . 0.0 111.177 -173.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.5 t -125.03 170.74 10.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.973 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -133.98 77.53 1.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.516 0.674 . . . . 0.0 110.311 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.518 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 94.7 mtt180 -133.23 179.09 6.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.743 176.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.565 HD11 ' CD1' ' A' ' 55' ' ' TRP . 3.0 mm -118.29 83.46 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 164.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.594 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.5 mm? -79.42 158.88 27.26 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.691 ' HD1' ' HD2' ' A' ' 18' ' ' LYS . 54.7 m170 -131.81 175.71 3.47 Favored Pre-proline 0 C--N 1.312 -1.052 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.151 -174.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.642 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 32.5 Cg_exo -56.4 -25.51 57.84 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.747 1.631 . . . . 0.0 109.282 164.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.691 ' HD2' ' HD1' ' A' ' 16' ' ' HIS . 64.0 mttm -49.38 -31.55 9.72 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.282 175.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 41' ' ' THR . 91.0 m-85 -124.1 0.32 8.45 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.44 ' CG1' ' HB3' ' A' ' 39' ' ' PHE . 1.4 mp -105.88 130.08 57.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.077 0.465 . . . . 0.0 112.105 -173.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.1 m -123.95 -5.76 7.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.468 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.12 162.6 30.21 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.409 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.659 ' CB ' HD13 ' A' ' 63' ' ' LEU . 1.1 t80 -158.04 133.65 9.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.981 0.42 . . . . 0.0 110.413 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.6 m -135.91 120.37 18.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.938 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -93.0 137.2 32.57 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.131 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.687 ' NE2' ' HB2' ' A' ' 6' ' ' CYS . 12.9 mt-30 -120.72 121.01 37.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.749 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.4 mp -102.45 165.91 10.84 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.026 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.27 18.36 11.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.401 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -139.61 1.98 1.97 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.781 0.324 . . . . 0.0 111.62 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -99.99 -21.73 15.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.107 0.479 . . . . 0.0 110.33 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.21 -53.95 0.1 OUTLIER Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.5 t -69.03 156.89 37.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -89.63 -20.07 24.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.455 0.645 . . . . 0.0 109.788 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.428 HG12 ' SG ' ' A' ' 6' ' ' CYS . 4.6 pt -116.26 -178.68 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -129.7 129.08 43.77 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.115 0.483 . . . . 0.0 110.557 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . -141.95 132.82 25.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.118 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.555 ' HB ' ' HB1' ' A' ' 49' ' ' ALA . 46.7 mm -82.34 125.17 39.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.9 mm -98.8 101.68 12.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 O-C-N 121.969 -0.457 . . . . 0.0 110.757 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.518 ' HE2' HG23 ' A' ' 56' ' ' VAL . 18.6 m-85 -87.99 123.49 32.75 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 173.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -92.88 112.75 24.81 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 36.7 p -75.22 160.52 30.29 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.663 -176.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -71.93 5.62 2.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.476 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.452 ' H ' ' C ' ' A' ' 41' ' ' THR . 0.5 OUTLIER -106.57 12.28 29.62 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.335 176.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 68.14 19.39 9.2 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.079 174.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.8 mt -112.7 136.19 52.57 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.991 0.424 . . . . 0.0 110.925 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.6 p -84.88 115.79 22.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.623 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 83.0 t -89.12 126.6 42.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.625 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 16.5 m -83.09 81.24 8.77 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.616 0.722 . . . . 0.0 109.238 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.555 ' HB1' ' HB ' ' A' ' 37' ' ' ILE . . . -71.85 134.48 46.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.671 -175.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.738 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -80.64 124.29 82.04 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -65.62 -0.44 3.73 Favored 'Trans proline' 0 C--N 1.328 -0.537 0 C-N-CA 121.862 1.708 . . . . 0.0 111.933 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.462 ' H ' ' C ' ' A' ' 50' ' ' ASN . 51.0 mtpt -85.0 -25.46 27.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.874 -175.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.493 HE21 ' CG2' ' A' ' 56' ' ' VAL . 5.4 pt20 -103.37 145.95 29.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.7 -167.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.41 -32.59 68.58 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -171.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.594 ' CZ3' ' HB2' ' A' ' 15' ' ' LEU . 48.3 p-90 -63.48 -32.91 74.49 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.859 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.518 HG23 ' HE2' ' A' ' 39' ' ' PHE . 4.5 t -69.75 -46.95 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.314 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.744 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 65.0 mttm -58.04 -40.6 81.29 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.098 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -62.93 -53.11 59.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.188 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.443 HG22 ' CD1' ' A' ' 63' ' ' LEU . 85.0 mt -63.79 -41.06 91.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.314 -177.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.1 p -68.44 -25.62 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.132 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.744 ' HG2' ' O ' ' A' ' 57' ' ' LYS . 1.3 mmp_? -66.43 -45.19 80.71 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 122.007 -0.433 . . . . 0.0 109.999 174.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.9 mt -68.72 -36.42 78.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.821 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.659 HD13 ' CB ' ' A' ' 23' ' ' PHE . 81.3 mt -72.3 -18.54 61.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.92 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 m -94.47 -11.37 29.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.816 0.341 . . . . 0.0 110.969 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -119.91 47.07 1.81 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.764 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.431 ' HE2' ' HB3' ' A' ' 66' ' ' LYS . 39.9 mtpt -75.98 77.92 2.85 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.705 173.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.6 p -87.37 133.59 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.421 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -79.86 88.42 5.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.395 0.617 . . . . 0.0 111.295 -175.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -95.93 -43.81 7.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.436 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 52.9 ttm . . . . . 0 C--O 1.248 1.011 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.861 -177.866 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.96 0.409 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 m -114.13 106.35 14.28 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -61.25 -52.17 65.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.29 0.567 . . . . 0.0 109.941 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -132.23 -174.21 3.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.591 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -133.57 115.31 14.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.147 171.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.737 ' SG ' HG12 ' A' ' 34' ' ' ILE . 20.8 p -46.37 150.8 0.6 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.999 172.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 55.8 m -61.36 117.65 5.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.684 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.3 mt -68.82 -16.55 63.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.292 0.568 . . . . 0.0 110.242 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.1 88.17 0.19 Allowed Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.121 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.445 ' HB2' ' ND2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -74.39 157.31 35.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.111 0.482 . . . . 0.0 110.533 174.583 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 48' ' ' CYS . 15.1 t -82.3 159.34 23.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -164.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -118.54 74.23 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.51 ' HB2' HD23 ' A' ' 15' ' ' LEU . 1.8 mmp_? -131.65 178.53 6.67 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.586 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.544 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.9 mm -121.6 84.46 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.237 161.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.545 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 1.9 mm? -84.59 167.58 16.15 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 175.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 1.011 ' HD1' ' HD2' ' A' ' 18' ' ' LYS . 63.5 m170 -133.04 168.14 19.45 Favored Pre-proline 0 C--N 1.311 -1.088 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.689 -175.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 17.3 Cg_endo -59.49 -23.05 69.1 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.316 2.011 . . . . 0.0 109.207 165.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 1.011 ' HD2' ' HD1' ' A' ' 16' ' ' HIS . 65.1 mttm -49.53 -27.68 4.67 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 113.846 -1.525 . . . . 0.0 111.628 170.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -124.99 -1.46 7.8 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -172.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.531 HD13 HG23 ' A' ' 59' ' ' ILE . 27.7 mt -105.99 124.64 61.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.838 0.351 . . . . 0.0 111.544 -173.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.2 m -121.13 0.69 7.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.002 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.99 158.7 30.0 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.587 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.572 ' CZ ' HG21 ' A' ' 60' ' ' VAL . 2.1 t80 -153.24 134.31 14.05 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.346 0.593 . . . . 0.0 110.93 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.9 m -141.95 112.56 7.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.495 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -80.29 103.08 9.91 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.961 0.41 . . . . 0.0 110.381 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.562 ' NE2' ' HA ' ' A' ' 6' ' ' CYS . 8.5 tt0 -74.27 126.11 29.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.045 -177.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.481 ' HB3' HD21 ' A' ' 29' ' ' ASN . 87.8 mt -100.59 156.39 17.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.499 0.666 . . . . 0.0 112.606 -170.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.57 -30.65 36.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.909 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.481 HD21 ' HB3' ' A' ' 27' ' ' LEU . 44.3 m-80 -49.94 -34.06 19.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.534 -1.212 . . . . 0.0 113.069 -175.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -99.83 27.3 5.55 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -172.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.13 -44.82 1.03 Allowed Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.722 172.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -80.56 -167.1 1.23 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.008 0.432 . . . . 0.0 111.955 -174.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -122.54 -28.54 4.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.718 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.737 HG12 ' SG ' ' A' ' 6' ' ' CYS . 1.4 pt -111.69 169.51 4.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -116.2 123.35 47.55 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.01 121.62 43.69 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.715 0.293 . . . . 0.0 110.847 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.71 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 48.6 mm -69.74 104.94 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.371 176.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.425 HD13 ' NE2' ' A' ' 26' ' ' GLN . 33.4 mm -85.89 97.64 6.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 O-C-N 122.059 -0.401 . . . . 0.0 110.113 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.483 ' HB3' HG12 ' A' ' 20' ' ' ILE . 9.6 m-85 -85.77 122.88 30.48 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -93.45 106.76 18.69 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.8 p -78.09 162.92 26.31 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.073 -173.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -65.9 -7.8 18.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.326 173.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -91.16 2.82 56.06 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.282 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 68.41 17.73 9.12 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.936 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.6 mt -106.69 125.98 51.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.517 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.4 p -76.72 108.35 9.67 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.652 177.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 99.6 t -91.63 131.35 38.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.662 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.438 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 62.8 m -88.7 90.97 8.63 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.71 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . . . -77.95 141.15 39.18 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.958 -176.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.573 ' N ' HD21 ' A' ' 50' ' ' ASN . 0.7 OUTLIER -82.38 130.34 59.66 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.82 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -71.48 2.93 4.01 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.099 1.866 . . . . 0.0 112.041 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -90.32 -21.62 21.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.918 -176.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.509 HE21 HG22 ' A' ' 56' ' ' VAL . 5.0 pt20 -103.14 142.27 34.43 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.437 -168.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 p -74.3 -28.79 61.34 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -171.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.617 ' O ' HG13 ' A' ' 59' ' ' ILE . 47.2 p-90 -62.57 -33.73 75.54 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.387 176.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.521 ' CG2' ' HB1' ' A' ' 49' ' ' ALA . 4.5 t -70.99 -47.92 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.413 174.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -56.98 -36.71 70.65 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 123.761 0.663 . . . . 0.0 110.85 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -65.77 -49.47 68.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.838 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.617 HG13 ' O ' ' A' ' 55' ' ' TRP . 60.0 mt -67.76 -47.86 78.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.039 -175.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.572 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 11.7 p -62.69 -29.84 47.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 120.803 0.335 . . . . 0.0 110.762 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -64.47 -45.26 88.17 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 34.8 mt -70.26 -30.81 67.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.934 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.574 HD22 HG22 ' A' ' 59' ' ' ILE . 2.0 mm? -68.45 -36.65 79.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.539 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 m -74.87 -42.96 56.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.694 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -109.03 86.22 2.24 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.17 0.51 . . . . 0.0 110.503 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -92.71 112.86 24.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.18 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.9 m -98.49 160.68 3.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.011 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -104.33 114.07 28.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.138 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -74.53 -38.87 62.65 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.1 ttt . . . . . 0 C--O 1.246 0.905 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.678 178.732 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 120.804 0.335 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.442 ' HA ' ' HA3' ' A' ' 31' ' ' GLY . 23.5 m -76.54 91.08 3.34 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.441 0.638 . . . . 0.0 111.103 -175.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -69.43 -41.76 75.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.674 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.727 ' CE1' ' HB2' ' A' ' 26' ' ' GLN . 29.2 p90 -121.04 -176.61 3.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.008 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -140.51 103.43 4.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.255 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.802 ' SG ' HG12 ' A' ' 34' ' ' ILE . 26.2 p -49.72 146.88 4.01 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.687 1.195 . . . . 0.0 112.918 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.652 ' O ' HD12 ' A' ' 34' ' ' ILE . 58.3 m -60.2 130.25 45.72 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.136 174.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.3 mt -84.5 0.13 50.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.209 0.528 . . . . 0.0 110.108 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.54 136.44 6.94 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 174.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.81 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 29.0 m-85 -97.3 176.65 5.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.798 0.332 . . . . 0.0 110.226 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.488 HG21 ' CG1' ' A' ' 47' ' ' VAL . 2.7 t -112.91 137.85 50.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.168 0.509 . . . . 0.0 111.015 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -108.02 68.9 0.72 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.564 0.697 . . . . 0.0 109.363 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.478 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 4.3 mmp_? -129.19 -173.21 2.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.586 -177.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.569 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.4 mm -124.98 89.65 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.208 165.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.594 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.7 mm? -89.12 162.83 15.75 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.787 ' HD1' ' HD2' ' A' ' 18' ' ' LYS . 58.3 m170 -132.05 166.65 26.92 Favored Pre-proline 0 C--N 1.312 -1.051 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.994 -172.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 12.2 Cg_endo -57.57 -27.14 75.53 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.176 1.917 . . . . 0.0 109.149 166.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.787 ' HD2' ' HD1' ' A' ' 16' ' ' HIS . 65.6 mttm -45.0 -35.47 2.93 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.384 171.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -116.89 -13.48 10.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.903 -172.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.663 HG12 ' HB3' ' A' ' 39' ' ' PHE . 21.8 mt -92.39 127.18 44.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.768 0.318 . . . . 0.0 111.327 -172.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 m -122.33 -7.6 8.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.157 0.503 . . . . 0.0 110.995 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -152.21 163.1 30.1 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.656 ' CB ' HD13 ' A' ' 63' ' ' LEU . 2.4 t80 -156.6 134.28 10.91 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 117.325 0.563 . . . . 0.0 110.897 -175.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.545 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 83.5 m -140.41 107.8 5.55 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.112 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 25' ' ' ARG . 14.8 ptp180 -86.5 102.78 14.42 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.776 HE21 ' HB2' ' A' ' 36' ' ' ALA . 19.9 pt20 -93.25 136.04 33.88 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 86.7 mt -119.64 163.72 16.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.214 0.53 . . . . 0.0 111.882 -170.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.58 35.03 0.49 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.824 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -132.73 -52.62 0.93 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.396 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -60.97 -43.21 99.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.799 -173.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 2' ' ' SER . . . -157.16 -65.03 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.279 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.8 t -71.42 169.3 15.64 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.378 0.609 . . . . 0.0 112.384 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -90.1 -24.67 21.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.653 -173.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.802 HG12 ' SG ' ' A' ' 6' ' ' CYS . 2.1 pt -120.41 170.16 10.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -118.86 128.18 54.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.778 0.323 . . . . 0.0 111.178 -176.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.776 ' HB2' HE21 ' A' ' 26' ' ' GLN . . . -131.9 143.6 50.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.958 0.409 . . . . 0.0 110.928 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.599 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 49.9 mm -90.2 101.34 12.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.229 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.545 ' HB ' ' HB ' ' A' ' 24' ' ' THR . 63.9 mt -79.49 104.75 7.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.019 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.663 ' HB3' HG12 ' A' ' 20' ' ' ILE . 12.5 m-85 -95.26 111.35 23.21 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 172.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -82.67 110.25 17.57 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.439 ' C ' ' H ' ' A' ' 43' ' ' LYS . 37.0 p -85.06 163.13 19.01 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.412 0.625 . . . . 0.0 112.008 -174.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -68.75 -2.53 9.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.032 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.439 ' H ' ' C ' ' A' ' 41' ' ' THR . 27.1 tptp -90.58 3.04 55.2 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.769 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt 69.47 22.86 6.24 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.015 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 97.3 mt -114.75 139.6 49.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.144 0.497 . . . . 0.0 110.712 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.0 p -90.07 95.41 10.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.694 174.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.488 ' CG1' HG21 ' A' ' 11' ' ' THR . 59.0 t -76.33 130.2 36.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.834 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.0 m -92.64 81.74 4.78 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.018 0.913 . . . . 0.0 109.591 -175.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -69.87 144.63 52.46 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.794 -176.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.81 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -83.8 129.39 59.49 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.758 -179.126 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -72.01 21.33 0.27 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.406 2.071 . . . . 0.0 111.988 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.502 ' H ' ' C ' ' A' ' 50' ' ' ASN . 35.3 mtmm -119.42 -4.93 10.36 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.99 -173.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.509 HE21 HG23 ' A' ' 56' ' ' VAL . 4.7 pt20 -117.26 146.37 43.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.027 0.441 . . . . 0.0 111.555 -172.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 p -69.86 -36.32 75.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -171.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.594 ' CZ3' ' HB2' ' A' ' 15' ' ' LEU . 47.9 p-90 -61.05 -30.75 70.51 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 60' ' ' VAL . 12.6 t -74.21 -49.04 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.244 174.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 84.1 mttt -57.0 -34.05 67.76 Favored 'General case' 0 C--N 1.334 -0.089 0 O-C-N 123.457 0.473 . . . . 0.0 110.506 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -66.1 -54.73 22.06 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.527 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.66 HG23 HD11 ' A' ' 20' ' ' ILE . 72.7 mt -65.57 -43.82 94.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.477 -174.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.566 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 13.8 p -66.71 -33.83 66.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.092 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -62.89 -43.14 99.59 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.37 0.605 . . . . 0.0 109.494 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.3 tp -66.2 -41.06 90.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.041 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.656 HD13 ' CB ' ' A' ' 23' ' ' PHE . 75.3 mt -76.28 -7.44 54.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.355 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 77.7 p -100.22 -4.61 29.09 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.864 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -132.25 8.08 4.3 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.326 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -119.8 16.31 12.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.618 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.4 m -110.48 142.26 23.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.721 176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -76.19 109.1 9.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.05 0.452 . . . . 0.0 110.466 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -97.87 -9.86 25.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.056 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 54.1 ttm . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.509 -0.758 . . . . 0.0 109.487 -179.156 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.747 ' HB3' ' HA2' ' A' ' 31' ' ' GLY . 1.2 m -76.0 88.24 2.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.911 0.386 . . . . 0.0 110.841 -176.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -77.06 -36.22 56.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.642 0.734 . . . . 0.0 109.023 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.44 ' CE1' ' HA ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -130.68 -166.84 1.74 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.107 173.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.556 ' C ' ' HB2' ' A' ' 32' ' ' CYS . 5.5 m-20 -112.03 -104.44 0.39 Allowed 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 122.04 0.924 . . . . 0.0 109.81 171.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.71 ' HA ' ' HB3' ' A' ' 26' ' ' GLN . 7.9 p -144.98 -160.33 1.12 Allowed 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 113.932 -1.485 . . . . 0.0 109.302 -176.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.483 ' O ' HD11 ' A' ' 34' ' ' ILE . 94.8 m -105.91 122.75 46.76 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 166.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.6 mt -67.7 -26.69 66.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.345 0.593 . . . . 0.0 109.536 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -129.06 135.38 8.43 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.206 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.759 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 6.9 m-85 -100.58 -160.12 0.78 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.1 t -129.12 158.7 38.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.214 176.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.492 ' O ' ' HD2' ' A' ' 13' ' ' ARG . 1.5 m-20 -118.55 69.23 0.79 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.858 0.361 . . . . 0.0 110.087 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.492 ' HD2' ' O ' ' A' ' 12' ' ' ASP . 8.4 mmm180 -131.36 175.89 8.75 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.411 0.624 . . . . 0.0 112.122 -177.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.551 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.1 mm -120.18 90.05 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.001 164.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.498 ' O ' ' HD2' ' A' ' 16' ' ' HIS . 1.9 mm? -92.35 163.26 13.94 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.775 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 34.9 m170 -131.24 176.39 2.93 Favored Pre-proline 0 C--N 1.313 -1.013 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.277 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.775 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 13.2 Cg_endo -58.68 -21.28 54.99 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.631 1.554 . . . . 0.0 109.353 167.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.759 ' HD3' ' HD1' ' A' ' 16' ' ' HIS . 28.5 mtpp -45.17 -32.77 1.97 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.844 171.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 41' ' ' THR . 77.9 m-85 -124.27 -5.08 7.82 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -174.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.611 HG12 ' HB3' ' A' ' 39' ' ' PHE . 18.3 mt -100.26 128.45 52.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.777 0.323 . . . . 0.0 111.666 -173.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.6 m -120.68 -11.48 9.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.195 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.3 165.74 31.42 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.709 ' HB2' HD12 ' A' ' 63' ' ' LEU . 2.7 t80 -155.01 133.44 11.87 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.23 0.538 . . . . 0.0 111.666 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.7 m -142.1 121.42 13.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.603 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -98.11 119.16 36.26 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.512 -0.475 . . . . 0.0 112.112 -176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.71 ' HB3' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -76.17 130.09 37.72 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 170.756 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.6 mt -97.9 152.52 19.13 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -169.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.87 5.48 43.39 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.059 173.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -100.26 -64.61 1.03 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.146 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -116.98 86.41 2.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.63 0.728 . . . . 0.0 110.079 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.747 ' HA2' ' HB3' ' A' ' 2' ' ' SER . . . 162.56 -77.37 0.16 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.444 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.556 ' HB2' ' C ' ' A' ' 5' ' ' ASP . 47.1 t -117.9 176.51 5.17 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -87.38 -23.28 24.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.351 0.596 . . . . 0.0 109.405 171.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.686 HG12 ' SG ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -113.33 162.97 11.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.519 ' HB2' ' O ' ' A' ' 26' ' ' GLN . 7.0 p30 -129.11 138.35 51.77 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.286 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.88 148.56 52.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.017 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.779 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 47.8 mm -95.48 116.81 38.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.715 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.407 HD11 HE22 ' A' ' 26' ' ' GLN . 44.4 mm -90.31 98.38 8.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.085 0.469 . . . . 0.0 110.047 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.611 ' HB3' HG12 ' A' ' 20' ' ' ILE . 8.8 m-85 -87.94 115.01 25.11 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -82.03 108.14 15.28 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 42.0 p -82.55 159.15 22.85 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.195 0.521 . . . . 0.0 111.471 -175.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -67.28 -2.42 5.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.358 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -95.15 3.71 54.42 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.842 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt 70.33 11.92 7.5 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.451 0.7 . . . . 0.0 111.176 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.3 mt -92.85 125.82 37.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.098 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 p -86.06 93.79 9.08 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.3 t -85.64 130.92 35.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.687 -174.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 82.3 m -86.29 84.73 7.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 122.016 0.912 . . . . 0.0 109.506 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.779 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . . . -69.51 143.03 53.58 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.6 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.759 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -88.14 122.52 69.83 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -178.362 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.493 ' HG3' ' OD1' ' A' ' 35' ' ' ASN . 9.5 Cg_endo -57.33 -8.19 3.49 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.889 2.393 . . . . 0.0 112.471 172.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 50' ' ' ASN . 51.5 mttm -77.2 -34.54 56.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.961 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.683 ' CG ' ' HB2' ' A' ' 50' ' ' ASN . 0.4 OUTLIER -85.43 140.53 30.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.719 -169.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.64 -27.68 61.39 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -176.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.551 ' CD1' HD13 ' A' ' 14' ' ' ILE . 47.8 p-90 -62.74 -32.4 73.53 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.592 HG21 HE21 ' A' ' 53' ' ' GLN . 7.4 t -73.03 -48.78 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.494 174.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 66.7 mttm -53.93 -36.5 62.83 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.584 0.552 . . . . 0.0 110.575 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -66.52 -57.28 7.64 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.691 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.564 HG23 HD13 ' A' ' 20' ' ' ILE . 75.2 mt -62.67 -43.3 98.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.201 -175.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.62 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 12.6 p -63.5 -33.42 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 121.309 -0.156 . . . . 0.0 111.328 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -63.75 -41.99 97.91 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.268 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.4 mt -81.48 4.81 19.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.023 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.709 HD12 ' HB2' ' A' ' 23' ' ' PHE . 55.9 mt -117.7 -14.86 10.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.321 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -108.35 -63.38 1.34 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.761 0.315 . . . . 0.0 110.185 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.72 78.33 1.82 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.277 0.56 . . . . 0.0 109.667 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -119.67 142.55 48.36 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.558 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.49 105.63 17.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.71 -175.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -100.01 102.47 13.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.971 0.415 . . . . 0.0 110.325 176.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -112.65 -80.97 0.59 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 174.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.152 176.036 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 m -55.94 128.04 33.29 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.493 0.496 . . . . 0.0 111.346 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -80.99 -53.28 6.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.135 0.493 . . . . 0.0 110.469 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -131.03 -170.64 2.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.77 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -140.38 110.44 6.54 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.474 0.654 . . . . 0.0 110.485 172.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.701 ' SG ' HG12 ' A' ' 34' ' ' ILE . 19.3 p -40.76 147.55 0.12 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.985 173.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.9 m -61.6 134.68 57.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.808 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt -86.72 6.62 30.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.592 0.711 . . . . 0.0 109.885 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.67 119.79 0.95 Allowed Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.676 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.402 ' HD1' ' H ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -118.62 161.38 20.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.944 0.402 . . . . 0.0 110.833 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.401 HG22 ' HA ' ' A' ' 49' ' ' ALA . 14.4 t -73.38 -171.52 0.99 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -167.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -147.27 14.19 1.12 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.634 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -88.81 170.43 10.75 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.408 -171.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.56 HD11 ' CD1' ' A' ' 55' ' ' TRP . 8.7 mm -105.3 84.57 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 163.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.571 HD11 ' CH2' ' A' ' 55' ' ' TRP . 1.1 mt -92.14 160.49 15.17 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.741 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 52.1 m170 -132.51 171.5 9.03 Favored Pre-proline 0 C--N 1.313 -1.014 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.005 -173.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.572 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 32.1 Cg_exo -55.83 -24.24 46.09 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.181 1.921 . . . . 0.0 109.255 165.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.741 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 64.9 mttm -44.51 -32.65 1.47 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 114.24 -1.346 . . . . 0.0 112.082 171.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -126.81 -3.48 6.52 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 122.243 -0.286 . . . . 0.0 111.449 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.619 HG13 ' HB3' ' A' ' 39' ' ' PHE . 1.2 mp -92.88 120.12 41.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.02 0.438 . . . . 0.0 110.344 -175.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.3 m -113.63 -5.87 11.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.735 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.19 158.37 29.13 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.36 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.658 ' CZ ' HG21 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -146.97 137.39 23.58 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.139 0.495 . . . . 0.0 110.258 -179.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.2 m -144.38 109.45 5.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.518 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -75.9 118.14 18.37 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.418 ' NE2' HD13 ' A' ' 38' ' ' ILE . 8.4 tt0 -101.88 106.35 17.29 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -177.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.449 ' HA ' HD21 ' A' ' 35' ' ' ASN . 6.6 mp -81.7 164.5 21.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.457 0.646 . . . . 0.0 111.984 -173.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.24 -57.8 3.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.862 175.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -74.62 19.67 0.13 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -170.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -115.19 23.86 12.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.281 0.562 . . . . 0.0 110.494 173.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.25 -12.86 4.36 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.647 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.426 ' HB2' ' H ' ' A' ' 6' ' ' CYS . 2.4 t -120.06 -153.69 0.55 Allowed 'General case' 0 C--N 1.319 -0.742 0 O-C-N 122.454 -0.439 . . . . 0.0 111.563 -177.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -129.61 -27.95 2.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.576 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.701 HG12 ' SG ' ' A' ' 6' ' ' CYS . 2.8 pt -118.61 169.51 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.449 HD21 ' HA ' ' A' ' 27' ' ' LEU . 14.9 m120 -103.39 131.06 50.78 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 174.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.14 126.14 36.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.28 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.666 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 46.7 mm -88.72 98.08 7.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.34 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.418 HD13 ' NE2' ' A' ' 26' ' ' GLN . 70.2 mt -75.49 105.95 4.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.867 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.619 ' HB3' HG13 ' A' ' 20' ' ' ILE . 13.6 m-85 -97.73 116.94 30.93 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 171.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -86.88 106.46 17.77 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 43' ' ' LYS . 42.7 p -74.75 164.1 26.94 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.642 -176.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -74.26 4.79 5.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.963 0.887 . . . . 0.0 108.912 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 14.5 tppt? -87.87 -1.36 57.93 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.004 176.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt 70.6 12.26 7.32 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.828 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.6 mt -109.44 129.2 55.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.598 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.8 p -79.84 107.07 12.33 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.821 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 73.0 t -93.23 127.25 45.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 57.4 m -88.94 100.5 13.24 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.703 0.763 . . . . 0.0 109.493 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.666 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . . . -78.66 143.38 36.38 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.934 -177.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.621 ' N ' HD21 ' A' ' 50' ' ' ASN . 0.7 OUTLIER -80.41 130.98 63.13 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.59 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.53 -10.63 28.54 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.678 2.252 . . . . 0.0 112.044 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -74.93 -27.76 60.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.231 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.601 HE21 HG22 ' A' ' 56' ' ' VAL . 5.1 mt-30 -84.64 139.29 32.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.036 -168.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 p -76.33 -31.1 57.93 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.856 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.571 ' CH2' HD11 ' A' ' 15' ' ' LEU . 51.9 p-90 -60.35 -33.8 72.94 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 174.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.601 HG22 HE21 ' A' ' 53' ' ' GLN . 25.7 t -68.54 -52.06 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.252 173.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 67.6 mttm -54.2 -38.21 65.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.683 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -63.46 -52.45 61.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.787 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 55' ' ' TRP . 72.6 mt -63.52 -47.65 90.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.296 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.658 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 7.5 p -63.99 -36.19 75.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -175.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -68.7 -31.67 70.92 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.303 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 30.2 tp -74.28 -41.88 60.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.828 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.45 HD12 ' HB3' ' A' ' 23' ' ' PHE . 2.4 mm? -66.25 -29.09 69.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.039 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.9 t -73.11 -28.91 62.54 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.0 -176.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -135.98 48.73 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.111 0.482 . . . . 0.0 110.92 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -74.87 88.68 2.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.942 -177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.9 m -116.15 -177.28 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.799 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -103.56 -43.62 5.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.846 0.355 . . . . 0.0 111.35 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -107.86 136.74 47.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.373 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 66.5 mtm . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.691 -177.131 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.51 0.195 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.73 ' HA ' ' HA3' ' A' ' 31' ' ' GLY . 2.3 p -114.51 110.48 19.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.483 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -83.66 -44.46 14.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.92 177.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.571 ' CZ ' ' HB2' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -131.13 -171.92 2.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.189 178.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -138.29 104.17 5.11 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.438 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.689 ' SG ' ' HG2' ' A' ' 26' ' ' GLN . 93.8 m -47.99 146.99 2.25 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.137 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 67.1 m -49.3 122.29 5.92 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.284 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.7 mt -65.24 -24.82 67.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.087 0.47 . . . . 0.0 110.406 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.72 134.77 7.43 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.11 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.824 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 28.9 m-85 -92.66 178.41 5.8 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.566 0.222 . . . . 0.0 110.445 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.652 HG21 HG13 ' A' ' 47' ' ' VAL . 3.4 t -127.08 130.58 50.18 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.371 0.605 . . . . 0.0 111.758 -177.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.66 72.57 2.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 122.007 0.908 . . . . 0.0 108.6 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.428 ' HB2' HD13 ' A' ' 15' ' ' LEU . 18.2 mmt180 -104.42 -178.9 3.79 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.925 177.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.455 HD13 ' CD1' ' A' ' 55' ' ' TRP . 9.1 mm -126.74 87.68 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 162.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.701 HD12 HG12 ' A' ' 47' ' ' VAL . 1.2 mt -99.82 162.27 13.1 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.273 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.956 ' HD1' ' HD2' ' A' ' 18' ' ' LYS . 63.1 m170 -132.59 167.08 24.41 Favored Pre-proline 0 C--N 1.316 -0.889 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.087 -172.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.602 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 18.3 Cg_endo -61.3 -22.53 74.86 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.315 2.01 . . . . 0.0 108.925 166.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.956 ' HD2' ' HD1' ' A' ' 16' ' ' HIS . 66.4 mttm -52.46 -28.31 19.68 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.718 172.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -124.0 -2.71 8.17 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.426 -175.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.602 ' HB ' ' HA ' ' A' ' 17' ' ' PRO . 0.9 OUTLIER -94.19 124.18 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 120.995 0.426 . . . . 0.0 110.891 -174.078 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.4 m -120.32 -1.96 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.547 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.3 160.22 31.95 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.432 -0.889 . . . . 0.0 111.962 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.54 ' CB ' ' HG ' ' A' ' 63' ' ' LEU . 1.7 t80 -149.3 134.5 18.23 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.5 m -140.95 107.18 5.23 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.381 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.503 ' HD3' HD23 ' A' ' 27' ' ' LEU . 32.4 ttm180 -82.37 107.52 15.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.168 0.509 . . . . 0.0 110.013 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.689 ' HG2' ' SG ' ' A' ' 6' ' ' CYS . 4.1 tt0 -80.14 115.56 19.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.906 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.503 HD23 ' HD3' ' A' ' 25' ' ' ARG . 65.2 mt -103.39 148.18 26.2 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -166.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.62 15.88 0.44 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.272 176.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.445 ' H ' ' C ' ' A' ' 27' ' ' LEU . 34.3 m-80 -116.04 -6.99 11.96 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.783 -177.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . 34.2 mm-40 -103.69 -1.06 28.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.474 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.73 ' HA3' ' HA ' ' A' ' 2' ' ' SER . . . 145.99 -48.65 0.68 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.496 -0.859 . . . . 0.0 113.311 177.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 34' ' ' ILE . 13.4 p -68.16 171.04 7.52 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -112.52 6.76 18.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.553 0.692 . . . . 0.0 111.035 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.415 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 25.0 pt -131.34 -171.81 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 8.9 p30 -142.62 124.08 14.83 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.874 174.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.99 137.89 51.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.729 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 50.0 mm -89.04 98.23 7.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.089 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.682 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 2.6 mp -85.46 99.7 7.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.346 -0.541 . . . . 0.0 110.541 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.534 ' HE2' HG21 ' A' ' 56' ' ' VAL . 20.1 m-85 -86.89 125.93 34.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 171.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -93.32 112.32 24.22 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.4 p -79.13 155.39 28.72 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -65.62 -6.72 11.97 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.283 175.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -99.21 12.32 36.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.989 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.9 mttm 70.68 19.89 5.87 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.372 172.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.8 mt -104.48 124.72 49.77 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.416 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.8 p -80.85 109.56 15.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.302 0.572 . . . . 0.0 109.769 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.701 HG12 HD12 ' A' ' 15' ' ' LEU . 70.0 t -87.1 132.14 33.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.025 -176.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 65.0 m -93.34 76.97 4.51 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.863 0.84 . . . . 0.0 108.832 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.578 ' HB2' ' CG2' ' A' ' 56' ' ' VAL . . . -70.71 141.13 51.56 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.898 -175.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.824 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -79.0 129.63 72.52 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.3 -179.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.54 -3.08 8.44 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 121.794 1.663 . . . . 0.0 111.122 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.46 ' H ' ' C ' ' A' ' 50' ' ' ASN . 53.8 mtmt -88.58 -18.85 27.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.048 -173.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.547 HE21 HG22 ' A' ' 56' ' ' VAL . 5.5 pt20 -104.54 145.21 30.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.953 0.406 . . . . 0.0 111.05 -170.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 p -69.72 -36.06 75.56 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -172.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.643 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 36.1 p-90 -60.14 -30.93 69.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.453 0.644 . . . . 0.0 109.466 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.578 ' CG2' ' HB2' ' A' ' 49' ' ' ALA . 15.1 t -75.27 -49.54 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.198 175.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -56.09 -33.61 65.22 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 123.454 0.471 . . . . 0.0 110.401 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -66.48 -56.96 8.44 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.872 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.452 HG12 ' HD3' ' A' ' 17' ' ' PRO . 72.4 mt -64.65 -43.94 96.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.142 -176.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 56' ' ' VAL . 7.1 p -67.07 -24.46 32.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.586 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 61' ' ' ARG . 8.4 ttp180 -69.61 -33.28 72.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.154 0.502 . . . . 0.0 110.114 174.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.6 mt -73.22 -44.45 59.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.872 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.54 ' HG ' ' CB ' ' A' ' 23' ' ' PHE . 3.7 mm? -61.96 -49.81 74.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.776 176.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.1 t -87.15 60.8 6.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.479 0.657 . . . . 0.0 109.8 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -66.27 103.53 1.02 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.762 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -91.1 -17.42 26.21 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.916 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.5 p -81.4 101.53 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.514 0.673 . . . . 0.0 110.123 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -86.71 77.21 9.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.381 0.61 . . . . 0.0 110.246 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -132.01 -82.95 0.5 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.558 177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 17.8 tpt . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.192 -0.908 . . . . 0.0 109.28 178.906 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 121.067 0.461 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -117.42 118.74 33.04 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.815 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -63.13 -48.7 77.4 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.443 ' CE1' ' HB2' ' A' ' 26' ' ' GLN . 2.2 p90 -132.01 -178.84 5.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.616 173.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -122.53 111.85 17.31 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.36 0.6 . . . . 0.0 109.618 169.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.808 ' HA ' ' HG3' ' A' ' 26' ' ' GLN . 82.8 m -50.48 138.13 17.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.94 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.0 t -56.76 118.58 5.04 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 123.396 0.435 . . . . 0.0 110.062 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.33 -24.98 66.83 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.167 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.25 142.41 10.48 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.998 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.827 ' HB2' ' ND2' ' A' ' 50' ' ' ASN . 0.3 OUTLIER -105.24 171.32 7.38 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.027 0.441 . . . . 0.0 111.973 -178.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 t -93.12 154.11 18.27 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -169.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -95.19 59.53 2.25 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.419 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.594 ' HB3' HD23 ' A' ' 15' ' ' LEU . 6.7 mtm180 -129.34 173.66 10.32 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.497 HD11 ' CD1' ' A' ' 55' ' ' TRP . 14.5 mm -120.71 79.74 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 113.979 -1.464 . . . . 0.0 108.528 168.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.594 HD23 ' HB3' ' A' ' 13' ' ' ARG . 2.8 mm? -79.31 159.12 27.33 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.93 ' HD1' ' HD2' ' A' ' 18' ' ' LYS . 52.3 m170 -134.24 172.05 7.99 Favored Pre-proline 0 C--N 1.309 -1.19 0 O-C-N 122.028 -0.42 . . . . 0.0 111.064 -176.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.586 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 14.4 Cg_endo -59.56 -21.64 63.08 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.732 1.622 . . . . 0.0 109.177 165.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.93 ' HD2' ' HD1' ' A' ' 16' ' ' HIS . 67.6 mttm -49.01 -34.28 12.88 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.151 174.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 41' ' ' THR . 12.0 m-85 -122.83 1.79 9.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.745 0.307 . . . . 0.0 111.135 -173.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.48 HD11 ' O ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -95.63 129.57 45.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.666 -174.27 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.35 -8.3 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.061 0.458 . . . . 0.0 110.389 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.02 159.43 30.34 Favored Glycine 0 N--CA 1.453 -0.193 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.564 ' CB ' HD12 ' A' ' 63' ' ' LEU . 1.6 t80 -147.04 131.0 17.16 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.617 0.722 . . . . 0.0 111.281 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.693 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 38.2 m -129.42 144.17 51.14 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.341 -1.3 . . . . 0.0 107.82 174.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -127.73 121.62 30.79 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.434 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.808 ' HG3' ' HA ' ' A' ' 6' ' ' CYS . 1.2 pm0 -97.75 123.92 41.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.301 177.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.458 ' C ' ' H ' ' A' ' 29' ' ' ASN . 82.8 mt -103.72 159.54 15.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.507 -176.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.48 ' C ' HD21 ' A' ' 29' ' ' ASN . . . -78.04 32.82 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.445 0.64 . . . . 0.0 110.662 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.48 HD21 ' C ' ' A' ' 28' ' ' ALA . 0.9 OUTLIER -116.86 -30.37 5.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.167 -174.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -104.24 30.91 4.92 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -170.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.81 -60.06 0.67 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.741 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 0.5 OUTLIER -70.3 139.14 52.02 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 122.198 0.199 . . . . 0.0 111.058 178.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.36 -18.98 47.47 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.362 0.601 . . . . 0.0 109.419 176.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.3 pt -97.53 174.25 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.039 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -143.02 145.62 33.08 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.55 177.11 8.51 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.078 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 1.024 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 42.6 mm -122.31 133.26 69.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.693 ' HB ' ' HB ' ' A' ' 24' ' ' THR . 72.9 mt -101.78 99.13 7.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.844 0.354 . . . . 0.0 110.091 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.4 ' HE2' HG21 ' A' ' 56' ' ' VAL . 10.0 m-85 -91.76 114.06 26.49 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 172.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -86.56 113.49 22.51 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -176.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 41.5 p -79.75 162.08 25.36 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.142 0.496 . . . . 0.0 111.314 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -69.87 -2.66 12.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.829 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -93.67 7.26 45.44 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.777 176.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm 72.63 8.62 5.64 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.444 0.698 . . . . 0.0 111.002 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.77 120.74 36.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.03 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 p -79.94 105.57 11.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.358 0.599 . . . . 0.0 109.769 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 96.5 t -86.01 130.43 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.805 -176.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.9 m -82.1 92.22 6.8 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.855 0.835 . . . . 0.0 109.09 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 1.024 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -70.38 142.7 52.07 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.315 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.827 ' ND2' ' HB2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -81.79 151.79 68.23 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -174.178 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -89.76 39.16 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.562 2.174 . . . . 0.0 112.835 168.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.597 ' O ' ' HE2' ' A' ' 57' ' ' LYS . 64.9 mttm -131.97 -80.79 0.51 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.046 0.451 . . . . 0.0 111.234 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.67 HE22 ' CG2' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -40.1 139.31 0.71 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.664 1.186 . . . . 0.0 113.543 177.387 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.446 HG21 ' HD2' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -75.1 -16.93 60.53 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -172.395 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.586 ' CD1' ' HB2' ' A' ' 53' ' ' GLN . 60.7 p-90 -65.01 -30.82 71.82 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.586 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.67 ' CG2' HE22 ' A' ' 53' ' ' GLN . 0.9 OUTLIER -71.39 -47.94 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.914 174.019 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.597 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 68.3 mttm -54.41 -34.98 62.4 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 123.779 0.674 . . . . 0.0 110.386 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -68.33 -56.27 9.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.128 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.567 HG12 ' HD3' ' A' ' 17' ' ' PRO . 63.5 mt -64.57 -46.59 92.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.641 0.258 . . . . 0.0 111.486 -175.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 56' ' ' VAL . 12.7 p -71.4 -28.5 32.14 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.016 -174.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -68.9 -35.02 76.37 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.4 tp -72.1 -37.53 69.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.323 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.564 HD12 ' CB ' ' A' ' 23' ' ' PHE . 95.9 mt -82.4 -37.62 25.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.819 -177.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.4 t -96.23 52.43 1.27 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -56.18 103.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.836 -174.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -86.32 -4.29 59.14 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.912 174.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.9 p -96.75 -10.44 8.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.235 0.541 . . . . 0.0 111.765 -173.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -133.34 107.69 8.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.406 0.622 . . . . 0.0 111.892 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -130.92 -51.62 1.04 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.854 169.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 39.5 tpp . . . . . 0 C--O 1.245 0.854 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.693 177.299 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 120.671 0.272 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -59.96 133.98 56.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.875 173.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -58.53 -53.15 61.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.507 0.67 . . . . 0.0 109.412 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.681 ' CE1' ' HG2' ' A' ' 26' ' ' GLN . 1.4 p90 -131.83 178.08 7.04 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.543 173.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -121.39 117.38 26.79 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.629 0.728 . . . . 0.0 110.199 169.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.553 ' SG ' HG12 ' A' ' 34' ' ' ILE . 25.1 p -36.35 142.09 0.09 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 113.87 -1.514 . . . . 0.0 113.683 170.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 46.8 t -61.7 126.29 26.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.624 177.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -64.21 -24.91 67.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.929 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.27 122.57 1.74 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.565 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.691 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 3.2 m-85 -79.15 -178.42 6.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.561 0.696 . . . . 0.0 110.306 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.2 t -107.38 -166.26 1.14 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.065 175.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -160.22 81.42 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 170.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.439 ' HB2' HD23 ' A' ' 15' ' ' LEU . 23.1 mmm180 -131.59 -173.99 3.28 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.479 -168.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.499 HD11 ' CD1' ' A' ' 55' ' ' TRP . 7.6 mm -126.89 86.3 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 113.647 -1.615 . . . . 0.0 107.872 160.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.626 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 1.9 mm? -91.2 169.92 10.44 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.747 ' HD1' ' HD2' ' A' ' 18' ' ' LYS . 63.1 m170 -134.25 170.21 11.88 Favored Pre-proline 0 C--N 1.311 -1.073 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.879 -175.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 31.6 Cg_exo -55.73 -26.89 58.76 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 121.951 1.767 . . . . 0.0 109.251 164.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.747 ' HD2' ' HD1' ' A' ' 16' ' ' HIS . 62.6 mttm -45.5 -38.25 6.07 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 113.95 -1.477 . . . . 0.0 112.085 172.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 41' ' ' THR . 14.0 m-85 -118.14 2.59 12.02 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -170.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.675 HG12 ' HB3' ' A' ' 39' ' ' PHE . 17.2 mt -106.45 122.53 60.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.874 0.369 . . . . 0.0 111.058 -175.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.57 -0.52 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.822 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -157.42 158.32 28.87 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.537 ' CB ' HD12 ' A' ' 63' ' ' LEU . 2.8 t80 -155.29 133.29 11.49 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.514 0.673 . . . . 0.0 110.545 -176.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.3 m -136.87 108.82 7.12 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.07 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 25' ' ' ARG . 0.4 OUTLIER -80.15 105.28 11.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.967 0.889 . . . . 0.0 110.464 -177.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.681 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.7 OUTLIER -84.67 120.15 26.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.449 178.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.663 ' H ' ' HZ ' ' A' ' 4' ' ' PHE . 2.8 mm? -114.89 155.12 27.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.494 0.664 . . . . 0.0 112.036 -170.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.2 22.27 1.25 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.909 -175.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.453 ' ND2' ' HB3' ' A' ' 27' ' ' LEU . 7.8 p30 -127.08 -3.17 6.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -103.8 25.19 10.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.029 0.443 . . . . 0.0 110.974 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.14 -64.83 0.6 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.634 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.56 152.8 41.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.772 0.32 . . . . 0.0 111.288 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -90.97 -14.46 31.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.012 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.553 HG12 ' SG ' ' A' ' 6' ' ' CYS . 3.6 pt -111.71 140.31 31.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -110.43 126.97 54.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.314 0.578 . . . . 0.0 110.519 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.642 ' O ' ' HB3' ' A' ' 26' ' ' GLN . . . -127.11 132.01 50.69 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.683 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.424 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 47.0 mm -77.61 112.28 15.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.1 mm -90.21 97.79 7.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 122.044 -0.41 . . . . 0.0 111.087 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.675 ' HB3' HG12 ' A' ' 20' ' ' ILE . 16.7 m-85 -90.52 119.07 30.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 6.6 m-70 -89.31 115.1 26.54 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.435 ' C ' ' H ' ' A' ' 43' ' ' LYS . 15.0 p -84.86 159.47 20.37 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.774 0.797 . . . . 0.0 112.509 -171.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -67.9 -0.7 4.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.055 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 41' ' ' THR . 67.6 mttm -98.61 20.62 12.57 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.68 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt 67.9 22.64 8.6 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.58 175.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.32 173.65 8.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.724 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 40' ' ' HIS . 49.1 m -127.75 122.3 32.47 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 173.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.4 t -92.01 131.51 38.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.439 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 20.6 m -82.87 82.18 8.27 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.471 ' HB2' ' CG2' ' A' ' 56' ' ' VAL . . . -72.16 141.28 49.08 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.155 -173.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.691 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -82.41 131.42 55.68 Favored Pre-proline 0 CA--C 1.508 -0.671 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.733 -175.379 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.69 15.3 1.09 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.025 1.817 . . . . 0.0 111.632 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.43 ' H ' ' C ' ' A' ' 50' ' ' ASN . 1.1 ttpp -89.82 -28.66 19.15 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.664 176.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.581 HE21 HG23 ' A' ' 56' ' ' VAL . 5.3 pt20 -105.95 138.8 41.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.746 -163.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.29 -29.81 66.65 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -173.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.626 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 46.0 p-90 -63.19 -33.76 76.17 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.421 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.581 HG23 HE21 ' A' ' 53' ' ' GLN . 2.7 t -70.17 -46.99 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.918 174.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.465 ' HA ' HG13 ' A' ' 60' ' ' VAL . 91.1 mttt -62.19 -29.06 70.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.855 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -68.19 -51.01 50.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.79 0.329 . . . . 0.0 110.419 173.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 55' ' ' TRP . 58.1 mt -68.53 -43.91 83.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.322 -175.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.532 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 14.9 p -68.22 -33.29 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.08 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 5.9 tmm_? -66.04 -40.19 90.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.103 0.478 . . . . 0.0 109.78 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.0 tp -66.69 -47.64 71.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.992 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.537 HD12 ' CB ' ' A' ' 23' ' ' PHE . 83.0 mt -65.5 -36.37 83.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.377 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.5 m -81.84 -1.23 46.79 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 61' ' ' ARG . 33.8 mmtp -108.62 -13.19 14.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.021 0.439 . . . . 0.0 111.423 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -114.01 -37.34 4.49 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.194 -175.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.7 t -90.57 13.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 122.125 0.964 . . . . 0.0 109.483 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -93.6 -14.38 26.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.38 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -105.47 145.9 30.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.569 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 13.1 tpt . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.415 -179.577 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 120.778 0.323 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.869 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . 24.2 m -95.28 -168.73 1.84 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.175 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.605 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 8.0 t30 -74.46 -72.14 0.3 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.666 0.269 . . . . 0.0 110.814 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.603 ' CD2' ' HB2' ' A' ' 5' ' ' ASP . 6.1 p90 -130.77 -42.85 1.12 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -176.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.603 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 0.8 OUTLIER -141.05 -34.91 0.48 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -169.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.869 ' SG ' ' HB3' ' A' ' 2' ' ' SER . 1.8 p -40.0 117.39 0.76 Allowed 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.852 0.72 . . . . 0.0 112.709 177.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.51 ' C ' ' H ' ' A' ' 9' ' ' GLY . 73.4 m -62.84 155.39 27.1 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.609 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 pp -77.34 25.7 0.17 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.428 0.632 . . . . 0.0 110.638 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 7' ' ' CYS . . . 131.15 156.98 8.69 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -175.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.637 ' HB2' ' ND2' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -105.96 172.03 7.03 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.53 178.86 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 t -84.66 -174.96 5.56 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.032 -172.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -135.66 70.99 1.42 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 173.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -131.65 178.51 6.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.541 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.57 HD12 ' CD1' ' A' ' 55' ' ' TRP . 5.2 mm -124.51 94.79 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.374 167.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.511 HD12 ' CH2' ' A' ' 55' ' ' TRP . 1.1 mt -106.75 158.08 17.24 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.877 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.795 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 26.4 m170 -132.19 178.81 1.58 Allowed Pre-proline 0 C--N 1.314 -0.969 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.716 -173.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.795 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 9.4 Cg_endo -55.42 -20.32 25.64 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.281 1.987 . . . . 0.0 110.046 164.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.649 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 22.0 mtpp -47.16 -27.03 1.29 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.308 172.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 41' ' ' THR . 55.2 m-85 -126.15 -10.85 6.47 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.427 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.493 HD12 ' O ' ' A' ' 16' ' ' HIS . 1.5 mp -95.13 128.42 46.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.046 0.45 . . . . 0.0 111.649 -170.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -122.53 -16.96 5.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.591 172.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -145.07 162.37 28.13 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.588 ' CZ ' HG21 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -155.16 136.03 13.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.002 0.429 . . . . 0.0 111.006 -175.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.2 m -134.47 123.25 23.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.501 174.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 25' ' ' ARG . 6.6 ptp85 -91.18 91.89 8.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.612 0.72 . . . . 0.0 110.298 176.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.704 ' NE2' ' HA ' ' A' ' 6' ' ' CYS . 0.9 OUTLIER -68.76 121.61 16.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.95 179.2 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.7 mt -113.82 147.8 37.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.899 -168.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.83 46.84 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.159 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -139.32 -29.49 0.75 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.244 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -90.56 28.62 1.45 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -168.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.32 -37.99 2.7 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.74 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 3' ' ' ASN . 57.7 m -91.14 158.56 16.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.856 0.36 . . . . 0.0 110.735 175.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -110.45 -12.39 14.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.539 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.509 ' O ' HG13 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -105.93 133.42 50.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 174.119 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -108.54 136.84 47.48 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.929 0.395 . . . . 0.0 110.872 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 26' ' ' GLN . . . -140.19 140.19 35.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.94 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 45.8 mm -79.94 101.95 5.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -87.03 98.33 7.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 O-C-N 121.87 -0.519 . . . . 0.0 110.747 -176.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.522 ' HE2' HG21 ' A' ' 56' ' ' VAL . 11.3 m-85 -86.23 135.15 33.67 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -105.96 116.91 32.75 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 41.7 p -79.85 163.63 24.23 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.34 -172.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -63.57 -12.19 30.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.551 170.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -84.04 0.16 49.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.278 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 67.9 mttm 71.27 12.4 6.74 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.778 0.831 . . . . 0.0 111.368 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.7 mt -107.86 141.68 39.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.423 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.8 p -92.47 124.16 36.31 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.102 0.477 . . . . 0.0 110.721 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.4 t -105.16 134.1 47.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.43 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 69.6 m -85.32 86.2 7.39 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.582 0.706 . . . . 0.0 109.634 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.598 ' HB2' ' CG2' ' A' ' 56' ' ' VAL . . . -72.78 149.12 43.92 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.451 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.637 ' ND2' ' HB2' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -83.48 151.76 62.74 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.865 -172.295 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -88.91 32.16 0.39 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.263 1.975 . . . . 0.0 113.771 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.671 ' O ' ' HE3' ' A' ' 57' ' ' LYS . 50.9 mtpt -132.25 -61.43 0.87 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -174.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.655 HE22 ' CG2' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -56.49 143.14 36.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.55 0.691 . . . . 0.0 112.272 -179.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p -74.94 -20.49 59.67 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -172.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.57 ' CD1' HD12 ' A' ' 14' ' ' ILE . 60.4 p-90 -63.22 -32.47 73.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.068 176.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.655 ' CG2' HE22 ' A' ' 53' ' ' GLN . 1.0 OUTLIER -68.92 -46.31 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.922 174.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.671 ' HE3' ' O ' ' A' ' 52' ' ' LYS . 92.6 mttt -63.81 -24.55 67.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.573 -178.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -74.12 -49.83 22.09 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.547 174.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.446 HD11 ' O ' ' A' ' 15' ' ' LEU . 76.8 mt -65.66 -48.15 83.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.06 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.588 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 14.1 p -65.37 -29.14 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 120.579 0.228 . . . . 0.0 110.743 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.534 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 28.3 ttm180 -63.79 -43.92 94.89 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.4 mt -64.75 -43.33 93.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.69 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.605 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.9 mm? -57.48 -49.95 74.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.951 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.8 m -67.32 -17.23 64.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.989 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -108.32 1.02 21.6 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -118.36 -3.98 10.93 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.06 0.457 . . . . 0.0 110.506 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.605 HG12 ' O ' ' A' ' 63' ' ' LEU . 9.3 m -69.73 136.63 25.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.862 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -85.73 94.15 9.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.625 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -89.98 -2.26 58.11 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 171.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 66.2 mtm . . . . . 0 C--O 1.248 1.016 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.96 176.329 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 120.459 0.171 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.6 m -72.57 107.15 4.93 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.568 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -60.98 -53.99 50.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.004 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.589 ' HZ ' ' H ' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -132.01 -178.5 4.92 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.384 177.201 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -120.34 112.36 18.92 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.164 0.507 . . . . 0.0 110.303 172.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.829 ' HA ' ' CD ' ' A' ' 26' ' ' GLN . 30.2 p -38.6 142.31 0.2 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.056 167.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.438 ' O ' HD11 ' A' ' 34' ' ' ILE . 74.1 m -57.0 143.2 39.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.209 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.3 mt -82.56 10.27 7.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.91 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.22 162.89 34.29 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.172 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.722 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 39.1 m-85 -116.19 -178.89 3.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.913 0.387 . . . . 0.0 110.304 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.8 t -96.0 -178.68 4.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.135 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -144.83 23.37 1.56 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.073 0.463 . . . . 0.0 110.717 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.529 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 40.6 mtt180 -109.65 -174.08 2.41 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.76 0.791 . . . . 0.0 113.001 -173.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.549 HD12 ' CD1' ' A' ' 55' ' ' TRP . 6.2 mm -117.71 77.69 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 113.598 -1.637 . . . . 0.0 107.912 167.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 13' ' ' ARG . 2.8 mm? -75.45 158.33 32.81 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.798 ' HD1' ' HD2' ' A' ' 18' ' ' LYS . 42.1 m170 -132.1 174.59 4.52 Favored Pre-proline 0 C--N 1.306 -1.285 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.857 -176.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.72 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 9.4 Cg_endo -54.52 -26.56 45.85 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.807 1.671 . . . . 0.0 108.954 166.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.798 ' HD2' ' HD1' ' A' ' 16' ' ' HIS . 67.4 mttm -46.27 -34.8 4.71 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 113.676 -1.602 . . . . 0.0 111.726 173.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -124.93 -4.6 7.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.632 0.253 . . . . 0.0 111.626 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.79 HG12 ' HB3' ' A' ' 39' ' ' PHE . 11.6 mt -102.83 114.86 43.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.071 0.462 . . . . 0.0 110.86 -173.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.9 -5.36 11.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.63 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -150.8 159.94 28.38 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.459 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 2.3 t80 -154.66 137.07 14.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.222 0.534 . . . . 0.0 110.483 -176.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.2 m -143.82 104.01 4.12 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.674 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -73.77 104.13 4.56 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.898 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.829 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 11.0 tt0 -90.14 125.88 35.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.216 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.589 ' H ' ' HZ ' ' A' ' 4' ' ' PHE . 7.9 mp -105.93 173.97 6.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.46 0.647 . . . . 0.0 112.156 -170.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.43 16.82 21.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.286 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -118.11 7.55 12.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.287 -173.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -119.63 37.49 4.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.174 0.511 . . . . 0.0 110.751 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.68 -62.31 0.29 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.052 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -71.64 143.75 49.66 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -97.27 9.78 41.3 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -170.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.76 HG12 ' SG ' ' A' ' 6' ' ' CYS . 4.5 pt -128.23 156.83 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 172.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -120.23 122.25 40.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.194 0.521 . . . . 0.0 111.524 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 26' ' ' GLN . . . -121.2 137.11 54.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.809 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.619 ' HB ' ' HB1' ' A' ' 49' ' ' ALA . 48.0 mm -82.6 98.56 4.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.158 0.504 . . . . 0.0 109.905 178.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.463 HG22 ' HB2' ' A' ' 46' ' ' SER . 67.0 mt -76.91 105.83 6.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.036 0.446 . . . . 0.0 111.273 -176.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.79 ' HB3' HG12 ' A' ' 20' ' ' ILE . 19.8 m-85 -96.29 119.42 34.75 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -89.01 106.09 18.2 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.429 ' C ' ' H ' ' A' ' 43' ' ' LYS . 21.9 p -72.57 164.0 27.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.645 -175.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -71.47 6.54 1.77 Allowed 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.421 0.629 . . . . 0.0 110.55 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.429 ' H ' ' C ' ' A' ' 41' ' ' THR . 63.1 tttm -101.81 9.41 40.8 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.126 173.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 68.41 14.07 9.09 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.663 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.5 mt -103.05 131.48 50.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.051 0.453 . . . . 0.0 110.699 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.463 ' HB2' HG22 ' A' ' 38' ' ' ILE . 5.7 p -80.58 102.54 9.85 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.541 177.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 77.8 t -84.93 124.03 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.743 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.8 m -88.82 90.58 8.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.739 0.781 . . . . 0.0 109.496 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.619 ' HB1' ' HB ' ' A' ' 37' ' ' ILE . . . -70.87 134.82 47.62 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.818 -174.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.722 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -70.26 129.15 90.8 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.22 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.39 -6.5 13.58 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.387 2.058 . . . . 0.0 112.676 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -76.43 -37.56 56.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.777 0.799 . . . . 0.0 111.254 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.611 HE21 HG23 ' A' ' 56' ' ' VAL . 7.0 mt-30 -72.79 134.96 45.16 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.862 -164.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.22 -26.62 60.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.861 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.549 ' CD1' HD12 ' A' ' 14' ' ' ILE . 55.8 p-90 -65.31 -32.45 74.1 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 173.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.611 HG23 HE21 ' A' ' 53' ' ' GLN . 43.2 t -70.04 -50.5 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.829 173.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 96.5 mttt -59.3 -28.08 66.46 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.696 0.622 . . . . 0.0 111.281 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -71.06 -56.86 5.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.7 0.286 . . . . 0.0 110.309 173.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.656 HG22 HD21 ' A' ' 63' ' ' LEU . 81.9 mt -60.19 -45.95 95.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 -177.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 56' ' ' VAL . 9.8 p -70.3 -26.42 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.362 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -60.55 -43.11 97.6 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 174.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.2 mt -72.78 -41.2 65.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.489 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.656 HD21 HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -62.31 -46.4 88.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.348 -0.387 . . . . 0.0 112.043 -179.017 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 p -64.34 -25.18 67.92 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -173.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 65' ' ' LYS . 11.5 mptt -101.41 -7.79 22.6 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -112.17 -31.79 6.76 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.984 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 48.1 t -82.72 119.38 32.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.046 0.451 . . . . 0.0 111.029 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -85.72 105.52 16.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.82 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -93.76 -6.23 46.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.273 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 51.1 tpp . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.936 179.26 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.46 148.95 47.97 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -68.5 -66.01 0.63 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 171.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.516 ' HE2' ' HG2' ' A' ' 26' ' ' GLN . 17.2 p90 -131.03 162.82 28.96 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.584 -1.189 . . . . 0.0 107.953 172.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -118.73 111.5 18.57 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.008 0.909 . . . . 0.0 110.323 173.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.559 ' HB3' ' HG2' ' A' ' 26' ' ' GLN . 30.1 p -60.43 -179.85 0.13 Allowed 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 113.779 -1.555 . . . . 0.0 113.125 -179.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.8 t -50.74 114.14 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.607 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.1 mt -90.45 17.92 6.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.662 -176.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.54 113.39 0.7 Allowed Glycine 0 C--O 1.225 -0.415 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.75 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 33.6 m-85 -85.27 168.68 14.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.126 0.489 . . . . 0.0 111.239 -173.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.569 HG23 ' HA ' ' A' ' 49' ' ' ALA . 11.1 t -86.75 -177.48 6.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.938 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -141.23 16.57 2.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.935 -177.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.534 ' HB3' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -104.76 175.16 5.58 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.213 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.547 HD11 ' CD1' ' A' ' 55' ' ' TRP . 2.8 mm -110.34 90.07 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 113.813 -1.539 . . . . 0.0 108.173 161.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.583 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 2.5 mm? -88.97 167.2 13.39 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.597 ' O ' HD13 ' A' ' 20' ' ' ILE . 63.2 m170 -133.07 167.83 21.01 Favored Pre-proline 0 C--N 1.314 -0.947 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.0 -175.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.638 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 22.8 Cg_endo -63.42 -19.07 67.29 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.121 1.881 . . . . 0.0 109.214 165.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.594 ' HD2' ' HD1' ' A' ' 16' ' ' HIS . 85.6 mttt -55.35 -24.66 30.47 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.417 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 41' ' ' THR . 50.2 m-85 -128.29 2.53 5.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.946 -175.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.638 ' HB ' ' HA ' ' A' ' 17' ' ' PRO . 1.0 OUTLIER -100.85 122.78 53.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.098 0.475 . . . . 0.0 110.587 -175.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.03 -9.96 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.67 175.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -148.43 161.28 28.6 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.41 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.539 ' CE2' HG23 ' A' ' 60' ' ' VAL . 1.8 t80 -156.05 134.01 11.25 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -176.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.498 HG22 ' OE1' ' A' ' 26' ' ' GLN . 22.9 m -141.02 112.69 7.58 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.399 176.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 11.7 ttp180 -101.73 117.65 35.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.936 0.398 . . . . 0.0 111.202 -176.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.559 ' HG2' ' HB3' ' A' ' 6' ' ' CYS . 1.2 mp0 -97.75 139.01 34.26 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.806 174.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.522 HD11 ' HG3' ' A' ' 30' ' ' GLU . 5.2 mp -124.64 159.54 30.53 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 123.628 0.58 . . . . 0.0 109.767 -177.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.719 ' HA ' ' O ' ' A' ' 32' ' ' CYS . . . -77.01 1.08 18.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.818 0.818 . . . . 0.0 110.722 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -116.44 2.77 13.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.619 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.522 ' HG3' HD11 ' A' ' 27' ' ' LEU . 7.1 mm-40 -107.48 -8.75 16.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.849 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.12 -56.74 0.47 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.154 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.719 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 9.5 t -57.99 151.07 19.24 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 122.88 0.472 . . . . 0.0 109.98 174.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -84.39 -21.74 30.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.092 0.472 . . . . 0.0 109.911 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.415 HG13 ' SG ' ' A' ' 6' ' ' CYS . 46.9 pt -110.41 -171.46 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 173.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -138.86 119.29 13.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.445 0.64 . . . . 0.0 110.477 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.74 137.53 53.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.055 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 15.5 mm -96.47 92.32 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.217 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 40.5 mt -79.63 101.16 4.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.852 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.471 ' CE1' ' HD2' ' A' ' 23' ' ' PHE . 20.8 m-85 -85.13 131.2 34.48 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 171.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -100.02 107.89 19.94 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 41.1 p -71.14 159.21 35.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.762 -174.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -3.08 12.28 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.576 0.703 . . . . 0.0 109.642 171.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -90.97 1.22 57.22 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.112 174.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 70.42 16.32 7.13 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.638 -1.164 . . . . 0.0 112.057 173.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.8 mt -107.2 136.56 46.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.825 175.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.8 p -84.47 120.82 26.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.062 0.458 . . . . 0.0 110.477 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 91.0 t -104.2 124.36 58.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.962 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.5 m -85.53 82.79 8.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.661 0.743 . . . . 0.0 109.385 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.575 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -69.64 143.55 53.19 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.034 -173.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.75 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -81.29 128.33 70.72 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.924 -176.046 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -71.19 13.49 0.4 Allowed 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.761 2.308 . . . . 0.0 112.303 173.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 50' ' ' ASN . 55.6 mtpt -99.47 -23.94 14.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.172 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.53 HE21 HG23 ' A' ' 56' ' ' VAL . 5.0 pt20 -102.63 145.77 29.16 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.737 -167.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.3 -30.83 63.66 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.638 -171.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.583 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 42.6 p-90 -63.34 -32.87 74.41 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.368 177.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.575 ' CG2' ' HB1' ' A' ' 49' ' ' ALA . 8.6 t -72.09 -46.14 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.38 174.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.491 ' HA ' HG11 ' A' ' 60' ' ' VAL . 88.6 mttt -60.5 -34.65 74.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.903 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -64.37 -50.07 69.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.395 174.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 55' ' ' TRP . 68.0 mt -68.88 -45.96 79.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.481 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.539 HG23 ' CE2' ' A' ' 23' ' ' PHE . 12.8 p -65.65 -35.35 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.89 -0.141 . . . . 0.0 111.297 -178.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 36.9 ttm180 -65.39 -33.84 76.89 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 30.6 tp -74.64 -38.1 62.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.236 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.446 ' HG ' ' CB ' ' A' ' 23' ' ' PHE . 2.8 mm? -69.52 -26.17 64.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.55 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.1 p -98.38 12.56 34.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.322 0.582 . . . . 0.0 110.25 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 59.8 tttp -102.17 8.47 40.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.946 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -79.28 58.01 2.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.916 0.865 . . . . 0.0 109.885 176.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -104.23 178.0 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.165 -176.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -78.23 91.88 4.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -98.3 -57.82 2.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.318 -175.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 17.1 tpt . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.139 -0.934 . . . . 0.0 109.261 -179.676 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 120.926 0.393 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.482 ' HB3' ' HA2' ' A' ' 31' ' ' GLY . 17.1 m -68.96 125.99 28.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.609 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -69.27 -45.85 68.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.298 0.571 . . . . 0.0 109.642 175.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.49 ' HZ ' ' H ' ' A' ' 27' ' ' LEU . 2.1 p90 -130.06 -172.64 2.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.804 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -135.09 116.45 14.59 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.821 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.699 ' SG ' HG12 ' A' ' 34' ' ' ILE . 19.6 p -38.08 150.84 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.321 170.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.0 t -62.63 152.69 34.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.328 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.9 mt -74.97 2.14 11.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.45 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.13 -153.92 12.31 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.81 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 64.0 m-85 -137.37 -171.47 2.98 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.516 HG22 ' CG1' ' A' ' 47' ' ' VAL . 11.2 t -127.19 136.88 52.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.075 0.464 . . . . 0.0 111.045 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -101.97 56.65 0.81 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.822 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.548 ' NE ' ' HA ' ' A' ' 13' ' ' ARG . 3.3 mmp_? -122.65 -177.16 3.57 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.517 0.675 . . . . 0.0 112.088 -177.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.606 HD11 ' CD1' ' A' ' 55' ' ' TRP . 3.5 mm -125.4 87.2 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 114.228 -1.351 . . . . 0.0 107.789 167.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.588 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.8 mm? -88.14 161.0 17.53 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.714 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 48.4 m170 -131.77 174.8 4.28 Favored Pre-proline 0 C--N 1.31 -1.115 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.275 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.714 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 10.1 Cg_endo -56.05 -23.22 42.83 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.8 1.667 . . . . 0.0 108.99 167.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.659 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 9.5 mmmt -47.35 -26.59 1.32 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 113.541 -1.663 . . . . 0.0 112.245 173.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.443 ' O ' ' HA ' ' A' ' 41' ' ' THR . 86.4 m-85 -126.86 -11.35 6.03 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 122.195 -0.316 . . . . 0.0 111.682 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.564 HG13 ' HB3' ' A' ' 39' ' ' PHE . 1.4 mp -89.65 122.59 41.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.062 0.458 . . . . 0.0 110.988 -171.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.53 -8.07 8.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.769 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -154.19 155.59 26.28 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.709 ' HB2' HD11 ' A' ' 63' ' ' LEU . 2.4 t80 -147.67 137.54 22.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.908 0.385 . . . . 0.0 110.278 -177.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 50.3 m -145.22 110.58 5.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.577 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -83.9 139.3 32.7 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.619 ' NE2' ' HA ' ' A' ' 6' ' ' CYS . 1.9 pt20 -119.26 108.41 14.6 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.784 0.802 . . . . 0.0 110.704 177.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.49 ' H ' ' HZ ' ' A' ' 4' ' ' PHE . 86.2 mt -98.24 165.04 12.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.958 -175.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.791 ' HA ' ' O ' ' A' ' 32' ' ' CYS . . . -82.7 11.31 6.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.586 -177.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -108.58 -19.87 13.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.839 0.352 . . . . 0.0 111.73 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.406 ' HG3' ' CE2' ' A' ' 4' ' ' PHE . 2.7 pt-20 -134.39 30.77 3.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.118 0.485 . . . . 0.0 111.769 -170.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.482 ' HA2' ' HB3' ' A' ' 2' ' ' SER . . . 176.72 -86.83 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 119.933 -1.127 . . . . 0.0 113.119 177.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.791 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 42.2 t -105.64 170.11 8.08 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.572 -0.314 . . . . 0.0 110.904 -175.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.402 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 9.5 m-20 -83.59 -21.87 32.47 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.096 0.247 . . . . 0.0 111.618 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.699 HG12 ' SG ' ' A' ' 6' ' ' CYS . 2.0 pt -100.0 157.33 3.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -115.26 130.54 56.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.367 0.603 . . . . 0.0 111.246 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.59 ' HB1' ' OE1' ' A' ' 26' ' ' GLN . . . -139.08 166.46 24.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.597 175.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 43.5 mm -113.88 106.19 20.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.161 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 66.0 mt -83.64 105.08 12.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 O-C-N 121.734 -0.603 . . . . 0.0 111.238 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.564 ' HB3' HG13 ' A' ' 20' ' ' ILE . 14.0 m-85 -94.96 111.85 23.61 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 171.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -84.45 112.98 20.86 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 28.2 p -76.33 166.01 24.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.128 0.49 . . . . 0.0 111.123 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -71.14 2.97 3.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.617 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.425 ' H ' ' C ' ' A' ' 41' ' ' THR . 36.0 mmtp -98.82 5.64 47.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.568 176.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 67.2 mttm 68.42 12.58 8.77 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.805 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.5 mt -97.82 130.65 44.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.022 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.4 p -86.66 106.64 17.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.298 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.516 ' CG1' HG22 ' A' ' 11' ' ' THR . 66.4 t -86.82 124.93 40.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.9 m -88.61 83.89 6.76 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.718 0.771 . . . . 0.0 109.985 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.556 ' HB2' ' CG2' ' A' ' 56' ' ' VAL . . . -69.82 141.59 53.27 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.397 -175.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.81 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -80.53 130.21 65.72 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.083 -179.075 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -73.2 23.47 0.31 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.831 1.688 . . . . 0.0 111.666 171.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 50' ' ' ASN . 32.2 mtmm -115.24 -17.21 11.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.547 -176.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.526 HE21 HG22 ' A' ' 56' ' ' VAL . 5.8 pt20 -109.5 145.23 36.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 -170.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.679 ' HA ' ' HG2' ' A' ' 57' ' ' LYS . 1.3 p -81.5 -23.1 37.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -170.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.606 ' CD1' HD11 ' A' ' 14' ' ' ILE . 54.9 p-90 -63.19 -32.83 74.33 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 173.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.556 ' CG2' ' HB2' ' A' ' 49' ' ' ALA . 25.3 t -69.16 -46.98 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.792 172.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.679 ' HG2' ' HA ' ' A' ' 54' ' ' THR . 6.9 mmtp -55.89 -38.47 70.22 Favored 'General case' 0 C--O 1.222 -0.383 0 O-C-N 123.426 0.454 . . . . 0.0 110.737 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -65.22 -53.81 38.93 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.707 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.516 HG22 HD12 ' A' ' 63' ' ' LEU . 78.9 mt -62.74 -45.71 98.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.874 -177.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.548 HG11 ' O ' ' A' ' 56' ' ' VAL . 12.5 p -70.02 -24.9 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 120.911 -0.315 . . . . 0.0 110.903 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 49.8 ttp180 -64.45 -35.14 79.95 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.16 0.505 . . . . 0.0 110.256 176.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.6 mt -84.42 -25.22 29.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.968 177.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.709 HD11 ' HB2' ' A' ' 23' ' ' PHE . 77.5 mt -87.68 -31.28 19.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.307 -176.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t -79.84 -34.51 39.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.215 0.531 . . . . 0.0 109.74 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.743 ' HB3' ' HZ2' ' A' ' 65' ' ' LYS . 4.5 ttpm? -127.8 86.81 2.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.299 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -96.96 108.08 20.73 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.9 m -93.11 124.35 45.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.53 0.681 . . . . 0.0 111.759 -174.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.867 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -106.7 0.81 24.56 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.842 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -117.29 146.62 43.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.934 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 81.1 mtp . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.152 177.762 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 120.726 0.298 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.493 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 14.2 m -127.81 116.53 20.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.565 -0.288 . . . . 0.0 110.227 178.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -75.1 -44.94 44.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.178 0.513 . . . . 0.0 110.012 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.732 ' HZ ' ' H ' ' A' ' 27' ' ' LEU . 0.9 OUTLIER -130.65 -172.92 2.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.493 176.518 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -131.02 106.04 8.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.328 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.791 ' HA ' ' CD ' ' A' ' 26' ' ' GLN . 26.6 p -35.62 142.55 0.07 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 114.878 -1.055 . . . . 0.0 113.678 170.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.476 ' O ' HD13 ' A' ' 34' ' ' ILE . 43.1 t -73.03 127.75 33.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.088 171.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.7 mt -81.93 45.34 0.9 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.146 0.498 . . . . 0.0 110.742 -174.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 166.26 157.65 10.37 Favored Glycine 0 N--CA 1.44 -1.048 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.812 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 25.2 m-85 -123.87 162.33 23.5 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 117.159 0.479 . . . . 0.0 110.488 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.5 t -90.18 -175.58 4.58 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.404 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -144.78 31.18 1.17 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.553 0.692 . . . . 0.0 109.813 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.534 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 35.2 mmt180 -87.68 -176.6 5.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.714 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.489 HD11 ' CD1' ' A' ' 55' ' ' TRP . 16.4 mm -124.93 77.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.654 165.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.745 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.2 mm? -74.76 153.7 38.68 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.057 -178.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.706 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 42.9 m170 -132.66 173.63 5.66 Favored Pre-proline 0 C--N 1.317 -0.847 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.622 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.706 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 13.0 Cg_endo -58.86 -23.84 69.33 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 121.718 1.612 . . . . 0.0 108.825 167.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 8.7 mmmt -47.22 -34.4 6.38 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 113.434 -1.712 . . . . 0.0 111.931 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.672 ' HA ' ' HE3' ' A' ' 42' ' ' LYS . 27.0 m-85 -125.44 -0.2 7.59 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.655 0.264 . . . . 0.0 111.338 -175.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.441 HD11 ' O ' ' A' ' 16' ' ' HIS . 1.3 mp -96.46 126.75 49.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.0 0.428 . . . . 0.0 110.635 -175.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.12 -6.8 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.999 174.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -157.73 154.27 25.38 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.542 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.597 ' CZ ' HG22 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -145.02 132.99 21.29 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.477 0.656 . . . . 0.0 110.386 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.7 m -132.93 121.06 22.27 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.469 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -86.68 114.03 23.04 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.508 0.671 . . . . 0.0 110.412 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.791 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 21.6 tt0 -104.27 121.91 44.31 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.876 177.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.732 ' H ' ' HZ ' ' A' ' 4' ' ' PHE . 6.5 mp -109.31 178.65 4.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.946 -170.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -111.52 26.58 10.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.922 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -130.7 -12.82 3.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.489 -175.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -115.05 23.51 12.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.462 -174.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 2' ' ' SER . . . 164.42 -91.79 0.11 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.358 177.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 6' ' ' CYS . 18.5 m -66.16 169.56 6.89 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.997 0.427 . . . . 0.0 111.976 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -99.22 -6.02 28.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.089 176.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.476 HD13 ' O ' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -108.61 153.41 10.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 174.561 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.501 ' OD1' ' HG2' ' A' ' 51' ' ' PRO . 4.8 p30 -127.09 129.64 48.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.801 -0.181 . . . . 0.0 111.28 -173.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.753 ' O ' ' HB3' ' A' ' 26' ' ' GLN . . . -134.68 127.37 30.93 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.244 0.545 . . . . 0.0 111.962 176.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.3 mm -70.05 117.61 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 170.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 55.8 mt -94.42 104.41 15.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 120.834 0.349 . . . . 0.0 111.117 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.672 ' CE2' HG12 ' A' ' 56' ' ' VAL . 12.1 m-85 -93.98 127.73 39.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 173.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -98.03 108.81 21.6 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.1 p -74.0 160.15 31.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.068 -174.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.672 ' HE3' ' HA ' ' A' ' 19' ' ' PHE . 18.0 ptpt -66.07 -3.03 4.71 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.317 172.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -89.66 0.54 56.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.633 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.722 ' HB2' ' HZ2' ' A' ' 44' ' ' LYS . 8.3 mtmp? 71.89 15.6 5.69 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.981 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.0 mt -107.88 136.66 47.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.904 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.1 p -87.16 118.57 26.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.301 0.572 . . . . 0.0 110.007 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 76.5 t -97.24 134.05 36.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.083 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.3 m -89.12 87.44 7.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.429 ' HB1' ' CG1' ' A' ' 56' ' ' VAL . . . -79.49 143.07 35.25 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.409 -174.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.812 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -82.53 122.19 78.6 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.524 -174.2 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.501 ' HG2' ' OD1' ' A' ' 35' ' ' ASN . 19.8 Cg_exo -70.18 9.8 0.62 Allowed 'Trans proline' 0 C--N 1.329 -0.479 0 C-N-CA 122.279 1.986 . . . . 0.0 112.368 175.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.429 ' H ' ' C ' ' A' ' 50' ' ' ASN . 51.3 mttm -104.33 -14.27 15.83 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.406 -176.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.739 ' CG ' ' HB2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -89.53 168.13 12.42 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -176.454 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.23 -33.51 14.65 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.745 ' CZ3' ' HB2' ' A' ' 15' ' ' LEU . 59.3 p-90 -62.19 -28.58 69.77 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.823 -177.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.672 HG12 ' CE2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -71.04 -49.91 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 174.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 93.9 mttt -55.03 -33.85 63.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.687 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -64.37 -52.67 57.12 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.211 0.529 . . . . 0.0 110.486 174.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 15' ' ' LEU . 87.7 mt -65.85 -48.96 80.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.74 -176.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.597 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 7.8 p -65.53 -28.37 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.836 0.35 . . . . 0.0 110.754 -176.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -69.03 -35.43 76.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.212 0.53 . . . . 0.0 109.672 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.4 tp -79.02 -32.63 45.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.995 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.468 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 1.9 mm? -67.63 -42.5 82.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.275 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.7 p -77.09 -49.98 14.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.894 0.378 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -94.59 69.94 3.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.159 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -68.77 97.89 0.86 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.328 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.1 p -100.54 -16.82 7.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.504 0.669 . . . . 0.0 110.118 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -77.65 108.6 10.97 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.889 -176.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -119.77 129.48 54.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.356 176.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 60.0 ttp . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.77 178.769 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p -83.1 93.76 7.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.086 0.469 . . . . 0.0 111.783 -175.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -66.25 -41.83 89.41 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 167.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.562 ' CZ ' ' HA ' ' A' ' 26' ' ' GLN . 44.5 p90 -131.1 -168.01 1.93 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.77 -1.559 . . . . 0.0 107.511 168.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.691 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 4.3 p-10 -128.79 -93.1 0.45 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.764 0.793 . . . . 0.0 111.573 173.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.756 ' HB2' HG12 ' A' ' 34' ' ' ILE . 18.7 p -146.88 -168.78 3.13 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 125.146 1.378 . . . . 0.0 108.7 -177.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.1 t -106.54 158.37 16.97 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.927 -0.483 . . . . 0.0 110.425 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.7 mt -77.73 -27.94 50.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.933 0.397 . . . . 0.0 110.828 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.83 136.3 4.08 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.768 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 20.1 m-85 -78.47 173.63 12.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.486 0.66 . . . . 0.0 111.047 -177.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.8 t -89.02 -178.55 5.72 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.94 174.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -140.63 1.86 1.76 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.011 0.434 . . . . 0.0 110.169 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.601 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 32.7 mtt180 -94.23 -172.42 2.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.641 -166.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.606 HD11 ' CD1' ' A' ' 55' ' ' TRP . 3.3 mm -117.64 88.79 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.599 -1.182 . . . . 0.0 107.982 167.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.601 ' CD2' ' HB2' ' A' ' 13' ' ' ARG . 2.9 mm? -88.34 164.77 15.39 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.926 ' HD1' ' HD2' ' A' ' 18' ' ' LYS . 63.2 m170 -132.97 163.63 49.66 Favored Pre-proline 0 C--N 1.311 -1.105 0 C-N-CA 119.831 -0.748 . . . . 0.0 112.151 -174.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.621 ' HD3' HG12 ' A' ' 59' ' ' ILE . 26.7 Cg_endo -64.28 -17.18 58.75 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.213 1.942 . . . . 0.0 109.174 167.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.926 ' HD2' ' HD1' ' A' ' 16' ' ' HIS . 60.8 mttm -51.66 -29.23 17.14 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.361 172.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -128.01 11.37 6.55 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.62 -174.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.624 HG12 ' O ' ' A' ' 16' ' ' HIS . 7.5 mm -106.69 127.64 62.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -173.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.3 m -118.56 -3.49 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.146 0.498 . . . . 0.0 110.934 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -155.29 158.91 28.76 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.004 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.703 ' HB2' HD12 ' A' ' 63' ' ' LEU . 1.4 t80 -155.47 134.68 12.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.239 0.542 . . . . 0.0 110.183 -177.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.427 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 25.5 m -142.06 107.08 4.93 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.867 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 25' ' ' ARG . 14.1 ptp180 -77.02 109.03 10.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.827 0.822 . . . . 0.0 110.112 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.576 ' OE1' ' HB1' ' A' ' 36' ' ' ALA . 2.4 tt0 -99.05 133.11 43.79 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.218 -175.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.535 ' H ' ' HE1' ' A' ' 4' ' ' PHE . 96.0 mt -122.18 158.9 28.36 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -159.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.72 31.24 4.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.737 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -99.41 -73.42 0.63 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.745 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -110.9 23.12 14.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.574 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -129.53 -71.93 0.13 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.345 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.691 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 47.3 t -128.63 -172.08 2.62 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.441 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 0.9 OUTLIER -96.85 -23.55 16.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.957 0.408 . . . . 0.0 109.923 178.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.756 HG12 ' HB2' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -109.03 159.75 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 175.352 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -132.56 132.13 42.24 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.915 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.576 ' HB1' ' OE1' ' A' ' 26' ' ' GLN . . . -129.1 145.13 51.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.415 0.626 . . . . 0.0 111.63 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.739 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 47.9 mm -88.79 104.77 15.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.861 177.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 24' ' ' THR . 58.1 mt -79.65 103.05 6.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 O-C-N 122.108 -0.37 . . . . 0.0 111.386 -176.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -91.65 123.82 35.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 171.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -97.66 108.93 21.76 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.2 p -75.84 157.49 33.29 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.116 0.484 . . . . 0.0 111.37 -175.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -68.17 -10.33 53.44 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.426 ' HE2' ' HB2' ' A' ' 43' ' ' LYS . 23.0 ttmm -89.92 14.18 12.77 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.702 -177.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp 71.0 13.55 6.94 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.046 173.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.5 mt -112.66 142.15 45.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.968 0.413 . . . . 0.0 111.042 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.0 p -99.13 112.64 24.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.222 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.2 t -92.48 120.31 41.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.354 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.9 m -83.44 89.21 7.02 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.808 0.813 . . . . 0.0 109.269 177.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.739 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -71.18 140.33 50.47 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.387 -174.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.768 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -79.97 126.06 80.6 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.175 -179.213 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.1 13.98 0.48 Allowed 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.321 2.014 . . . . 0.0 111.613 174.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.503 ' H ' ' C ' ' A' ' 50' ' ' ASN . 74.8 mttt -100.5 -21.51 15.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.136 -175.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.565 HE21 ' CG2' ' A' ' 56' ' ' VAL . 5.8 pt20 -109.57 148.46 31.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.646 -167.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p -75.03 -33.65 61.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -170.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.606 ' CD1' HD11 ' A' ' 14' ' ' ILE . 49.7 p-90 -61.34 -32.58 72.47 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.352 0.596 . . . . 0.0 109.491 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.607 HG21 ' HB2' ' A' ' 49' ' ' ALA . 14.7 t -70.51 -51.29 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.171 174.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 95.2 mttt -58.05 -32.12 67.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.968 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -68.04 -56.37 9.15 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.395 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.621 HG12 ' HD3' ' A' ' 17' ' ' PRO . 72.5 mt -61.02 -43.34 95.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.222 -176.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.633 HG22 ' CE1' ' A' ' 23' ' ' PHE . 13.8 p -65.45 -35.03 74.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.374 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -68.63 -33.08 73.41 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.989 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 29.8 mt -77.66 -33.44 53.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.094 0.473 . . . . 0.0 110.701 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.703 HD12 ' HB2' ' A' ' 23' ' ' PHE . 78.7 mt -79.24 -12.49 59.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.989 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 m -121.18 67.37 0.87 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.526 173.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -60.12 86.67 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.532 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -101.46 14.28 32.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.263 0.554 . . . . 0.0 110.172 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.9 m -85.07 14.24 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.999 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -103.59 -19.91 14.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.488 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.545 ' C ' HD21 ' A' ' 69' ' ' ASN . 0.3 OUTLIER -110.08 176.15 5.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.662 -178.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 45.9 tpp . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.537 -0.744 . . . . 0.0 109.573 176.482 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -86.99 131.43 34.09 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 173.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.789 HD21 ' HD1' ' A' ' 4' ' ' PHE . 6.4 t30 -57.21 -57.72 11.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.027 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.789 ' HD1' HD21 ' A' ' 3' ' ' ASN . 38.0 p90 -133.75 -169.51 2.31 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.144 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.512 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 30.0 t0 -141.6 112.18 7.09 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 163.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.639 ' HB3' ' HG2' ' A' ' 26' ' ' GLN . 18.5 p -58.36 174.65 0.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.788 -169.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.2 m -41.26 98.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 -169.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.1 mt -63.65 -37.28 86.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.548 173.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.38 85.58 0.42 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.775 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.511 ' HB2' ' ND2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -88.11 155.03 20.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.994 0.426 . . . . 0.0 111.254 177.504 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.408 HG22 HG13 ' A' ' 47' ' ' VAL . 14.9 t -91.11 141.94 28.28 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -166.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -104.58 74.57 1.16 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.68 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -123.44 -171.8 2.38 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.055 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.542 HD13 ' CD1' ' A' ' 55' ' ' TRP . 8.2 mm -126.54 91.78 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.147 165.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.623 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 1.7 mm? -98.15 162.77 13.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.78 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 34.2 m170 -132.63 175.46 3.69 Favored Pre-proline 0 C--N 1.317 -0.841 0 O-C-N 122.054 -0.404 . . . . 0.0 110.757 -178.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.78 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 18.9 Cg_endo -60.25 -16.95 43.68 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.106 1.871 . . . . 0.0 109.453 166.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 9.1 mtmt -45.91 -35.54 4.69 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 114.111 -1.404 . . . . 0.0 111.779 172.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -126.68 2.22 6.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.024 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.592 ' HB ' ' HA ' ' A' ' 17' ' ' PRO . 1.2 mp -92.44 124.32 44.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.81 0.338 . . . . 0.0 110.116 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.3 m -121.34 -1.18 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.977 0.418 . . . . 0.0 110.333 176.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.92 157.94 29.48 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.676 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.721 ' HB2' HD13 ' A' ' 63' ' ' LEU . 2.8 t80 -151.01 134.29 16.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.193 0.521 . . . . 0.0 110.564 -177.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.405 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 32.2 m -146.15 102.32 3.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.265 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -74.58 126.7 31.37 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.711 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.639 ' HG2' ' HB3' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -101.35 126.87 48.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.689 -177.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.3 mp -125.17 153.42 43.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.335 0.588 . . . . 0.0 111.712 -171.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HA ' ' C ' ' A' ' 32' ' ' CYS . . . -64.57 -23.58 67.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.328 174.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.409 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.9 OUTLIER -67.38 -24.87 65.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.366 -176.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -102.72 -32.62 9.76 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.866 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.38 41.24 0.02 OUTLIER Glycine 0 C--O 1.221 -0.682 0 C-N-CA 119.998 -1.096 . . . . 0.0 112.306 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 53.8 t -133.8 -179.71 5.71 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 173.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -118.23 -32.18 4.77 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.974 169.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.5 pt -95.75 -156.58 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 169.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -150.93 137.36 18.63 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.115 0.483 . . . . 0.0 110.132 174.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.49 145.11 33.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.071 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.783 ' HB ' ' HB1' ' A' ' 49' ' ' ALA . 46.4 mm -93.57 108.25 20.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 24' ' ' THR . 33.6 mm -85.91 99.03 7.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 O-C-N 121.982 -0.449 . . . . 0.0 110.636 -177.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.433 ' HB3' HG13 ' A' ' 20' ' ' ILE . 17.1 m-85 -90.59 122.9 33.8 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 174.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -93.6 107.35 19.22 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.5 p -79.36 164.58 23.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.119 0.485 . . . . 0.0 111.698 -174.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -72.86 -1.63 17.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 122.151 0.976 . . . . 0.0 108.59 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.409 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 12.6 tptt -86.14 9.0 18.71 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.505 173.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.8 pttm 46.89 34.04 2.48 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.455 1.102 . . . . 0.0 111.686 -173.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 43' ' ' LYS . 94.0 mt -119.47 131.13 55.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.072 175.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.9 p -84.9 105.69 15.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.382 0.611 . . . . 0.0 110.651 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.408 HG13 HG22 ' A' ' 11' ' ' THR . 54.3 t -79.62 126.28 39.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.601 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 58.8 m -84.67 88.86 7.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.783 ' HB1' ' HB ' ' A' ' 37' ' ' ILE . . . -76.72 134.67 39.14 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.629 -176.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.587 ' N ' HD21 ' A' ' 50' ' ' ASN . 0.7 OUTLIER -77.35 134.99 66.01 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.106 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -74.25 7.29 2.62 Favored 'Trans proline' 0 C--N 1.33 -0.398 0 C-N-CA 122.502 2.135 . . . . 0.0 110.614 168.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.465 ' H ' ' C ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -90.3 -17.48 27.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.265 -177.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.525 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 6.2 pt20 -118.83 150.72 39.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.859 -168.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.73 ' HA ' ' HG2' ' A' ' 57' ' ' LYS . 1.7 p -91.45 -17.75 25.27 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -170.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.623 ' CZ3' ' HB2' ' A' ' 15' ' ' LEU . 58.1 p-90 -63.62 -32.8 74.38 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 172.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 49' ' ' ALA . 38.9 t -66.52 -47.28 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.839 171.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.73 ' HG2' ' HA ' ' A' ' 54' ' ' THR . 13.4 mmtp -54.45 -39.0 66.98 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.168 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.495 ' HD1' HH21 ' A' ' 61' ' ' ARG . 5.8 t80 -67.41 -53.69 26.94 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.087 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.54 HG21 HD11 ' A' ' 63' ' ' LEU . 71.0 mt -61.34 -45.16 99.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.954 -176.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.539 HG11 ' O ' ' A' ' 56' ' ' VAL . 12.0 p -70.15 -23.47 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 120.784 0.326 . . . . 0.0 110.688 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.495 HH21 ' HD1' ' A' ' 58' ' ' TYR . 43.5 ttp180 -66.46 -29.64 69.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.136 0.493 . . . . 0.0 110.113 175.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.3 mp -87.58 -36.74 17.37 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.599 174.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.721 HD13 ' HB2' ' A' ' 23' ' ' PHE . 91.0 mt -81.8 2.12 31.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.646 -176.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.3 p -95.41 -38.55 10.43 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.701 0.286 . . . . 0.0 111.054 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -105.2 54.41 0.71 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.774 0.797 . . . . 0.0 110.691 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -58.22 108.58 0.63 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.922 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.0 m -102.65 140.62 20.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.426 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -106.62 4.34 27.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.734 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.643 HD21 ' HG2' ' A' ' 70' ' ' MET . 13.5 t30 -96.07 -65.23 0.98 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.279 -175.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.643 ' HG2' HD21 ' A' ' 69' ' ' ASN . 26.0 mmt . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.744 -0.646 . . . . 0.0 109.552 177.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 121.025 0.44 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 m -148.6 132.33 16.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.314 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -82.79 -45.03 14.85 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.606 ' CE1' ' HG3' ' A' ' 26' ' ' GLN . 15.8 p90 -130.69 -169.63 2.19 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.221 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -137.59 107.16 6.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.239 175.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.653 ' HA ' ' CD ' ' A' ' 26' ' ' GLN . 22.0 p -37.48 146.43 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 171.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 37.7 m -74.96 148.26 40.14 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.211 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.6 mt -70.69 -9.26 56.75 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.153 0.501 . . . . 0.0 110.681 176.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.62 160.27 28.53 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.89 ' HB2' HD21 ' A' ' 50' ' ' ASN . 0.3 OUTLIER -113.65 158.62 20.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.716 0.258 . . . . 0.0 110.846 177.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 t -88.94 145.56 25.45 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -168.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -95.12 66.2 2.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.662 0.744 . . . . 0.0 109.46 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.479 ' C ' HD11 ' A' ' 14' ' ' ILE . 36.2 mtp180 -130.85 -178.08 4.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.523 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.56 HG22 ' CD2' ' A' ' 16' ' ' HIS . 2.4 mp -121.89 91.39 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 163.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.527 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 3.5 mm? -72.14 155.87 39.79 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.031 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.717 ' HB2' ' HG2' ' A' ' 18' ' ' LYS . 65.5 m170 -131.64 159.22 72.83 Favored Pre-proline 0 C--N 1.315 -0.898 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.905 -168.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.51 -30.47 74.12 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.553 2.169 . . . . 0.0 109.882 167.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.717 ' HG2' ' HB2' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -62.95 -18.32 63.02 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.226 178.353 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -118.84 -13.3 9.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.582 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.5 HG12 ' HB3' ' A' ' 39' ' ' PHE . 23.4 mt -97.83 127.43 50.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.025 0.44 . . . . 0.0 111.249 -172.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.9 p -111.61 -16.81 8.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.419 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.48 150.89 21.85 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.584 -0.607 . . . . 0.0 111.584 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.549 ' CZ ' HG22 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -134.15 134.79 42.58 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.253 0.549 . . . . 0.0 110.637 -178.461 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.412 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 20.6 m -139.86 112.61 7.99 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.099 175.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 25' ' ' ARG . 9.0 ptp180 -75.78 130.27 38.36 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.014 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.653 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -101.03 127.02 47.74 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.898 179.161 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.575 ' H ' ' HZ ' ' A' ' 4' ' ' PHE . 4.2 mp -117.86 169.13 9.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.854 0.359 . . . . 0.0 111.125 -170.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.7 29.72 1.12 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.615 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -127.25 -53.9 1.38 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.251 -174.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -83.82 36.38 0.55 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.189 0.518 . . . . 0.0 111.707 -172.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.88 -96.28 0.16 Allowed Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.312 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 42.2 t -70.77 160.83 31.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.496 -0.352 . . . . 0.0 110.772 -178.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -92.36 0.39 57.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.597 -177.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.452 HG12 ' SG ' ' A' ' 6' ' ' CYS . 3.4 pt -116.2 167.91 8.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -132.79 136.94 46.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.973 0.416 . . . . 0.0 111.556 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.469 ' HA ' ' HG3' ' A' ' 51' ' ' PRO . . . -138.56 164.78 28.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.634 172.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.677 ' HB ' ' HB1' ' A' ' 49' ' ' ALA . 49.9 mm -96.9 112.06 28.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.432 HD13 HE21 ' A' ' 26' ' ' GLN . 60.2 mt -88.78 102.39 12.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 O-C-N 121.707 -0.62 . . . . 0.0 111.152 -178.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.565 ' HE2' HG23 ' A' ' 56' ' ' VAL . 6.9 m-85 -95.58 119.81 34.73 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.406 ' HE2' ' CB ' ' A' ' 24' ' ' THR . 4.8 m-70 -94.27 111.56 23.3 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.2 p -78.77 153.18 30.98 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.299 0.571 . . . . 0.0 111.41 -175.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -58.17 -17.83 21.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.742 173.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -83.94 10.45 9.78 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.214 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 74.62 7.34 4.46 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.416 0.686 . . . . 0.0 111.911 173.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.7 mt -102.9 135.74 44.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.866 0.365 . . . . 0.0 110.524 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.8 p -92.61 110.54 21.97 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.4 HG12 ' HG ' ' A' ' 15' ' ' LEU . 49.0 t -94.67 132.15 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.971 -176.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.8 m -85.85 91.26 8.29 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.759 0.79 . . . . 0.0 108.982 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.677 ' HB1' ' HB ' ' A' ' 37' ' ' ILE . . . -74.47 143.31 44.71 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.473 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.89 HD21 ' HB2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -81.38 142.3 50.27 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -174.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.469 ' HG3' ' HA ' ' A' ' 36' ' ' ALA . 5.1 Cg_exo -82.5 1.5 9.11 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.125 1.883 . . . . 0.0 112.714 176.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -98.03 -48.81 4.99 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -175.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.81 ' OE1' ' HB ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -65.14 166.99 8.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.122 0.487 . . . . 0.0 112.17 -174.647 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.97 -25.59 16.45 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -175.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.68 ' O ' HG13 ' A' ' 59' ' ' ILE . 58.7 p-90 -58.25 -34.75 70.82 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.73 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.81 ' HB ' ' OE1' ' A' ' 53' ' ' GLN . 1.1 t -69.59 -46.21 76.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.959 175.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -58.77 -31.7 68.61 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.482 0.489 . . . . 0.0 110.67 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -64.75 -51.79 60.45 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.918 172.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.68 HG13 ' O ' ' A' ' 55' ' ' TRP . 23.8 mt -61.64 -56.86 15.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.268 -176.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.686 HG11 ' O ' ' A' ' 56' ' ' VAL . 4.4 p -62.1 -25.45 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.337 -175.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -63.43 -47.29 82.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.764 0.316 . . . . 0.0 110.187 172.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.3 mt -78.0 -1.44 32.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.044 0.45 . . . . 0.0 110.872 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 3.4 mm? -96.84 -58.28 2.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.64 176.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.5 m -65.02 -40.0 94.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.426 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -92.58 3.91 54.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.845 0.355 . . . . 0.0 111.722 -175.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 66' ' ' LYS . 35.1 ttmt -101.18 -56.73 2.24 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.841 0.353 . . . . 0.0 110.724 -177.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 63' ' ' LEU . 14.5 m -82.66 90.31 2.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.965 0.888 . . . . 0.0 110.361 -178.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -119.02 108.62 14.96 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.893 -175.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -115.21 172.19 7.23 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.532 174.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.8 tmm? . . . . . 0 C--O 1.246 0.894 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.465 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.819 0.342 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.682 ' HA ' ' HA3' ' A' ' 31' ' ' GLY . 5.9 m -92.68 108.1 19.72 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.918 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -59.35 -52.23 66.54 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 171.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.571 ' CE2' ' HG2' ' A' ' 26' ' ' GLN . 48.3 p90 -131.62 165.0 24.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.019 173.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -122.49 114.75 21.12 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.383 0.611 . . . . 0.0 109.621 168.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.604 ' SG ' HG12 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -50.4 149.12 3.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.107 -0.951 . . . . 0.0 113.504 177.458 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 t -43.62 118.54 1.41 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.941 170.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.0 mt -68.25 -26.67 65.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.249 -174.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.87 140.12 12.19 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.716 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 42.6 m-85 -91.79 179.85 5.51 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.071 0.462 . . . . 0.0 110.708 -176.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.58 ' OG1' ' HG2' ' A' ' 13' ' ' ARG . 14.4 t -97.78 -172.02 2.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.931 177.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -147.6 17.38 1.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.005 0.431 . . . . 0.0 110.609 177.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.638 ' HB2' HD22 ' A' ' 15' ' ' LEU . 18.0 mmm180 -88.1 -173.61 4.32 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.379 0.609 . . . . 0.0 112.462 -171.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.554 HD12 ' CD1' ' A' ' 55' ' ' TRP . 5.2 mm -125.31 90.35 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 114.176 -1.374 . . . . 0.0 108.423 167.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.638 HD22 ' HB2' ' A' ' 13' ' ' ARG . 2.8 mm? -93.31 165.07 12.97 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 1.006 ' HD1' ' HD2' ' A' ' 18' ' ' LYS . 63.2 m170 -133.29 168.28 18.71 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.569 -175.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 14.0 Cg_endo -59.02 -24.3 72.78 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.055 1.836 . . . . 0.0 108.94 166.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 1.006 ' HD2' ' HD1' ' A' ' 16' ' ' HIS . 60.7 mttm -49.26 -33.3 12.56 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 114.011 -1.449 . . . . 0.0 111.04 171.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 41' ' ' THR . 76.5 m-85 -120.51 -0.98 10.19 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.744 -171.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.647 HG12 ' HB3' ' A' ' 39' ' ' PHE . 19.5 mt -104.68 118.86 52.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.061 0.457 . . . . 0.0 111.211 -173.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.86 -5.96 11.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.779 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -152.05 151.58 23.44 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.493 ' CZ ' HG22 ' A' ' 60' ' ' VAL . 1.1 t80 -148.99 129.8 14.2 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.137 0.494 . . . . 0.0 110.495 -177.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.5 m -131.4 126.28 34.74 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.033 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 25' ' ' ARG . 10.3 ptp180 -98.41 103.63 15.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.307 0.575 . . . . 0.0 111.09 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.591 ' OE1' ' HA ' ' A' ' 6' ' ' CYS . 13.9 mt-30 -77.77 126.65 31.18 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.254 176.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.697 ' HB3' HD21 ' A' ' 29' ' ' ASN . 34.2 mt -119.94 145.07 47.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.925 -171.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.699 ' HA ' ' O ' ' A' ' 32' ' ' CYS . . . -76.47 63.97 2.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.971 172.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.697 HD21 ' HB3' ' A' ' 27' ' ' LEU . 32.2 m-80 -135.42 -66.13 0.58 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.504 -174.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -105.9 51.48 0.75 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.249 0.547 . . . . 0.0 111.889 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.682 ' HA3' ' HA ' ' A' ' 2' ' ' SER . . . 130.79 -58.31 0.71 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.9 173.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 1.1 t -60.7 136.46 58.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.716 0.293 . . . . 0.0 110.733 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -87.67 -30.16 20.61 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.238 -175.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.604 HG12 ' SG ' ' A' ' 6' ' ' CYS . 37.3 pt -105.55 -152.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -153.41 121.67 6.2 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 171.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . -132.9 129.11 37.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.581 -177.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 47.1 mm -81.71 113.14 20.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.771 177.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 42.8 mt -91.47 103.66 14.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.558 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.647 ' HB3' HG12 ' A' ' 20' ' ' ILE . 16.5 m-85 -87.81 113.69 23.71 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 172.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -87.95 105.71 17.63 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 58.2 p -75.51 158.49 32.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.462 0.648 . . . . 0.0 111.826 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.538 ' HD3' ' O ' ' A' ' 42' ' ' LYS . 1.9 tmtp? -60.21 -20.99 61.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.423 172.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 82.5 tttt -84.03 11.91 7.15 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.486 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 75.4 mmtt 77.87 -20.92 0.35 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.831 0.852 . . . . 0.0 112.285 174.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.6 mt -73.46 126.57 30.5 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.971 0.415 . . . . 0.0 111.192 -177.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 p -87.18 105.34 17.13 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.843 175.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 62.1 t -82.65 130.54 35.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.804 -174.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.4 m -85.62 76.46 9.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.522 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -69.43 138.12 53.27 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.032 -173.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.716 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -80.44 127.46 75.86 Favored Pre-proline 0 CA--C 1.507 -0.678 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -177.433 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.24 14.52 0.22 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.221 1.947 . . . . 0.0 111.811 172.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.556 ' H ' ' C ' ' A' ' 50' ' ' ASN . 0.4 OUTLIER -106.44 -19.07 13.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.875 -174.239 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.612 HE21 HG21 ' A' ' 56' ' ' VAL . 5.6 pt20 -105.05 140.65 37.92 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.032 -168.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 p -64.83 -36.24 83.7 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -172.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.583 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 43.9 p-90 -60.83 -32.62 72.0 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.726 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.612 HG21 HE21 ' A' ' 53' ' ' GLN . 4.8 t -73.58 -50.42 30.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.324 174.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 94.8 mttt -54.92 -36.95 65.78 Favored 'General case' 0 CA--C 1.522 -0.126 0 O-C-N 123.602 0.564 . . . . 0.0 110.421 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -65.95 -58.64 5.08 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.642 176.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 55' ' ' TRP . 78.6 mt -59.1 -48.0 88.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -175.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 56' ' ' VAL . 11.9 p -65.45 -31.62 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.992 -177.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.0 ttp85 -63.83 -41.57 97.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.847 0.356 . . . . 0.0 110.517 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.523 HD11 ' HZ2' ' A' ' 68' ' ' LYS . 4.4 mm? -79.37 -29.86 42.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.138 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.453 HD12 ' CB ' ' A' ' 23' ' ' PHE . 28.5 mt -72.4 -46.46 55.13 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.558 177.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.7 t -81.13 -43.31 19.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.373 -174.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.493 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -98.9 93.01 5.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.458 0.646 . . . . 0.0 110.064 -179.539 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -83.93 82.8 8.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.961 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.5 t -87.25 1.96 5.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 122.181 0.991 . . . . 0.0 108.871 174.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.523 ' HZ2' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -95.33 21.99 7.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.301 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -68.88 -22.95 64.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.301 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 49.9 ttm . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.922 177.481 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 120.866 0.365 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 m -85.19 97.18 9.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.232 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -61.26 -47.09 87.62 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.543 0.687 . . . . 0.0 109.247 175.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.66 -167.76 1.92 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.675 169.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.663 ' C ' ' HB2' ' A' ' 32' ' ' CYS . 3.1 p-10 -114.29 -99.42 0.43 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.89 0.852 . . . . 0.0 110.394 170.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.673 ' SG ' HG12 ' A' ' 34' ' ' ILE . 3.7 p -142.26 -142.71 0.14 Allowed 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 125.353 1.461 . . . . 0.0 107.843 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.422 ' O ' HD12 ' A' ' 34' ' ' ILE . 19.3 t -125.99 135.33 51.69 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 166.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 pp -65.87 -13.6 59.91 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.48 0.487 . . . . 0.0 111.873 -176.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.72 166.9 28.75 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.836 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 81.0 m-85 -119.39 -168.56 1.6 Allowed 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 176.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.465 ' H ' ' ND2' ' A' ' 50' ' ' ASN . 14.9 t -129.03 148.29 50.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.493 -178.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -107.15 62.69 0.62 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.449 ' HB3' HD22 ' A' ' 15' ' ' LEU . 15.9 mtm180 -131.25 173.18 11.31 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.1 mm -122.4 91.13 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.428 165.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.451 ' O ' ' HD2' ' A' ' 16' ' ' HIS . 2.9 mm? -88.9 167.19 13.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.521 ' HD1' ' HD2' ' A' ' 18' ' ' LYS . 63.6 m170 -132.56 166.78 26.44 Favored Pre-proline 0 C--N 1.313 -0.994 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.894 -174.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 19.5 Cg_endo -60.39 -21.96 69.52 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.852 1.701 . . . . 0.0 109.213 166.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.521 ' HD2' ' HD1' ' A' ' 16' ' ' HIS . 83.7 mttt -52.94 -27.34 18.4 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 113.938 -1.483 . . . . 0.0 111.01 172.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -125.5 2.0 7.64 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.987 -174.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.677 HG12 ' HB3' ' A' ' 39' ' ' PHE . 13.3 mt -106.93 123.66 62.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.997 0.427 . . . . 0.0 111.275 -174.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.3 m -117.09 -16.19 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.02 177.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.66 160.17 26.51 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.532 ' CZ ' HG21 ' A' ' 60' ' ' VAL . 2.0 t80 -155.7 134.03 11.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.533 0.682 . . . . 0.0 110.606 -175.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.9 m -138.02 135.65 36.11 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.801 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -116.2 117.81 31.08 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.09 0.471 . . . . 0.0 111.847 -175.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.6 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 1.1 mp0 -94.32 135.96 35.14 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 174.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.9 156.07 18.35 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.1 0.476 . . . . 0.0 111.516 -170.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.17 11.93 26.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.278 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -126.83 -58.33 1.31 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.781 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -103.12 89.31 3.38 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.918 177.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.57 -63.11 0.52 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.973 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.663 ' HB2' ' C ' ' A' ' 5' ' ' ASP . 49.1 t -130.76 171.28 13.3 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -86.25 -20.19 28.83 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.673 HG12 ' SG ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -111.35 169.75 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 171.052 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -127.03 144.89 50.91 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 121.961 -0.462 . . . . 0.0 111.39 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.45 146.72 35.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.431 174.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.574 HG12 ' HG3' ' A' ' 51' ' ' PRO . 49.5 mm -106.96 102.4 13.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.882 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.586 HG13 HE22 ' A' ' 26' ' ' GLN . 70.0 mt -78.96 104.99 7.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.978 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.677 ' HB3' HG12 ' A' ' 20' ' ' ILE . 19.5 m-85 -88.91 120.15 30.07 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 170.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -90.25 104.85 17.38 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.4 p -74.38 161.79 29.5 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.779 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -68.18 -3.47 10.68 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.353 172.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 21.6 ttmm -95.47 8.39 43.41 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.245 176.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 31.3 mmmt 76.53 -24.17 0.23 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.244 1.018 . . . . 0.0 112.446 176.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.94 130.55 41.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.066 0.46 . . . . 0.0 111.38 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 p -86.51 108.84 18.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.185 176.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 60.9 t -91.97 128.96 43.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.434 -175.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 79.4 m -85.18 82.21 8.49 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.676 0.75 . . . . 0.0 109.143 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.499 ' HB3' ' CG2' ' A' ' 56' ' ' VAL . . . -72.45 136.79 46.08 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.091 -177.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.836 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -77.59 126.88 83.88 Favored Pre-proline 0 CA--C 1.51 -0.565 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.677 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.574 ' HG3' HG12 ' A' ' 37' ' ' ILE . 27.0 Cg_exo -63.99 -5.95 10.23 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 122.425 2.083 . . . . 0.0 111.903 177.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.469 ' O ' ' HE3' ' A' ' 57' ' ' LYS . 83.2 mttt -82.61 -29.8 29.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.634 -176.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.57 HE21 HG22 ' A' ' 56' ' ' VAL . 12.1 mt-30 -72.71 134.16 44.9 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.289 -175.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.5 -33.18 75.32 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.538 ' O ' HG13 ' A' ' 59' ' ' ILE . 49.0 p-90 -63.42 -33.11 74.83 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 175.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.57 HG22 HE21 ' A' ' 53' ' ' GLN . 8.7 t -72.67 -47.14 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.308 174.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 82.0 mttt -60.65 -28.07 68.29 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -70.1 -52.66 22.02 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.166 173.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.648 HG23 HD13 ' A' ' 20' ' ' ILE . 70.4 mt -68.03 -40.19 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.627 -176.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.532 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 15.0 p -70.44 -30.3 42.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 O-C-N 122.122 -0.361 . . . . 0.0 110.555 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -66.0 -30.66 71.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.789 0.804 . . . . 0.0 108.999 173.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 28.1 tp -84.12 -20.66 32.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.435 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.525 HD12 ' HB2' ' A' ' 23' ' ' PHE . 65.4 mt -108.89 4.27 23.24 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -175.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.3 t -63.69 -54.3 37.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.457 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -132.19 12.88 4.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.535 ' HZ1' ' HB3' ' A' ' 66' ' ' LYS . 2.7 mmmp? -105.84 2.82 28.06 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.551 -176.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 69.8 t -87.27 115.9 28.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.182 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -86.11 88.0 7.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.022 0.439 . . . . 0.0 110.11 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -105.26 109.89 22.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.132 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 56.6 ttp . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.214 177.403 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.92 0 CA-C-O 120.808 0.337 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 m -125.86 135.76 52.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -65.44 -57.1 9.12 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 172.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -133.9 165.89 23.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.456 173.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -112.89 114.42 26.92 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 162.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.707 ' SG ' HG12 ' A' ' 34' ' ' ILE . 31.8 p -56.19 164.44 1.29 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.49 -172.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.427 ' O ' HD12 ' A' ' 34' ' ' ILE . 61.0 m -54.97 128.82 35.29 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.931 -176.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 pp -81.57 -14.53 56.71 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.275 0.56 . . . . 0.0 110.121 174.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.61 140.65 11.99 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.667 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.827 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 5.7 m-85 -107.07 -163.12 0.88 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.59 0.233 . . . . 0.0 110.415 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.487 HG23 ' CG1' ' A' ' 47' ' ' VAL . 4.7 t -137.46 149.99 47.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.974 0.416 . . . . 0.0 111.354 177.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -116.6 73.51 0.86 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.228 0.537 . . . . 0.0 109.783 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.521 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 57.5 mtt180 -129.23 -171.39 2.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.294 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.575 HD12 ' CD1' ' A' ' 55' ' ' TRP . 13.7 mm -125.59 78.58 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.344 168.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.555 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.6 mm? -81.7 161.86 23.21 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.834 ' HD1' ' HD3' ' A' ' 18' ' ' LYS . 65.5 m170 -133.82 162.17 59.31 Favored Pre-proline 0 C--N 1.31 -1.125 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.938 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.826 ' HD3' HG12 ' A' ' 59' ' ' ILE . 27.7 Cg_endo -64.55 -16.87 57.48 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.341 2.027 . . . . 0.0 108.746 166.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.834 ' HD3' ' HD1' ' A' ' 16' ' ' HIS . 28.8 mtpp -53.43 -21.58 6.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 113.38 -1.736 . . . . 0.0 110.966 170.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -130.31 3.74 4.72 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.642 ' HB ' ' HA ' ' A' ' 17' ' ' PRO . 3.9 mm -100.37 122.9 52.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -170.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.3 m -114.49 -10.13 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.483 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.52 158.46 27.67 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.668 ' CB ' HD13 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -156.52 134.7 11.29 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.065 0.46 . . . . 0.0 109.867 -175.686 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.409 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 30.7 m -138.4 103.23 4.84 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.495 178.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.429 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 11.5 ptm180 -78.36 89.76 4.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.785 0.802 . . . . 0.0 109.787 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.649 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 4.0 tt0 -72.46 114.92 11.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.842 -175.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 25' ' ' ARG . 97.7 mt -116.71 164.07 15.18 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.225 -171.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.62 -37.44 65.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.826 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -62.14 -19.96 63.58 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -174.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -94.1 13.89 21.67 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.76 -30.17 2.79 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.092 -1.051 . . . . 0.0 113.658 174.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 3.7 t -86.08 -168.6 2.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.18 0.514 . . . . 0.0 111.659 -177.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -120.12 -36.2 3.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.216 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.707 HG12 ' SG ' ' A' ' 6' ' ' CYS . 6.8 pt -104.75 -175.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -138.16 112.16 8.46 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.345 0.593 . . . . 0.0 111.922 -173.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.5 119.88 39.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.527 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.457 ' O ' ' HB1' ' A' ' 49' ' ' ALA . 41.3 mm -80.38 98.05 3.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.051 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.491 ' CG2' ' HB3' ' A' ' 46' ' ' SER . 23.7 mt -80.37 111.74 17.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 O-C-N 121.832 -0.542 . . . . 0.0 111.495 -174.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.437 ' HE2' HG22 ' A' ' 56' ' ' VAL . 30.3 m-85 -97.28 122.45 40.32 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 9.2 m-70 -97.66 111.36 23.67 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -176.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.5 p -71.17 163.63 27.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.099 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -66.92 -3.08 6.13 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.846 171.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -94.36 0.5 55.54 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.691 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm 78.64 -1.31 2.43 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.25 1.02 . . . . 0.0 111.496 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.4 mt -83.78 119.81 25.27 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.491 ' HB3' ' CG2' ' A' ' 38' ' ' ILE . 3.4 m -88.87 106.99 18.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.19 0.519 . . . . 0.0 109.901 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.487 ' CG1' HG23 ' A' ' 11' ' ' THR . 24.4 t -91.08 132.9 34.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.597 -175.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.8 m -88.19 91.6 8.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.749 0.785 . . . . 0.0 109.515 -178.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.634 ' HB3' HG22 ' A' ' 56' ' ' VAL . . . -76.52 146.0 38.73 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.077 -174.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.827 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -84.16 128.68 61.39 Favored Pre-proline 0 CA--C 1.512 -0.495 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.293 -177.578 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.79 6.55 1.28 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.248 1.965 . . . . 0.0 112.65 176.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 50' ' ' ASN . 49.0 mtpt -92.34 -24.7 18.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.863 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.503 HE21 HG23 ' A' ' 56' ' ' VAL . 4.8 pt20 -103.61 142.7 33.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.056 -165.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 p -65.6 -37.2 85.95 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -172.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.575 ' CD1' HD12 ' A' ' 14' ' ' ILE . 49.9 p-90 -60.49 -33.84 73.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.221 0.534 . . . . 0.0 109.752 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.634 HG22 ' HB3' ' A' ' 49' ' ' ALA . 14.2 t -70.72 -50.62 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.154 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 95.7 mttt -54.82 -37.38 66.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.378 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -67.77 -54.39 19.61 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.836 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.826 HG12 ' HD3' ' A' ' 17' ' ' PRO . 75.0 mt -62.82 -45.52 98.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.634 0.254 . . . . 0.0 111.038 -176.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.556 HG23 ' CE1' ' A' ' 23' ' ' PHE . 10.2 p -64.4 -29.22 46.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.807 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -67.59 -43.95 79.29 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.988 0.423 . . . . 0.0 110.194 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.6 mt -75.07 -32.36 61.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.816 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.668 HD13 ' CB ' ' A' ' 23' ' ' PHE . 82.7 mt -71.73 -35.95 70.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.858 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.3 m -94.08 57.9 2.46 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 172.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.541 ' HB3' ' HZ3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -74.02 69.94 1.49 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.897 0.856 . . . . 0.0 110.745 -178.392 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -82.14 37.62 0.5 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.347 -173.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.5 m -129.95 12.13 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.415 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -138.08 146.99 43.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.111 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -80.59 119.49 23.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.099 0.476 . . . . 0.0 111.001 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 21.8 ptm . . . . . 0 C--O 1.246 0.883 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.118 174.804 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.6 m -76.96 126.29 30.72 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.811 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -71.3 -48.87 48.0 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.635 ' CE1' ' HG2' ' A' ' 26' ' ' GLN . 51.9 p90 -132.08 170.39 15.03 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.366 177.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -123.46 116.73 23.7 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.945 168.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.5 ' HA ' ' NE2' ' A' ' 26' ' ' GLN . 0.6 OUTLIER -54.37 165.8 0.5 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 179.444 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.4 t -66.35 128.63 36.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.467 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.6 mt -75.21 -17.94 60.25 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.196 0.31 . . . . 0.0 111.436 -176.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.31 117.58 1.39 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.285 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.733 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 1.6 m-85 -75.63 168.51 19.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.274 0.559 . . . . 0.0 109.709 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.431 ' OG1' ' HG3' ' A' ' 13' ' ' ARG . 4.8 t -94.7 -176.42 3.88 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.762 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -150.3 72.63 1.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.494 ' HB2' HD22 ' A' ' 15' ' ' LEU . 2.2 mtp180 -132.68 -179.56 5.54 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.121 -175.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.558 HD11 ' CD1' ' A' ' 55' ' ' TRP . 19.1 mm -126.4 84.33 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.014 167.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.529 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.3 mm? -89.32 161.57 16.29 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.996 ' HD1' ' HD2' ' A' ' 18' ' ' LYS . 55.3 m170 -133.95 177.96 2.0 Allowed Pre-proline 0 C--N 1.312 -1.053 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.185 -177.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.645 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 51.8 Cg_exo -53.26 -30.7 52.73 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.676 1.584 . . . . 0.0 109.272 161.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.996 ' HD2' ' HD1' ' A' ' 16' ' ' HIS . 64.6 mttm -44.42 -34.0 1.88 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.582 169.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 41' ' ' THR . 98.7 m-85 -127.16 2.15 6.45 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -173.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 16' ' ' HIS . 1.2 mp -98.12 130.47 46.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.811 0.338 . . . . 0.0 110.46 -175.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 p -124.27 -7.2 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.492 0.663 . . . . 0.0 110.199 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.02 156.9 26.5 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.803 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.928 ' HB3' HD11 ' A' ' 63' ' ' LEU . 1.9 t80 -140.7 138.08 33.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.256 0.551 . . . . 0.0 110.769 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.6 m -143.59 105.26 4.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.697 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.506 ' H ' ' NE ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -77.68 115.6 17.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.394 0.616 . . . . 0.0 111.117 -178.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.635 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.6 OUTLIER -86.18 117.12 24.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.247 -179.174 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.778 ' HB3' HD21 ' A' ' 29' ' ' ASN . 98.2 mt -103.85 145.95 29.36 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -167.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.88 50.29 1.94 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.42 176.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.778 HD21 ' HB3' ' A' ' 27' ' ' LEU . 52.9 m-80 -127.23 -64.42 1.0 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.201 -175.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -85.55 53.4 2.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.653 0.739 . . . . 0.0 111.902 -174.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.55 -61.5 0.51 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.809 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -55.06 152.13 8.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.842 -0.679 . . . . 0.0 111.63 175.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -120.35 -5.86 9.86 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.439 ' O ' HG13 ' A' ' 34' ' ' ILE . 26.1 pt -127.85 115.75 40.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 CA-C-O 121.911 0.862 . . . . 0.0 111.069 176.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -83.55 118.2 23.64 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 121.475 -0.766 . . . . 0.0 111.442 -172.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.1 139.06 53.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.767 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.587 HG12 ' HG3' ' A' ' 51' ' ' PRO . 43.5 mm -85.48 109.89 18.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.249 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.531 HD11 ' NE2' ' A' ' 26' ' ' GLN . 42.3 mm -90.4 100.17 10.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.989 0.423 . . . . 0.0 110.814 -177.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.564 ' HE2' HG21 ' A' ' 56' ' ' VAL . 11.7 m-85 -92.22 118.53 30.96 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.882 173.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -89.03 115.19 26.4 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.465 ' C ' ' H ' ' A' ' 43' ' ' LYS . 33.1 p -82.21 162.24 22.45 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.468 0.652 . . . . 0.0 112.249 -172.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -60.32 -4.43 0.84 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.313 170.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.465 ' H ' ' C ' ' A' ' 41' ' ' THR . 75.2 mmtt -109.74 16.56 22.0 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.944 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 59.7 mttp 75.17 -21.44 0.3 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.87 0.868 . . . . 0.0 112.525 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.3 mt -68.5 118.29 11.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.868 0.366 . . . . 0.0 111.159 -173.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.2 p -79.24 101.64 8.11 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 175.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 76.3 t -83.16 132.63 30.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.456 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.0 m -85.41 74.38 10.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.863 0.839 . . . . 0.0 109.094 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HA ' HG22 ' A' ' 11' ' ' THR . . . -69.71 142.45 53.32 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.657 -175.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.733 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -84.02 127.8 65.41 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.197 -177.114 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.587 ' HG3' HG12 ' A' ' 37' ' ' ILE . 24.1 Cg_exo -64.75 3.18 0.97 Allowed 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.728 2.285 . . . . 0.0 111.824 174.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.513 ' H ' ' C ' ' A' ' 50' ' ' ASN . 57.7 mtpt -92.67 -22.7 19.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.627 -176.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.648 ' CG ' ' HB2' ' A' ' 50' ' ' ASN . 0.6 OUTLIER -93.27 134.31 35.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.536 -169.585 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 p -64.34 -32.42 74.02 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.558 ' CD1' HD11 ' A' ' 14' ' ' ILE . 47.3 p-90 -61.94 -33.32 74.05 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.638 HG22 HE21 ' A' ' 53' ' ' GLN . 14.0 t -70.34 -49.77 51.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.99 173.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.444 ' HA ' HG13 ' A' ' 60' ' ' VAL . 96.4 mttt -56.72 -35.05 68.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.26 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -66.09 -56.43 11.52 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.012 175.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 16' ' ' HIS . 86.6 mt -60.84 -48.07 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.121 -176.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.648 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 14.4 p -62.55 -31.68 52.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -177.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -62.45 -47.78 82.51 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.066 0.46 . . . . 0.0 110.039 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.86 -40.54 75.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.304 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.928 HD11 ' HB3' ' A' ' 23' ' ' PHE . 3.6 mm? -70.11 -7.62 42.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.55 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -90.03 -63.03 1.34 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.95 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -134.5 25.75 3.76 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -171.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -120.1 114.79 22.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.207 0.527 . . . . 0.0 110.476 176.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.01 126.37 75.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.12 -174.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -139.24 -63.45 0.52 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.204 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -106.49 148.22 28.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.393 0.616 . . . . 0.0 112.334 -171.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.013 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.315 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.564 ' HB2' ' OE1' ' A' ' 26' ' ' GLN . 13.7 p . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.0 t -52.15 118.72 3.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.787 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.419 ' HA ' HD11 ' A' ' 34' ' ' ILE . 80.2 mt -84.61 -15.75 44.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.217 -177.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -120.88 108.8 1.43 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.594 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 17.8 m-85 -79.92 -167.49 1.29 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.263 0.554 . . . . 0.0 111.177 -173.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.5 t -125.03 170.74 10.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.973 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -133.98 77.53 1.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.516 0.674 . . . . 0.0 110.311 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.526 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 94.7 mtt180 -133.23 179.09 6.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.743 176.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.566 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.0 mm -118.29 83.46 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 164.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.591 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.5 mm? -79.42 158.88 27.26 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.661 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 54.7 m170 -131.81 175.71 3.47 Favored Pre-proline 0 C--N 1.312 -1.052 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.151 -174.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.653 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 32.5 Cg_exo -56.4 -25.51 57.84 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.747 1.631 . . . . 0.0 109.282 164.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.661 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 64.0 mttm -49.38 -31.55 9.72 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.282 175.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 41' ' ' THR . 91.0 m-85 -124.1 0.32 8.45 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.443 ' CG1' ' HB3' ' A' ' 39' ' ' PHE . 1.4 mp -105.88 130.08 57.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.077 0.465 . . . . 0.0 112.105 -173.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.1 m -123.95 -5.76 7.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.468 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.12 162.6 30.21 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.409 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.679 ' CB ' HD13 ' A' ' 63' ' ' LEU . 1.1 t80 -158.04 133.65 9.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.981 0.42 . . . . 0.0 110.413 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.6 m -135.91 120.37 18.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.938 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -93.0 137.2 32.57 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.131 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.564 ' OE1' ' HB2' ' A' ' 6' ' ' CYS . 81.6 mt-30 -120.72 121.01 37.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.749 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.4 mp -102.45 165.91 10.84 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.026 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.27 18.36 11.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.401 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -139.61 1.98 1.97 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.781 0.324 . . . . 0.0 111.62 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -99.99 -21.73 15.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.107 0.479 . . . . 0.0 110.33 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.21 -53.95 0.1 OUTLIER Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.5 t -69.03 156.89 37.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -89.63 -20.07 24.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.455 0.645 . . . . 0.0 109.788 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.452 HG12 ' SG ' ' A' ' 6' ' ' CYS . 4.6 pt -116.26 -178.68 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.4 ' OD1' ' HG2' ' A' ' 51' ' ' PRO . 4.7 p30 -129.7 129.08 43.77 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.115 0.483 . . . . 0.0 110.557 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . -141.95 132.82 25.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.118 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 46.7 mm -82.34 125.17 39.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.9 mm -98.8 101.68 12.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 O-C-N 121.969 -0.457 . . . . 0.0 110.757 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.521 ' HE2' HG22 ' A' ' 56' ' ' VAL . 18.6 m-85 -87.99 123.49 32.75 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 173.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -92.88 112.75 24.81 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 36.7 p -75.22 160.52 30.29 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.663 -176.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -71.93 5.62 2.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.476 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 41' ' ' THR . 0.5 OUTLIER -106.57 12.28 29.62 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.335 176.759 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 68.14 19.39 9.2 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.079 174.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.8 mt -112.7 136.19 52.57 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.991 0.424 . . . . 0.0 110.925 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.6 p -84.88 115.79 22.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.623 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 83.0 t -89.12 126.6 42.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.625 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 16.5 m -83.09 81.24 8.77 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.616 0.722 . . . . 0.0 109.238 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.524 ' HB1' HG22 ' A' ' 56' ' ' VAL . . . -71.85 134.48 46.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.671 -175.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.594 ' OD1' ' HB3' ' A' ' 10' ' ' TYR . 1.5 m-20 -80.64 124.29 82.04 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.4 ' HG2' ' OD1' ' A' ' 35' ' ' ASN . 25.6 Cg_exo -65.62 -0.44 3.73 Favored 'Trans proline' 0 C--N 1.328 -0.537 0 C-N-CA 121.862 1.708 . . . . 0.0 111.933 174.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.418 ' H ' ' C ' ' A' ' 50' ' ' ASN . 51.0 mtpt -85.0 -25.46 27.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.874 -175.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.502 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 0.9 OUTLIER -103.37 145.95 29.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.7 -167.412 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.41 -32.59 68.58 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -171.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.591 ' CZ3' ' HB2' ' A' ' 15' ' ' LEU . 48.3 p-90 -63.48 -32.91 74.49 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.859 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.524 HG22 ' HB1' ' A' ' 49' ' ' ALA . 4.5 t -69.75 -46.95 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.314 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.754 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 65.0 mttm -58.04 -40.6 81.29 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.098 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -62.93 -53.11 59.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.188 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.456 HG22 ' CD1' ' A' ' 63' ' ' LEU . 85.0 mt -63.79 -41.06 91.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.314 -177.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.1 p -68.44 -25.62 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.132 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.754 ' HG2' ' O ' ' A' ' 57' ' ' LYS . 1.3 mmp_? -66.43 -45.19 80.71 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 122.007 -0.433 . . . . 0.0 109.999 174.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.9 mt -68.72 -36.42 78.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.821 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.679 HD13 ' CB ' ' A' ' 23' ' ' PHE . 81.3 mt -72.3 -18.54 61.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.92 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 C--N 1.327 -0.38 0 CA-C-O 120.816 0.341 . . . . 0.0 110.969 173.68 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.754 ' SG ' HG12 ' A' ' 34' ' ' ILE . 20.8 p . . . . . 0 N--CA 1.449 -0.476 0 CA-C-O 120.949 0.404 . . . . 0.0 110.999 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 55.8 m -61.36 117.65 5.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.684 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.3 mt -68.82 -16.55 63.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.292 0.568 . . . . 0.0 110.242 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.1 88.17 0.19 Allowed Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.121 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.483 ' HA ' ' HB2' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -74.39 157.31 35.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.111 0.482 . . . . 0.0 110.533 174.583 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 48' ' ' CYS . 15.1 t -82.3 159.34 23.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -164.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -118.54 74.23 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.52 ' HB2' HD22 ' A' ' 15' ' ' LEU . 1.8 mmp_? -131.65 178.53 6.67 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.586 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.539 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.9 mm -121.6 84.46 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.237 161.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.541 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 1.9 mm? -84.59 167.58 16.15 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 175.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.694 ' ND1' ' HD2' ' A' ' 18' ' ' LYS . 63.5 m170 -133.04 168.14 19.45 Favored Pre-proline 0 C--N 1.311 -1.088 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.689 -175.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 17.3 Cg_endo -59.49 -23.05 69.1 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.316 2.011 . . . . 0.0 109.207 165.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.694 ' HD2' ' ND1' ' A' ' 16' ' ' HIS . 65.1 mttm -49.53 -27.68 4.67 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 113.846 -1.525 . . . . 0.0 111.628 170.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -124.99 -1.46 7.8 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -172.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.529 HD12 HD13 ' A' ' 59' ' ' ILE . 27.7 mt -105.99 124.64 61.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.838 0.351 . . . . 0.0 111.544 -173.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.2 m -121.13 0.69 7.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.002 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.99 158.7 30.0 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.587 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.586 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 2.1 t80 -153.24 134.31 14.05 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.346 0.593 . . . . 0.0 110.93 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.9 m -141.95 112.56 7.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.495 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -80.29 103.08 9.91 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.961 0.41 . . . . 0.0 110.381 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.443 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 46.0 tt0 -74.27 126.11 29.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.045 -177.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.409 ' HA ' ' OD1' ' A' ' 35' ' ' ASN . 87.8 mt -100.59 156.39 17.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.499 0.666 . . . . 0.0 112.606 -170.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.57 -30.65 36.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.909 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -49.94 -34.06 19.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.534 -1.212 . . . . 0.0 113.069 -175.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -99.83 27.3 5.55 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -172.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.13 -44.82 1.03 Allowed Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.722 172.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -80.56 -167.1 1.23 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.008 0.432 . . . . 0.0 111.955 -174.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -122.54 -28.54 4.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.718 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.754 HG12 ' SG ' ' A' ' 6' ' ' CYS . 1.4 pt -111.69 169.51 4.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.409 ' OD1' ' HA ' ' A' ' 27' ' ' LEU . 34.1 m-80 -116.2 123.35 47.55 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.01 121.62 43.69 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.715 0.293 . . . . 0.0 110.847 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.721 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 48.6 mm -69.74 104.94 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.371 176.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.4 mm -85.89 97.64 6.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 O-C-N 122.059 -0.401 . . . . 0.0 110.113 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.487 ' HB3' HG12 ' A' ' 20' ' ' ILE . 9.6 m-85 -85.77 122.88 30.48 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -93.45 106.76 18.69 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.8 p -78.09 162.92 26.31 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.073 -173.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -65.9 -7.8 18.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.326 173.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -91.16 2.82 56.06 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.282 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 68.41 17.73 9.12 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.936 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.6 mt -106.69 125.98 51.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.517 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.4 p -76.72 108.35 9.67 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.652 177.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 99.6 t -91.63 131.35 38.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.662 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 62.8 m -88.7 90.97 8.63 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.721 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -77.95 141.15 39.18 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.958 -176.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.485 ' HB2' ' HG2' ' A' ' 53' ' ' GLN . 2.5 m-20 -82.38 130.34 59.66 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.82 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -71.48 2.93 4.01 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.099 1.866 . . . . 0.0 112.041 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -90.32 -21.62 21.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.918 -176.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.485 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 0.8 OUTLIER -103.14 142.27 34.43 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.437 -168.499 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 p -74.3 -28.79 61.34 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -171.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.616 ' O ' HG13 ' A' ' 59' ' ' ILE . 47.2 p-90 -62.57 -33.73 75.54 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.387 176.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.535 ' CG2' ' HB1' ' A' ' 49' ' ' ALA . 4.5 t -70.99 -47.92 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.413 174.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -56.98 -36.71 70.65 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 123.761 0.663 . . . . 0.0 110.85 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -65.77 -49.47 68.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.838 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.616 HG13 ' O ' ' A' ' 55' ' ' TRP . 60.0 mt -67.76 -47.86 78.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.039 -175.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.586 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 11.7 p -62.69 -29.84 47.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 120.803 0.335 . . . . 0.0 110.762 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -64.47 -45.26 88.17 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 34.8 mt -70.26 -30.81 67.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.934 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.592 HD23 HG22 ' A' ' 59' ' ' ILE . 2.0 mm? -68.45 -36.65 79.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.539 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.694 -178.777 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.818 ' SG ' HG12 ' A' ' 34' ' ' ILE . 26.2 p . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.665 ' O ' HD11 ' A' ' 34' ' ' ILE . 58.3 m -60.2 130.25 45.72 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.136 174.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.3 mt -84.5 0.13 50.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.209 0.528 . . . . 0.0 110.108 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.54 136.44 6.94 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 174.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.67 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 29.0 m-85 -97.3 176.65 5.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.798 0.332 . . . . 0.0 110.226 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.479 HG21 ' CG1' ' A' ' 47' ' ' VAL . 2.7 t -112.91 137.85 50.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.168 0.509 . . . . 0.0 111.015 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -108.02 68.9 0.72 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.564 0.697 . . . . 0.0 109.363 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.483 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 4.3 mmp_? -129.19 -173.21 2.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.586 -177.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.556 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.4 mm -124.98 89.65 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.208 165.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.59 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.7 mm? -89.12 162.83 15.75 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 58.3 m170 -132.05 166.65 26.92 Favored Pre-proline 0 C--N 1.312 -1.051 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.994 -172.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 12.2 Cg_endo -57.57 -27.14 75.53 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.176 1.917 . . . . 0.0 109.149 166.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 65.6 mttm -45.0 -35.47 2.93 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.384 171.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -116.89 -13.48 10.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.903 -172.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.673 HG12 ' HB3' ' A' ' 39' ' ' PHE . 21.8 mt -92.39 127.18 44.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.768 0.318 . . . . 0.0 111.327 -172.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 m -122.33 -7.6 8.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.157 0.503 . . . . 0.0 110.995 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -152.21 163.1 30.1 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.683 ' HB2' HD13 ' A' ' 63' ' ' LEU . 2.4 t80 -156.6 134.28 10.91 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 117.325 0.563 . . . . 0.0 110.897 -175.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.562 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 83.5 m -140.41 107.8 5.55 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.112 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.52 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 14.8 ptp180 -86.5 102.78 14.42 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.725 ' NE2' ' HA ' ' A' ' 6' ' ' CYS . 3.2 pt20 -93.25 136.04 33.88 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.421 ' HA ' ' HB3' ' A' ' 35' ' ' ASN . 86.7 mt -119.64 163.72 16.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.214 0.53 . . . . 0.0 111.882 -170.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.58 35.03 0.49 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.824 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -132.73 -52.62 0.93 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.396 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -60.97 -43.21 99.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.799 -173.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -157.16 -65.03 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.279 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.8 t -71.42 169.3 15.64 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.378 0.609 . . . . 0.0 112.384 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -90.1 -24.67 21.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.653 -173.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.818 HG12 ' SG ' ' A' ' 6' ' ' CYS . 2.1 pt -120.41 170.16 10.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.421 ' HB3' ' HA ' ' A' ' 27' ' ' LEU . 6.1 p30 -118.86 128.18 54.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.778 0.323 . . . . 0.0 111.178 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.626 ' O ' ' HG2' ' A' ' 26' ' ' GLN . . . -131.9 143.6 50.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.958 0.409 . . . . 0.0 110.928 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.603 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 49.9 mm -90.2 101.34 12.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.229 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.562 ' HB ' ' HB ' ' A' ' 24' ' ' THR . 63.9 mt -79.49 104.75 7.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.019 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.673 ' HB3' HG12 ' A' ' 20' ' ' ILE . 12.5 m-85 -95.26 111.35 23.21 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 172.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -82.67 110.25 17.57 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.0 p -85.06 163.13 19.01 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.412 0.625 . . . . 0.0 112.008 -174.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -68.75 -2.53 9.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.032 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -90.58 3.04 55.2 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.769 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt 69.47 22.86 6.24 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.015 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 97.3 mt -114.75 139.6 49.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.144 0.497 . . . . 0.0 110.712 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.422 ' HB2' HG23 ' A' ' 38' ' ' ILE . 12.0 p -90.07 95.41 10.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.694 174.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.479 ' CG1' HG21 ' A' ' 11' ' ' THR . 59.0 t -76.33 130.2 36.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.834 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.0 m -92.64 81.74 4.78 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.018 0.913 . . . . 0.0 109.591 -175.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.603 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -69.87 144.63 52.46 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.794 -176.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.67 ' OD1' ' HB3' ' A' ' 10' ' ' TYR . 2.0 m-20 -83.8 129.39 59.49 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.758 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -72.01 21.33 0.27 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.406 2.071 . . . . 0.0 111.988 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 50' ' ' ASN . 35.3 mtmm -119.42 -4.93 10.36 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.99 -173.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.475 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 0.7 OUTLIER -117.26 146.37 43.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.027 0.441 . . . . 0.0 111.555 -172.056 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 p -69.86 -36.32 75.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -171.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.59 ' CZ3' ' HB2' ' A' ' 15' ' ' LEU . 47.9 p-90 -61.05 -30.75 70.51 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.554 ' O ' HG12 ' A' ' 60' ' ' VAL . 12.6 t -74.21 -49.04 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.244 174.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 84.1 mttt -57.0 -34.05 67.76 Favored 'General case' 0 C--N 1.334 -0.089 0 O-C-N 123.457 0.473 . . . . 0.0 110.506 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -66.1 -54.73 22.06 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.527 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.668 HG21 HD13 ' A' ' 20' ' ' ILE . 72.7 mt -65.57 -43.82 94.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.477 -174.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.573 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 13.8 p -66.71 -33.83 66.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.092 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -62.89 -43.14 99.59 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.37 0.605 . . . . 0.0 109.494 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.3 tp -66.2 -41.06 90.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.041 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 23' ' ' PHE . 75.3 mt -76.28 -7.44 54.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.355 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 C--N 1.327 -0.391 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.864 178.092 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.701 ' HA ' ' HB3' ' A' ' 26' ' ' GLN . 7.9 p . . . . . 0 N--CA 1.44 -0.932 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.498 ' O ' HD11 ' A' ' 34' ' ' ILE . 94.8 m -105.91 122.75 46.76 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 166.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.6 mt -67.7 -26.69 66.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.345 0.593 . . . . 0.0 109.536 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -129.06 135.38 8.43 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.206 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.631 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 6.9 m-85 -100.58 -160.12 0.78 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.1 t -129.12 158.7 38.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.214 176.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.498 ' O ' ' HD2' ' A' ' 13' ' ' ARG . 1.5 m-20 -118.55 69.23 0.79 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.858 0.361 . . . . 0.0 110.087 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.498 ' HD2' ' O ' ' A' ' 12' ' ' ASP . 8.4 mmm180 -131.36 175.89 8.75 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.411 0.624 . . . . 0.0 112.122 -177.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.529 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.1 mm -120.18 90.05 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.001 164.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.495 ' CD2' ' HB2' ' A' ' 13' ' ' ARG . 1.9 mm? -92.35 163.26 13.94 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.78 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 34.9 m170 -131.24 176.39 2.93 Favored Pre-proline 0 C--N 1.313 -1.013 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.277 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.78 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 13.2 Cg_endo -58.68 -21.28 54.99 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.631 1.554 . . . . 0.0 109.353 167.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.729 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 28.5 mtpp -45.17 -32.77 1.97 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.844 171.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 41' ' ' THR . 77.9 m-85 -124.27 -5.08 7.82 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -174.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.615 HG12 ' HB3' ' A' ' 39' ' ' PHE . 18.3 mt -100.26 128.45 52.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.777 0.323 . . . . 0.0 111.666 -173.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.6 m -120.68 -11.48 9.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.195 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.3 165.74 31.42 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.736 ' HB2' HD13 ' A' ' 63' ' ' LEU . 2.7 t80 -155.01 133.44 11.87 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.23 0.538 . . . . 0.0 111.666 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.7 m -142.1 121.42 13.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.603 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -98.11 119.16 36.26 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.512 -0.475 . . . . 0.0 112.112 -176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.701 ' HB3' ' HA ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -76.17 130.09 37.72 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 170.756 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.6 mt -97.9 152.52 19.13 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -169.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 32' ' ' CYS . . . -100.87 5.48 43.39 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.059 173.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -100.26 -64.61 1.03 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.146 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -116.98 86.41 2.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.63 0.728 . . . . 0.0 110.079 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.56 -77.37 0.16 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.444 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 47.1 t -117.9 176.51 5.17 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -87.38 -23.28 24.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.351 0.596 . . . . 0.0 109.405 171.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.691 HG12 ' SG ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -113.33 162.97 11.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.853 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 26' ' ' GLN . 7.0 p30 -129.11 138.35 51.77 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.286 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.88 148.56 52.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.017 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.776 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 47.8 mm -95.48 116.81 38.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.715 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.4 mm -90.31 98.38 8.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.085 0.469 . . . . 0.0 110.047 174.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.615 ' HB3' HG12 ' A' ' 20' ' ' ILE . 8.8 m-85 -87.94 115.01 25.11 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -82.03 108.14 15.28 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 42.0 p -82.55 159.15 22.85 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.195 0.521 . . . . 0.0 111.471 -175.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -67.28 -2.42 5.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.358 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -95.15 3.71 54.42 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.842 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt 70.33 11.92 7.5 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.451 0.7 . . . . 0.0 111.176 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.3 mt -92.85 125.82 37.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.098 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 p -86.06 93.79 9.08 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.3 t -85.64 130.92 35.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.687 -174.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 82.3 m -86.29 84.73 7.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 122.016 0.912 . . . . 0.0 109.506 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.776 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -69.51 143.03 53.58 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.6 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.698 ' HB2' ' CG ' ' A' ' 53' ' ' GLN . 1.3 m-20 -88.14 122.52 69.83 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.494 ' HG3' ' OD1' ' A' ' 35' ' ' ASN . 9.5 Cg_endo -57.33 -8.19 3.49 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.889 2.393 . . . . 0.0 112.471 172.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -77.2 -34.54 56.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.961 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.698 ' CG ' ' HB2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -85.43 140.53 30.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.719 -169.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.64 -27.68 61.39 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -176.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.529 ' CD1' HD13 ' A' ' 14' ' ' ILE . 47.8 p-90 -62.74 -32.4 73.53 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.581 ' O ' HG12 ' A' ' 60' ' ' VAL . 7.4 t -73.03 -48.78 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.494 174.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 66.7 mttm -53.93 -36.5 62.83 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.584 0.552 . . . . 0.0 110.575 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -66.52 -57.28 7.64 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.691 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.577 HG21 HD13 ' A' ' 20' ' ' ILE . 75.2 mt -62.67 -43.3 98.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.201 -175.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.632 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 12.6 p -63.5 -33.42 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 121.309 -0.156 . . . . 0.0 111.328 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -63.75 -41.99 97.91 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.268 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.4 mt -81.48 4.81 19.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.023 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.736 HD13 ' HB2' ' A' ' 23' ' ' PHE . 55.9 mt -117.7 -14.86 10.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.321 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--N 1.325 -0.466 0 CA-C-O 120.761 0.315 . . . . 0.0 110.185 179.064 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.719 ' SG ' HG12 ' A' ' 34' ' ' ILE . 19.3 p . . . . . 0 N--CA 1.451 -0.421 0 CA-C-O 120.963 0.411 . . . . 0.0 111.985 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.9 m -61.6 134.68 57.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.808 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt -86.72 6.62 30.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.592 0.711 . . . . 0.0 109.885 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.67 119.79 0.95 Allowed Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.676 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.49 ' HD1' ' H ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -118.62 161.38 20.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.944 0.402 . . . . 0.0 110.833 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 49' ' ' ALA . 14.4 t -73.38 -171.52 0.99 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -167.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -147.27 14.19 1.12 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.634 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -88.81 170.43 10.75 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.408 -171.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.569 HD13 ' CD1' ' A' ' 55' ' ' TRP . 8.7 mm -105.3 84.57 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 163.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.588 HD12 ' CH2' ' A' ' 55' ' ' TRP . 1.1 mt -92.14 160.49 15.17 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.739 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 52.1 m170 -132.51 171.5 9.03 Favored Pre-proline 0 C--N 1.313 -1.014 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.005 -173.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.575 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 32.1 Cg_exo -55.83 -24.24 46.09 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.181 1.921 . . . . 0.0 109.255 165.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.739 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 64.9 mttm -44.51 -32.65 1.47 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 114.24 -1.346 . . . . 0.0 112.082 171.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -126.81 -3.48 6.52 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 122.243 -0.286 . . . . 0.0 111.449 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.62 HG13 ' HB3' ' A' ' 39' ' ' PHE . 1.2 mp -92.88 120.12 41.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.02 0.438 . . . . 0.0 110.344 -175.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.3 m -113.63 -5.87 11.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.735 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.19 158.37 29.13 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.36 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.665 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -146.97 137.39 23.58 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.139 0.495 . . . . 0.0 110.258 -179.813 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.2 m -144.38 109.45 5.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.518 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 25' ' ' ARG . 8.6 ptp180 -75.9 118.14 18.37 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -101.88 106.35 17.29 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -177.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.6 mp -81.7 164.5 21.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.457 0.646 . . . . 0.0 111.984 -173.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.24 -57.8 3.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.862 175.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -74.62 19.67 0.13 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -170.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -115.19 23.86 12.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.281 0.562 . . . . 0.0 110.494 173.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.25 -12.86 4.36 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.647 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.4 t -120.06 -153.69 0.55 Allowed 'General case' 0 C--N 1.319 -0.742 0 O-C-N 122.454 -0.439 . . . . 0.0 111.563 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -129.61 -27.95 2.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.576 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.719 HG12 ' SG ' ' A' ' 6' ' ' CYS . 2.8 pt -118.61 169.51 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -103.39 131.06 50.78 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 174.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.14 126.14 36.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.28 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.67 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 46.7 mm -88.72 98.08 7.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.34 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.411 HG23 ' HB2' ' A' ' 46' ' ' SER . 70.2 mt -75.49 105.95 4.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.867 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.62 ' HB3' HG13 ' A' ' 20' ' ' ILE . 13.6 m-85 -97.73 116.94 30.93 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 171.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -86.88 106.46 17.77 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 43' ' ' LYS . 42.7 p -74.75 164.1 26.94 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.642 -176.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -74.26 4.79 5.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.963 0.887 . . . . 0.0 108.912 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.483 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 14.5 tppt? -87.87 -1.36 57.93 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.004 176.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt 70.6 12.26 7.32 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.828 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.6 mt -109.44 129.2 55.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.598 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.411 ' HB2' HG23 ' A' ' 38' ' ' ILE . 11.8 p -79.84 107.07 12.33 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.821 176.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 73.0 t -93.23 127.25 45.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.437 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 57.4 m -88.94 100.5 13.24 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.703 0.763 . . . . 0.0 109.493 -174.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.67 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -78.66 143.38 36.38 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.934 -177.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.565 ' HB2' ' CG ' ' A' ' 53' ' ' GLN . 2.2 m-20 -80.41 130.98 63.13 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.59 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.53 -10.63 28.54 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.678 2.252 . . . . 0.0 112.044 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -74.93 -27.76 60.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.231 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.58 ' NE2' ' HE1' ' A' ' 55' ' ' TRP . 4.4 mt-30 -84.64 139.29 32.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.036 -168.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 p -76.33 -31.1 57.93 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.856 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.588 ' CH2' HD12 ' A' ' 15' ' ' LEU . 51.9 p-90 -60.35 -33.8 72.94 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 174.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.538 ' O ' HG12 ' A' ' 60' ' ' VAL . 25.7 t -68.54 -52.06 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.252 173.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 67.6 mttm -54.2 -38.21 65.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.683 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -63.46 -52.45 61.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.787 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 55' ' ' TRP . 72.6 mt -63.52 -47.65 90.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.296 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.665 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 7.5 p -63.99 -36.19 75.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -175.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -68.7 -31.67 70.92 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.303 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 30.2 tp -74.28 -41.88 60.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.828 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.482 HD12 ' HB3' ' A' ' 23' ' ' PHE . 2.4 mm? -66.25 -29.09 69.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.039 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.0 -176.924 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.685 ' SG ' ' HG2' ' A' ' 26' ' ' GLN . 93.8 m . . . . . 0 N--CA 1.452 -0.352 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 67.1 m -49.3 122.29 5.92 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.284 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.7 mt -65.24 -24.82 67.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.087 0.47 . . . . 0.0 110.406 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.72 134.77 7.43 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.11 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.686 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 28.9 m-85 -92.66 178.41 5.8 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.566 0.222 . . . . 0.0 110.445 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.657 HG21 HG13 ' A' ' 47' ' ' VAL . 3.4 t -127.08 130.58 50.18 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.371 0.605 . . . . 0.0 111.758 -177.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.66 72.57 2.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 122.007 0.908 . . . . 0.0 108.6 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.44 ' HB2' HD12 ' A' ' 15' ' ' LEU . 18.2 mmt180 -104.42 -178.9 3.79 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.925 177.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.471 HD13 ' CD1' ' A' ' 55' ' ' TRP . 9.1 mm -126.74 87.68 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 162.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.714 HD13 HG11 ' A' ' 47' ' ' VAL . 1.2 mt -99.82 162.27 13.1 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.273 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.577 ' O ' HD13 ' A' ' 20' ' ' ILE . 63.1 m170 -132.59 167.08 24.41 Favored Pre-proline 0 C--N 1.316 -0.889 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.087 -172.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.624 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 18.3 Cg_endo -61.3 -22.53 74.86 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.315 2.01 . . . . 0.0 108.925 166.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.557 ' HD2' ' ND1' ' A' ' 16' ' ' HIS . 66.4 mttm -52.46 -28.31 19.68 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.718 172.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -124.0 -2.71 8.17 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.426 -175.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.624 ' HB ' ' HA ' ' A' ' 17' ' ' PRO . 0.9 OUTLIER -94.19 124.18 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 120.995 0.426 . . . . 0.0 110.891 -174.078 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.4 m -120.32 -1.96 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.547 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.3 160.22 31.95 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.432 -0.889 . . . . 0.0 111.962 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.54 ' CB ' ' HG ' ' A' ' 63' ' ' LEU . 1.7 t80 -149.3 134.5 18.23 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.5 m -140.95 107.18 5.23 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.381 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.515 ' HD3' HD21 ' A' ' 27' ' ' LEU . 32.4 ttm180 -82.37 107.52 15.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.168 0.509 . . . . 0.0 110.013 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.685 ' HG2' ' SG ' ' A' ' 6' ' ' CYS . 13.6 tt0 -80.14 115.56 19.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.906 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.515 HD21 ' HD3' ' A' ' 25' ' ' ARG . 65.2 mt -103.39 148.18 26.2 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -166.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.62 15.88 0.44 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.272 176.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 27' ' ' LEU . 18.1 m120 -116.04 -6.99 11.96 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.783 -177.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.426 ' HG2' ' HB2' ' A' ' 27' ' ' LEU . 34.2 mm-40 -103.69 -1.06 28.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.474 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.99 -48.65 0.68 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.496 -0.859 . . . . 0.0 113.311 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 34' ' ' ILE . 13.4 p -68.16 171.04 7.52 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -112.52 6.76 18.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.553 0.692 . . . . 0.0 111.035 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.415 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 25.0 pt -131.34 -171.81 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 8.9 p30 -142.62 124.08 14.83 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.874 174.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.99 137.89 51.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.729 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.504 HG23 ' HE1' ' A' ' 23' ' ' PHE . 50.0 mm -89.04 98.23 7.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.089 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.678 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 2.6 mp -85.46 99.7 7.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.346 -0.541 . . . . 0.0 110.541 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.527 ' HE2' HG22 ' A' ' 56' ' ' VAL . 20.1 m-85 -86.89 125.93 34.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 171.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -93.32 112.32 24.22 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.4 p -79.13 155.39 28.72 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -65.62 -6.72 11.97 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.283 175.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -99.21 12.32 36.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.989 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.9 mttm 70.68 19.89 5.87 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.372 172.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.8 mt -104.48 124.72 49.77 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.416 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.8 p -80.85 109.56 15.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.302 0.572 . . . . 0.0 109.769 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.714 HG11 HD13 ' A' ' 15' ' ' LEU . 70.0 t -87.1 132.14 33.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.025 -176.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 65.0 m -93.34 76.97 4.51 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.863 0.84 . . . . 0.0 108.832 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.595 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -70.71 141.13 51.56 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.898 -175.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.686 ' OD1' ' HB3' ' A' ' 10' ' ' TYR . 2.0 m-20 -79.0 129.63 72.52 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.3 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.54 -3.08 8.44 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 121.794 1.663 . . . . 0.0 111.122 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.461 ' CE ' HD21 ' A' ' 50' ' ' ASN . 53.8 mtmt -88.58 -18.85 27.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.048 -173.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.504 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 0.9 OUTLIER -104.54 145.21 30.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.953 0.406 . . . . 0.0 111.05 -170.754 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 p -69.72 -36.06 75.56 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -172.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.639 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 36.1 p-90 -60.14 -30.93 69.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.453 0.644 . . . . 0.0 109.466 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.595 ' CG2' ' HB1' ' A' ' 49' ' ' ALA . 15.1 t -75.27 -49.54 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.198 175.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -56.09 -33.61 65.22 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 123.454 0.471 . . . . 0.0 110.401 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -66.48 -56.96 8.44 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.872 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.446 HG12 ' HD3' ' A' ' 17' ' ' PRO . 72.4 mt -64.65 -43.94 96.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.142 -176.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 56' ' ' VAL . 7.1 p -67.07 -24.46 32.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.586 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 61' ' ' ARG . 8.4 ttp180 -69.61 -33.28 72.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.154 0.502 . . . . 0.0 110.114 174.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.6 mt -73.22 -44.45 59.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.872 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.54 ' HG ' ' CB ' ' A' ' 23' ' ' PHE . 3.7 mm? -61.96 -49.81 74.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.776 176.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.1 t . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 121.479 0.657 . . . . 0.0 109.8 178.882 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.813 ' HA ' ' HG3' ' A' ' 26' ' ' GLN . 82.8 m . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 110.94 -0.022 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.0 t -56.76 118.58 5.04 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 123.396 0.435 . . . . 0.0 110.062 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.33 -24.98 66.83 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.167 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.25 142.41 10.48 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.998 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.684 ' HB2' ' OD1' ' A' ' 50' ' ' ASN . 0.3 OUTLIER -105.24 171.32 7.38 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.027 0.441 . . . . 0.0 111.973 -178.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 t -93.12 154.11 18.27 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -169.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -95.19 59.53 2.25 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.419 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.632 ' HB3' HD22 ' A' ' 15' ' ' LEU . 6.7 mtm180 -129.34 173.66 10.32 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.511 HD13 ' CD1' ' A' ' 55' ' ' TRP . 14.5 mm -120.71 79.74 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 113.979 -1.464 . . . . 0.0 108.528 168.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 13' ' ' ARG . 2.8 mm? -79.31 159.12 27.33 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.655 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 52.3 m170 -134.24 172.05 7.99 Favored Pre-proline 0 C--N 1.309 -1.19 0 O-C-N 122.028 -0.42 . . . . 0.0 111.064 -176.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.575 ' HD3' HG12 ' A' ' 59' ' ' ILE . 14.4 Cg_endo -59.56 -21.64 63.08 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.732 1.622 . . . . 0.0 109.177 165.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.655 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 67.6 mttm -49.01 -34.28 12.88 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.151 174.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 41' ' ' THR . 12.0 m-85 -122.83 1.79 9.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.745 0.307 . . . . 0.0 111.135 -173.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.486 HD13 ' O ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -95.63 129.57 45.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.666 -174.27 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.35 -8.3 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.061 0.458 . . . . 0.0 110.389 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.02 159.43 30.34 Favored Glycine 0 N--CA 1.453 -0.193 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.56 ' CB ' HD13 ' A' ' 63' ' ' LEU . 1.6 t80 -147.04 131.0 17.16 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.617 0.722 . . . . 0.0 111.281 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.711 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 38.2 m -129.42 144.17 51.14 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.341 -1.3 . . . . 0.0 107.82 174.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -127.73 121.62 30.79 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.434 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.813 ' HG3' ' HA ' ' A' ' 6' ' ' CYS . 1.2 pm0 -97.75 123.92 41.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.301 177.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.432 ' C ' ' H ' ' A' ' 29' ' ' ASN . 82.8 mt -103.72 159.54 15.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.507 -176.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 32' ' ' CYS . . . -78.04 32.82 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.445 0.64 . . . . 0.0 110.662 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.432 ' H ' ' C ' ' A' ' 27' ' ' LEU . 5.5 m-20 -116.86 -30.37 5.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.167 -174.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -104.24 30.91 4.92 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -170.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.81 -60.06 0.67 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.741 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 0.5 OUTLIER -70.3 139.14 52.02 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 122.198 0.199 . . . . 0.0 111.058 178.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.36 -18.98 47.47 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.362 0.601 . . . . 0.0 109.419 176.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.3 pt -97.53 174.25 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.039 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -143.02 145.62 33.08 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.482 ' H ' ' HG2' ' A' ' 26' ' ' GLN . . . -142.55 177.11 8.51 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.078 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.962 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 42.6 mm -122.31 133.26 69.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.711 ' HB ' ' HB ' ' A' ' 24' ' ' THR . 72.9 mt -101.78 99.13 7.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.844 0.354 . . . . 0.0 110.091 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -91.76 114.06 26.49 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -86.56 113.49 22.51 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -176.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 41.5 p -79.75 162.08 25.36 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.142 0.496 . . . . 0.0 111.314 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -69.87 -2.66 12.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.829 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -93.67 7.26 45.44 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.777 176.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm 72.63 8.62 5.64 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.444 0.698 . . . . 0.0 111.002 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.77 120.74 36.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.03 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 p -79.94 105.57 11.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.358 0.599 . . . . 0.0 109.769 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 96.5 t -86.01 130.43 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.805 -176.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.9 m -82.1 92.22 6.8 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.855 0.835 . . . . 0.0 109.09 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.962 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -70.38 142.7 52.07 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.315 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.684 ' OD1' ' HB2' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -81.79 151.79 68.23 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -174.178 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -89.76 39.16 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.562 2.174 . . . . 0.0 112.835 168.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.609 ' O ' ' HE2' ' A' ' 57' ' ' LYS . 64.9 mttm -131.97 -80.79 0.51 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.046 0.451 . . . . 0.0 111.234 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.673 HE22 ' CG2' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -40.1 139.31 0.71 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.664 1.186 . . . . 0.0 113.543 177.387 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.474 HG22 ' HD2' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -75.1 -16.93 60.53 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -172.395 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.594 ' CD1' ' HB2' ' A' ' 53' ' ' GLN . 60.7 p-90 -65.01 -30.82 71.82 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.586 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.673 ' CG2' HE22 ' A' ' 53' ' ' GLN . 0.9 OUTLIER -71.39 -47.94 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.914 174.019 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.609 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 68.3 mttm -54.41 -34.98 62.4 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 123.779 0.674 . . . . 0.0 110.386 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -68.33 -56.27 9.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.128 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.575 HG12 ' HD3' ' A' ' 17' ' ' PRO . 63.5 mt -64.57 -46.59 92.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.641 0.258 . . . . 0.0 111.486 -175.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.638 HG12 ' O ' ' A' ' 56' ' ' VAL . 12.7 p -71.4 -28.5 32.14 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.016 -174.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -68.9 -35.02 76.37 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.4 tp -72.1 -37.53 69.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.323 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.56 HD13 ' CB ' ' A' ' 23' ' ' PHE . 95.9 mt -82.4 -37.62 25.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.819 -177.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 C--N 1.324 -0.519 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.808 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.564 ' SG ' HG12 ' A' ' 34' ' ' ILE . 25.1 p . . . . . 0 N--CA 1.447 -0.578 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 46.8 t -61.7 126.29 26.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.624 177.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.451 HD23 ' H ' ' A' ' 8' ' ' LEU . 2.3 pt? -64.21 -24.91 67.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.929 -176.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.27 122.57 1.74 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.565 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.562 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 3.2 m-85 -79.15 -178.42 6.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.561 0.696 . . . . 0.0 110.306 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.2 t -107.38 -166.26 1.14 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.065 175.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -160.22 81.42 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 170.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.459 ' HB2' HD22 ' A' ' 15' ' ' LEU . 23.1 mmm180 -131.59 -173.99 3.28 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.479 -168.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.504 HD13 ' CD1' ' A' ' 55' ' ' TRP . 7.6 mm -126.89 86.3 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 113.647 -1.615 . . . . 0.0 107.872 160.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.63 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 1.9 mm? -91.2 169.92 10.44 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.694 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 63.1 m170 -134.25 170.21 11.88 Favored Pre-proline 0 C--N 1.311 -1.073 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.879 -175.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 31.6 Cg_exo -55.73 -26.89 58.76 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 121.951 1.767 . . . . 0.0 109.251 164.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.694 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 62.6 mttm -45.5 -38.25 6.07 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 113.95 -1.477 . . . . 0.0 112.085 172.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 41' ' ' THR . 14.0 m-85 -118.14 2.59 12.02 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -170.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.681 HG12 ' HB3' ' A' ' 39' ' ' PHE . 17.2 mt -106.45 122.53 60.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.874 0.369 . . . . 0.0 111.058 -175.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.57 -0.52 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.822 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -157.42 158.32 28.87 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.548 ' CB ' HD13 ' A' ' 63' ' ' LEU . 2.8 t80 -155.29 133.29 11.49 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.514 0.673 . . . . 0.0 110.545 -176.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.3 m -136.87 108.82 7.12 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.07 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 25' ' ' ARG . 0.4 OUTLIER -80.15 105.28 11.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.967 0.889 . . . . 0.0 110.464 -177.67 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.652 ' HB3' ' O ' ' A' ' 36' ' ' ALA . 0.8 OUTLIER -84.67 120.15 26.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.449 178.596 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.409 ' HA ' ' HB2' ' A' ' 35' ' ' ASN . 2.8 mm? -114.89 155.12 27.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.494 0.664 . . . . 0.0 112.036 -170.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.2 22.27 1.25 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.909 -175.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -127.08 -3.17 6.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -103.8 25.19 10.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.029 0.443 . . . . 0.0 110.974 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.14 -64.83 0.6 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.634 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.56 152.8 41.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.772 0.32 . . . . 0.0 111.288 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -90.97 -14.46 31.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.012 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.564 HG12 ' SG ' ' A' ' 6' ' ' CYS . 3.6 pt -111.71 140.31 31.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.409 ' HB2' ' HA ' ' A' ' 27' ' ' LEU . 9.6 p30 -110.43 126.97 54.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.314 0.578 . . . . 0.0 110.519 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.652 ' O ' ' HB3' ' A' ' 26' ' ' GLN . . . -127.11 132.01 50.69 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.683 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.44 HG23 ' HE1' ' A' ' 23' ' ' PHE . 47.0 mm -77.61 112.28 15.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.1 mm -90.21 97.79 7.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 122.044 -0.41 . . . . 0.0 111.087 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.681 ' HB3' HG12 ' A' ' 20' ' ' ILE . 16.7 m-85 -90.52 119.07 30.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 6.6 m-70 -89.31 115.1 26.54 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 15.0 p -84.86 159.47 20.37 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.774 0.797 . . . . 0.0 112.509 -171.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -67.9 -0.7 4.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.055 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -98.61 20.62 12.57 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.68 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt 67.9 22.64 8.6 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.58 175.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.32 173.65 8.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.724 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 40' ' ' HIS . 49.1 m -127.75 122.3 32.47 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 173.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.4 t -92.01 131.51 38.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.439 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.455 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 20.6 m -82.87 82.18 8.27 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.486 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -72.16 141.28 49.08 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.155 -173.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.753 HD21 ' HE3' ' A' ' 52' ' ' LYS . 2.8 m-20 -82.41 131.42 55.68 Favored Pre-proline 0 CA--C 1.508 -0.671 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.733 -175.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 50' ' ' ASN . 5.8 Cg_exo -76.69 15.3 1.09 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.025 1.817 . . . . 0.0 111.632 169.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.753 ' HE3' HD21 ' A' ' 50' ' ' ASN . 1.1 ttpp -89.82 -28.66 19.15 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.664 176.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.447 ' CD ' ' HB2' ' A' ' 50' ' ' ASN . 0.8 OUTLIER -105.95 138.8 41.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.746 -163.277 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.29 -29.81 66.65 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -173.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.63 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 46.0 p-90 -63.19 -33.76 76.17 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.421 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.561 HG22 ' HE2' ' A' ' 39' ' ' PHE . 2.7 t -70.17 -46.99 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.918 174.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.474 ' HA ' HG12 ' A' ' 60' ' ' VAL . 91.1 mttt -62.19 -29.06 70.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.855 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -68.19 -51.01 50.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.79 0.329 . . . . 0.0 110.419 173.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 55' ' ' TRP . 58.1 mt -68.53 -43.91 83.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.322 -175.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.544 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 14.9 p -68.22 -33.29 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.08 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -66.04 -40.19 90.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.103 0.478 . . . . 0.0 109.78 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.0 tp -66.69 -47.64 71.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.992 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.548 HD13 ' CB ' ' A' ' 23' ' ' PHE . 83.0 mt -65.5 -36.37 83.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.377 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.5 m . . . . . 0 C--N 1.32 -0.691 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.453 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.558 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 1.8 p . . . . . 0 CA--C 1.52 -0.18 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.479 ' C ' ' H ' ' A' ' 9' ' ' GLY . 73.4 m -62.84 155.39 27.1 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.609 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 1.2 pp -77.34 25.7 0.17 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.428 0.632 . . . . 0.0 110.638 173.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 7' ' ' CYS . . . 131.15 156.98 8.69 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -175.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.499 ' HB2' ' OD1' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -105.96 172.03 7.03 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.53 178.86 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 t -84.66 -174.96 5.56 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.032 -172.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -135.66 70.99 1.42 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 173.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -131.65 178.51 6.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.541 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.576 HD13 ' CD1' ' A' ' 55' ' ' TRP . 5.2 mm -124.51 94.79 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.374 167.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.513 HD12 ' CH2' ' A' ' 55' ' ' TRP . 1.1 mt -106.75 158.08 17.24 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.877 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.77 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 26.4 m170 -132.19 178.81 1.58 Allowed Pre-proline 0 C--N 1.314 -0.969 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.716 -173.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.77 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 9.4 Cg_endo -55.42 -20.32 25.64 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.281 1.987 . . . . 0.0 110.046 164.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.634 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 22.0 mtpp -47.16 -27.03 1.29 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.308 172.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 41' ' ' THR . 55.2 m-85 -126.15 -10.85 6.47 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.427 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 16' ' ' HIS . 1.5 mp -95.13 128.42 46.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.046 0.45 . . . . 0.0 111.649 -170.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -122.53 -16.96 5.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.591 172.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -145.07 162.37 28.13 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.603 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -155.16 136.03 13.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.002 0.429 . . . . 0.0 111.006 -175.178 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.2 m -134.47 123.25 23.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.501 174.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 25' ' ' ARG . 6.6 ptp85 -91.18 91.89 8.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.612 0.72 . . . . 0.0 110.298 176.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.558 ' OE1' ' HA ' ' A' ' 6' ' ' CYS . 1.6 tm0? -68.76 121.61 16.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.95 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.7 mt -113.82 147.8 37.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.899 -168.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.83 46.84 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.159 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -139.32 -29.49 0.75 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.244 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -90.56 28.62 1.45 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -168.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.32 -37.99 2.7 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.74 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.7 m -91.14 158.56 16.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.856 0.36 . . . . 0.0 110.735 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -110.45 -12.39 14.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.539 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.555 HG13 ' HB2' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -105.93 133.42 50.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 174.119 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -108.54 136.84 47.48 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.929 0.395 . . . . 0.0 110.872 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 26' ' ' GLN . . . -140.19 140.19 35.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.94 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 45.8 mm -79.94 101.95 5.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -87.03 98.33 7.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 O-C-N 121.87 -0.519 . . . . 0.0 110.747 -176.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.492 ' HE2' HG22 ' A' ' 56' ' ' VAL . 11.3 m-85 -86.23 135.15 33.67 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -105.96 116.91 32.75 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 41.7 p -79.85 163.63 24.23 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.34 -172.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -63.57 -12.19 30.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.551 170.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -84.04 0.16 49.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.278 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 67.9 mttm 71.27 12.4 6.74 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.778 0.831 . . . . 0.0 111.368 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.7 mt -107.86 141.68 39.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.423 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.8 p -92.47 124.16 36.31 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.102 0.477 . . . . 0.0 110.721 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.4 t -105.16 134.1 47.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.43 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 69.6 m -85.32 86.2 7.39 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.582 0.706 . . . . 0.0 109.634 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.628 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -72.78 149.12 43.92 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.451 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.575 ' HB2' ' OE1' ' A' ' 53' ' ' GLN . 0.4 OUTLIER -83.48 151.76 62.74 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.865 -172.295 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -88.91 32.16 0.39 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.263 1.975 . . . . 0.0 113.771 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.675 ' O ' ' HE3' ' A' ' 57' ' ' LYS . 50.9 mtpt -132.25 -61.43 0.87 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -174.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.64 HE22 ' CG2' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -56.49 143.14 36.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.55 0.691 . . . . 0.0 112.272 -179.575 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p -74.94 -20.49 59.67 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -172.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.576 ' CD1' HD13 ' A' ' 14' ' ' ILE . 60.4 p-90 -63.22 -32.47 73.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.068 176.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.64 ' CG2' HE22 ' A' ' 53' ' ' GLN . 1.0 OUTLIER -68.92 -46.31 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.922 174.356 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.675 ' HE3' ' O ' ' A' ' 52' ' ' LYS . 92.6 mttt -63.81 -24.55 67.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.573 -178.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -74.12 -49.83 22.09 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.547 174.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.47 HD11 ' O ' ' A' ' 15' ' ' LEU . 76.8 mt -65.66 -48.15 83.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.06 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.603 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 14.1 p -65.37 -29.14 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 120.579 0.228 . . . . 0.0 110.743 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 28.3 ttm180 -63.79 -43.92 94.89 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.4 mt -64.75 -43.33 93.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.69 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.491 ' HG ' ' CB ' ' A' ' 23' ' ' PHE . 3.9 mm? -57.48 -49.95 74.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.951 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.8 m . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.989 -176.461 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.836 ' HA ' ' CD ' ' A' ' 26' ' ' GLN . 30.2 p . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 121.452 0.644 . . . . 0.0 112.056 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.428 ' O ' HD11 ' A' ' 34' ' ' ILE . 74.1 m -57.0 143.2 39.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.209 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.3 mt -82.56 10.27 7.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.91 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.22 162.89 34.29 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.172 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.576 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 39.1 m-85 -116.19 -178.89 3.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.913 0.387 . . . . 0.0 110.304 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 49' ' ' ALA . 13.8 t -96.0 -178.68 4.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.135 176.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -144.83 23.37 1.56 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.073 0.463 . . . . 0.0 110.717 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.534 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 40.6 mtt180 -109.65 -174.08 2.41 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.76 0.791 . . . . 0.0 113.001 -173.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.553 HD13 ' CD1' ' A' ' 55' ' ' TRP . 6.2 mm -117.71 77.69 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 113.598 -1.637 . . . . 0.0 107.912 167.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.534 ' CD2' ' HB2' ' A' ' 13' ' ' ARG . 2.8 mm? -75.45 158.33 32.81 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.693 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 42.1 m170 -132.1 174.59 4.52 Favored Pre-proline 0 C--N 1.306 -1.285 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.857 -176.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.693 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 9.4 Cg_endo -54.52 -26.56 45.85 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.807 1.671 . . . . 0.0 108.954 166.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.657 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 67.4 mttm -46.27 -34.8 4.71 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 113.676 -1.602 . . . . 0.0 111.726 173.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -124.93 -4.6 7.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.632 0.253 . . . . 0.0 111.626 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.797 HG12 ' HB3' ' A' ' 39' ' ' PHE . 11.6 mt -102.83 114.86 43.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.071 0.462 . . . . 0.0 110.86 -173.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.9 -5.36 11.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.63 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -150.8 159.94 28.38 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.476 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 2.3 t80 -154.66 137.07 14.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.222 0.534 . . . . 0.0 110.483 -176.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.2 m -143.82 104.01 4.12 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.674 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -73.77 104.13 4.56 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.898 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.836 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 11.0 tt0 -90.14 125.88 35.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.216 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.9 mp -105.93 173.97 6.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.46 0.647 . . . . 0.0 112.156 -170.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.43 16.82 21.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.286 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -118.11 7.55 12.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.287 -173.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -119.63 37.49 4.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.174 0.511 . . . . 0.0 110.751 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.68 -62.31 0.29 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.052 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -71.64 143.75 49.66 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.413 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -97.27 9.78 41.3 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -170.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.768 HG12 ' SG ' ' A' ' 6' ' ' CYS . 4.5 pt -128.23 156.83 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 172.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -120.23 122.25 40.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.194 0.521 . . . . 0.0 111.524 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.535 ' O ' ' HB3' ' A' ' 26' ' ' GLN . . . -121.2 137.11 54.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.809 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.637 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 48.0 mm -82.6 98.56 4.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.158 0.504 . . . . 0.0 109.905 178.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.49 HG23 ' HB2' ' A' ' 46' ' ' SER . 67.0 mt -76.91 105.83 6.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.036 0.446 . . . . 0.0 111.273 -176.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.797 ' HB3' HG12 ' A' ' 20' ' ' ILE . 19.8 m-85 -96.29 119.42 34.75 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -89.01 106.09 18.2 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.9 p -72.57 164.0 27.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.645 -175.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -71.47 6.54 1.77 Allowed 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.421 0.629 . . . . 0.0 110.55 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -101.81 9.41 40.8 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.126 173.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 68.41 14.07 9.09 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.663 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.5 mt -103.05 131.48 50.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.051 0.453 . . . . 0.0 110.699 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.49 ' HB2' HG23 ' A' ' 38' ' ' ILE . 5.7 p -80.58 102.54 9.85 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.541 177.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 77.8 t -84.93 124.03 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.743 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 25.8 m -88.82 90.58 8.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.739 0.781 . . . . 0.0 109.496 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.637 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -70.87 134.82 47.62 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.818 -174.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.579 ' HB2' ' CG ' ' A' ' 53' ' ' GLN . 2.1 m-20 -70.26 129.15 90.8 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 50' ' ' ASN . 21.8 Cg_exo -65.39 -6.5 13.58 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.387 2.058 . . . . 0.0 112.676 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -76.43 -37.56 56.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.777 0.799 . . . . 0.0 111.254 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.608 ' NE2' ' HE1' ' A' ' 55' ' ' TRP . 6.5 mt-30 -72.79 134.96 45.16 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.862 -164.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.22 -26.62 60.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.861 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.608 ' HE1' ' NE2' ' A' ' 53' ' ' GLN . 55.8 p-90 -65.31 -32.45 74.1 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 173.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.539 ' O ' HG12 ' A' ' 60' ' ' VAL . 43.2 t -70.04 -50.5 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.829 173.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.549 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 96.5 mttt -59.3 -28.08 66.46 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.696 0.622 . . . . 0.0 111.281 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -71.06 -56.86 5.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.7 0.286 . . . . 0.0 110.309 173.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.673 HG22 HD22 ' A' ' 63' ' ' LEU . 81.9 mt -60.19 -45.95 95.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 -177.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.539 HG12 ' O ' ' A' ' 56' ' ' VAL . 9.8 p -70.3 -26.42 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.362 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -60.55 -43.11 97.6 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 174.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.2 mt -72.78 -41.2 65.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.489 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.673 HD22 HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -62.31 -46.4 88.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.348 -0.387 . . . . 0.0 112.043 -179.017 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 p . . . . . 0 C--N 1.323 -0.586 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -173.21 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.579 ' HB3' ' HG2' ' A' ' 26' ' ' GLN . 30.1 p . . . . . 0 N--CA 1.444 -0.754 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.8 t -50.74 114.14 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.607 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.1 mt -90.45 17.92 6.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.662 -176.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.54 113.39 0.7 Allowed Glycine 0 C--O 1.225 -0.415 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.616 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 33.6 m-85 -85.27 168.68 14.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.126 0.489 . . . . 0.0 111.239 -173.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 49' ' ' ALA . 11.1 t -86.75 -177.48 6.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.938 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -141.23 16.57 2.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.935 -177.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.592 ' HB3' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -104.76 175.16 5.58 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.213 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.549 HD13 ' CD1' ' A' ' 55' ' ' TRP . 2.8 mm -110.34 90.07 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 113.813 -1.539 . . . . 0.0 108.173 161.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.592 HD22 ' HB3' ' A' ' 13' ' ' ARG . 2.5 mm? -88.97 167.2 13.39 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.599 ' O ' HD13 ' A' ' 20' ' ' ILE . 63.2 m170 -133.07 167.83 21.01 Favored Pre-proline 0 C--N 1.314 -0.947 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.0 -175.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.661 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 22.8 Cg_endo -63.42 -19.07 67.29 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.121 1.881 . . . . 0.0 109.214 165.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 85.6 mttt -55.35 -24.66 30.47 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.417 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' A' ' 41' ' ' THR . 50.2 m-85 -128.29 2.53 5.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.946 -175.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.661 ' HB ' ' HA ' ' A' ' 17' ' ' PRO . 1.0 OUTLIER -100.85 122.78 53.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.098 0.475 . . . . 0.0 110.587 -175.685 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.03 -9.96 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.67 175.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -148.43 161.28 28.6 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.41 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.542 ' CE2' HG23 ' A' ' 60' ' ' VAL . 1.8 t80 -156.05 134.01 11.25 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -176.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.695 HG22 ' NE2' ' A' ' 26' ' ' GLN . 22.9 m -141.02 112.69 7.58 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.399 176.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 11.7 ttp180 -101.73 117.65 35.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.936 0.398 . . . . 0.0 111.202 -176.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.695 ' NE2' HG22 ' A' ' 24' ' ' THR . 1.8 mp0 -97.75 139.01 34.26 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.806 174.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.536 HD13 ' HG3' ' A' ' 30' ' ' GLU . 5.2 mp -124.64 159.54 30.53 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 123.628 0.58 . . . . 0.0 109.767 -177.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.739 ' HA ' ' O ' ' A' ' 32' ' ' CYS . . . -77.01 1.08 18.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.818 0.818 . . . . 0.0 110.722 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -116.44 2.77 13.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.619 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.536 ' HG3' HD13 ' A' ' 27' ' ' LEU . 7.1 mm-40 -107.48 -8.75 16.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.849 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.12 -56.74 0.47 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.154 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.739 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 9.5 t -57.99 151.07 19.24 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 122.88 0.472 . . . . 0.0 109.98 174.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -84.39 -21.74 30.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.092 0.472 . . . . 0.0 109.911 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.428 HG13 ' SG ' ' A' ' 6' ' ' CYS . 46.9 pt -110.41 -171.46 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 173.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -138.86 119.29 13.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.445 0.64 . . . . 0.0 110.477 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.74 137.53 53.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.055 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.525 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 15.5 mm -96.47 92.32 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.217 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 40.5 mt -79.63 101.16 4.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.852 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.472 ' CE1' ' HD2' ' A' ' 23' ' ' PHE . 20.8 m-85 -85.13 131.2 34.48 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 171.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -100.02 107.89 19.94 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 41.1 p -71.14 159.21 35.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.762 -174.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -3.08 12.28 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.576 0.703 . . . . 0.0 109.642 171.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -90.97 1.22 57.22 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.112 174.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 70.42 16.32 7.13 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.638 -1.164 . . . . 0.0 112.057 173.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.8 mt -107.2 136.56 46.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.825 175.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.8 p -84.47 120.82 26.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.062 0.458 . . . . 0.0 110.477 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 91.0 t -104.2 124.36 58.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.962 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.5 m -85.53 82.79 8.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.661 0.743 . . . . 0.0 109.385 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.601 ' HA ' HG22 ' A' ' 11' ' ' THR . . . -69.64 143.55 53.19 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.034 -173.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.616 ' OD1' ' HB3' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -81.29 128.33 70.72 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.924 -176.046 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -71.19 13.49 0.4 Allowed 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.761 2.308 . . . . 0.0 112.303 173.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 50' ' ' ASN . 55.6 mtpt -99.47 -23.94 14.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.172 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.516 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 0.8 OUTLIER -102.63 145.77 29.16 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.737 -167.047 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.3 -30.83 63.66 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.638 -171.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.578 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 42.6 p-90 -63.34 -32.87 74.41 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.368 177.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.589 ' CG2' ' HB1' ' A' ' 49' ' ' ALA . 8.6 t -72.09 -46.14 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.38 174.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.511 ' HA ' HG12 ' A' ' 60' ' ' VAL . 88.6 mttt -60.5 -34.65 74.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.903 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -64.37 -50.07 69.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.395 174.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 55' ' ' TRP . 68.0 mt -68.88 -45.96 79.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.481 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.542 HG23 ' CE2' ' A' ' 23' ' ' PHE . 12.8 p -65.65 -35.35 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.89 -0.141 . . . . 0.0 111.297 -178.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -65.39 -33.84 76.89 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 30.6 tp -74.64 -38.1 62.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.236 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.443 ' HG ' ' CB ' ' A' ' 23' ' ' PHE . 2.8 mm? -69.52 -26.17 64.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.55 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.1 p . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 121.322 0.582 . . . . 0.0 110.25 175.948 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.703 ' SG ' HG12 ' A' ' 34' ' ' ILE . 19.6 p . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.0 t -62.63 152.69 34.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.328 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.9 mt -74.97 2.14 11.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.45 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.13 -153.92 12.31 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.675 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 64.0 m-85 -137.37 -171.47 2.98 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.525 HG21 ' CG1' ' A' ' 47' ' ' VAL . 11.2 t -127.19 136.88 52.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.075 0.464 . . . . 0.0 111.045 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -101.97 56.65 0.81 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.822 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.543 ' NE ' ' HA ' ' A' ' 13' ' ' ARG . 3.3 mmp_? -122.65 -177.16 3.57 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.517 0.675 . . . . 0.0 112.088 -177.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.599 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.5 mm -125.4 87.2 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 114.228 -1.351 . . . . 0.0 107.789 167.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.585 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.8 mm? -88.14 161.0 17.53 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.705 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 4.0 m-70 -131.77 174.8 4.28 Favored Pre-proline 0 C--N 1.31 -1.115 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.275 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.705 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 10.1 Cg_endo -56.05 -23.22 42.83 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.8 1.667 . . . . 0.0 108.99 167.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.666 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 9.5 mmmt -47.35 -26.59 1.32 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 113.541 -1.663 . . . . 0.0 112.245 173.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 41' ' ' THR . 86.4 m-85 -126.86 -11.35 6.03 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 122.195 -0.316 . . . . 0.0 111.682 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.555 HG13 ' HB3' ' A' ' 39' ' ' PHE . 1.4 mp -89.65 122.59 41.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.062 0.458 . . . . 0.0 110.988 -171.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.53 -8.07 8.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.769 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -154.19 155.59 26.28 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.737 ' HB2' HD13 ' A' ' 63' ' ' LEU . 2.4 t80 -147.67 137.54 22.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.908 0.385 . . . . 0.0 110.278 -177.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 50.3 m -145.22 110.58 5.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.577 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -83.9 139.3 32.7 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.658 ' NE2' ' HA ' ' A' ' 6' ' ' CYS . 1.9 pt20 -119.26 108.41 14.6 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.784 0.802 . . . . 0.0 110.704 177.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 86.2 mt -98.24 165.04 12.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.958 -175.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.791 ' HA ' ' O ' ' A' ' 32' ' ' CYS . . . -82.7 11.31 6.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.586 -177.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -108.58 -19.87 13.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.839 0.352 . . . . 0.0 111.73 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -134.39 30.77 3.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.118 0.485 . . . . 0.0 111.769 -170.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.72 -86.83 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 119.933 -1.127 . . . . 0.0 113.119 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.791 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 42.2 t -105.64 170.11 8.08 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.572 -0.314 . . . . 0.0 110.904 -175.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.402 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 9.5 m-20 -83.59 -21.87 32.47 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.096 0.247 . . . . 0.0 111.618 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.703 HG12 ' SG ' ' A' ' 6' ' ' CYS . 2.0 pt -100.0 157.33 3.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -115.26 130.54 56.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.367 0.603 . . . . 0.0 111.246 -178.748 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.565 ' HB3' ' OE1' ' A' ' 26' ' ' GLN . . . -139.08 166.46 24.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.597 175.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.536 HG23 ' HE1' ' A' ' 23' ' ' PHE . 43.5 mm -113.88 106.19 20.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.161 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 66.0 mt -83.64 105.08 12.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 O-C-N 121.734 -0.603 . . . . 0.0 111.238 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.555 ' HB3' HG13 ' A' ' 20' ' ' ILE . 14.0 m-85 -94.96 111.85 23.61 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 171.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -84.45 112.98 20.86 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 28.2 p -76.33 166.01 24.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.128 0.49 . . . . 0.0 111.123 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -71.14 2.97 3.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.617 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.0 mmtp -98.82 5.64 47.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.568 176.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 67.2 mttm 68.42 12.58 8.77 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.805 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.5 mt -97.82 130.65 44.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.022 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.4 p -86.66 106.64 17.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.298 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.525 ' CG1' HG21 ' A' ' 11' ' ' THR . 66.4 t -86.82 124.93 40.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.9 m -88.61 83.89 6.76 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.718 0.771 . . . . 0.0 109.985 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.572 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -69.82 141.59 53.27 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.397 -175.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.675 ' OD1' ' HB3' ' A' ' 10' ' ' TYR . 2.2 m-20 -80.53 130.21 65.72 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.083 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -73.2 23.47 0.31 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.831 1.688 . . . . 0.0 111.666 171.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 50' ' ' ASN . 32.2 mtmm -115.24 -17.21 11.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.547 -176.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.496 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 1.0 OUTLIER -109.5 145.23 36.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 -170.678 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.69 ' HA ' ' HG2' ' A' ' 57' ' ' LYS . 1.3 p -81.5 -23.1 37.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -170.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.599 ' CD1' HD13 ' A' ' 14' ' ' ILE . 54.9 p-90 -63.19 -32.83 74.33 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 173.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.572 ' CG2' ' HB1' ' A' ' 49' ' ' ALA . 25.3 t -69.16 -46.98 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.792 172.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.69 ' HG2' ' HA ' ' A' ' 54' ' ' THR . 6.9 mmtp -55.89 -38.47 70.22 Favored 'General case' 0 C--O 1.222 -0.383 0 O-C-N 123.426 0.454 . . . . 0.0 110.737 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -65.22 -53.81 38.93 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.707 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.499 HG22 HD12 ' A' ' 63' ' ' LEU . 78.9 mt -62.74 -45.71 98.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.874 -177.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.554 HG12 ' O ' ' A' ' 56' ' ' VAL . 12.5 p -70.02 -24.9 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 120.911 -0.315 . . . . 0.0 110.903 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 49.8 ttp180 -64.45 -35.14 79.95 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.16 0.505 . . . . 0.0 110.256 176.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.6 mt -84.42 -25.22 29.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.968 177.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.737 HD13 ' HB2' ' A' ' 23' ' ' PHE . 77.5 mt -87.68 -31.28 19.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.307 -176.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 121.215 0.531 . . . . 0.0 109.74 178.074 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.824 ' HA ' ' CD ' ' A' ' 26' ' ' GLN . 26.6 p . . . . . 0 C--O 1.231 0.118 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.479 ' O ' HD11 ' A' ' 34' ' ' ILE . 43.1 t -73.03 127.75 33.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.088 171.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.7 mt -81.93 45.34 0.9 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.146 0.498 . . . . 0.0 110.742 -174.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 166.26 157.65 10.37 Favored Glycine 0 N--CA 1.44 -1.048 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.672 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 25.2 m-85 -123.87 162.33 23.5 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 117.159 0.479 . . . . 0.0 110.488 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.5 t -90.18 -175.58 4.58 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.404 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -144.78 31.18 1.17 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.553 0.692 . . . . 0.0 109.813 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.595 ' HB2' HD22 ' A' ' 15' ' ' LEU . 35.2 mmt180 -87.68 -176.6 5.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.714 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.494 HD13 ' CD1' ' A' ' 55' ' ' TRP . 16.4 mm -124.93 77.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.654 165.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.741 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.2 mm? -74.76 153.7 38.68 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.057 -178.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.692 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 42.9 m170 -132.66 173.63 5.66 Favored Pre-proline 0 C--N 1.317 -0.847 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.622 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.692 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 13.0 Cg_endo -58.86 -23.84 69.33 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 121.718 1.612 . . . . 0.0 108.825 167.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.674 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 8.7 mmmt -47.22 -34.4 6.38 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 113.434 -1.712 . . . . 0.0 111.931 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.687 ' HA ' ' HE3' ' A' ' 42' ' ' LYS . 27.0 m-85 -125.44 -0.2 7.59 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.655 0.264 . . . . 0.0 111.338 -175.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.507 HD13 ' O ' ' A' ' 16' ' ' HIS . 1.3 mp -96.46 126.75 49.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.0 0.428 . . . . 0.0 110.635 -175.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.12 -6.8 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.999 174.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -157.73 154.27 25.38 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.542 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.606 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -145.02 132.99 21.29 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.477 0.656 . . . . 0.0 110.386 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.7 m -132.93 121.06 22.27 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.469 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -86.68 114.03 23.04 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.508 0.671 . . . . 0.0 110.412 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.824 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 21.6 tt0 -104.27 121.91 44.31 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.876 177.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.5 mp -109.31 178.65 4.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.946 -170.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -111.52 26.58 10.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.922 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -130.7 -12.82 3.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.489 -175.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -115.05 23.51 12.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.462 -174.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.42 -91.79 0.11 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.358 177.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 6' ' ' CYS . 18.5 m -66.16 169.56 6.89 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.997 0.427 . . . . 0.0 111.976 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -99.22 -6.02 28.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.089 176.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.479 HD11 ' O ' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -108.61 153.41 10.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 174.561 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.497 ' OD1' ' HG2' ' A' ' 51' ' ' PRO . 4.8 p30 -127.09 129.64 48.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.801 -0.181 . . . . 0.0 111.28 -173.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.762 ' O ' ' HB3' ' A' ' 26' ' ' GLN . . . -134.68 127.37 30.93 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.244 0.545 . . . . 0.0 111.962 176.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.408 HG23 ' HE1' ' A' ' 23' ' ' PHE . 48.3 mm -70.05 117.61 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 170.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 55.8 mt -94.42 104.41 15.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 120.834 0.349 . . . . 0.0 111.117 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.703 ' CE2' HG12 ' A' ' 56' ' ' VAL . 12.1 m-85 -93.98 127.73 39.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 173.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -98.03 108.81 21.6 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.1 p -74.0 160.15 31.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.068 -174.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.687 ' HE3' ' HA ' ' A' ' 19' ' ' PHE . 18.0 ptpt -66.07 -3.03 4.71 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.317 172.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -89.66 0.54 56.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.633 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.546 ' NZ ' ' HB2' ' A' ' 44' ' ' LYS . 8.3 mtmp? 71.89 15.6 5.69 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.981 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.0 mt -107.88 136.66 47.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.904 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.1 p -87.16 118.57 26.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.301 0.572 . . . . 0.0 110.007 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 76.5 t -97.24 134.05 36.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.083 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.3 m -89.12 87.44 7.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.424 ' HB1' ' CG1' ' A' ' 56' ' ' VAL . . . -79.49 143.07 35.25 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.409 -174.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.749 ' HB2' ' CG ' ' A' ' 53' ' ' GLN . 1.6 m-20 -82.53 122.19 78.6 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.524 -174.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HG2' ' OD1' ' A' ' 35' ' ' ASN . 19.8 Cg_exo -70.18 9.8 0.62 Allowed 'Trans proline' 0 C--N 1.329 -0.479 0 C-N-CA 122.279 1.986 . . . . 0.0 112.368 175.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 50' ' ' ASN . 51.3 mttm -104.33 -14.27 15.83 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.406 -176.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.749 ' CG ' ' HB2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -89.53 168.13 12.42 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -176.454 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.23 -33.51 14.65 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.741 ' CZ3' ' HB2' ' A' ' 15' ' ' LEU . 59.3 p-90 -62.19 -28.58 69.77 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.823 -177.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.718 HG21 ' O ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -71.04 -49.91 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 174.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 93.9 mttt -55.03 -33.85 63.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.687 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -64.37 -52.67 57.12 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.211 0.529 . . . . 0.0 110.486 174.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.536 HG12 ' HD3' ' A' ' 17' ' ' PRO . 87.7 mt -65.85 -48.96 80.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.74 -176.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.606 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 7.8 p -65.53 -28.37 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.836 0.35 . . . . 0.0 110.754 -176.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -69.03 -35.43 76.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.212 0.53 . . . . 0.0 109.672 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.4 tp -79.02 -32.63 45.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.995 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 1.9 mm? -67.63 -42.5 82.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.275 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.7 p . . . . . 0 C--N 1.323 -0.545 0 CA-C-O 120.894 0.378 . . . . 0.0 110.901 -179.969 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.767 ' HB2' HG12 ' A' ' 34' ' ' ILE . 18.7 p . . . . . 0 N--CA 1.441 -0.892 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.1 t -106.54 158.37 16.97 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.927 -0.483 . . . . 0.0 110.425 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.7 mt -77.73 -27.94 50.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.933 0.397 . . . . 0.0 110.828 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.83 136.3 4.08 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.624 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 20.1 m-85 -78.47 173.63 12.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.486 0.66 . . . . 0.0 111.047 -177.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.8 t -89.02 -178.55 5.72 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.94 174.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -140.63 1.86 1.76 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.011 0.434 . . . . 0.0 110.169 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.603 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 32.7 mtt180 -94.23 -172.42 2.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.641 -166.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.614 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.3 mm -117.64 88.79 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.599 -1.182 . . . . 0.0 107.982 167.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.603 ' CD2' ' HB2' ' A' ' 13' ' ' ARG . 2.9 mm? -88.34 164.77 15.39 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.732 ' ND1' ' HD2' ' A' ' 18' ' ' LYS . 63.2 m170 -132.97 163.63 49.66 Favored Pre-proline 0 C--N 1.311 -1.105 0 C-N-CA 119.831 -0.748 . . . . 0.0 112.151 -174.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.612 ' HD3' HG12 ' A' ' 59' ' ' ILE . 26.7 Cg_endo -64.28 -17.18 58.75 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.213 1.942 . . . . 0.0 109.174 167.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.732 ' HD2' ' ND1' ' A' ' 16' ' ' HIS . 60.8 mttm -51.66 -29.23 17.14 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.361 172.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -128.01 11.37 6.55 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.62 -174.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.641 HG12 ' O ' ' A' ' 16' ' ' HIS . 7.5 mm -106.69 127.64 62.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -173.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.3 m -118.56 -3.49 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.146 0.498 . . . . 0.0 110.934 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -155.29 158.91 28.76 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.004 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.739 ' HB2' HD13 ' A' ' 63' ' ' LEU . 1.4 t80 -155.47 134.68 12.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.239 0.542 . . . . 0.0 110.183 -177.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.449 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 25.5 m -142.06 107.08 4.93 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.867 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 14.1 ptp180 -77.02 109.03 10.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.827 0.822 . . . . 0.0 110.112 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.589 ' OE1' ' HB3' ' A' ' 36' ' ' ALA . 2.4 tt0 -99.05 133.11 43.79 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.218 -175.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.0 mt -122.18 158.9 28.36 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -159.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.72 31.24 4.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.737 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -99.41 -73.42 0.63 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.745 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -110.9 23.12 14.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.574 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -129.53 -71.93 0.13 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.345 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 47.3 t -128.63 -172.08 2.62 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.441 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 0.9 OUTLIER -96.85 -23.55 16.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.957 0.408 . . . . 0.0 109.923 178.697 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.767 HG12 ' HB2' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -109.03 159.75 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 175.352 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -132.56 132.13 42.24 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.915 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.589 ' HB3' ' OE1' ' A' ' 26' ' ' GLN . . . -129.1 145.13 51.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.415 0.626 . . . . 0.0 111.63 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.691 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 47.9 mm -88.79 104.77 15.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.861 177.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.449 ' HB ' ' HB ' ' A' ' 24' ' ' THR . 58.1 mt -79.65 103.05 6.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 O-C-N 122.108 -0.37 . . . . 0.0 111.386 -176.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -91.65 123.82 35.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 171.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -97.66 108.93 21.76 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.2 p -75.84 157.49 33.29 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.116 0.484 . . . . 0.0 111.37 -175.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -68.17 -10.33 53.44 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 43' ' ' LYS . 23.0 ttmm -89.92 14.18 12.77 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.702 -177.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp 71.0 13.55 6.94 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.046 173.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.5 mt -112.66 142.15 45.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.968 0.413 . . . . 0.0 111.042 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.0 p -99.13 112.64 24.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.222 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.2 t -92.48 120.31 41.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.354 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.9 m -83.44 89.21 7.02 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.808 0.813 . . . . 0.0 109.269 177.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.691 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -71.18 140.33 50.47 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.387 -174.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.624 ' OD1' ' HB3' ' A' ' 10' ' ' TYR . 2.1 m-20 -79.97 126.06 80.6 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.175 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.1 13.98 0.48 Allowed 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.321 2.014 . . . . 0.0 111.613 174.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 50' ' ' ASN . 74.8 mttt -100.5 -21.51 15.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.136 -175.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.528 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 1.1 pt20 -109.57 148.46 31.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.646 -167.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p -75.03 -33.65 61.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -170.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.614 ' CD1' HD13 ' A' ' 14' ' ' ILE . 49.7 p-90 -61.34 -32.58 72.47 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.352 0.596 . . . . 0.0 109.491 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.626 HG22 ' HB1' ' A' ' 49' ' ' ALA . 14.7 t -70.51 -51.29 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.171 174.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 95.2 mttt -58.05 -32.12 67.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.968 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -68.04 -56.37 9.15 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.395 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.612 HG12 ' HD3' ' A' ' 17' ' ' PRO . 72.5 mt -61.02 -43.34 95.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.222 -176.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.641 HG23 ' CE1' ' A' ' 23' ' ' PHE . 13.8 p -65.45 -35.03 74.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.374 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -68.63 -33.08 73.41 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.989 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 29.8 mt -77.66 -33.44 53.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.094 0.473 . . . . 0.0 110.701 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.739 HD13 ' HB2' ' A' ' 23' ' ' PHE . 78.7 mt -79.24 -12.49 59.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.989 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--N 1.32 -0.691 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.526 173.079 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.642 ' HB3' ' HG2' ' A' ' 26' ' ' GLN . 18.5 p . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.2 m -41.26 98.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 -169.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.1 mt -63.65 -37.28 86.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.548 173.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.38 85.58 0.42 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.775 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.468 ' HA ' ' HB2' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -88.11 155.03 20.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.994 0.426 . . . . 0.0 111.254 177.504 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.454 HG21 HG13 ' A' ' 47' ' ' VAL . 14.9 t -91.11 141.94 28.28 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -166.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -104.58 74.57 1.16 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.68 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.407 ' HD2' HD21 ' A' ' 15' ' ' LEU . 99.5 mtt180 -123.44 -171.8 2.38 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.055 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.537 HD13 ' CD1' ' A' ' 55' ' ' TRP . 8.2 mm -126.54 91.78 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.147 165.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.623 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 1.7 mm? -98.15 162.77 13.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.77 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 4.2 m-70 -132.63 175.46 3.69 Favored Pre-proline 0 C--N 1.317 -0.841 0 O-C-N 122.054 -0.404 . . . . 0.0 110.757 -178.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.77 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 18.9 Cg_endo -60.25 -16.95 43.68 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.106 1.871 . . . . 0.0 109.453 166.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.608 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 9.1 mtmt -45.91 -35.54 4.69 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 114.111 -1.404 . . . . 0.0 111.779 172.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -126.68 2.22 6.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.024 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.626 ' HB ' ' HA ' ' A' ' 17' ' ' PRO . 1.2 mp -92.44 124.32 44.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.81 0.338 . . . . 0.0 110.116 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.3 m -121.34 -1.18 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.977 0.418 . . . . 0.0 110.333 176.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.92 157.94 29.48 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.676 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.751 ' HB2' HD13 ' A' ' 63' ' ' LEU . 2.8 t80 -151.01 134.29 16.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.193 0.521 . . . . 0.0 110.564 -177.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.42 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 32.2 m -146.15 102.32 3.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.265 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -74.58 126.7 31.37 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.711 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.642 ' HG2' ' HB3' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -101.35 126.87 48.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.689 -177.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.3 mp -125.17 153.42 43.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.335 0.588 . . . . 0.0 111.712 -171.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.41 ' HA ' ' C ' ' A' ' 32' ' ' CYS . . . -64.57 -23.58 67.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.328 174.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -67.38 -24.87 65.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.366 -176.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -102.72 -32.62 9.76 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.866 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.38 41.24 0.02 OUTLIER Glycine 0 C--O 1.221 -0.682 0 C-N-CA 119.998 -1.096 . . . . 0.0 112.306 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.576 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 53.8 t -133.8 -179.71 5.71 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 173.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -118.23 -32.18 4.77 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.974 169.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.5 pt -95.75 -156.58 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 169.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -150.93 137.36 18.63 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.115 0.483 . . . . 0.0 110.132 174.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.49 145.11 33.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.071 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.809 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 46.4 mm -93.57 108.25 20.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.42 ' HB ' ' O ' ' A' ' 24' ' ' THR . 33.6 mm -85.91 99.03 7.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 O-C-N 121.982 -0.449 . . . . 0.0 110.636 -177.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.434 ' HB3' HG13 ' A' ' 20' ' ' ILE . 17.1 m-85 -90.59 122.9 33.8 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 174.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -93.6 107.35 19.22 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.5 p -79.36 164.58 23.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.119 0.485 . . . . 0.0 111.698 -174.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -72.86 -1.63 17.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 122.151 0.976 . . . . 0.0 108.59 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.42 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 12.6 tptt -86.14 9.0 18.71 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.505 173.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.8 pttm 46.89 34.04 2.48 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.455 1.102 . . . . 0.0 111.686 -173.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 43' ' ' LYS . 94.0 mt -119.47 131.13 55.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.072 175.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.9 p -84.9 105.69 15.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.382 0.611 . . . . 0.0 110.651 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.454 HG13 HG21 ' A' ' 11' ' ' THR . 54.3 t -79.62 126.28 39.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.601 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 58.8 m -84.67 88.86 7.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.809 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -76.72 134.67 39.14 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.629 -176.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.527 ' HB2' ' HG2' ' A' ' 53' ' ' GLN . 2.5 m-20 -77.35 134.99 66.01 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.106 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -74.25 7.29 2.62 Favored 'Trans proline' 0 C--N 1.33 -0.398 0 C-N-CA 122.502 2.135 . . . . 0.0 110.614 168.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -90.3 -17.48 27.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.265 -177.44 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.527 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 1.0 OUTLIER -118.83 150.72 39.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.859 -168.622 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.766 ' HA ' ' HG2' ' A' ' 57' ' ' LYS . 1.7 p -91.45 -17.75 25.27 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -170.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.623 ' CZ3' ' HB2' ' A' ' 15' ' ' LEU . 58.1 p-90 -63.62 -32.8 74.38 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 172.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.544 ' O ' HG12 ' A' ' 60' ' ' VAL . 38.9 t -66.52 -47.28 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.839 171.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.766 ' HG2' ' HA ' ' A' ' 54' ' ' THR . 13.4 mmtp -54.45 -39.0 66.98 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.168 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.52 ' HD1' HH21 ' A' ' 61' ' ' ARG . 5.8 t80 -67.41 -53.69 26.94 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.087 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.568 HG22 HD12 ' A' ' 63' ' ' LEU . 71.0 mt -61.34 -45.16 99.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.954 -176.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 56' ' ' VAL . 12.0 p -70.15 -23.47 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 120.784 0.326 . . . . 0.0 110.688 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.52 HH21 ' HD1' ' A' ' 58' ' ' TYR . 43.5 ttp180 -66.46 -29.64 69.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.136 0.493 . . . . 0.0 110.113 175.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.3 mp -87.58 -36.74 17.37 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.599 174.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.751 HD13 ' HB2' ' A' ' 23' ' ' PHE . 91.0 mt -81.8 2.12 31.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.646 -176.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 120.701 0.286 . . . . 0.0 111.054 175.045 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.646 ' HA ' ' CD ' ' A' ' 26' ' ' GLN . 22.0 p . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 37.7 m -74.96 148.26 40.14 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.211 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.6 mt -70.69 -9.26 56.75 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.153 0.501 . . . . 0.0 110.681 176.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.62 160.27 28.53 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.621 ' HB2' ' OD1' ' A' ' 50' ' ' ASN . 0.3 OUTLIER -113.65 158.62 20.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.716 0.258 . . . . 0.0 110.846 177.637 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 t -88.94 145.56 25.45 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -168.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -95.12 66.2 2.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.662 0.744 . . . . 0.0 109.46 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.492 ' C ' HD12 ' A' ' 14' ' ' ILE . 36.2 mtp180 -130.85 -178.08 4.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.523 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.559 HG22 ' CD2' ' A' ' 16' ' ' HIS . 2.4 mp -121.89 91.39 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 163.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.511 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 3.5 mm? -72.14 155.87 39.79 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.031 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.763 ' HB2' ' HG2' ' A' ' 18' ' ' LYS . 65.5 m170 -131.64 159.22 72.83 Favored Pre-proline 0 C--N 1.315 -0.898 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.905 -168.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.51 -30.47 74.12 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.553 2.169 . . . . 0.0 109.882 167.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.763 ' HG2' ' HB2' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -62.95 -18.32 63.02 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.226 178.353 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -118.84 -13.3 9.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.582 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.501 HG12 ' HB3' ' A' ' 39' ' ' PHE . 23.4 mt -97.83 127.43 50.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.025 0.44 . . . . 0.0 111.249 -172.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.9 p -111.61 -16.81 8.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.419 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.48 150.89 21.85 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.584 -0.607 . . . . 0.0 111.584 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.546 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -134.15 134.79 42.58 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.253 0.549 . . . . 0.0 110.637 -178.461 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.425 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 20.6 m -139.86 112.61 7.99 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.099 175.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 25' ' ' ARG . 9.0 ptp180 -75.78 130.27 38.36 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.014 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.646 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -101.03 127.02 47.74 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.898 179.161 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.2 mp -117.86 169.13 9.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.854 0.359 . . . . 0.0 111.125 -170.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.7 29.72 1.12 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.615 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -127.25 -53.9 1.38 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.251 -174.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -83.82 36.38 0.55 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.189 0.518 . . . . 0.0 111.707 -172.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.88 -96.28 0.16 Allowed Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.312 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 42.2 t -70.77 160.83 31.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.496 -0.352 . . . . 0.0 110.772 -178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -92.36 0.39 57.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.597 -177.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.457 HG12 ' SG ' ' A' ' 6' ' ' CYS . 3.4 pt -116.2 167.91 8.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -132.79 136.94 46.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.973 0.416 . . . . 0.0 111.556 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.502 ' HA ' ' HG3' ' A' ' 51' ' ' PRO . . . -138.56 164.78 28.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.634 172.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.671 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 49.9 mm -96.9 112.06 28.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.483 HD11 HE21 ' A' ' 26' ' ' GLN . 60.2 mt -88.78 102.39 12.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 O-C-N 121.707 -0.62 . . . . 0.0 111.152 -178.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.566 ' HE2' HG22 ' A' ' 56' ' ' VAL . 6.9 m-85 -95.58 119.81 34.73 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -94.27 111.56 23.3 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.2 p -78.77 153.18 30.98 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.299 0.571 . . . . 0.0 111.41 -175.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -58.17 -17.83 21.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.742 173.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -83.94 10.45 9.78 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.214 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 74.62 7.34 4.46 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.416 0.686 . . . . 0.0 111.911 173.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.7 mt -102.9 135.74 44.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.866 0.365 . . . . 0.0 110.524 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.8 p -92.61 110.54 21.97 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.404 HG11 ' HG ' ' A' ' 15' ' ' LEU . 49.0 t -94.67 132.15 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.971 -176.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.8 m -85.85 91.26 8.29 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.759 0.79 . . . . 0.0 108.982 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.671 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -74.47 143.31 44.71 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.473 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.621 ' OD1' ' HB2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -81.38 142.3 50.27 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -174.674 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.502 ' HG3' ' HA ' ' A' ' 36' ' ' ALA . 5.1 Cg_exo -82.5 1.5 9.11 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.125 1.883 . . . . 0.0 112.714 176.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -98.03 -48.81 4.99 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -175.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.806 ' OE1' ' HB ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -65.14 166.99 8.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.122 0.487 . . . . 0.0 112.17 -174.647 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.97 -25.59 16.45 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -175.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.687 ' O ' HG13 ' A' ' 59' ' ' ILE . 58.7 p-90 -58.25 -34.75 70.82 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.73 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.806 ' HB ' ' OE1' ' A' ' 53' ' ' GLN . 1.1 t -69.59 -46.21 76.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.959 175.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -58.77 -31.7 68.61 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.482 0.489 . . . . 0.0 110.67 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -64.75 -51.79 60.45 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.918 172.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.687 HG13 ' O ' ' A' ' 55' ' ' TRP . 23.8 mt -61.64 -56.86 15.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.268 -176.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 56' ' ' VAL . 4.4 p -62.1 -25.45 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.337 -175.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -63.43 -47.29 82.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.764 0.316 . . . . 0.0 110.187 172.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.3 mt -78.0 -1.44 32.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.044 0.45 . . . . 0.0 110.872 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 3.4 mm? -96.84 -58.28 2.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.64 176.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.5 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.426 -170.578 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.75 ' HA ' ' NE2' ' A' ' 26' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 t -43.62 118.54 1.41 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.941 170.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.0 mt -68.25 -26.67 65.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.249 -174.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.87 140.12 12.19 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.586 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 42.6 m-85 -91.79 179.85 5.51 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.071 0.462 . . . . 0.0 110.708 -176.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.588 ' OG1' ' HG2' ' A' ' 13' ' ' ARG . 14.4 t -97.78 -172.02 2.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.931 177.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -147.6 17.38 1.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.005 0.431 . . . . 0.0 110.609 177.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.617 ' HB2' HD22 ' A' ' 15' ' ' LEU . 18.0 mmm180 -88.1 -173.61 4.32 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.379 0.609 . . . . 0.0 112.462 -171.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.552 HD13 ' CD1' ' A' ' 55' ' ' TRP . 5.2 mm -125.31 90.35 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 114.176 -1.374 . . . . 0.0 108.423 167.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.617 HD22 ' HB2' ' A' ' 13' ' ' ARG . 2.8 mm? -93.31 165.07 12.97 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.687 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 63.2 m170 -133.29 168.28 18.71 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.569 -175.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.464 ' HD3' HG12 ' A' ' 59' ' ' ILE . 14.0 Cg_endo -59.02 -24.3 72.78 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.055 1.836 . . . . 0.0 108.94 166.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.687 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 60.7 mttm -49.26 -33.3 12.56 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 114.011 -1.449 . . . . 0.0 111.04 171.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 41' ' ' THR . 76.5 m-85 -120.51 -0.98 10.19 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.744 -171.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.649 HG12 ' HB3' ' A' ' 39' ' ' PHE . 19.5 mt -104.68 118.86 52.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.061 0.457 . . . . 0.0 111.211 -173.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.86 -5.96 11.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.779 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -152.05 151.58 23.44 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.497 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 1.1 t80 -148.99 129.8 14.2 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.137 0.494 . . . . 0.0 110.495 -177.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.5 m -131.4 126.28 34.74 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.033 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.456 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 10.3 ptp180 -98.41 103.63 15.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.307 0.575 . . . . 0.0 111.09 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.75 ' NE2' ' HA ' ' A' ' 6' ' ' CYS . 78.9 mt-30 -77.77 126.65 31.18 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.254 176.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 34.2 mt -119.94 145.07 47.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.925 -171.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.709 ' HA ' ' O ' ' A' ' 32' ' ' CYS . . . -76.47 63.97 2.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.971 172.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -135.42 -66.13 0.58 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.504 -174.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -105.9 51.48 0.75 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.249 0.547 . . . . 0.0 111.889 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.79 -58.31 0.71 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.9 173.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.709 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 1.1 t -60.7 136.46 58.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.716 0.293 . . . . 0.0 110.733 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -87.67 -30.16 20.61 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.238 -175.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.625 HG12 ' SG ' ' A' ' 6' ' ' CYS . 37.3 pt -105.55 -152.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -153.41 121.67 6.2 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 171.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . -132.9 129.11 37.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.581 -177.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.444 HG23 ' HE1' ' A' ' 23' ' ' PHE . 47.1 mm -81.71 113.14 20.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.771 177.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 42.8 mt -91.47 103.66 14.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.558 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.649 ' HB3' HG12 ' A' ' 20' ' ' ILE . 16.5 m-85 -87.81 113.69 23.71 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 172.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -87.95 105.71 17.63 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 58.2 p -75.51 158.49 32.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.462 0.648 . . . . 0.0 111.826 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.551 ' HD3' ' O ' ' A' ' 42' ' ' LYS . 1.9 tmtp? -60.21 -20.99 61.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.423 172.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 82.5 tttt -84.03 11.91 7.15 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.486 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 75.4 mmtt 77.87 -20.92 0.35 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.831 0.852 . . . . 0.0 112.285 174.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.6 mt -73.46 126.57 30.5 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.971 0.415 . . . . 0.0 111.192 -177.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 p -87.18 105.34 17.13 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.843 175.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 62.1 t -82.65 130.54 35.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.804 -174.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.4 m -85.62 76.46 9.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.538 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -69.43 138.12 53.27 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.032 -173.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.586 ' OD1' ' HB3' ' A' ' 10' ' ' TYR . 1.6 m-20 -80.44 127.46 75.86 Favored Pre-proline 0 CA--C 1.507 -0.678 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -177.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.24 14.52 0.22 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.221 1.947 . . . . 0.0 111.811 172.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 50' ' ' ASN . 0.4 OUTLIER -106.44 -19.07 13.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.875 -174.239 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.517 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 0.9 OUTLIER -105.05 140.65 37.92 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.032 -168.983 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 p -64.83 -36.24 83.7 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -172.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.578 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 43.9 p-90 -60.83 -32.62 72.0 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.726 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.591 ' O ' HG12 ' A' ' 60' ' ' VAL . 4.8 t -73.58 -50.42 30.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.324 174.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 94.8 mttt -54.92 -36.95 65.78 Favored 'General case' 0 CA--C 1.522 -0.126 0 O-C-N 123.602 0.564 . . . . 0.0 110.421 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.404 ' O ' HD23 ' A' ' 62' ' ' LEU . 22.8 t80 -65.95 -58.64 5.08 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.642 176.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 55' ' ' TRP . 78.6 mt -59.1 -48.0 88.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -175.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.591 HG12 ' O ' ' A' ' 56' ' ' VAL . 11.9 p -65.45 -31.62 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.992 -177.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.0 ttp85 -63.83 -41.57 97.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.847 0.356 . . . . 0.0 110.517 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.404 HD23 ' O ' ' A' ' 58' ' ' TYR . 4.4 mm? -79.37 -29.86 42.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.138 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.459 HD13 ' CB ' ' A' ' 23' ' ' PHE . 28.5 mt -72.4 -46.46 55.13 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.558 177.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.7 t . . . . . 0 C--N 1.323 -0.576 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.373 -174.709 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.686 ' SG ' HG12 ' A' ' 34' ' ' ILE . 3.7 p . . . . . 0 N--CA 1.437 -1.105 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.432 ' O ' HD11 ' A' ' 34' ' ' ILE . 19.3 t -125.99 135.33 51.69 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 166.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 pp -65.87 -13.6 59.91 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.48 0.487 . . . . 0.0 111.873 -176.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.72 166.9 28.75 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.701 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 81.0 m-85 -119.39 -168.56 1.6 Allowed 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 176.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.9 t -129.03 148.29 50.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.493 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -107.15 62.69 0.62 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.542 ' HB3' HD22 ' A' ' 15' ' ' LEU . 15.9 mtm180 -131.25 173.18 11.31 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.1 mm -122.4 91.13 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.428 165.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.542 HD22 ' HB3' ' A' ' 13' ' ' ARG . 2.9 mm? -88.9 167.19 13.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 63.6 m170 -132.56 166.78 26.44 Favored Pre-proline 0 C--N 1.313 -0.994 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.894 -174.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 19.5 Cg_endo -60.39 -21.96 69.52 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.852 1.701 . . . . 0.0 109.213 166.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 83.7 mttt -52.94 -27.34 18.4 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 113.938 -1.483 . . . . 0.0 111.01 172.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -125.5 2.0 7.64 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.987 -174.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.677 HG12 ' HB3' ' A' ' 39' ' ' PHE . 13.3 mt -106.93 123.66 62.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.997 0.427 . . . . 0.0 111.275 -174.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.3 m -117.09 -16.19 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.02 177.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.66 160.17 26.51 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.539 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 2.0 t80 -155.7 134.03 11.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.533 0.682 . . . . 0.0 110.606 -175.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.9 m -138.02 135.65 36.11 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.801 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -116.2 117.81 31.08 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.09 0.471 . . . . 0.0 111.847 -175.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.608 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -94.32 135.96 35.14 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 174.38 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.9 156.07 18.35 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.1 0.476 . . . . 0.0 111.516 -170.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.17 11.93 26.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.278 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -126.83 -58.33 1.31 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.781 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -103.12 89.31 3.38 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.918 177.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.57 -63.11 0.52 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.973 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.557 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 49.1 t -130.76 171.28 13.3 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -86.25 -20.19 28.83 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.686 HG12 ' SG ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -111.35 169.75 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 171.052 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -127.03 144.89 50.91 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 121.961 -0.462 . . . . 0.0 111.39 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.45 146.72 35.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.431 174.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.571 HG12 ' HG3' ' A' ' 51' ' ' PRO . 49.5 mm -106.96 102.4 13.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.882 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.522 HG13 HE22 ' A' ' 26' ' ' GLN . 70.0 mt -78.96 104.99 7.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.978 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.677 ' HB3' HG12 ' A' ' 20' ' ' ILE . 19.5 m-85 -88.91 120.15 30.07 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 170.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -90.25 104.85 17.38 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.4 p -74.38 161.79 29.5 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.779 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -68.18 -3.47 10.68 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.353 172.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 21.6 ttmm -95.47 8.39 43.41 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.245 176.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 31.3 mmmt 76.53 -24.17 0.23 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.244 1.018 . . . . 0.0 112.446 176.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.94 130.55 41.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.066 0.46 . . . . 0.0 111.38 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 p -86.51 108.84 18.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.185 176.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 60.9 t -91.97 128.96 43.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.434 -175.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 79.4 m -85.18 82.21 8.49 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.676 0.75 . . . . 0.0 109.143 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.503 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -72.45 136.79 46.08 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.091 -177.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.701 ' OD1' ' HB3' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -77.59 126.88 83.88 Favored Pre-proline 0 CA--C 1.51 -0.565 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.677 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.571 ' HG3' HG12 ' A' ' 37' ' ' ILE . 27.0 Cg_exo -63.99 -5.95 10.23 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 122.425 2.083 . . . . 0.0 111.903 177.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.487 ' O ' ' HE3' ' A' ' 57' ' ' LYS . 83.2 mttt -82.61 -29.8 29.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.634 -176.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.712 ' NE2' ' HE1' ' A' ' 55' ' ' TRP . 11.4 mt-30 -72.71 134.16 44.9 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.289 -175.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.5 -33.18 75.32 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.712 ' HE1' ' NE2' ' A' ' 53' ' ' GLN . 49.0 p-90 -63.42 -33.11 74.83 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 175.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.546 HG22 ' HE2' ' A' ' 39' ' ' PHE . 8.7 t -72.67 -47.14 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.308 174.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 82.0 mttt -60.65 -28.07 68.29 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -70.1 -52.66 22.02 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.166 173.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.642 HG21 HD13 ' A' ' 20' ' ' ILE . 70.4 mt -68.03 -40.19 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.627 -176.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 56' ' ' VAL . 15.0 p -70.44 -30.3 42.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 O-C-N 122.122 -0.361 . . . . 0.0 110.555 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -66.0 -30.66 71.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.789 0.804 . . . . 0.0 108.999 173.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.1 tp -84.12 -20.66 32.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.435 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 23' ' ' PHE . 65.4 mt -108.89 4.27 23.24 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -175.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.3 t . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.457 -177.993 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.733 ' SG ' HG12 ' A' ' 34' ' ' ILE . 31.8 p . . . . . 0 N--CA 1.442 -0.833 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.442 ' O ' HD11 ' A' ' 34' ' ' ILE . 61.0 m -54.97 128.82 35.29 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.931 -176.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.432 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 2.0 pp -81.57 -14.53 56.71 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.275 0.56 . . . . 0.0 110.121 174.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.61 140.65 11.99 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.667 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.693 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 5.7 m-85 -107.07 -163.12 0.88 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.59 0.233 . . . . 0.0 110.415 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.482 HG21 ' CG1' ' A' ' 47' ' ' VAL . 4.7 t -137.46 149.99 47.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.974 0.416 . . . . 0.0 111.354 177.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -116.6 73.51 0.86 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.228 0.537 . . . . 0.0 109.783 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.527 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 57.5 mtt180 -129.23 -171.39 2.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.294 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.586 HD13 ' CD1' ' A' ' 55' ' ' TRP . 13.7 mm -125.59 78.58 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.344 168.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.552 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.6 mm? -81.7 161.86 23.21 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.771 ' ND1' ' HD3' ' A' ' 18' ' ' LYS . 65.5 m170 -133.82 162.17 59.31 Favored Pre-proline 0 C--N 1.31 -1.125 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.938 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.825 ' HD3' HG12 ' A' ' 59' ' ' ILE . 27.7 Cg_endo -64.55 -16.87 57.48 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.341 2.027 . . . . 0.0 108.746 166.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.771 ' HD3' ' ND1' ' A' ' 16' ' ' HIS . 28.8 mtpp -53.43 -21.58 6.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 113.38 -1.736 . . . . 0.0 110.966 170.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -130.31 3.74 4.72 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.675 ' HB ' ' HA ' ' A' ' 17' ' ' PRO . 3.9 mm -100.37 122.9 52.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -170.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.3 m -114.49 -10.13 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.483 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.52 158.46 27.67 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.681 ' HB2' HD13 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -156.52 134.7 11.29 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.065 0.46 . . . . 0.0 109.867 -175.686 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.436 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 30.7 m -138.4 103.23 4.84 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.495 178.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.435 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 11.5 ptm180 -78.36 89.76 4.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.785 0.802 . . . . 0.0 109.787 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.647 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 11.0 tt0 -72.46 114.92 11.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.842 -175.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 25' ' ' ARG . 97.7 mt -116.71 164.07 15.18 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.225 -171.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.62 -37.44 65.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.826 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -62.14 -19.96 63.58 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -174.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -94.1 13.89 21.67 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.76 -30.17 2.79 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.092 -1.051 . . . . 0.0 113.658 174.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 3.7 t -86.08 -168.6 2.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.18 0.514 . . . . 0.0 111.659 -177.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -120.12 -36.2 3.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.216 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.733 HG12 ' SG ' ' A' ' 6' ' ' CYS . 6.8 pt -104.75 -175.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -138.16 112.16 8.46 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.345 0.593 . . . . 0.0 111.922 -173.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.5 119.88 39.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.527 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.485 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 41.3 mm -80.38 98.05 3.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.051 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.508 ' CG2' ' HB3' ' A' ' 46' ' ' SER . 23.7 mt -80.37 111.74 17.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 O-C-N 121.832 -0.542 . . . . 0.0 111.495 -174.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.445 ' HE2' HG22 ' A' ' 56' ' ' VAL . 30.3 m-85 -97.28 122.45 40.32 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 9.2 m-70 -97.66 111.36 23.67 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -176.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.5 p -71.17 163.63 27.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.099 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -66.92 -3.08 6.13 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.846 171.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -94.36 0.5 55.54 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.691 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm 78.64 -1.31 2.43 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.25 1.02 . . . . 0.0 111.496 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.4 mt -83.78 119.81 25.27 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.508 ' HB3' ' CG2' ' A' ' 38' ' ' ILE . 3.4 m -88.87 106.99 18.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.19 0.519 . . . . 0.0 109.901 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.482 ' CG1' HG21 ' A' ' 11' ' ' THR . 24.4 t -91.08 132.9 34.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.597 -175.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.8 m -88.19 91.6 8.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.749 0.785 . . . . 0.0 109.515 -178.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.641 ' HB1' HG22 ' A' ' 56' ' ' VAL . . . -76.52 146.0 38.73 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.077 -174.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.693 ' OD1' ' HB3' ' A' ' 10' ' ' TYR . 2.5 m-20 -84.16 128.68 61.39 Favored Pre-proline 0 CA--C 1.512 -0.495 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.293 -177.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.79 6.55 1.28 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.248 1.965 . . . . 0.0 112.65 176.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -92.34 -24.7 18.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.863 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.465 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 0.7 OUTLIER -103.61 142.7 33.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.056 -165.659 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 p -65.6 -37.2 85.95 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -172.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.586 ' CD1' HD13 ' A' ' 14' ' ' ILE . 49.9 p-90 -60.49 -33.84 73.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.221 0.534 . . . . 0.0 109.752 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.641 HG22 ' HB1' ' A' ' 49' ' ' ALA . 14.2 t -70.72 -50.62 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.154 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 95.7 mttt -54.82 -37.38 66.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.378 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -67.77 -54.39 19.61 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.836 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.825 HG12 ' HD3' ' A' ' 17' ' ' PRO . 75.0 mt -62.82 -45.52 98.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.634 0.254 . . . . 0.0 111.038 -176.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.564 HG23 ' CE1' ' A' ' 23' ' ' PHE . 10.2 p -64.4 -29.22 46.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.807 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -67.59 -43.95 79.29 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.988 0.423 . . . . 0.0 110.194 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.6 mt -75.07 -32.36 61.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.816 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.681 HD13 ' HB2' ' A' ' 23' ' ' PHE . 82.7 mt -71.73 -35.95 70.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.858 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 C--N 1.326 -0.44 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 172.897 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.4 t -66.35 128.63 36.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.467 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.6 mt -75.21 -17.94 60.25 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.196 0.31 . . . . 0.0 111.436 -176.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.31 117.58 1.39 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.285 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.599 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 1.6 m-85 -75.63 168.51 19.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.274 0.559 . . . . 0.0 109.709 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.45 ' OG1' ' HG3' ' A' ' 13' ' ' ARG . 4.8 t -94.7 -176.42 3.88 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.762 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -150.3 72.63 1.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.519 ' HB2' HD22 ' A' ' 15' ' ' LEU . 2.2 mtp180 -132.68 -179.56 5.54 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.121 -175.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.577 HD13 ' CD1' ' A' ' 55' ' ' TRP . 19.1 mm -126.4 84.33 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.014 167.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.534 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.3 mm? -89.32 161.57 16.29 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.836 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 55.3 m170 -133.95 177.96 2.0 Allowed Pre-proline 0 C--N 1.312 -1.053 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.185 -177.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.643 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 51.8 Cg_exo -53.26 -30.7 52.73 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.676 1.584 . . . . 0.0 109.272 161.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.836 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 64.6 mttm -44.42 -34.0 1.88 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.582 169.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 41' ' ' THR . 98.7 m-85 -127.16 2.15 6.45 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -173.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 mp -98.12 130.47 46.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.811 0.338 . . . . 0.0 110.46 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 p -124.27 -7.2 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.492 0.663 . . . . 0.0 110.199 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.02 156.9 26.5 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.803 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.901 ' HB3' HD12 ' A' ' 63' ' ' LEU . 1.9 t80 -140.7 138.08 33.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.256 0.551 . . . . 0.0 110.769 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.6 m -143.59 105.26 4.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.697 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.566 ' NE ' ' H ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -77.68 115.6 17.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.394 0.616 . . . . 0.0 111.117 -178.739 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -86.18 117.12 24.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.247 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.2 mt -103.85 145.95 29.36 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -167.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.88 50.29 1.94 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.42 176.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -127.23 -64.42 1.0 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.201 -175.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -85.55 53.4 2.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.653 0.739 . . . . 0.0 111.902 -174.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.55 -61.5 0.51 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.809 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -55.06 152.13 8.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.842 -0.679 . . . . 0.0 111.63 175.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -120.35 -5.86 9.86 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 34' ' ' ILE . 26.1 pt -127.85 115.75 40.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 CA-C-O 121.911 0.862 . . . . 0.0 111.069 176.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -83.55 118.2 23.64 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 121.475 -0.766 . . . . 0.0 111.442 -172.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.1 139.06 53.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.767 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.573 HG12 ' HG3' ' A' ' 51' ' ' PRO . 43.5 mm -85.48 109.89 18.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.249 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.3 mm -90.4 100.17 10.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.989 0.423 . . . . 0.0 110.814 -177.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.582 ' HE2' HG22 ' A' ' 56' ' ' VAL . 11.7 m-85 -92.22 118.53 30.96 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.882 173.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -89.03 115.19 26.4 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.419 ' C ' ' H ' ' A' ' 43' ' ' LYS . 33.1 p -82.21 162.24 22.45 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.468 0.652 . . . . 0.0 112.249 -172.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -60.32 -4.43 0.84 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.313 170.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 41' ' ' THR . 75.2 mmtt -109.74 16.56 22.0 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.944 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 59.7 mttp 75.17 -21.44 0.3 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.87 0.868 . . . . 0.0 112.525 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.3 mt -68.5 118.29 11.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.868 0.366 . . . . 0.0 111.159 -173.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.2 p -79.24 101.64 8.11 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 175.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 76.3 t -83.16 132.63 30.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.456 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.0 m -85.41 74.38 10.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.863 0.839 . . . . 0.0 109.094 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.437 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -69.71 142.45 53.32 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.657 -175.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.66 ' HB2' ' CG ' ' A' ' 53' ' ' GLN . 1.7 m-20 -84.02 127.8 65.41 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.197 -177.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.573 ' HG3' HG12 ' A' ' 37' ' ' ILE . 24.1 Cg_exo -64.75 3.18 0.97 Allowed 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.728 2.285 . . . . 0.0 111.824 174.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 50' ' ' ASN . 57.7 mtpt -92.67 -22.7 19.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.627 -176.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.66 ' CG ' ' HB2' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -93.27 134.31 35.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.536 -169.585 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 p -64.34 -32.42 74.02 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.577 ' CD1' HD13 ' A' ' 14' ' ' ILE . 47.3 p-90 -61.94 -33.32 74.05 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.582 HG22 ' HE2' ' A' ' 39' ' ' PHE . 14.0 t -70.34 -49.77 51.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.99 173.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 96.4 mttt -56.72 -35.05 68.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.26 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -66.09 -56.43 11.52 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.012 175.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.426 HD11 ' HA ' ' A' ' 16' ' ' HIS . 86.6 mt -60.84 -48.07 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.121 -176.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.649 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 14.4 p -62.55 -31.68 52.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -177.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -62.45 -47.78 82.51 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.066 0.46 . . . . 0.0 110.039 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.86 -40.54 75.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.304 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.901 HD12 ' HB3' ' A' ' 23' ' ' PHE . 3.6 mm? -70.11 -7.62 42.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.55 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.95 178.451 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.895 0 CA-C-O 120.589 0.233 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.3 m -80.0 129.25 34.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.918 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -62.26 -55.06 32.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.072 0.463 . . . . 0.0 110.353 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.653 ' CE2' ' HG2' ' A' ' 26' ' ' GLN . 48.7 p90 -131.68 175.52 9.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.699 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -131.92 103.92 6.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.593 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.564 ' HB2' ' OE1' ' A' ' 26' ' ' GLN . 13.7 p -50.86 157.58 0.79 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 123.983 0.913 . . . . 0.0 113.379 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.0 t -52.15 118.72 3.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.787 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.419 ' HA ' HD11 ' A' ' 34' ' ' ILE . 80.2 mt -84.61 -15.75 44.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.217 -177.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -120.88 108.8 1.43 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.594 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 17.8 m-85 -79.92 -167.49 1.29 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.263 0.554 . . . . 0.0 111.177 -173.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.5 t -125.03 170.74 10.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.973 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -133.98 77.53 1.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.516 0.674 . . . . 0.0 110.311 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.526 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 94.7 mtt180 -133.23 179.09 6.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.743 176.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.566 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.0 mm -118.29 83.46 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 164.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.591 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.5 mm? -79.42 158.88 27.26 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.661 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 54.7 m170 -131.81 175.71 3.47 Favored Pre-proline 0 C--N 1.312 -1.052 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.151 -174.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.653 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 32.5 Cg_exo -56.4 -25.51 57.84 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.747 1.631 . . . . 0.0 109.282 164.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.661 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 64.0 mttm -49.38 -31.55 9.72 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.282 175.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 41' ' ' THR . 91.0 m-85 -124.1 0.32 8.45 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.443 ' CG1' ' HB3' ' A' ' 39' ' ' PHE . 1.4 mp -105.88 130.08 57.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.077 0.465 . . . . 0.0 112.105 -173.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.1 m -123.95 -5.76 7.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.468 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.12 162.6 30.21 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.409 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.679 ' CB ' HD13 ' A' ' 63' ' ' LEU . 1.1 t80 -158.04 133.65 9.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.981 0.42 . . . . 0.0 110.413 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.6 m -135.91 120.37 18.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.938 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -93.0 137.2 32.57 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.131 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.653 ' HG2' ' CE2' ' A' ' 4' ' ' PHE . 81.6 mt-30 -120.72 121.01 37.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.749 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.4 mp -102.45 165.91 10.84 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.026 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.27 18.36 11.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.401 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -139.61 1.98 1.97 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.781 0.324 . . . . 0.0 111.62 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -99.99 -21.73 15.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.107 0.479 . . . . 0.0 110.33 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.21 -53.95 0.1 OUTLIER Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.416 ' HB2' ' H ' ' A' ' 6' ' ' CYS . 8.5 t -69.03 156.89 37.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 177.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -89.63 -20.07 24.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.455 0.645 . . . . 0.0 109.788 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.452 HG12 ' SG ' ' A' ' 6' ' ' CYS . 4.6 pt -116.26 -178.68 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.4 ' OD1' ' HG2' ' A' ' 51' ' ' PRO . 4.7 p30 -129.7 129.08 43.77 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.115 0.483 . . . . 0.0 110.557 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . -141.95 132.82 25.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.118 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 46.7 mm -82.34 125.17 39.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.9 mm -98.8 101.68 12.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 O-C-N 121.969 -0.457 . . . . 0.0 110.757 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.521 ' HE2' HG22 ' A' ' 56' ' ' VAL . 18.6 m-85 -87.99 123.49 32.75 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 173.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -92.88 112.75 24.81 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 36.7 p -75.22 160.52 30.29 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.663 -176.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -71.93 5.62 2.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.476 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 41' ' ' THR . 0.5 OUTLIER -106.57 12.28 29.62 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.335 176.759 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 68.14 19.39 9.2 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.079 174.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.8 mt -112.7 136.19 52.57 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.991 0.424 . . . . 0.0 110.925 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.6 p -84.88 115.79 22.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.623 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 83.0 t -89.12 126.6 42.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.625 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 16.5 m -83.09 81.24 8.77 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.616 0.722 . . . . 0.0 109.238 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.524 ' HB1' HG22 ' A' ' 56' ' ' VAL . . . -71.85 134.48 46.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.671 -175.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.594 ' OD1' ' HB3' ' A' ' 10' ' ' TYR . 1.5 m-20 -80.64 124.29 82.04 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.4 ' HG2' ' OD1' ' A' ' 35' ' ' ASN . 25.6 Cg_exo -65.62 -0.44 3.73 Favored 'Trans proline' 0 C--N 1.328 -0.537 0 C-N-CA 121.862 1.708 . . . . 0.0 111.933 174.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.418 ' H ' ' C ' ' A' ' 50' ' ' ASN . 51.0 mtpt -85.0 -25.46 27.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.874 -175.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.502 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 0.9 OUTLIER -103.37 145.95 29.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.7 -167.412 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.41 -32.59 68.58 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -171.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.591 ' CZ3' ' HB2' ' A' ' 15' ' ' LEU . 48.3 p-90 -63.48 -32.91 74.49 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.859 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.524 HG22 ' HB1' ' A' ' 49' ' ' ALA . 4.5 t -69.75 -46.95 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.314 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.754 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 65.0 mttm -58.04 -40.6 81.29 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.098 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -62.93 -53.11 59.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.188 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.456 HG22 ' CD1' ' A' ' 63' ' ' LEU . 85.0 mt -63.79 -41.06 91.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.314 -177.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.1 p -68.44 -25.62 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.132 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.754 ' HG2' ' O ' ' A' ' 57' ' ' LYS . 1.3 mmp_? -66.43 -45.19 80.71 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 122.007 -0.433 . . . . 0.0 109.999 174.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.9 mt -68.72 -36.42 78.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.821 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.679 HD13 ' CB ' ' A' ' 23' ' ' PHE . 81.3 mt -72.3 -18.54 61.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.92 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 m -94.47 -11.37 29.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.816 0.341 . . . . 0.0 110.969 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -119.91 47.07 1.81 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.764 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 66' ' ' LYS . 39.9 mtpt -75.98 77.92 2.85 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.705 173.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.6 p -87.37 133.59 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.421 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -79.86 88.42 5.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.395 0.617 . . . . 0.0 111.295 -175.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -95.93 -43.81 7.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.436 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 52.9 ttm . . . . . 0 C--O 1.248 1.011 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.861 -177.866 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.96 0.409 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 m -114.13 106.35 14.28 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -61.25 -52.17 65.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.29 0.567 . . . . 0.0 109.941 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -132.23 -174.21 3.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.591 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -133.57 115.31 14.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.147 171.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.754 ' SG ' HG12 ' A' ' 34' ' ' ILE . 20.8 p -46.37 150.8 0.6 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.999 172.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 55.8 m -61.36 117.65 5.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.684 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.3 mt -68.82 -16.55 63.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.292 0.568 . . . . 0.0 110.242 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.1 88.17 0.19 Allowed Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.121 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.483 ' HA ' ' HB2' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -74.39 157.31 35.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.111 0.482 . . . . 0.0 110.533 174.583 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 48' ' ' CYS . 15.1 t -82.3 159.34 23.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -164.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -118.54 74.23 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.52 ' HB2' HD22 ' A' ' 15' ' ' LEU . 1.8 mmp_? -131.65 178.53 6.67 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.586 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.539 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.9 mm -121.6 84.46 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.237 161.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.541 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 1.9 mm? -84.59 167.58 16.15 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 175.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.694 ' ND1' ' HD2' ' A' ' 18' ' ' LYS . 63.5 m170 -133.04 168.14 19.45 Favored Pre-proline 0 C--N 1.311 -1.088 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.689 -175.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 17.3 Cg_endo -59.49 -23.05 69.1 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.316 2.011 . . . . 0.0 109.207 165.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.694 ' HD2' ' ND1' ' A' ' 16' ' ' HIS . 65.1 mttm -49.53 -27.68 4.67 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 113.846 -1.525 . . . . 0.0 111.628 170.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -124.99 -1.46 7.8 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -172.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.529 HD12 HD13 ' A' ' 59' ' ' ILE . 27.7 mt -105.99 124.64 61.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.838 0.351 . . . . 0.0 111.544 -173.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.2 m -121.13 0.69 7.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.002 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.99 158.7 30.0 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.587 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.586 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 2.1 t80 -153.24 134.31 14.05 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.346 0.593 . . . . 0.0 110.93 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.9 m -141.95 112.56 7.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.495 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -80.29 103.08 9.91 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.961 0.41 . . . . 0.0 110.381 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.443 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 46.0 tt0 -74.27 126.11 29.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.045 -177.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.409 ' HA ' ' OD1' ' A' ' 35' ' ' ASN . 87.8 mt -100.59 156.39 17.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.499 0.666 . . . . 0.0 112.606 -170.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.57 -30.65 36.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.909 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -49.94 -34.06 19.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.534 -1.212 . . . . 0.0 113.069 -175.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -99.83 27.3 5.55 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -172.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.13 -44.82 1.03 Allowed Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.722 172.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -80.56 -167.1 1.23 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.008 0.432 . . . . 0.0 111.955 -174.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -122.54 -28.54 4.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.718 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.754 HG12 ' SG ' ' A' ' 6' ' ' CYS . 1.4 pt -111.69 169.51 4.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.409 ' OD1' ' HA ' ' A' ' 27' ' ' LEU . 34.1 m-80 -116.2 123.35 47.55 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.01 121.62 43.69 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.715 0.293 . . . . 0.0 110.847 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.721 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 48.6 mm -69.74 104.94 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.371 176.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.4 mm -85.89 97.64 6.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 O-C-N 122.059 -0.401 . . . . 0.0 110.113 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.487 ' HB3' HG12 ' A' ' 20' ' ' ILE . 9.6 m-85 -85.77 122.88 30.48 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -93.45 106.76 18.69 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.8 p -78.09 162.92 26.31 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.073 -173.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -65.9 -7.8 18.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.326 173.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -91.16 2.82 56.06 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.282 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 68.41 17.73 9.12 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.936 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.6 mt -106.69 125.98 51.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.517 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.4 p -76.72 108.35 9.67 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.652 177.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 99.6 t -91.63 131.35 38.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.662 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 62.8 m -88.7 90.97 8.63 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.721 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -77.95 141.15 39.18 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.958 -176.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.485 ' HB2' ' HG2' ' A' ' 53' ' ' GLN . 2.5 m-20 -82.38 130.34 59.66 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.82 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -71.48 2.93 4.01 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.099 1.866 . . . . 0.0 112.041 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -90.32 -21.62 21.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.918 -176.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.485 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 0.8 OUTLIER -103.14 142.27 34.43 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.437 -168.499 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 p -74.3 -28.79 61.34 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -171.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.616 ' O ' HG13 ' A' ' 59' ' ' ILE . 47.2 p-90 -62.57 -33.73 75.54 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.387 176.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.535 ' CG2' ' HB1' ' A' ' 49' ' ' ALA . 4.5 t -70.99 -47.92 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.413 174.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -56.98 -36.71 70.65 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 123.761 0.663 . . . . 0.0 110.85 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -65.77 -49.47 68.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.838 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.616 HG13 ' O ' ' A' ' 55' ' ' TRP . 60.0 mt -67.76 -47.86 78.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.039 -175.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.586 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 11.7 p -62.69 -29.84 47.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 120.803 0.335 . . . . 0.0 110.762 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -64.47 -45.26 88.17 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 34.8 mt -70.26 -30.81 67.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.934 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.592 HD23 HG22 ' A' ' 59' ' ' ILE . 2.0 mm? -68.45 -36.65 79.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.539 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 m -74.87 -42.96 56.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.694 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -109.03 86.22 2.24 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.17 0.51 . . . . 0.0 110.503 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -92.71 112.86 24.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.18 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.9 m -98.49 160.68 3.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.011 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -104.33 114.07 28.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.138 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -74.53 -38.87 62.65 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.1 ttt . . . . . 0 C--O 1.246 0.905 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.678 178.732 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 120.804 0.335 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.479 ' HA ' ' HA3' ' A' ' 31' ' ' GLY . 23.5 m -76.54 91.08 3.34 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.441 0.638 . . . . 0.0 111.103 -175.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -69.43 -41.76 75.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.674 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.745 ' CE1' ' HB2' ' A' ' 26' ' ' GLN . 29.2 p90 -121.04 -176.61 3.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.008 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -140.51 103.43 4.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.255 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.818 ' SG ' HG12 ' A' ' 34' ' ' ILE . 26.2 p -49.72 146.88 4.01 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.687 1.195 . . . . 0.0 112.918 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.665 ' O ' HD11 ' A' ' 34' ' ' ILE . 58.3 m -60.2 130.25 45.72 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.136 174.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.3 mt -84.5 0.13 50.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.209 0.528 . . . . 0.0 110.108 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.54 136.44 6.94 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 174.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.67 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 29.0 m-85 -97.3 176.65 5.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.798 0.332 . . . . 0.0 110.226 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.479 HG21 ' CG1' ' A' ' 47' ' ' VAL . 2.7 t -112.91 137.85 50.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.168 0.509 . . . . 0.0 111.015 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -108.02 68.9 0.72 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.564 0.697 . . . . 0.0 109.363 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.483 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 4.3 mmp_? -129.19 -173.21 2.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.586 -177.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.556 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.4 mm -124.98 89.65 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.208 165.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.59 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.7 mm? -89.12 162.83 15.75 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 58.3 m170 -132.05 166.65 26.92 Favored Pre-proline 0 C--N 1.312 -1.051 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.994 -172.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 12.2 Cg_endo -57.57 -27.14 75.53 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.176 1.917 . . . . 0.0 109.149 166.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 65.6 mttm -45.0 -35.47 2.93 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.384 171.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -116.89 -13.48 10.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.903 -172.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.673 HG12 ' HB3' ' A' ' 39' ' ' PHE . 21.8 mt -92.39 127.18 44.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.768 0.318 . . . . 0.0 111.327 -172.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 m -122.33 -7.6 8.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.157 0.503 . . . . 0.0 110.995 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -152.21 163.1 30.1 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.683 ' HB2' HD13 ' A' ' 63' ' ' LEU . 2.4 t80 -156.6 134.28 10.91 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 117.325 0.563 . . . . 0.0 110.897 -175.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.562 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 83.5 m -140.41 107.8 5.55 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.112 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.52 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 14.8 ptp180 -86.5 102.78 14.42 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.745 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . 3.2 pt20 -93.25 136.04 33.88 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.421 ' HA ' ' HB3' ' A' ' 35' ' ' ASN . 86.7 mt -119.64 163.72 16.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.214 0.53 . . . . 0.0 111.882 -170.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.58 35.03 0.49 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.824 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -132.73 -52.62 0.93 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.396 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -60.97 -43.21 99.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.799 -173.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 2' ' ' SER . . . -157.16 -65.03 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.279 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.457 ' CB ' ' H ' ' A' ' 6' ' ' CYS . 2.8 t -71.42 169.3 15.64 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.378 0.609 . . . . 0.0 112.384 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -90.1 -24.67 21.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.653 -173.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.818 HG12 ' SG ' ' A' ' 6' ' ' CYS . 2.1 pt -120.41 170.16 10.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.421 ' HB3' ' HA ' ' A' ' 27' ' ' LEU . 6.1 p30 -118.86 128.18 54.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.778 0.323 . . . . 0.0 111.178 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.626 ' O ' ' HG2' ' A' ' 26' ' ' GLN . . . -131.9 143.6 50.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.958 0.409 . . . . 0.0 110.928 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.603 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 49.9 mm -90.2 101.34 12.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.229 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.562 ' HB ' ' HB ' ' A' ' 24' ' ' THR . 63.9 mt -79.49 104.75 7.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.019 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.673 ' HB3' HG12 ' A' ' 20' ' ' ILE . 12.5 m-85 -95.26 111.35 23.21 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 172.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -82.67 110.25 17.57 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.0 p -85.06 163.13 19.01 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.412 0.625 . . . . 0.0 112.008 -174.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -68.75 -2.53 9.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.032 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -90.58 3.04 55.2 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.769 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt 69.47 22.86 6.24 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.015 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 97.3 mt -114.75 139.6 49.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.144 0.497 . . . . 0.0 110.712 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.422 ' HB2' HG23 ' A' ' 38' ' ' ILE . 12.0 p -90.07 95.41 10.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.694 174.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.479 ' CG1' HG21 ' A' ' 11' ' ' THR . 59.0 t -76.33 130.2 36.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.834 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.0 m -92.64 81.74 4.78 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.018 0.913 . . . . 0.0 109.591 -175.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.603 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -69.87 144.63 52.46 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.794 -176.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.67 ' OD1' ' HB3' ' A' ' 10' ' ' TYR . 2.0 m-20 -83.8 129.39 59.49 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.758 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -72.01 21.33 0.27 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.406 2.071 . . . . 0.0 111.988 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 50' ' ' ASN . 35.3 mtmm -119.42 -4.93 10.36 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.99 -173.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.475 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 0.7 OUTLIER -117.26 146.37 43.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.027 0.441 . . . . 0.0 111.555 -172.056 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 p -69.86 -36.32 75.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -171.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.59 ' CZ3' ' HB2' ' A' ' 15' ' ' LEU . 47.9 p-90 -61.05 -30.75 70.51 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.554 ' O ' HG12 ' A' ' 60' ' ' VAL . 12.6 t -74.21 -49.04 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.244 174.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 84.1 mttt -57.0 -34.05 67.76 Favored 'General case' 0 C--N 1.334 -0.089 0 O-C-N 123.457 0.473 . . . . 0.0 110.506 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -66.1 -54.73 22.06 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.527 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.668 HG21 HD13 ' A' ' 20' ' ' ILE . 72.7 mt -65.57 -43.82 94.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.477 -174.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.573 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 13.8 p -66.71 -33.83 66.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.092 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -62.89 -43.14 99.59 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.37 0.605 . . . . 0.0 109.494 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.3 tp -66.2 -41.06 90.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.041 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 23' ' ' PHE . 75.3 mt -76.28 -7.44 54.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.355 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 77.7 p -100.22 -4.61 29.09 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.864 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -132.25 8.08 4.3 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.326 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -119.8 16.31 12.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.618 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.4 m -110.48 142.26 23.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.721 176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -76.19 109.1 9.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.05 0.452 . . . . 0.0 110.466 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -97.87 -9.86 25.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.056 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 54.1 ttm . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.509 -0.758 . . . . 0.0 109.487 -179.156 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.725 ' HB3' ' HA2' ' A' ' 31' ' ' GLY . 1.2 m -76.0 88.24 2.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.911 0.386 . . . . 0.0 110.841 -176.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -77.06 -36.22 56.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.642 0.734 . . . . 0.0 109.023 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.458 ' CE1' ' HA ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -130.68 -166.84 1.74 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.107 173.657 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.571 ' C ' ' HB2' ' A' ' 32' ' ' CYS . 5.5 m-20 -112.03 -104.44 0.39 Allowed 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 122.04 0.924 . . . . 0.0 109.81 171.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.701 ' HA ' ' HB3' ' A' ' 26' ' ' GLN . 7.9 p -144.98 -160.33 1.12 Allowed 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 113.932 -1.485 . . . . 0.0 109.302 -176.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.498 ' O ' HD11 ' A' ' 34' ' ' ILE . 94.8 m -105.91 122.75 46.76 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 166.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.6 mt -67.7 -26.69 66.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.345 0.593 . . . . 0.0 109.536 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -129.06 135.38 8.43 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.206 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.631 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 6.9 m-85 -100.58 -160.12 0.78 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.1 t -129.12 158.7 38.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.214 176.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.498 ' O ' ' HD2' ' A' ' 13' ' ' ARG . 1.5 m-20 -118.55 69.23 0.79 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.858 0.361 . . . . 0.0 110.087 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.498 ' HD2' ' O ' ' A' ' 12' ' ' ASP . 8.4 mmm180 -131.36 175.89 8.75 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.411 0.624 . . . . 0.0 112.122 -177.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.529 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.1 mm -120.18 90.05 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.001 164.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.495 ' CD2' ' HB2' ' A' ' 13' ' ' ARG . 1.9 mm? -92.35 163.26 13.94 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.78 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 34.9 m170 -131.24 176.39 2.93 Favored Pre-proline 0 C--N 1.313 -1.013 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.277 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.78 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 13.2 Cg_endo -58.68 -21.28 54.99 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.631 1.554 . . . . 0.0 109.353 167.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.729 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 28.5 mtpp -45.17 -32.77 1.97 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.844 171.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 41' ' ' THR . 77.9 m-85 -124.27 -5.08 7.82 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -174.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.615 HG12 ' HB3' ' A' ' 39' ' ' PHE . 18.3 mt -100.26 128.45 52.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.777 0.323 . . . . 0.0 111.666 -173.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.6 m -120.68 -11.48 9.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.195 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.3 165.74 31.42 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.736 ' HB2' HD13 ' A' ' 63' ' ' LEU . 2.7 t80 -155.01 133.44 11.87 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.23 0.538 . . . . 0.0 111.666 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.7 m -142.1 121.42 13.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.603 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -98.11 119.16 36.26 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.512 -0.475 . . . . 0.0 112.112 -176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.701 ' HB3' ' HA ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -76.17 130.09 37.72 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 170.756 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.6 mt -97.9 152.52 19.13 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -169.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 32' ' ' CYS . . . -100.87 5.48 43.39 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.059 173.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -100.26 -64.61 1.03 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.146 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -116.98 86.41 2.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.63 0.728 . . . . 0.0 110.079 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.725 ' HA2' ' HB3' ' A' ' 2' ' ' SER . . . 162.56 -77.37 0.16 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.444 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.571 ' HB2' ' C ' ' A' ' 5' ' ' ASP . 47.1 t -117.9 176.51 5.17 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -87.38 -23.28 24.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.351 0.596 . . . . 0.0 109.405 171.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.691 HG12 ' SG ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -113.33 162.97 11.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.853 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 26' ' ' GLN . 7.0 p30 -129.11 138.35 51.77 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.286 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.88 148.56 52.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.017 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.776 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 47.8 mm -95.48 116.81 38.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.715 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.4 mm -90.31 98.38 8.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.085 0.469 . . . . 0.0 110.047 174.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.615 ' HB3' HG12 ' A' ' 20' ' ' ILE . 8.8 m-85 -87.94 115.01 25.11 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -82.03 108.14 15.28 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 42.0 p -82.55 159.15 22.85 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.195 0.521 . . . . 0.0 111.471 -175.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -67.28 -2.42 5.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.358 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -95.15 3.71 54.42 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.842 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt 70.33 11.92 7.5 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.451 0.7 . . . . 0.0 111.176 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.3 mt -92.85 125.82 37.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.098 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 p -86.06 93.79 9.08 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.3 t -85.64 130.92 35.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.687 -174.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 82.3 m -86.29 84.73 7.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 122.016 0.912 . . . . 0.0 109.506 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.776 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -69.51 143.03 53.58 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.6 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.698 ' HB2' ' CG ' ' A' ' 53' ' ' GLN . 1.3 m-20 -88.14 122.52 69.83 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.494 ' HG3' ' OD1' ' A' ' 35' ' ' ASN . 9.5 Cg_endo -57.33 -8.19 3.49 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.889 2.393 . . . . 0.0 112.471 172.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -77.2 -34.54 56.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.961 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.698 ' CG ' ' HB2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -85.43 140.53 30.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.719 -169.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.64 -27.68 61.39 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -176.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.529 ' CD1' HD13 ' A' ' 14' ' ' ILE . 47.8 p-90 -62.74 -32.4 73.53 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.581 ' O ' HG12 ' A' ' 60' ' ' VAL . 7.4 t -73.03 -48.78 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.494 174.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 66.7 mttm -53.93 -36.5 62.83 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.584 0.552 . . . . 0.0 110.575 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -66.52 -57.28 7.64 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.691 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.577 HG21 HD13 ' A' ' 20' ' ' ILE . 75.2 mt -62.67 -43.3 98.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.201 -175.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.632 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 12.6 p -63.5 -33.42 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 121.309 -0.156 . . . . 0.0 111.328 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -63.75 -41.99 97.91 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.268 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.4 mt -81.48 4.81 19.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.023 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.736 HD13 ' HB2' ' A' ' 23' ' ' PHE . 55.9 mt -117.7 -14.86 10.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.321 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -108.35 -63.38 1.34 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.761 0.315 . . . . 0.0 110.185 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.72 78.33 1.82 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.277 0.56 . . . . 0.0 109.667 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.403 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . 15.9 ptmt -119.67 142.55 48.36 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.558 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.49 105.63 17.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.71 -175.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -100.01 102.47 13.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.971 0.415 . . . . 0.0 110.325 176.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -112.65 -80.97 0.59 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 174.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.152 176.036 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 m -55.94 128.04 33.29 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.493 0.496 . . . . 0.0 111.346 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -80.99 -53.28 6.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.135 0.493 . . . . 0.0 110.469 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -131.03 -170.64 2.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.77 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -140.38 110.44 6.54 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.474 0.654 . . . . 0.0 110.485 172.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.719 ' SG ' HG12 ' A' ' 34' ' ' ILE . 19.3 p -40.76 147.55 0.12 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.985 173.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.9 m -61.6 134.68 57.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.808 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt -86.72 6.62 30.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.592 0.711 . . . . 0.0 109.885 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.67 119.79 0.95 Allowed Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.676 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.49 ' HD1' ' H ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -118.62 161.38 20.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.944 0.402 . . . . 0.0 110.833 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 49' ' ' ALA . 14.4 t -73.38 -171.52 0.99 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -167.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -147.27 14.19 1.12 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.634 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -88.81 170.43 10.75 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.408 -171.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.569 HD13 ' CD1' ' A' ' 55' ' ' TRP . 8.7 mm -105.3 84.57 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 163.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.588 HD12 ' CH2' ' A' ' 55' ' ' TRP . 1.1 mt -92.14 160.49 15.17 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.739 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 52.1 m170 -132.51 171.5 9.03 Favored Pre-proline 0 C--N 1.313 -1.014 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.005 -173.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.575 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 32.1 Cg_exo -55.83 -24.24 46.09 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.181 1.921 . . . . 0.0 109.255 165.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.739 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 64.9 mttm -44.51 -32.65 1.47 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 114.24 -1.346 . . . . 0.0 112.082 171.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -126.81 -3.48 6.52 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 122.243 -0.286 . . . . 0.0 111.449 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.62 HG13 ' HB3' ' A' ' 39' ' ' PHE . 1.2 mp -92.88 120.12 41.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.02 0.438 . . . . 0.0 110.344 -175.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.3 m -113.63 -5.87 11.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.735 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.19 158.37 29.13 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.36 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.665 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -146.97 137.39 23.58 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.139 0.495 . . . . 0.0 110.258 -179.813 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.2 m -144.38 109.45 5.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.518 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 25' ' ' ARG . 8.6 ptp180 -75.9 118.14 18.37 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -101.88 106.35 17.29 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -177.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.6 mp -81.7 164.5 21.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.457 0.646 . . . . 0.0 111.984 -173.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.24 -57.8 3.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.862 175.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -74.62 19.67 0.13 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -170.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -115.19 23.86 12.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.281 0.562 . . . . 0.0 110.494 173.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.25 -12.86 4.36 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.647 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.479 ' HB2' ' H ' ' A' ' 6' ' ' CYS . 2.4 t -120.06 -153.69 0.55 Allowed 'General case' 0 C--N 1.319 -0.742 0 O-C-N 122.454 -0.439 . . . . 0.0 111.563 -177.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -129.61 -27.95 2.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.576 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.719 HG12 ' SG ' ' A' ' 6' ' ' CYS . 2.8 pt -118.61 169.51 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -103.39 131.06 50.78 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 174.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.14 126.14 36.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.28 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.67 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 46.7 mm -88.72 98.08 7.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.34 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.411 HG23 ' HB2' ' A' ' 46' ' ' SER . 70.2 mt -75.49 105.95 4.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.867 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.62 ' HB3' HG13 ' A' ' 20' ' ' ILE . 13.6 m-85 -97.73 116.94 30.93 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 171.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -86.88 106.46 17.77 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 43' ' ' LYS . 42.7 p -74.75 164.1 26.94 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.642 -176.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -74.26 4.79 5.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.963 0.887 . . . . 0.0 108.912 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.483 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 14.5 tppt? -87.87 -1.36 57.93 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.004 176.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt 70.6 12.26 7.32 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.828 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.6 mt -109.44 129.2 55.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.598 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.411 ' HB2' HG23 ' A' ' 38' ' ' ILE . 11.8 p -79.84 107.07 12.33 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.821 176.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 73.0 t -93.23 127.25 45.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.437 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 57.4 m -88.94 100.5 13.24 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.703 0.763 . . . . 0.0 109.493 -174.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.67 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -78.66 143.38 36.38 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.934 -177.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.565 ' HB2' ' CG ' ' A' ' 53' ' ' GLN . 2.2 m-20 -80.41 130.98 63.13 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.59 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.53 -10.63 28.54 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.678 2.252 . . . . 0.0 112.044 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -74.93 -27.76 60.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.231 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.58 ' NE2' ' HE1' ' A' ' 55' ' ' TRP . 4.4 mt-30 -84.64 139.29 32.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.036 -168.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 p -76.33 -31.1 57.93 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.856 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.588 ' CH2' HD12 ' A' ' 15' ' ' LEU . 51.9 p-90 -60.35 -33.8 72.94 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 174.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.538 ' O ' HG12 ' A' ' 60' ' ' VAL . 25.7 t -68.54 -52.06 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.252 173.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 67.6 mttm -54.2 -38.21 65.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.683 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -63.46 -52.45 61.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.787 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 55' ' ' TRP . 72.6 mt -63.52 -47.65 90.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.296 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.665 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 7.5 p -63.99 -36.19 75.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -175.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -68.7 -31.67 70.92 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.303 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 30.2 tp -74.28 -41.88 60.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.828 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.482 HD12 ' HB3' ' A' ' 23' ' ' PHE . 2.4 mm? -66.25 -29.09 69.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.039 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.9 t -73.11 -28.91 62.54 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.0 -176.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -135.98 48.73 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.111 0.482 . . . . 0.0 110.92 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 66' ' ' LYS . 18.6 ttpp -74.87 88.68 2.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.942 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.9 m -116.15 -177.28 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.799 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -103.56 -43.62 5.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.846 0.355 . . . . 0.0 111.35 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -107.86 136.74 47.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.373 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 66.5 mtm . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.691 -177.131 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.51 0.195 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.764 ' HA ' ' HA3' ' A' ' 31' ' ' GLY . 2.3 p -114.51 110.48 19.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.483 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -83.66 -44.46 14.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.92 177.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.574 ' CZ ' ' HB2' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -131.13 -171.92 2.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.189 178.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -138.29 104.17 5.11 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.438 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.685 ' SG ' ' HG2' ' A' ' 26' ' ' GLN . 93.8 m -47.99 146.99 2.25 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.137 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 67.1 m -49.3 122.29 5.92 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.284 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.7 mt -65.24 -24.82 67.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.087 0.47 . . . . 0.0 110.406 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.72 134.77 7.43 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.11 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.686 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 28.9 m-85 -92.66 178.41 5.8 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.566 0.222 . . . . 0.0 110.445 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.657 HG21 HG13 ' A' ' 47' ' ' VAL . 3.4 t -127.08 130.58 50.18 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.371 0.605 . . . . 0.0 111.758 -177.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.66 72.57 2.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 122.007 0.908 . . . . 0.0 108.6 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.44 ' HB2' HD12 ' A' ' 15' ' ' LEU . 18.2 mmt180 -104.42 -178.9 3.79 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.925 177.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.471 HD13 ' CD1' ' A' ' 55' ' ' TRP . 9.1 mm -126.74 87.68 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 162.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.714 HD13 HG11 ' A' ' 47' ' ' VAL . 1.2 mt -99.82 162.27 13.1 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.273 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.577 ' O ' HD13 ' A' ' 20' ' ' ILE . 63.1 m170 -132.59 167.08 24.41 Favored Pre-proline 0 C--N 1.316 -0.889 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.087 -172.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.624 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 18.3 Cg_endo -61.3 -22.53 74.86 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.315 2.01 . . . . 0.0 108.925 166.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.557 ' HD2' ' ND1' ' A' ' 16' ' ' HIS . 66.4 mttm -52.46 -28.31 19.68 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.718 172.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -124.0 -2.71 8.17 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.426 -175.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.624 ' HB ' ' HA ' ' A' ' 17' ' ' PRO . 0.9 OUTLIER -94.19 124.18 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 120.995 0.426 . . . . 0.0 110.891 -174.078 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.4 m -120.32 -1.96 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.547 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.3 160.22 31.95 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.432 -0.889 . . . . 0.0 111.962 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.54 ' CB ' ' HG ' ' A' ' 63' ' ' LEU . 1.7 t80 -149.3 134.5 18.23 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.5 m -140.95 107.18 5.23 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.381 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.515 ' HD3' HD21 ' A' ' 27' ' ' LEU . 32.4 ttm180 -82.37 107.52 15.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.168 0.509 . . . . 0.0 110.013 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.685 ' HG2' ' SG ' ' A' ' 6' ' ' CYS . 13.6 tt0 -80.14 115.56 19.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.906 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.515 HD21 ' HD3' ' A' ' 25' ' ' ARG . 65.2 mt -103.39 148.18 26.2 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -166.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.62 15.88 0.44 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.272 176.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 27' ' ' LEU . 18.1 m120 -116.04 -6.99 11.96 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.783 -177.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . 34.2 mm-40 -103.69 -1.06 28.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.474 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.764 ' HA3' ' HA ' ' A' ' 2' ' ' SER . . . 145.99 -48.65 0.68 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.496 -0.859 . . . . 0.0 113.311 177.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.468 ' HB3' ' H ' ' A' ' 6' ' ' CYS . 13.4 p -68.16 171.04 7.52 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -112.52 6.76 18.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.553 0.692 . . . . 0.0 111.035 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.415 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 25.0 pt -131.34 -171.81 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 8.9 p30 -142.62 124.08 14.83 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.874 174.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.99 137.89 51.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.729 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.504 HG23 ' HE1' ' A' ' 23' ' ' PHE . 50.0 mm -89.04 98.23 7.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.089 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.678 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 2.6 mp -85.46 99.7 7.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.346 -0.541 . . . . 0.0 110.541 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.527 ' HE2' HG22 ' A' ' 56' ' ' VAL . 20.1 m-85 -86.89 125.93 34.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 171.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -93.32 112.32 24.22 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.4 p -79.13 155.39 28.72 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -65.62 -6.72 11.97 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.283 175.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -99.21 12.32 36.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.989 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.9 mttm 70.68 19.89 5.87 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.372 172.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.8 mt -104.48 124.72 49.77 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.416 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.8 p -80.85 109.56 15.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.302 0.572 . . . . 0.0 109.769 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.714 HG11 HD13 ' A' ' 15' ' ' LEU . 70.0 t -87.1 132.14 33.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.025 -176.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 65.0 m -93.34 76.97 4.51 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.863 0.84 . . . . 0.0 108.832 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.595 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -70.71 141.13 51.56 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.898 -175.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.686 ' OD1' ' HB3' ' A' ' 10' ' ' TYR . 2.0 m-20 -79.0 129.63 72.52 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.3 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.54 -3.08 8.44 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 121.794 1.663 . . . . 0.0 111.122 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.461 ' CE ' HD21 ' A' ' 50' ' ' ASN . 53.8 mtmt -88.58 -18.85 27.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.048 -173.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.504 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 0.9 OUTLIER -104.54 145.21 30.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.953 0.406 . . . . 0.0 111.05 -170.754 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 p -69.72 -36.06 75.56 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -172.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.639 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 36.1 p-90 -60.14 -30.93 69.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.453 0.644 . . . . 0.0 109.466 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.595 ' CG2' ' HB1' ' A' ' 49' ' ' ALA . 15.1 t -75.27 -49.54 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.198 175.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -56.09 -33.61 65.22 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 123.454 0.471 . . . . 0.0 110.401 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -66.48 -56.96 8.44 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.872 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.446 HG12 ' HD3' ' A' ' 17' ' ' PRO . 72.4 mt -64.65 -43.94 96.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.142 -176.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 56' ' ' VAL . 7.1 p -67.07 -24.46 32.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.586 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 61' ' ' ARG . 8.4 ttp180 -69.61 -33.28 72.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.154 0.502 . . . . 0.0 110.114 174.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.6 mt -73.22 -44.45 59.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.872 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.54 ' HG ' ' CB ' ' A' ' 23' ' ' PHE . 3.7 mm? -61.96 -49.81 74.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.776 176.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.1 t -87.15 60.8 6.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.479 0.657 . . . . 0.0 109.8 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -66.27 103.53 1.02 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.762 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -91.1 -17.42 26.21 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.916 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.5 p -81.4 101.53 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.514 0.673 . . . . 0.0 110.123 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -86.71 77.21 9.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.381 0.61 . . . . 0.0 110.246 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -132.01 -82.95 0.5 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.558 177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 17.8 tpt . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.192 -0.908 . . . . 0.0 109.28 178.906 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 121.067 0.461 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -117.42 118.74 33.04 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.815 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -63.13 -48.7 77.4 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.464 ' CE1' ' HB2' ' A' ' 26' ' ' GLN . 2.2 p90 -132.01 -178.84 5.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.616 173.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -122.53 111.85 17.31 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.36 0.6 . . . . 0.0 109.618 169.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.813 ' HA ' ' HG3' ' A' ' 26' ' ' GLN . 82.8 m -50.48 138.13 17.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.94 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.0 t -56.76 118.58 5.04 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 123.396 0.435 . . . . 0.0 110.062 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.33 -24.98 66.83 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.167 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.25 142.41 10.48 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.998 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.684 ' HB2' ' OD1' ' A' ' 50' ' ' ASN . 0.3 OUTLIER -105.24 171.32 7.38 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.027 0.441 . . . . 0.0 111.973 -178.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 t -93.12 154.11 18.27 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -169.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -95.19 59.53 2.25 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.419 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.632 ' HB3' HD22 ' A' ' 15' ' ' LEU . 6.7 mtm180 -129.34 173.66 10.32 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.511 HD13 ' CD1' ' A' ' 55' ' ' TRP . 14.5 mm -120.71 79.74 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 113.979 -1.464 . . . . 0.0 108.528 168.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 13' ' ' ARG . 2.8 mm? -79.31 159.12 27.33 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.655 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 52.3 m170 -134.24 172.05 7.99 Favored Pre-proline 0 C--N 1.309 -1.19 0 O-C-N 122.028 -0.42 . . . . 0.0 111.064 -176.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.575 ' HD3' HG12 ' A' ' 59' ' ' ILE . 14.4 Cg_endo -59.56 -21.64 63.08 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.732 1.622 . . . . 0.0 109.177 165.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.655 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 67.6 mttm -49.01 -34.28 12.88 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.151 174.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 41' ' ' THR . 12.0 m-85 -122.83 1.79 9.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.745 0.307 . . . . 0.0 111.135 -173.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.486 HD13 ' O ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -95.63 129.57 45.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.666 -174.27 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.35 -8.3 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.061 0.458 . . . . 0.0 110.389 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.02 159.43 30.34 Favored Glycine 0 N--CA 1.453 -0.193 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.56 ' CB ' HD13 ' A' ' 63' ' ' LEU . 1.6 t80 -147.04 131.0 17.16 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.617 0.722 . . . . 0.0 111.281 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.711 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 38.2 m -129.42 144.17 51.14 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.341 -1.3 . . . . 0.0 107.82 174.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -127.73 121.62 30.79 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.434 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.813 ' HG3' ' HA ' ' A' ' 6' ' ' CYS . 1.2 pm0 -97.75 123.92 41.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.301 177.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.432 ' C ' ' H ' ' A' ' 29' ' ' ASN . 82.8 mt -103.72 159.54 15.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.507 -176.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 32' ' ' CYS . . . -78.04 32.82 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.445 0.64 . . . . 0.0 110.662 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.432 ' H ' ' C ' ' A' ' 27' ' ' LEU . 5.5 m-20 -116.86 -30.37 5.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.167 -174.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -104.24 30.91 4.92 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -170.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.81 -60.06 0.67 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.741 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 0.5 OUTLIER -70.3 139.14 52.02 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 122.198 0.199 . . . . 0.0 111.058 178.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.36 -18.98 47.47 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.362 0.601 . . . . 0.0 109.419 176.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.3 pt -97.53 174.25 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.039 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -143.02 145.62 33.08 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.482 ' H ' ' HG2' ' A' ' 26' ' ' GLN . . . -142.55 177.11 8.51 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.078 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.962 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 42.6 mm -122.31 133.26 69.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.711 ' HB ' ' HB ' ' A' ' 24' ' ' THR . 72.9 mt -101.78 99.13 7.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.844 0.354 . . . . 0.0 110.091 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -91.76 114.06 26.49 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -86.56 113.49 22.51 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -176.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 41.5 p -79.75 162.08 25.36 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.142 0.496 . . . . 0.0 111.314 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -69.87 -2.66 12.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.829 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -93.67 7.26 45.44 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.777 176.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm 72.63 8.62 5.64 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.444 0.698 . . . . 0.0 111.002 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.77 120.74 36.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.03 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 p -79.94 105.57 11.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.358 0.599 . . . . 0.0 109.769 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 96.5 t -86.01 130.43 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.805 -176.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.9 m -82.1 92.22 6.8 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.855 0.835 . . . . 0.0 109.09 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.962 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -70.38 142.7 52.07 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.315 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.684 ' OD1' ' HB2' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -81.79 151.79 68.23 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -174.178 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -89.76 39.16 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.562 2.174 . . . . 0.0 112.835 168.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.609 ' O ' ' HE2' ' A' ' 57' ' ' LYS . 64.9 mttm -131.97 -80.79 0.51 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.046 0.451 . . . . 0.0 111.234 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.673 HE22 ' CG2' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -40.1 139.31 0.71 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.664 1.186 . . . . 0.0 113.543 177.387 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.474 HG22 ' HD2' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -75.1 -16.93 60.53 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -172.395 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.594 ' CD1' ' HB2' ' A' ' 53' ' ' GLN . 60.7 p-90 -65.01 -30.82 71.82 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.586 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.673 ' CG2' HE22 ' A' ' 53' ' ' GLN . 0.9 OUTLIER -71.39 -47.94 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.914 174.019 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.609 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 68.3 mttm -54.41 -34.98 62.4 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 123.779 0.674 . . . . 0.0 110.386 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -68.33 -56.27 9.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.128 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.575 HG12 ' HD3' ' A' ' 17' ' ' PRO . 63.5 mt -64.57 -46.59 92.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.641 0.258 . . . . 0.0 111.486 -175.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.638 HG12 ' O ' ' A' ' 56' ' ' VAL . 12.7 p -71.4 -28.5 32.14 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.016 -174.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -68.9 -35.02 76.37 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.4 tp -72.1 -37.53 69.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.323 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.56 HD13 ' CB ' ' A' ' 23' ' ' PHE . 95.9 mt -82.4 -37.62 25.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.819 -177.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.4 t -96.23 52.43 1.27 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -56.18 103.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.836 -174.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -86.32 -4.29 59.14 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.912 174.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.9 p -96.75 -10.44 8.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.235 0.541 . . . . 0.0 111.765 -173.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -133.34 107.69 8.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.406 0.622 . . . . 0.0 111.892 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -130.92 -51.62 1.04 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.854 169.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 39.5 tpp . . . . . 0 C--O 1.245 0.854 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.693 177.299 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 120.671 0.272 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -59.96 133.98 56.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.875 173.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -58.53 -53.15 61.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.507 0.67 . . . . 0.0 109.412 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.712 ' HZ ' ' H ' ' A' ' 27' ' ' LEU . 1.4 p90 -131.83 178.08 7.04 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.543 173.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -121.39 117.38 26.79 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.629 0.728 . . . . 0.0 110.199 169.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.564 ' SG ' HG12 ' A' ' 34' ' ' ILE . 25.1 p -36.35 142.09 0.09 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 113.87 -1.514 . . . . 0.0 113.683 170.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 46.8 t -61.7 126.29 26.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.624 177.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.451 HD23 ' H ' ' A' ' 8' ' ' LEU . 2.3 pt? -64.21 -24.91 67.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.929 -176.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.27 122.57 1.74 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.565 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.562 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 3.2 m-85 -79.15 -178.42 6.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.561 0.696 . . . . 0.0 110.306 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.2 t -107.38 -166.26 1.14 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.065 175.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -160.22 81.42 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 170.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.459 ' HB2' HD22 ' A' ' 15' ' ' LEU . 23.1 mmm180 -131.59 -173.99 3.28 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.479 -168.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.504 HD13 ' CD1' ' A' ' 55' ' ' TRP . 7.6 mm -126.89 86.3 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 113.647 -1.615 . . . . 0.0 107.872 160.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.63 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 1.9 mm? -91.2 169.92 10.44 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.694 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 63.1 m170 -134.25 170.21 11.88 Favored Pre-proline 0 C--N 1.311 -1.073 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.879 -175.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 31.6 Cg_exo -55.73 -26.89 58.76 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 121.951 1.767 . . . . 0.0 109.251 164.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.694 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 62.6 mttm -45.5 -38.25 6.07 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 113.95 -1.477 . . . . 0.0 112.085 172.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 41' ' ' THR . 14.0 m-85 -118.14 2.59 12.02 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -170.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.681 HG12 ' HB3' ' A' ' 39' ' ' PHE . 17.2 mt -106.45 122.53 60.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.874 0.369 . . . . 0.0 111.058 -175.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.57 -0.52 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.822 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -157.42 158.32 28.87 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.548 ' CB ' HD13 ' A' ' 63' ' ' LEU . 2.8 t80 -155.29 133.29 11.49 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.514 0.673 . . . . 0.0 110.545 -176.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.3 m -136.87 108.82 7.12 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.07 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 25' ' ' ARG . 0.4 OUTLIER -80.15 105.28 11.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.967 0.889 . . . . 0.0 110.464 -177.67 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.686 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.8 OUTLIER -84.67 120.15 26.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.449 178.596 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.712 ' H ' ' HZ ' ' A' ' 4' ' ' PHE . 2.8 mm? -114.89 155.12 27.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.494 0.664 . . . . 0.0 112.036 -170.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.2 22.27 1.25 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.909 -175.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -127.08 -3.17 6.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -103.8 25.19 10.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.029 0.443 . . . . 0.0 110.974 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.14 -64.83 0.6 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.634 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.56 152.8 41.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.772 0.32 . . . . 0.0 111.288 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -90.97 -14.46 31.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.012 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.564 HG12 ' SG ' ' A' ' 6' ' ' CYS . 3.6 pt -111.71 140.31 31.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.409 ' HB2' ' HA ' ' A' ' 27' ' ' LEU . 9.6 p30 -110.43 126.97 54.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.314 0.578 . . . . 0.0 110.519 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.652 ' O ' ' HB3' ' A' ' 26' ' ' GLN . . . -127.11 132.01 50.69 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.683 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.44 HG23 ' HE1' ' A' ' 23' ' ' PHE . 47.0 mm -77.61 112.28 15.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.1 mm -90.21 97.79 7.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 122.044 -0.41 . . . . 0.0 111.087 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.681 ' HB3' HG12 ' A' ' 20' ' ' ILE . 16.7 m-85 -90.52 119.07 30.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 6.6 m-70 -89.31 115.1 26.54 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 15.0 p -84.86 159.47 20.37 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.774 0.797 . . . . 0.0 112.509 -171.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -67.9 -0.7 4.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.055 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -98.61 20.62 12.57 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.68 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt 67.9 22.64 8.6 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.58 175.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.32 173.65 8.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.724 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 40' ' ' HIS . 49.1 m -127.75 122.3 32.47 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 173.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.4 t -92.01 131.51 38.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.439 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.455 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 20.6 m -82.87 82.18 8.27 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.486 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -72.16 141.28 49.08 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.155 -173.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.753 HD21 ' HE3' ' A' ' 52' ' ' LYS . 2.8 m-20 -82.41 131.42 55.68 Favored Pre-proline 0 CA--C 1.508 -0.671 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.733 -175.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 50' ' ' ASN . 5.8 Cg_exo -76.69 15.3 1.09 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.025 1.817 . . . . 0.0 111.632 169.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.753 ' HE3' HD21 ' A' ' 50' ' ' ASN . 1.1 ttpp -89.82 -28.66 19.15 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.664 176.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.447 ' CD ' ' HB2' ' A' ' 50' ' ' ASN . 0.8 OUTLIER -105.95 138.8 41.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.746 -163.277 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.29 -29.81 66.65 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -173.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.63 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 46.0 p-90 -63.19 -33.76 76.17 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.421 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.561 HG22 ' HE2' ' A' ' 39' ' ' PHE . 2.7 t -70.17 -46.99 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.918 174.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.474 ' HA ' HG12 ' A' ' 60' ' ' VAL . 91.1 mttt -62.19 -29.06 70.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.855 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -68.19 -51.01 50.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.79 0.329 . . . . 0.0 110.419 173.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 55' ' ' TRP . 58.1 mt -68.53 -43.91 83.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.322 -175.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.544 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 14.9 p -68.22 -33.29 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.08 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.458 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 5.9 tmm_? -66.04 -40.19 90.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.103 0.478 . . . . 0.0 109.78 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.0 tp -66.69 -47.64 71.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.992 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.548 HD13 ' CB ' ' A' ' 23' ' ' PHE . 83.0 mt -65.5 -36.37 83.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.377 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.5 m -81.84 -1.23 46.79 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 61' ' ' ARG . 33.8 mmtp -108.62 -13.19 14.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.021 0.439 . . . . 0.0 111.423 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -114.01 -37.34 4.49 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.194 -175.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.7 t -90.57 13.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 122.125 0.964 . . . . 0.0 109.483 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -93.6 -14.38 26.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.38 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -105.47 145.9 30.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.569 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 13.1 tpt . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.415 -179.577 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 120.778 0.323 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.883 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . 24.2 m -95.28 -168.73 1.84 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.175 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.619 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 8.0 t30 -74.46 -72.14 0.3 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.666 0.269 . . . . 0.0 110.814 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.612 ' CD2' ' HB2' ' A' ' 5' ' ' ASP . 6.1 p90 -130.77 -42.85 1.12 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -176.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.612 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 0.8 OUTLIER -141.05 -34.91 0.48 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -169.638 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.883 ' SG ' ' HB3' ' A' ' 2' ' ' SER . 1.8 p -40.0 117.39 0.76 Allowed 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.852 0.72 . . . . 0.0 112.709 177.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.479 ' C ' ' H ' ' A' ' 9' ' ' GLY . 73.4 m -62.84 155.39 27.1 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.609 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 1.2 pp -77.34 25.7 0.17 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.428 0.632 . . . . 0.0 110.638 173.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 7' ' ' CYS . . . 131.15 156.98 8.69 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -175.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.499 ' HB2' ' OD1' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -105.96 172.03 7.03 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.53 178.86 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 t -84.66 -174.96 5.56 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.032 -172.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -135.66 70.99 1.42 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 173.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -131.65 178.51 6.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.541 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.576 HD13 ' CD1' ' A' ' 55' ' ' TRP . 5.2 mm -124.51 94.79 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.374 167.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.513 HD12 ' CH2' ' A' ' 55' ' ' TRP . 1.1 mt -106.75 158.08 17.24 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.877 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.77 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 26.4 m170 -132.19 178.81 1.58 Allowed Pre-proline 0 C--N 1.314 -0.969 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.716 -173.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.77 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 9.4 Cg_endo -55.42 -20.32 25.64 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.281 1.987 . . . . 0.0 110.046 164.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.634 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 22.0 mtpp -47.16 -27.03 1.29 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.308 172.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 41' ' ' THR . 55.2 m-85 -126.15 -10.85 6.47 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.427 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 16' ' ' HIS . 1.5 mp -95.13 128.42 46.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.046 0.45 . . . . 0.0 111.649 -170.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -122.53 -16.96 5.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.591 172.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -145.07 162.37 28.13 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.603 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -155.16 136.03 13.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.002 0.429 . . . . 0.0 111.006 -175.178 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.2 m -134.47 123.25 23.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.501 174.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 25' ' ' ARG . 6.6 ptp85 -91.18 91.89 8.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.612 0.72 . . . . 0.0 110.298 176.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.558 ' OE1' ' HA ' ' A' ' 6' ' ' CYS . 1.6 tm0? -68.76 121.61 16.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.95 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.7 mt -113.82 147.8 37.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.899 -168.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.83 46.84 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.159 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -139.32 -29.49 0.75 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.244 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -90.56 28.62 1.45 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -168.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.32 -37.99 2.7 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.74 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.619 ' SG ' ' HB3' ' A' ' 3' ' ' ASN . 57.7 m -91.14 158.56 16.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.856 0.36 . . . . 0.0 110.735 175.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -110.45 -12.39 14.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.539 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.555 HG13 ' HB2' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -105.93 133.42 50.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 174.119 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -108.54 136.84 47.48 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.929 0.395 . . . . 0.0 110.872 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 26' ' ' GLN . . . -140.19 140.19 35.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.94 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 45.8 mm -79.94 101.95 5.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -87.03 98.33 7.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 O-C-N 121.87 -0.519 . . . . 0.0 110.747 -176.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.492 ' HE2' HG22 ' A' ' 56' ' ' VAL . 11.3 m-85 -86.23 135.15 33.67 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -105.96 116.91 32.75 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 41.7 p -79.85 163.63 24.23 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.34 -172.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -63.57 -12.19 30.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.551 170.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -84.04 0.16 49.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.278 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 67.9 mttm 71.27 12.4 6.74 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.778 0.831 . . . . 0.0 111.368 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.7 mt -107.86 141.68 39.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.423 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.8 p -92.47 124.16 36.31 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.102 0.477 . . . . 0.0 110.721 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.4 t -105.16 134.1 47.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.43 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 69.6 m -85.32 86.2 7.39 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.582 0.706 . . . . 0.0 109.634 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.628 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -72.78 149.12 43.92 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.451 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.575 ' HB2' ' OE1' ' A' ' 53' ' ' GLN . 0.4 OUTLIER -83.48 151.76 62.74 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.865 -172.295 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -88.91 32.16 0.39 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.263 1.975 . . . . 0.0 113.771 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.675 ' O ' ' HE3' ' A' ' 57' ' ' LYS . 50.9 mtpt -132.25 -61.43 0.87 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -174.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.64 HE22 ' CG2' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -56.49 143.14 36.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.55 0.691 . . . . 0.0 112.272 -179.575 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p -74.94 -20.49 59.67 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -172.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.576 ' CD1' HD13 ' A' ' 14' ' ' ILE . 60.4 p-90 -63.22 -32.47 73.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.068 176.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.64 ' CG2' HE22 ' A' ' 53' ' ' GLN . 1.0 OUTLIER -68.92 -46.31 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.922 174.356 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.675 ' HE3' ' O ' ' A' ' 52' ' ' LYS . 92.6 mttt -63.81 -24.55 67.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.573 -178.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -74.12 -49.83 22.09 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.547 174.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.47 HD11 ' O ' ' A' ' 15' ' ' LEU . 76.8 mt -65.66 -48.15 83.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.06 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.603 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 14.1 p -65.37 -29.14 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 120.579 0.228 . . . . 0.0 110.743 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 28.3 ttm180 -63.79 -43.92 94.89 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.4 mt -64.75 -43.33 93.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.69 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.611 ' O ' HG13 ' A' ' 67' ' ' VAL . 3.9 mm? -57.48 -49.95 74.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.951 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.8 m -67.32 -17.23 64.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.989 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -108.32 1.02 21.6 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -118.36 -3.98 10.93 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.06 0.457 . . . . 0.0 110.506 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 63' ' ' LEU . 9.3 m -69.73 136.63 25.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.862 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -85.73 94.15 9.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.625 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -89.98 -2.26 58.11 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 171.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 66.2 mtm . . . . . 0 C--O 1.248 1.016 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.96 176.329 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 120.459 0.171 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.6 m -72.57 107.15 4.93 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.568 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -60.98 -53.99 50.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.004 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.583 ' CE1' ' HG3' ' A' ' 26' ' ' GLN . 0.4 OUTLIER -132.01 -178.5 4.92 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.384 177.201 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -120.34 112.36 18.92 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.164 0.507 . . . . 0.0 110.303 172.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.836 ' HA ' ' CD ' ' A' ' 26' ' ' GLN . 30.2 p -38.6 142.31 0.2 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.056 167.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.428 ' O ' HD11 ' A' ' 34' ' ' ILE . 74.1 m -57.0 143.2 39.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.209 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.3 mt -82.56 10.27 7.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.91 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.22 162.89 34.29 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.172 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.576 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 39.1 m-85 -116.19 -178.89 3.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.913 0.387 . . . . 0.0 110.304 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 49' ' ' ALA . 13.8 t -96.0 -178.68 4.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.135 176.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -144.83 23.37 1.56 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.073 0.463 . . . . 0.0 110.717 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.534 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 40.6 mtt180 -109.65 -174.08 2.41 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.76 0.791 . . . . 0.0 113.001 -173.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.553 HD13 ' CD1' ' A' ' 55' ' ' TRP . 6.2 mm -117.71 77.69 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 113.598 -1.637 . . . . 0.0 107.912 167.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.534 ' CD2' ' HB2' ' A' ' 13' ' ' ARG . 2.8 mm? -75.45 158.33 32.81 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.693 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 42.1 m170 -132.1 174.59 4.52 Favored Pre-proline 0 C--N 1.306 -1.285 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.857 -176.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.693 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 9.4 Cg_endo -54.52 -26.56 45.85 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.807 1.671 . . . . 0.0 108.954 166.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.657 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 67.4 mttm -46.27 -34.8 4.71 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 113.676 -1.602 . . . . 0.0 111.726 173.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -124.93 -4.6 7.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.632 0.253 . . . . 0.0 111.626 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.797 HG12 ' HB3' ' A' ' 39' ' ' PHE . 11.6 mt -102.83 114.86 43.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.071 0.462 . . . . 0.0 110.86 -173.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.9 -5.36 11.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.63 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -150.8 159.94 28.38 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.476 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 2.3 t80 -154.66 137.07 14.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.222 0.534 . . . . 0.0 110.483 -176.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.2 m -143.82 104.01 4.12 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.674 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -73.77 104.13 4.56 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.898 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.836 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 11.0 tt0 -90.14 125.88 35.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.216 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.582 ' H ' ' HZ ' ' A' ' 4' ' ' PHE . 7.9 mp -105.93 173.97 6.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.46 0.647 . . . . 0.0 112.156 -170.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.43 16.82 21.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.286 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -118.11 7.55 12.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.287 -173.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -119.63 37.49 4.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.174 0.511 . . . . 0.0 110.751 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.68 -62.31 0.29 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.052 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -71.64 143.75 49.66 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.413 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -97.27 9.78 41.3 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -170.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.768 HG12 ' SG ' ' A' ' 6' ' ' CYS . 4.5 pt -128.23 156.83 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 172.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -120.23 122.25 40.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.194 0.521 . . . . 0.0 111.524 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.535 ' O ' ' HB3' ' A' ' 26' ' ' GLN . . . -121.2 137.11 54.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.809 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.637 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 48.0 mm -82.6 98.56 4.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.158 0.504 . . . . 0.0 109.905 178.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.49 HG23 ' HB2' ' A' ' 46' ' ' SER . 67.0 mt -76.91 105.83 6.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.036 0.446 . . . . 0.0 111.273 -176.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.797 ' HB3' HG12 ' A' ' 20' ' ' ILE . 19.8 m-85 -96.29 119.42 34.75 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -89.01 106.09 18.2 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.9 p -72.57 164.0 27.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.645 -175.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -71.47 6.54 1.77 Allowed 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.421 0.629 . . . . 0.0 110.55 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -101.81 9.41 40.8 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.126 173.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 68.41 14.07 9.09 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.663 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.5 mt -103.05 131.48 50.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.051 0.453 . . . . 0.0 110.699 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.49 ' HB2' HG23 ' A' ' 38' ' ' ILE . 5.7 p -80.58 102.54 9.85 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.541 177.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 77.8 t -84.93 124.03 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.743 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 25.8 m -88.82 90.58 8.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.739 0.781 . . . . 0.0 109.496 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.637 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -70.87 134.82 47.62 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.818 -174.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.579 ' HB2' ' CG ' ' A' ' 53' ' ' GLN . 2.1 m-20 -70.26 129.15 90.8 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 50' ' ' ASN . 21.8 Cg_exo -65.39 -6.5 13.58 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.387 2.058 . . . . 0.0 112.676 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -76.43 -37.56 56.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.777 0.799 . . . . 0.0 111.254 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.608 ' NE2' ' HE1' ' A' ' 55' ' ' TRP . 6.5 mt-30 -72.79 134.96 45.16 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.862 -164.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.22 -26.62 60.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.861 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.608 ' HE1' ' NE2' ' A' ' 53' ' ' GLN . 55.8 p-90 -65.31 -32.45 74.1 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 173.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.539 ' O ' HG12 ' A' ' 60' ' ' VAL . 43.2 t -70.04 -50.5 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.829 173.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.549 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 96.5 mttt -59.3 -28.08 66.46 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.696 0.622 . . . . 0.0 111.281 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -71.06 -56.86 5.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.7 0.286 . . . . 0.0 110.309 173.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.673 HG22 HD22 ' A' ' 63' ' ' LEU . 81.9 mt -60.19 -45.95 95.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 -177.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.539 HG12 ' O ' ' A' ' 56' ' ' VAL . 9.8 p -70.3 -26.42 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.362 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -60.55 -43.11 97.6 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 174.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.2 mt -72.78 -41.2 65.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.489 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.673 HD22 HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -62.31 -46.4 88.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.348 -0.387 . . . . 0.0 112.043 -179.017 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 p -64.34 -25.18 67.92 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -173.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 11.5 mptt -101.41 -7.79 22.6 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -112.17 -31.79 6.76 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.984 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 48.1 t -82.72 119.38 32.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.046 0.451 . . . . 0.0 111.029 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -85.72 105.52 16.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.82 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -93.76 -6.23 46.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.273 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 51.1 tpp . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.936 179.26 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.46 148.95 47.97 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -68.5 -66.01 0.63 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 171.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.54 ' HE2' ' HG2' ' A' ' 26' ' ' GLN . 17.2 p90 -131.03 162.82 28.96 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.584 -1.189 . . . . 0.0 107.953 172.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -118.73 111.5 18.57 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.008 0.909 . . . . 0.0 110.323 173.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.579 ' HB3' ' HG2' ' A' ' 26' ' ' GLN . 30.1 p -60.43 -179.85 0.13 Allowed 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 113.779 -1.555 . . . . 0.0 113.125 -179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.8 t -50.74 114.14 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.607 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.1 mt -90.45 17.92 6.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.662 -176.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.54 113.39 0.7 Allowed Glycine 0 C--O 1.225 -0.415 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.616 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 33.6 m-85 -85.27 168.68 14.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.126 0.489 . . . . 0.0 111.239 -173.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 49' ' ' ALA . 11.1 t -86.75 -177.48 6.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.938 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -141.23 16.57 2.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.935 -177.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.592 ' HB3' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -104.76 175.16 5.58 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.213 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.549 HD13 ' CD1' ' A' ' 55' ' ' TRP . 2.8 mm -110.34 90.07 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 113.813 -1.539 . . . . 0.0 108.173 161.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.592 HD22 ' HB3' ' A' ' 13' ' ' ARG . 2.5 mm? -88.97 167.2 13.39 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.599 ' O ' HD13 ' A' ' 20' ' ' ILE . 63.2 m170 -133.07 167.83 21.01 Favored Pre-proline 0 C--N 1.314 -0.947 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.0 -175.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.661 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 22.8 Cg_endo -63.42 -19.07 67.29 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.121 1.881 . . . . 0.0 109.214 165.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 85.6 mttt -55.35 -24.66 30.47 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.417 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' A' ' 41' ' ' THR . 50.2 m-85 -128.29 2.53 5.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.946 -175.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.661 ' HB ' ' HA ' ' A' ' 17' ' ' PRO . 1.0 OUTLIER -100.85 122.78 53.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.098 0.475 . . . . 0.0 110.587 -175.685 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.03 -9.96 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.67 175.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -148.43 161.28 28.6 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.41 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.542 ' CE2' HG23 ' A' ' 60' ' ' VAL . 1.8 t80 -156.05 134.01 11.25 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -176.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.695 HG22 ' NE2' ' A' ' 26' ' ' GLN . 22.9 m -141.02 112.69 7.58 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.399 176.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 11.7 ttp180 -101.73 117.65 35.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.936 0.398 . . . . 0.0 111.202 -176.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.695 ' NE2' HG22 ' A' ' 24' ' ' THR . 1.8 mp0 -97.75 139.01 34.26 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.806 174.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.536 HD13 ' HG3' ' A' ' 30' ' ' GLU . 5.2 mp -124.64 159.54 30.53 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 123.628 0.58 . . . . 0.0 109.767 -177.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.739 ' HA ' ' O ' ' A' ' 32' ' ' CYS . . . -77.01 1.08 18.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.818 0.818 . . . . 0.0 110.722 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -116.44 2.77 13.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.619 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.536 ' HG3' HD13 ' A' ' 27' ' ' LEU . 7.1 mm-40 -107.48 -8.75 16.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.849 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.12 -56.74 0.47 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.154 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.739 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 9.5 t -57.99 151.07 19.24 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 122.88 0.472 . . . . 0.0 109.98 174.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -84.39 -21.74 30.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.092 0.472 . . . . 0.0 109.911 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.428 HG13 ' SG ' ' A' ' 6' ' ' CYS . 46.9 pt -110.41 -171.46 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 173.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -138.86 119.29 13.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.445 0.64 . . . . 0.0 110.477 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.74 137.53 53.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.055 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.525 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 15.5 mm -96.47 92.32 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.217 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 40.5 mt -79.63 101.16 4.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.852 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.472 ' CE1' ' HD2' ' A' ' 23' ' ' PHE . 20.8 m-85 -85.13 131.2 34.48 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 171.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -100.02 107.89 19.94 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 41.1 p -71.14 159.21 35.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.762 -174.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -3.08 12.28 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.576 0.703 . . . . 0.0 109.642 171.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -90.97 1.22 57.22 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.112 174.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 70.42 16.32 7.13 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.638 -1.164 . . . . 0.0 112.057 173.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.8 mt -107.2 136.56 46.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.825 175.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.8 p -84.47 120.82 26.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.062 0.458 . . . . 0.0 110.477 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 91.0 t -104.2 124.36 58.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.962 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.5 m -85.53 82.79 8.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.661 0.743 . . . . 0.0 109.385 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.601 ' HA ' HG22 ' A' ' 11' ' ' THR . . . -69.64 143.55 53.19 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.034 -173.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.616 ' OD1' ' HB3' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -81.29 128.33 70.72 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.924 -176.046 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -71.19 13.49 0.4 Allowed 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.761 2.308 . . . . 0.0 112.303 173.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 50' ' ' ASN . 55.6 mtpt -99.47 -23.94 14.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.172 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.516 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 0.8 OUTLIER -102.63 145.77 29.16 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.737 -167.047 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.3 -30.83 63.66 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.638 -171.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.578 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 42.6 p-90 -63.34 -32.87 74.41 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.368 177.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.589 ' CG2' ' HB1' ' A' ' 49' ' ' ALA . 8.6 t -72.09 -46.14 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.38 174.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.511 ' HA ' HG12 ' A' ' 60' ' ' VAL . 88.6 mttt -60.5 -34.65 74.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.903 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -64.37 -50.07 69.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.395 174.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 55' ' ' TRP . 68.0 mt -68.88 -45.96 79.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.481 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.542 HG23 ' CE2' ' A' ' 23' ' ' PHE . 12.8 p -65.65 -35.35 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.89 -0.141 . . . . 0.0 111.297 -178.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 36.9 ttm180 -65.39 -33.84 76.89 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 30.6 tp -74.64 -38.1 62.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.236 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.443 ' HG ' ' CB ' ' A' ' 23' ' ' PHE . 2.8 mm? -69.52 -26.17 64.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.55 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.1 p -98.38 12.56 34.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.322 0.582 . . . . 0.0 110.25 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 59.8 tttp -102.17 8.47 40.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.946 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -79.28 58.01 2.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.916 0.865 . . . . 0.0 109.885 176.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -104.23 178.0 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.165 -176.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -78.23 91.88 4.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -98.3 -57.82 2.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.318 -175.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 17.1 tpt . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.139 -0.934 . . . . 0.0 109.261 -179.676 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 120.926 0.393 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.479 ' HB3' ' HA2' ' A' ' 31' ' ' GLY . 17.1 m -68.96 125.99 28.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.609 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -69.27 -45.85 68.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.298 0.571 . . . . 0.0 109.642 175.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.505 ' HZ ' ' H ' ' A' ' 27' ' ' LEU . 2.1 p90 -130.06 -172.64 2.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.804 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -135.09 116.45 14.59 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.821 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.703 ' SG ' HG12 ' A' ' 34' ' ' ILE . 19.6 p -38.08 150.84 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.321 170.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.0 t -62.63 152.69 34.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.328 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.9 mt -74.97 2.14 11.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.45 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.13 -153.92 12.31 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.675 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 64.0 m-85 -137.37 -171.47 2.98 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.525 HG21 ' CG1' ' A' ' 47' ' ' VAL . 11.2 t -127.19 136.88 52.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.075 0.464 . . . . 0.0 111.045 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -101.97 56.65 0.81 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.822 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.543 ' NE ' ' HA ' ' A' ' 13' ' ' ARG . 3.3 mmp_? -122.65 -177.16 3.57 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.517 0.675 . . . . 0.0 112.088 -177.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.599 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.5 mm -125.4 87.2 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 114.228 -1.351 . . . . 0.0 107.789 167.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.585 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.8 mm? -88.14 161.0 17.53 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.705 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 4.0 m-70 -131.77 174.8 4.28 Favored Pre-proline 0 C--N 1.31 -1.115 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.275 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.705 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 10.1 Cg_endo -56.05 -23.22 42.83 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.8 1.667 . . . . 0.0 108.99 167.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.666 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 9.5 mmmt -47.35 -26.59 1.32 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 113.541 -1.663 . . . . 0.0 112.245 173.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 41' ' ' THR . 86.4 m-85 -126.86 -11.35 6.03 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 122.195 -0.316 . . . . 0.0 111.682 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.555 HG13 ' HB3' ' A' ' 39' ' ' PHE . 1.4 mp -89.65 122.59 41.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.062 0.458 . . . . 0.0 110.988 -171.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.53 -8.07 8.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.769 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -154.19 155.59 26.28 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.737 ' HB2' HD13 ' A' ' 63' ' ' LEU . 2.4 t80 -147.67 137.54 22.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.908 0.385 . . . . 0.0 110.278 -177.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 50.3 m -145.22 110.58 5.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.577 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -83.9 139.3 32.7 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.658 ' NE2' ' HA ' ' A' ' 6' ' ' CYS . 1.9 pt20 -119.26 108.41 14.6 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.784 0.802 . . . . 0.0 110.704 177.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.505 ' H ' ' HZ ' ' A' ' 4' ' ' PHE . 86.2 mt -98.24 165.04 12.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.958 -175.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.791 ' HA ' ' O ' ' A' ' 32' ' ' CYS . . . -82.7 11.31 6.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.586 -177.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -108.58 -19.87 13.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.839 0.352 . . . . 0.0 111.73 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.419 ' HG3' ' CE2' ' A' ' 4' ' ' PHE . 2.7 pt-20 -134.39 30.77 3.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.118 0.485 . . . . 0.0 111.769 -170.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.479 ' HA2' ' HB3' ' A' ' 2' ' ' SER . . . 176.72 -86.83 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 119.933 -1.127 . . . . 0.0 113.119 177.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.791 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 42.2 t -105.64 170.11 8.08 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.572 -0.314 . . . . 0.0 110.904 -175.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.402 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 9.5 m-20 -83.59 -21.87 32.47 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.096 0.247 . . . . 0.0 111.618 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.703 HG12 ' SG ' ' A' ' 6' ' ' CYS . 2.0 pt -100.0 157.33 3.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -115.26 130.54 56.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.367 0.603 . . . . 0.0 111.246 -178.748 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.565 ' HB3' ' OE1' ' A' ' 26' ' ' GLN . . . -139.08 166.46 24.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.597 175.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.536 HG23 ' HE1' ' A' ' 23' ' ' PHE . 43.5 mm -113.88 106.19 20.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.161 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 66.0 mt -83.64 105.08 12.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 O-C-N 121.734 -0.603 . . . . 0.0 111.238 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.555 ' HB3' HG13 ' A' ' 20' ' ' ILE . 14.0 m-85 -94.96 111.85 23.61 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 171.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -84.45 112.98 20.86 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 28.2 p -76.33 166.01 24.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.128 0.49 . . . . 0.0 111.123 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -71.14 2.97 3.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.617 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.0 mmtp -98.82 5.64 47.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.568 176.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 67.2 mttm 68.42 12.58 8.77 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.805 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.5 mt -97.82 130.65 44.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.022 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.4 p -86.66 106.64 17.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.298 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.525 ' CG1' HG21 ' A' ' 11' ' ' THR . 66.4 t -86.82 124.93 40.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.9 m -88.61 83.89 6.76 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.718 0.771 . . . . 0.0 109.985 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.572 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -69.82 141.59 53.27 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.397 -175.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.675 ' OD1' ' HB3' ' A' ' 10' ' ' TYR . 2.2 m-20 -80.53 130.21 65.72 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.083 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -73.2 23.47 0.31 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.831 1.688 . . . . 0.0 111.666 171.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 50' ' ' ASN . 32.2 mtmm -115.24 -17.21 11.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.547 -176.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.496 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 1.0 OUTLIER -109.5 145.23 36.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 -170.678 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.69 ' HA ' ' HG2' ' A' ' 57' ' ' LYS . 1.3 p -81.5 -23.1 37.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -170.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.599 ' CD1' HD13 ' A' ' 14' ' ' ILE . 54.9 p-90 -63.19 -32.83 74.33 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 173.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.572 ' CG2' ' HB1' ' A' ' 49' ' ' ALA . 25.3 t -69.16 -46.98 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.792 172.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.69 ' HG2' ' HA ' ' A' ' 54' ' ' THR . 6.9 mmtp -55.89 -38.47 70.22 Favored 'General case' 0 C--O 1.222 -0.383 0 O-C-N 123.426 0.454 . . . . 0.0 110.737 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -65.22 -53.81 38.93 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.707 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.499 HG22 HD12 ' A' ' 63' ' ' LEU . 78.9 mt -62.74 -45.71 98.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.874 -177.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.554 HG12 ' O ' ' A' ' 56' ' ' VAL . 12.5 p -70.02 -24.9 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 120.911 -0.315 . . . . 0.0 110.903 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 49.8 ttp180 -64.45 -35.14 79.95 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.16 0.505 . . . . 0.0 110.256 176.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.6 mt -84.42 -25.22 29.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.968 177.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.737 HD13 ' HB2' ' A' ' 23' ' ' PHE . 77.5 mt -87.68 -31.28 19.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.307 -176.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t -79.84 -34.51 39.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.215 0.531 . . . . 0.0 109.74 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.572 ' HB3' ' NZ ' ' A' ' 65' ' ' LYS . 4.5 ttpm? -127.8 86.81 2.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.299 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -96.96 108.08 20.73 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.9 m -93.11 124.35 45.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.53 0.681 . . . . 0.0 111.759 -174.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.887 ' HE2' ' HA ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -106.7 0.81 24.56 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.842 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -117.29 146.62 43.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.934 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 81.1 mtp . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.152 177.762 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 120.726 0.298 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.524 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 14.2 m -127.81 116.53 20.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.565 -0.288 . . . . 0.0 110.227 178.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -75.1 -44.94 44.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.178 0.513 . . . . 0.0 110.012 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.789 ' HZ ' ' H ' ' A' ' 27' ' ' LEU . 0.9 OUTLIER -130.65 -172.92 2.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.493 176.518 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -131.02 106.04 8.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.328 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.824 ' HA ' ' CD ' ' A' ' 26' ' ' GLN . 26.6 p -35.62 142.55 0.07 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 114.878 -1.055 . . . . 0.0 113.678 170.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.479 ' O ' HD11 ' A' ' 34' ' ' ILE . 43.1 t -73.03 127.75 33.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.088 171.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.7 mt -81.93 45.34 0.9 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.146 0.498 . . . . 0.0 110.742 -174.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 166.26 157.65 10.37 Favored Glycine 0 N--CA 1.44 -1.048 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.672 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 25.2 m-85 -123.87 162.33 23.5 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 117.159 0.479 . . . . 0.0 110.488 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.5 t -90.18 -175.58 4.58 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.404 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -144.78 31.18 1.17 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.553 0.692 . . . . 0.0 109.813 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.595 ' HB2' HD22 ' A' ' 15' ' ' LEU . 35.2 mmt180 -87.68 -176.6 5.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.714 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.494 HD13 ' CD1' ' A' ' 55' ' ' TRP . 16.4 mm -124.93 77.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.654 165.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.741 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.2 mm? -74.76 153.7 38.68 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.057 -178.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.692 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 42.9 m170 -132.66 173.63 5.66 Favored Pre-proline 0 C--N 1.317 -0.847 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.622 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.692 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 13.0 Cg_endo -58.86 -23.84 69.33 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 121.718 1.612 . . . . 0.0 108.825 167.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.674 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 8.7 mmmt -47.22 -34.4 6.38 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 113.434 -1.712 . . . . 0.0 111.931 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.687 ' HA ' ' HE3' ' A' ' 42' ' ' LYS . 27.0 m-85 -125.44 -0.2 7.59 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.655 0.264 . . . . 0.0 111.338 -175.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.507 HD13 ' O ' ' A' ' 16' ' ' HIS . 1.3 mp -96.46 126.75 49.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.0 0.428 . . . . 0.0 110.635 -175.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.12 -6.8 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.999 174.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -157.73 154.27 25.38 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.542 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.606 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -145.02 132.99 21.29 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.477 0.656 . . . . 0.0 110.386 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.7 m -132.93 121.06 22.27 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.469 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -86.68 114.03 23.04 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.508 0.671 . . . . 0.0 110.412 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.824 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 21.6 tt0 -104.27 121.91 44.31 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.876 177.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.789 ' H ' ' HZ ' ' A' ' 4' ' ' PHE . 6.5 mp -109.31 178.65 4.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.946 -170.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -111.52 26.58 10.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.922 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -130.7 -12.82 3.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.489 -175.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -115.05 23.51 12.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.462 -174.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 2' ' ' SER . . . 164.42 -91.79 0.11 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.358 177.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 6' ' ' CYS . 18.5 m -66.16 169.56 6.89 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.997 0.427 . . . . 0.0 111.976 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -99.22 -6.02 28.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.089 176.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.479 HD11 ' O ' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -108.61 153.41 10.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 174.561 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.497 ' OD1' ' HG2' ' A' ' 51' ' ' PRO . 4.8 p30 -127.09 129.64 48.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.801 -0.181 . . . . 0.0 111.28 -173.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.762 ' O ' ' HB3' ' A' ' 26' ' ' GLN . . . -134.68 127.37 30.93 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.244 0.545 . . . . 0.0 111.962 176.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.408 HG23 ' HE1' ' A' ' 23' ' ' PHE . 48.3 mm -70.05 117.61 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 170.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 55.8 mt -94.42 104.41 15.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 120.834 0.349 . . . . 0.0 111.117 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.703 ' CE2' HG12 ' A' ' 56' ' ' VAL . 12.1 m-85 -93.98 127.73 39.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 173.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -98.03 108.81 21.6 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.1 p -74.0 160.15 31.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.068 -174.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.687 ' HE3' ' HA ' ' A' ' 19' ' ' PHE . 18.0 ptpt -66.07 -3.03 4.71 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.317 172.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -89.66 0.54 56.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.633 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.546 ' NZ ' ' HB2' ' A' ' 44' ' ' LYS . 8.3 mtmp? 71.89 15.6 5.69 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.981 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.0 mt -107.88 136.66 47.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.904 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.1 p -87.16 118.57 26.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.301 0.572 . . . . 0.0 110.007 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 76.5 t -97.24 134.05 36.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.083 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.3 m -89.12 87.44 7.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.424 ' HB1' ' CG1' ' A' ' 56' ' ' VAL . . . -79.49 143.07 35.25 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.409 -174.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.749 ' HB2' ' CG ' ' A' ' 53' ' ' GLN . 1.6 m-20 -82.53 122.19 78.6 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.524 -174.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HG2' ' OD1' ' A' ' 35' ' ' ASN . 19.8 Cg_exo -70.18 9.8 0.62 Allowed 'Trans proline' 0 C--N 1.329 -0.479 0 C-N-CA 122.279 1.986 . . . . 0.0 112.368 175.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 50' ' ' ASN . 51.3 mttm -104.33 -14.27 15.83 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.406 -176.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.749 ' CG ' ' HB2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -89.53 168.13 12.42 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -176.454 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.23 -33.51 14.65 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.741 ' CZ3' ' HB2' ' A' ' 15' ' ' LEU . 59.3 p-90 -62.19 -28.58 69.77 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.823 -177.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.718 HG21 ' O ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -71.04 -49.91 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 174.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 93.9 mttt -55.03 -33.85 63.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.687 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -64.37 -52.67 57.12 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.211 0.529 . . . . 0.0 110.486 174.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.536 HG12 ' HD3' ' A' ' 17' ' ' PRO . 87.7 mt -65.85 -48.96 80.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.74 -176.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.606 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 7.8 p -65.53 -28.37 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.836 0.35 . . . . 0.0 110.754 -176.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -69.03 -35.43 76.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.212 0.53 . . . . 0.0 109.672 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.4 tp -79.02 -32.63 45.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.995 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 1.9 mm? -67.63 -42.5 82.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.275 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.7 p -77.09 -49.98 14.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.894 0.378 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -94.59 69.94 3.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.159 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -68.77 97.89 0.86 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.328 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.1 p -100.54 -16.82 7.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.504 0.669 . . . . 0.0 110.118 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 68' ' ' LYS . 21.7 tptm -77.65 108.6 10.97 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.889 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -119.77 129.48 54.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.356 176.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 60.0 ttp . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.77 178.769 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p -83.1 93.76 7.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.086 0.469 . . . . 0.0 111.783 -175.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -66.25 -41.83 89.41 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 167.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.609 ' CZ ' ' HA ' ' A' ' 26' ' ' GLN . 44.5 p90 -131.1 -168.01 1.93 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.77 -1.559 . . . . 0.0 107.511 168.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.696 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 4.3 p-10 -128.79 -93.1 0.45 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.764 0.793 . . . . 0.0 111.573 173.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.767 ' HB2' HG12 ' A' ' 34' ' ' ILE . 18.7 p -146.88 -168.78 3.13 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 125.146 1.378 . . . . 0.0 108.7 -177.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.1 t -106.54 158.37 16.97 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.927 -0.483 . . . . 0.0 110.425 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.7 mt -77.73 -27.94 50.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.933 0.397 . . . . 0.0 110.828 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.83 136.3 4.08 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.624 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 20.1 m-85 -78.47 173.63 12.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.486 0.66 . . . . 0.0 111.047 -177.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.8 t -89.02 -178.55 5.72 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.94 174.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -140.63 1.86 1.76 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.011 0.434 . . . . 0.0 110.169 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.603 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 32.7 mtt180 -94.23 -172.42 2.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.641 -166.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.614 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.3 mm -117.64 88.79 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.599 -1.182 . . . . 0.0 107.982 167.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.603 ' CD2' ' HB2' ' A' ' 13' ' ' ARG . 2.9 mm? -88.34 164.77 15.39 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.732 ' ND1' ' HD2' ' A' ' 18' ' ' LYS . 63.2 m170 -132.97 163.63 49.66 Favored Pre-proline 0 C--N 1.311 -1.105 0 C-N-CA 119.831 -0.748 . . . . 0.0 112.151 -174.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.612 ' HD3' HG12 ' A' ' 59' ' ' ILE . 26.7 Cg_endo -64.28 -17.18 58.75 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.213 1.942 . . . . 0.0 109.174 167.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.732 ' HD2' ' ND1' ' A' ' 16' ' ' HIS . 60.8 mttm -51.66 -29.23 17.14 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.361 172.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -128.01 11.37 6.55 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.62 -174.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.641 HG12 ' O ' ' A' ' 16' ' ' HIS . 7.5 mm -106.69 127.64 62.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -173.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.3 m -118.56 -3.49 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.146 0.498 . . . . 0.0 110.934 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -155.29 158.91 28.76 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.004 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.739 ' HB2' HD13 ' A' ' 63' ' ' LEU . 1.4 t80 -155.47 134.68 12.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.239 0.542 . . . . 0.0 110.183 -177.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.449 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 25.5 m -142.06 107.08 4.93 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.867 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 14.1 ptp180 -77.02 109.03 10.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.827 0.822 . . . . 0.0 110.112 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.609 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 2.4 tt0 -99.05 133.11 43.79 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.218 -175.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.488 ' H ' ' HE1' ' A' ' 4' ' ' PHE . 96.0 mt -122.18 158.9 28.36 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -159.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.72 31.24 4.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.737 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -99.41 -73.42 0.63 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.745 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -110.9 23.12 14.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.574 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -129.53 -71.93 0.13 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.345 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.696 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 47.3 t -128.63 -172.08 2.62 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.441 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 0.9 OUTLIER -96.85 -23.55 16.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.957 0.408 . . . . 0.0 109.923 178.697 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.767 HG12 ' HB2' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -109.03 159.75 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 175.352 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -132.56 132.13 42.24 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.915 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.589 ' HB3' ' OE1' ' A' ' 26' ' ' GLN . . . -129.1 145.13 51.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.415 0.626 . . . . 0.0 111.63 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.691 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 47.9 mm -88.79 104.77 15.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.861 177.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.449 ' HB ' ' HB ' ' A' ' 24' ' ' THR . 58.1 mt -79.65 103.05 6.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 O-C-N 122.108 -0.37 . . . . 0.0 111.386 -176.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -91.65 123.82 35.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 171.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -97.66 108.93 21.76 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.2 p -75.84 157.49 33.29 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.116 0.484 . . . . 0.0 111.37 -175.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -68.17 -10.33 53.44 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 43' ' ' LYS . 23.0 ttmm -89.92 14.18 12.77 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.702 -177.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp 71.0 13.55 6.94 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.046 173.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.5 mt -112.66 142.15 45.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.968 0.413 . . . . 0.0 111.042 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.0 p -99.13 112.64 24.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.222 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.2 t -92.48 120.31 41.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.354 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.9 m -83.44 89.21 7.02 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.808 0.813 . . . . 0.0 109.269 177.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.691 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -71.18 140.33 50.47 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.387 -174.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.624 ' OD1' ' HB3' ' A' ' 10' ' ' TYR . 2.1 m-20 -79.97 126.06 80.6 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.175 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.1 13.98 0.48 Allowed 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.321 2.014 . . . . 0.0 111.613 174.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 50' ' ' ASN . 74.8 mttt -100.5 -21.51 15.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.136 -175.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.528 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 1.1 pt20 -109.57 148.46 31.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.646 -167.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p -75.03 -33.65 61.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -170.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.614 ' CD1' HD13 ' A' ' 14' ' ' ILE . 49.7 p-90 -61.34 -32.58 72.47 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.352 0.596 . . . . 0.0 109.491 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.626 HG22 ' HB1' ' A' ' 49' ' ' ALA . 14.7 t -70.51 -51.29 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.171 174.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 95.2 mttt -58.05 -32.12 67.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.968 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -68.04 -56.37 9.15 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.395 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.612 HG12 ' HD3' ' A' ' 17' ' ' PRO . 72.5 mt -61.02 -43.34 95.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.222 -176.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.641 HG23 ' CE1' ' A' ' 23' ' ' PHE . 13.8 p -65.45 -35.03 74.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.374 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -68.63 -33.08 73.41 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.989 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 29.8 mt -77.66 -33.44 53.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.094 0.473 . . . . 0.0 110.701 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.739 HD13 ' HB2' ' A' ' 23' ' ' PHE . 78.7 mt -79.24 -12.49 59.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.989 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 m -121.18 67.37 0.87 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.526 173.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -60.12 86.67 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.532 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -101.46 14.28 32.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.263 0.554 . . . . 0.0 110.172 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.9 m -85.07 14.24 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.999 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -103.59 -19.91 14.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.488 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -110.08 176.15 5.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.662 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 45.9 tpp . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.537 -0.744 . . . . 0.0 109.573 176.482 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -86.99 131.43 34.09 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 173.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -57.21 -57.72 11.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.027 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.55 ' HE2' ' HG2' ' A' ' 26' ' ' GLN . 38.0 p90 -133.75 -169.51 2.31 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.144 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 30.0 t0 -141.6 112.18 7.09 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 163.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.642 ' HB3' ' HG2' ' A' ' 26' ' ' GLN . 18.5 p -58.36 174.65 0.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.788 -169.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.2 m -41.26 98.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 -169.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.1 mt -63.65 -37.28 86.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.548 173.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.38 85.58 0.42 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.775 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.468 ' HA ' ' HB2' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -88.11 155.03 20.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.994 0.426 . . . . 0.0 111.254 177.504 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.454 HG21 HG13 ' A' ' 47' ' ' VAL . 14.9 t -91.11 141.94 28.28 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -166.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -104.58 74.57 1.16 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.68 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.407 ' HD2' HD21 ' A' ' 15' ' ' LEU . 99.5 mtt180 -123.44 -171.8 2.38 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.055 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.537 HD13 ' CD1' ' A' ' 55' ' ' TRP . 8.2 mm -126.54 91.78 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.147 165.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.623 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 1.7 mm? -98.15 162.77 13.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.77 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 4.2 m-70 -132.63 175.46 3.69 Favored Pre-proline 0 C--N 1.317 -0.841 0 O-C-N 122.054 -0.404 . . . . 0.0 110.757 -178.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.77 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 18.9 Cg_endo -60.25 -16.95 43.68 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.106 1.871 . . . . 0.0 109.453 166.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.608 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 9.1 mtmt -45.91 -35.54 4.69 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 114.111 -1.404 . . . . 0.0 111.779 172.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -126.68 2.22 6.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.024 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.626 ' HB ' ' HA ' ' A' ' 17' ' ' PRO . 1.2 mp -92.44 124.32 44.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.81 0.338 . . . . 0.0 110.116 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.3 m -121.34 -1.18 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.977 0.418 . . . . 0.0 110.333 176.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.92 157.94 29.48 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.676 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.751 ' HB2' HD13 ' A' ' 63' ' ' LEU . 2.8 t80 -151.01 134.29 16.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.193 0.521 . . . . 0.0 110.564 -177.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.42 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 32.2 m -146.15 102.32 3.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.265 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -74.58 126.7 31.37 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.711 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.642 ' HG2' ' HB3' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -101.35 126.87 48.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.689 -177.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.3 mp -125.17 153.42 43.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.335 0.588 . . . . 0.0 111.712 -171.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.41 ' HA ' ' C ' ' A' ' 32' ' ' CYS . . . -64.57 -23.58 67.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.328 174.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -67.38 -24.87 65.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.366 -176.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -102.72 -32.62 9.76 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.866 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.38 41.24 0.02 OUTLIER Glycine 0 C--O 1.221 -0.682 0 C-N-CA 119.998 -1.096 . . . . 0.0 112.306 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 53.8 t -133.8 -179.71 5.71 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 173.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -118.23 -32.18 4.77 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.974 169.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.5 pt -95.75 -156.58 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 169.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -150.93 137.36 18.63 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.115 0.483 . . . . 0.0 110.132 174.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.49 145.11 33.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.071 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.809 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 46.4 mm -93.57 108.25 20.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.42 ' HB ' ' O ' ' A' ' 24' ' ' THR . 33.6 mm -85.91 99.03 7.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 O-C-N 121.982 -0.449 . . . . 0.0 110.636 -177.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.434 ' HB3' HG13 ' A' ' 20' ' ' ILE . 17.1 m-85 -90.59 122.9 33.8 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 174.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -93.6 107.35 19.22 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.5 p -79.36 164.58 23.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.119 0.485 . . . . 0.0 111.698 -174.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -72.86 -1.63 17.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 122.151 0.976 . . . . 0.0 108.59 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.42 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 12.6 tptt -86.14 9.0 18.71 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.505 173.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.8 pttm 46.89 34.04 2.48 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.455 1.102 . . . . 0.0 111.686 -173.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 43' ' ' LYS . 94.0 mt -119.47 131.13 55.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.072 175.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.9 p -84.9 105.69 15.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.382 0.611 . . . . 0.0 110.651 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.454 HG13 HG21 ' A' ' 11' ' ' THR . 54.3 t -79.62 126.28 39.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.601 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 58.8 m -84.67 88.86 7.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.809 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -76.72 134.67 39.14 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.629 -176.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.527 ' HB2' ' HG2' ' A' ' 53' ' ' GLN . 2.5 m-20 -77.35 134.99 66.01 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.106 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -74.25 7.29 2.62 Favored 'Trans proline' 0 C--N 1.33 -0.398 0 C-N-CA 122.502 2.135 . . . . 0.0 110.614 168.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -90.3 -17.48 27.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.265 -177.44 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.527 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 1.0 OUTLIER -118.83 150.72 39.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.859 -168.622 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.766 ' HA ' ' HG2' ' A' ' 57' ' ' LYS . 1.7 p -91.45 -17.75 25.27 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -170.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.623 ' CZ3' ' HB2' ' A' ' 15' ' ' LEU . 58.1 p-90 -63.62 -32.8 74.38 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 172.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.544 ' O ' HG12 ' A' ' 60' ' ' VAL . 38.9 t -66.52 -47.28 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.839 171.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.766 ' HG2' ' HA ' ' A' ' 54' ' ' THR . 13.4 mmtp -54.45 -39.0 66.98 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.168 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.52 ' HD1' HH21 ' A' ' 61' ' ' ARG . 5.8 t80 -67.41 -53.69 26.94 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.087 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.568 HG22 HD12 ' A' ' 63' ' ' LEU . 71.0 mt -61.34 -45.16 99.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.954 -176.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 56' ' ' VAL . 12.0 p -70.15 -23.47 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 120.784 0.326 . . . . 0.0 110.688 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.52 HH21 ' HD1' ' A' ' 58' ' ' TYR . 43.5 ttp180 -66.46 -29.64 69.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.136 0.493 . . . . 0.0 110.113 175.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.3 mp -87.58 -36.74 17.37 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.599 174.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.751 HD13 ' HB2' ' A' ' 23' ' ' PHE . 91.0 mt -81.8 2.12 31.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.646 -176.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.3 p -95.41 -38.55 10.43 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.701 0.286 . . . . 0.0 111.054 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -105.2 54.41 0.71 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.774 0.797 . . . . 0.0 110.691 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -58.22 108.58 0.63 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.922 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.0 m -102.65 140.62 20.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.426 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -106.62 4.34 27.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.734 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.483 ' OD1' ' HG2' ' A' ' 70' ' ' MET . 27.5 t-20 -96.07 -65.23 0.98 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.279 -175.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.483 ' HG2' ' OD1' ' A' ' 69' ' ' ASN . 26.0 mmt . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.744 -0.646 . . . . 0.0 109.552 177.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 121.025 0.44 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.405 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 24.9 m -148.6 132.33 16.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.314 176.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -82.79 -45.03 14.85 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.628 ' HZ ' ' H ' ' A' ' 27' ' ' LEU . 15.8 p90 -130.69 -169.63 2.19 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.221 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -137.59 107.16 6.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.239 175.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.646 ' HA ' ' CD ' ' A' ' 26' ' ' GLN . 22.0 p -37.48 146.43 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 171.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 37.7 m -74.96 148.26 40.14 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.211 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.6 mt -70.69 -9.26 56.75 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.153 0.501 . . . . 0.0 110.681 176.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.62 160.27 28.53 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.621 ' HB2' ' OD1' ' A' ' 50' ' ' ASN . 0.3 OUTLIER -113.65 158.62 20.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.716 0.258 . . . . 0.0 110.846 177.637 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 t -88.94 145.56 25.45 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -168.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -95.12 66.2 2.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.662 0.744 . . . . 0.0 109.46 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.492 ' C ' HD12 ' A' ' 14' ' ' ILE . 36.2 mtp180 -130.85 -178.08 4.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.523 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.559 HG22 ' CD2' ' A' ' 16' ' ' HIS . 2.4 mp -121.89 91.39 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 163.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.511 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 3.5 mm? -72.14 155.87 39.79 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.031 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.763 ' HB2' ' HG2' ' A' ' 18' ' ' LYS . 65.5 m170 -131.64 159.22 72.83 Favored Pre-proline 0 C--N 1.315 -0.898 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.905 -168.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.51 -30.47 74.12 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.553 2.169 . . . . 0.0 109.882 167.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.763 ' HG2' ' HB2' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -62.95 -18.32 63.02 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.226 178.353 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -118.84 -13.3 9.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.582 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.501 HG12 ' HB3' ' A' ' 39' ' ' PHE . 23.4 mt -97.83 127.43 50.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.025 0.44 . . . . 0.0 111.249 -172.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.9 p -111.61 -16.81 8.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.419 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.48 150.89 21.85 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.584 -0.607 . . . . 0.0 111.584 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.546 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -134.15 134.79 42.58 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.253 0.549 . . . . 0.0 110.637 -178.461 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.425 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 20.6 m -139.86 112.61 7.99 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.099 175.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 25' ' ' ARG . 9.0 ptp180 -75.78 130.27 38.36 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.014 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.646 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -101.03 127.02 47.74 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.898 179.161 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.628 ' H ' ' HZ ' ' A' ' 4' ' ' PHE . 4.2 mp -117.86 169.13 9.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.854 0.359 . . . . 0.0 111.125 -170.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.7 29.72 1.12 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.615 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -127.25 -53.9 1.38 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.251 -174.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -83.82 36.38 0.55 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.189 0.518 . . . . 0.0 111.707 -172.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 2' ' ' SER . . . 151.88 -96.28 0.16 Allowed Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.312 177.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 42.2 t -70.77 160.83 31.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.496 -0.352 . . . . 0.0 110.772 -178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -92.36 0.39 57.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.597 -177.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.457 HG12 ' SG ' ' A' ' 6' ' ' CYS . 3.4 pt -116.2 167.91 8.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -132.79 136.94 46.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.973 0.416 . . . . 0.0 111.556 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.502 ' HA ' ' HG3' ' A' ' 51' ' ' PRO . . . -138.56 164.78 28.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.634 172.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.671 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 49.9 mm -96.9 112.06 28.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.483 HD11 HE21 ' A' ' 26' ' ' GLN . 60.2 mt -88.78 102.39 12.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 O-C-N 121.707 -0.62 . . . . 0.0 111.152 -178.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.566 ' HE2' HG22 ' A' ' 56' ' ' VAL . 6.9 m-85 -95.58 119.81 34.73 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -94.27 111.56 23.3 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.2 p -78.77 153.18 30.98 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.299 0.571 . . . . 0.0 111.41 -175.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -58.17 -17.83 21.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.742 173.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -83.94 10.45 9.78 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.214 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 74.62 7.34 4.46 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.416 0.686 . . . . 0.0 111.911 173.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.7 mt -102.9 135.74 44.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.866 0.365 . . . . 0.0 110.524 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.8 p -92.61 110.54 21.97 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.404 HG11 ' HG ' ' A' ' 15' ' ' LEU . 49.0 t -94.67 132.15 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.971 -176.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.8 m -85.85 91.26 8.29 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.759 0.79 . . . . 0.0 108.982 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.671 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -74.47 143.31 44.71 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.473 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.621 ' OD1' ' HB2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -81.38 142.3 50.27 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -174.674 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.502 ' HG3' ' HA ' ' A' ' 36' ' ' ALA . 5.1 Cg_exo -82.5 1.5 9.11 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.125 1.883 . . . . 0.0 112.714 176.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -98.03 -48.81 4.99 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -175.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.806 ' OE1' ' HB ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -65.14 166.99 8.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.122 0.487 . . . . 0.0 112.17 -174.647 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.97 -25.59 16.45 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -175.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.687 ' O ' HG13 ' A' ' 59' ' ' ILE . 58.7 p-90 -58.25 -34.75 70.82 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.73 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.806 ' HB ' ' OE1' ' A' ' 53' ' ' GLN . 1.1 t -69.59 -46.21 76.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.959 175.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -58.77 -31.7 68.61 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.482 0.489 . . . . 0.0 110.67 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -64.75 -51.79 60.45 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.918 172.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.687 HG13 ' O ' ' A' ' 55' ' ' TRP . 23.8 mt -61.64 -56.86 15.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.268 -176.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 56' ' ' VAL . 4.4 p -62.1 -25.45 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.337 -175.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -63.43 -47.29 82.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.764 0.316 . . . . 0.0 110.187 172.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.3 mt -78.0 -1.44 32.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.044 0.45 . . . . 0.0 110.872 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 3.4 mm? -96.84 -58.28 2.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.64 176.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.5 m -65.02 -40.0 94.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.426 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -92.58 3.91 54.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.845 0.355 . . . . 0.0 111.722 -175.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 66' ' ' LYS . 35.1 ttmt -101.18 -56.73 2.24 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.841 0.353 . . . . 0.0 110.724 -177.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 63' ' ' LEU . 14.5 m -82.66 90.31 2.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.965 0.888 . . . . 0.0 110.361 -178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -119.02 108.62 14.96 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.893 -175.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -115.21 172.19 7.23 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.532 174.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.8 tmm? . . . . . 0 C--O 1.246 0.894 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.465 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.819 0.342 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.708 ' HA ' ' HA3' ' A' ' 31' ' ' GLY . 5.9 m -92.68 108.1 19.72 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.918 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -59.35 -52.23 66.54 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 171.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.57 ' CE2' ' HG2' ' A' ' 26' ' ' GLN . 48.3 p90 -131.62 165.0 24.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.019 173.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -122.49 114.75 21.12 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.383 0.611 . . . . 0.0 109.621 168.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.75 ' HA ' ' NE2' ' A' ' 26' ' ' GLN . 0.9 OUTLIER -50.4 149.12 3.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.107 -0.951 . . . . 0.0 113.504 177.458 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 t -43.62 118.54 1.41 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.941 170.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.0 mt -68.25 -26.67 65.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.249 -174.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.87 140.12 12.19 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.586 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 42.6 m-85 -91.79 179.85 5.51 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.071 0.462 . . . . 0.0 110.708 -176.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.588 ' OG1' ' HG2' ' A' ' 13' ' ' ARG . 14.4 t -97.78 -172.02 2.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.931 177.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -147.6 17.38 1.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.005 0.431 . . . . 0.0 110.609 177.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.617 ' HB2' HD22 ' A' ' 15' ' ' LEU . 18.0 mmm180 -88.1 -173.61 4.32 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.379 0.609 . . . . 0.0 112.462 -171.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.552 HD13 ' CD1' ' A' ' 55' ' ' TRP . 5.2 mm -125.31 90.35 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 114.176 -1.374 . . . . 0.0 108.423 167.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.617 HD22 ' HB2' ' A' ' 13' ' ' ARG . 2.8 mm? -93.31 165.07 12.97 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.687 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 63.2 m170 -133.29 168.28 18.71 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.569 -175.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.464 ' HD3' HG12 ' A' ' 59' ' ' ILE . 14.0 Cg_endo -59.02 -24.3 72.78 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.055 1.836 . . . . 0.0 108.94 166.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.687 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 60.7 mttm -49.26 -33.3 12.56 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 114.011 -1.449 . . . . 0.0 111.04 171.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 41' ' ' THR . 76.5 m-85 -120.51 -0.98 10.19 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.744 -171.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.649 HG12 ' HB3' ' A' ' 39' ' ' PHE . 19.5 mt -104.68 118.86 52.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.061 0.457 . . . . 0.0 111.211 -173.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.86 -5.96 11.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.779 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -152.05 151.58 23.44 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.497 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 1.1 t80 -148.99 129.8 14.2 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.137 0.494 . . . . 0.0 110.495 -177.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.5 m -131.4 126.28 34.74 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.033 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.456 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 10.3 ptp180 -98.41 103.63 15.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.307 0.575 . . . . 0.0 111.09 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.75 ' NE2' ' HA ' ' A' ' 6' ' ' CYS . 78.9 mt-30 -77.77 126.65 31.18 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.254 176.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 34.2 mt -119.94 145.07 47.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.925 -171.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.709 ' HA ' ' O ' ' A' ' 32' ' ' CYS . . . -76.47 63.97 2.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.971 172.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -135.42 -66.13 0.58 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.504 -174.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -105.9 51.48 0.75 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.249 0.547 . . . . 0.0 111.889 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.708 ' HA3' ' HA ' ' A' ' 2' ' ' SER . . . 130.79 -58.31 0.71 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.9 173.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.709 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 1.1 t -60.7 136.46 58.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.716 0.293 . . . . 0.0 110.733 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -87.67 -30.16 20.61 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.238 -175.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.625 HG12 ' SG ' ' A' ' 6' ' ' CYS . 37.3 pt -105.55 -152.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -153.41 121.67 6.2 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 171.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . -132.9 129.11 37.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.581 -177.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.444 HG23 ' HE1' ' A' ' 23' ' ' PHE . 47.1 mm -81.71 113.14 20.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.771 177.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 42.8 mt -91.47 103.66 14.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.558 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.649 ' HB3' HG12 ' A' ' 20' ' ' ILE . 16.5 m-85 -87.81 113.69 23.71 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 172.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -87.95 105.71 17.63 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 58.2 p -75.51 158.49 32.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.462 0.648 . . . . 0.0 111.826 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.551 ' HD3' ' O ' ' A' ' 42' ' ' LYS . 1.9 tmtp? -60.21 -20.99 61.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.423 172.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 82.5 tttt -84.03 11.91 7.15 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.486 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 75.4 mmtt 77.87 -20.92 0.35 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.831 0.852 . . . . 0.0 112.285 174.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.6 mt -73.46 126.57 30.5 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.971 0.415 . . . . 0.0 111.192 -177.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 p -87.18 105.34 17.13 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.843 175.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 62.1 t -82.65 130.54 35.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.804 -174.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.4 m -85.62 76.46 9.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.538 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -69.43 138.12 53.27 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.032 -173.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.586 ' OD1' ' HB3' ' A' ' 10' ' ' TYR . 1.6 m-20 -80.44 127.46 75.86 Favored Pre-proline 0 CA--C 1.507 -0.678 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -177.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.24 14.52 0.22 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.221 1.947 . . . . 0.0 111.811 172.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 50' ' ' ASN . 0.4 OUTLIER -106.44 -19.07 13.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.875 -174.239 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.517 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 0.9 OUTLIER -105.05 140.65 37.92 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.032 -168.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 p -64.83 -36.24 83.7 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -172.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.578 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 43.9 p-90 -60.83 -32.62 72.0 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.726 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.591 ' O ' HG12 ' A' ' 60' ' ' VAL . 4.8 t -73.58 -50.42 30.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.324 174.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 94.8 mttt -54.92 -36.95 65.78 Favored 'General case' 0 CA--C 1.522 -0.126 0 O-C-N 123.602 0.564 . . . . 0.0 110.421 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.404 ' O ' HD23 ' A' ' 62' ' ' LEU . 22.8 t80 -65.95 -58.64 5.08 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.642 176.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 55' ' ' TRP . 78.6 mt -59.1 -48.0 88.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -175.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.591 HG12 ' O ' ' A' ' 56' ' ' VAL . 11.9 p -65.45 -31.62 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.992 -177.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.0 ttp85 -63.83 -41.57 97.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.847 0.356 . . . . 0.0 110.517 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.404 HD23 ' O ' ' A' ' 58' ' ' TYR . 4.4 mm? -79.37 -29.86 42.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.138 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.459 HD13 ' CB ' ' A' ' 23' ' ' PHE . 28.5 mt -72.4 -46.46 55.13 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.558 177.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.7 t -81.13 -43.31 19.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.373 -174.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -98.9 93.01 5.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.458 0.646 . . . . 0.0 110.064 -179.539 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -83.93 82.8 8.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.961 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.5 t -87.25 1.96 5.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 122.181 0.991 . . . . 0.0 108.871 174.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.439 ' HD3' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -95.33 21.99 7.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.301 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -68.88 -22.95 64.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.301 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 49.9 ttm . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.922 177.481 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 120.866 0.365 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 m -85.19 97.18 9.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.232 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -61.26 -47.09 87.62 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.543 0.687 . . . . 0.0 109.247 175.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.66 -167.76 1.92 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.675 169.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.675 ' C ' ' HB2' ' A' ' 32' ' ' CYS . 3.1 p-10 -114.29 -99.42 0.43 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.89 0.852 . . . . 0.0 110.394 170.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.686 ' SG ' HG12 ' A' ' 34' ' ' ILE . 3.7 p -142.26 -142.71 0.14 Allowed 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 125.353 1.461 . . . . 0.0 107.843 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.432 ' O ' HD11 ' A' ' 34' ' ' ILE . 19.3 t -125.99 135.33 51.69 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 166.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 pp -65.87 -13.6 59.91 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.48 0.487 . . . . 0.0 111.873 -176.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.72 166.9 28.75 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.701 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 81.0 m-85 -119.39 -168.56 1.6 Allowed 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 176.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.9 t -129.03 148.29 50.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.493 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -107.15 62.69 0.62 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.542 ' HB3' HD22 ' A' ' 15' ' ' LEU . 15.9 mtm180 -131.25 173.18 11.31 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.1 mm -122.4 91.13 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.428 165.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.542 HD22 ' HB3' ' A' ' 13' ' ' ARG . 2.9 mm? -88.9 167.19 13.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 63.6 m170 -132.56 166.78 26.44 Favored Pre-proline 0 C--N 1.313 -0.994 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.894 -174.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 19.5 Cg_endo -60.39 -21.96 69.52 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.852 1.701 . . . . 0.0 109.213 166.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 83.7 mttt -52.94 -27.34 18.4 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 113.938 -1.483 . . . . 0.0 111.01 172.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -125.5 2.0 7.64 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.987 -174.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.677 HG12 ' HB3' ' A' ' 39' ' ' PHE . 13.3 mt -106.93 123.66 62.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.997 0.427 . . . . 0.0 111.275 -174.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.3 m -117.09 -16.19 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.02 177.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.66 160.17 26.51 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.539 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 2.0 t80 -155.7 134.03 11.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.533 0.682 . . . . 0.0 110.606 -175.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.9 m -138.02 135.65 36.11 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.801 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -116.2 117.81 31.08 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.09 0.471 . . . . 0.0 111.847 -175.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.608 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -94.32 135.96 35.14 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 174.38 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.9 156.07 18.35 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.1 0.476 . . . . 0.0 111.516 -170.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.17 11.93 26.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.278 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -126.83 -58.33 1.31 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.781 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -103.12 89.31 3.38 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.918 177.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.57 -63.11 0.52 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.973 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.675 ' HB2' ' C ' ' A' ' 5' ' ' ASP . 49.1 t -130.76 171.28 13.3 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -86.25 -20.19 28.83 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.686 HG12 ' SG ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -111.35 169.75 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 171.052 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -127.03 144.89 50.91 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 121.961 -0.462 . . . . 0.0 111.39 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.45 146.72 35.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.431 174.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.571 HG12 ' HG3' ' A' ' 51' ' ' PRO . 49.5 mm -106.96 102.4 13.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.882 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.522 HG13 HE22 ' A' ' 26' ' ' GLN . 70.0 mt -78.96 104.99 7.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.978 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.677 ' HB3' HG12 ' A' ' 20' ' ' ILE . 19.5 m-85 -88.91 120.15 30.07 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 170.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -90.25 104.85 17.38 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.4 p -74.38 161.79 29.5 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.779 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -68.18 -3.47 10.68 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.353 172.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 21.6 ttmm -95.47 8.39 43.41 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.245 176.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 31.3 mmmt 76.53 -24.17 0.23 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.244 1.018 . . . . 0.0 112.446 176.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.94 130.55 41.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.066 0.46 . . . . 0.0 111.38 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 p -86.51 108.84 18.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.185 176.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 60.9 t -91.97 128.96 43.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.434 -175.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 79.4 m -85.18 82.21 8.49 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.676 0.75 . . . . 0.0 109.143 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.503 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -72.45 136.79 46.08 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.091 -177.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.701 ' OD1' ' HB3' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -77.59 126.88 83.88 Favored Pre-proline 0 CA--C 1.51 -0.565 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.677 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.571 ' HG3' HG12 ' A' ' 37' ' ' ILE . 27.0 Cg_exo -63.99 -5.95 10.23 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 122.425 2.083 . . . . 0.0 111.903 177.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.487 ' O ' ' HE3' ' A' ' 57' ' ' LYS . 83.2 mttt -82.61 -29.8 29.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.634 -176.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.712 ' NE2' ' HE1' ' A' ' 55' ' ' TRP . 11.4 mt-30 -72.71 134.16 44.9 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.289 -175.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.5 -33.18 75.32 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.712 ' HE1' ' NE2' ' A' ' 53' ' ' GLN . 49.0 p-90 -63.42 -33.11 74.83 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 175.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.546 HG22 ' HE2' ' A' ' 39' ' ' PHE . 8.7 t -72.67 -47.14 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.308 174.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 82.0 mttt -60.65 -28.07 68.29 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -70.1 -52.66 22.02 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.166 173.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.642 HG21 HD13 ' A' ' 20' ' ' ILE . 70.4 mt -68.03 -40.19 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.627 -176.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 56' ' ' VAL . 15.0 p -70.44 -30.3 42.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 O-C-N 122.122 -0.361 . . . . 0.0 110.555 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -66.0 -30.66 71.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.789 0.804 . . . . 0.0 108.999 173.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 28.1 tp -84.12 -20.66 32.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.435 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 23' ' ' PHE . 65.4 mt -108.89 4.27 23.24 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -175.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.3 t -63.69 -54.3 37.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.457 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -132.19 12.88 4.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 2.7 mmmp? -105.84 2.82 28.06 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.551 -176.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 69.8 t -87.27 115.9 28.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.182 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -86.11 88.0 7.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.022 0.439 . . . . 0.0 110.11 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -105.26 109.89 22.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.132 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 56.6 ttp . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.214 177.403 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.92 0 CA-C-O 120.808 0.337 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 m -125.86 135.76 52.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -65.44 -57.1 9.12 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 172.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -133.9 165.89 23.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.456 173.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -112.89 114.42 26.92 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 162.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.733 ' SG ' HG12 ' A' ' 34' ' ' ILE . 31.8 p -56.19 164.44 1.29 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.49 -172.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.442 ' O ' HD11 ' A' ' 34' ' ' ILE . 61.0 m -54.97 128.82 35.29 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.931 -176.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.432 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 2.0 pp -81.57 -14.53 56.71 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.275 0.56 . . . . 0.0 110.121 174.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.61 140.65 11.99 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.667 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.693 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 5.7 m-85 -107.07 -163.12 0.88 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.59 0.233 . . . . 0.0 110.415 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.482 HG21 ' CG1' ' A' ' 47' ' ' VAL . 4.7 t -137.46 149.99 47.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.974 0.416 . . . . 0.0 111.354 177.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -116.6 73.51 0.86 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.228 0.537 . . . . 0.0 109.783 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.527 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 57.5 mtt180 -129.23 -171.39 2.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.294 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.586 HD13 ' CD1' ' A' ' 55' ' ' TRP . 13.7 mm -125.59 78.58 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.344 168.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.552 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.6 mm? -81.7 161.86 23.21 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.771 ' ND1' ' HD3' ' A' ' 18' ' ' LYS . 65.5 m170 -133.82 162.17 59.31 Favored Pre-proline 0 C--N 1.31 -1.125 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.938 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.825 ' HD3' HG12 ' A' ' 59' ' ' ILE . 27.7 Cg_endo -64.55 -16.87 57.48 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.341 2.027 . . . . 0.0 108.746 166.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.771 ' HD3' ' ND1' ' A' ' 16' ' ' HIS . 28.8 mtpp -53.43 -21.58 6.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 113.38 -1.736 . . . . 0.0 110.966 170.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -130.31 3.74 4.72 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.675 ' HB ' ' HA ' ' A' ' 17' ' ' PRO . 3.9 mm -100.37 122.9 52.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -170.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.3 m -114.49 -10.13 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.483 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.52 158.46 27.67 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.681 ' HB2' HD13 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -156.52 134.7 11.29 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.065 0.46 . . . . 0.0 109.867 -175.686 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.436 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 30.7 m -138.4 103.23 4.84 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.495 178.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.435 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 11.5 ptm180 -78.36 89.76 4.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.785 0.802 . . . . 0.0 109.787 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.647 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 11.0 tt0 -72.46 114.92 11.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.842 -175.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 25' ' ' ARG . 97.7 mt -116.71 164.07 15.18 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.225 -171.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.62 -37.44 65.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.826 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -62.14 -19.96 63.58 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -174.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -94.1 13.89 21.67 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.76 -30.17 2.79 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.092 -1.051 . . . . 0.0 113.658 174.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 3.7 t -86.08 -168.6 2.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.18 0.514 . . . . 0.0 111.659 -177.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -120.12 -36.2 3.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.216 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.733 HG12 ' SG ' ' A' ' 6' ' ' CYS . 6.8 pt -104.75 -175.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -138.16 112.16 8.46 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.345 0.593 . . . . 0.0 111.922 -173.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.5 119.88 39.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.527 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.485 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 41.3 mm -80.38 98.05 3.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.051 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.508 ' CG2' ' HB3' ' A' ' 46' ' ' SER . 23.7 mt -80.37 111.74 17.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 O-C-N 121.832 -0.542 . . . . 0.0 111.495 -174.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.445 ' HE2' HG22 ' A' ' 56' ' ' VAL . 30.3 m-85 -97.28 122.45 40.32 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 9.2 m-70 -97.66 111.36 23.67 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -176.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.5 p -71.17 163.63 27.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.099 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -66.92 -3.08 6.13 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.846 171.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -94.36 0.5 55.54 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.691 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm 78.64 -1.31 2.43 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.25 1.02 . . . . 0.0 111.496 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.4 mt -83.78 119.81 25.27 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.508 ' HB3' ' CG2' ' A' ' 38' ' ' ILE . 3.4 m -88.87 106.99 18.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.19 0.519 . . . . 0.0 109.901 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.482 ' CG1' HG21 ' A' ' 11' ' ' THR . 24.4 t -91.08 132.9 34.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.597 -175.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.8 m -88.19 91.6 8.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.749 0.785 . . . . 0.0 109.515 -178.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.641 ' HB1' HG22 ' A' ' 56' ' ' VAL . . . -76.52 146.0 38.73 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.077 -174.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.693 ' OD1' ' HB3' ' A' ' 10' ' ' TYR . 2.5 m-20 -84.16 128.68 61.39 Favored Pre-proline 0 CA--C 1.512 -0.495 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.293 -177.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.79 6.55 1.28 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.248 1.965 . . . . 0.0 112.65 176.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -92.34 -24.7 18.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.863 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.465 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 0.7 OUTLIER -103.61 142.7 33.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.056 -165.659 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 p -65.6 -37.2 85.95 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -172.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.586 ' CD1' HD13 ' A' ' 14' ' ' ILE . 49.9 p-90 -60.49 -33.84 73.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.221 0.534 . . . . 0.0 109.752 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.641 HG22 ' HB1' ' A' ' 49' ' ' ALA . 14.2 t -70.72 -50.62 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.154 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 95.7 mttt -54.82 -37.38 66.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.378 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -67.77 -54.39 19.61 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.836 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.825 HG12 ' HD3' ' A' ' 17' ' ' PRO . 75.0 mt -62.82 -45.52 98.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.634 0.254 . . . . 0.0 111.038 -176.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.564 HG23 ' CE1' ' A' ' 23' ' ' PHE . 10.2 p -64.4 -29.22 46.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.807 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -67.59 -43.95 79.29 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.988 0.423 . . . . 0.0 110.194 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.6 mt -75.07 -32.36 61.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.816 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.681 HD13 ' HB2' ' A' ' 23' ' ' PHE . 82.7 mt -71.73 -35.95 70.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.858 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.3 m -94.08 57.9 2.46 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 172.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.02 69.94 1.49 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.897 0.856 . . . . 0.0 110.745 -178.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -82.14 37.62 0.5 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.347 -173.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.5 m -129.95 12.13 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.415 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -138.08 146.99 43.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.111 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -80.59 119.49 23.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.099 0.476 . . . . 0.0 111.001 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 21.8 ptm . . . . . 0 C--O 1.246 0.883 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.118 174.804 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.6 m -76.96 126.29 30.72 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.811 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -71.3 -48.87 48.0 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.662 ' CE1' ' HG2' ' A' ' 26' ' ' GLN . 51.9 p90 -132.08 170.39 15.03 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.366 177.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -123.46 116.73 23.7 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.945 168.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -54.37 165.8 0.5 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.4 t -66.35 128.63 36.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.467 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.6 mt -75.21 -17.94 60.25 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.196 0.31 . . . . 0.0 111.436 -176.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.31 117.58 1.39 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.285 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.599 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 1.6 m-85 -75.63 168.51 19.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.274 0.559 . . . . 0.0 109.709 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.45 ' OG1' ' HG3' ' A' ' 13' ' ' ARG . 4.8 t -94.7 -176.42 3.88 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.762 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -150.3 72.63 1.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.519 ' HB2' HD22 ' A' ' 15' ' ' LEU . 2.2 mtp180 -132.68 -179.56 5.54 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.121 -175.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.577 HD13 ' CD1' ' A' ' 55' ' ' TRP . 19.1 mm -126.4 84.33 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.014 167.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.534 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.3 mm? -89.32 161.57 16.29 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.836 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 55.3 m170 -133.95 177.96 2.0 Allowed Pre-proline 0 C--N 1.312 -1.053 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.185 -177.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.643 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 51.8 Cg_exo -53.26 -30.7 52.73 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.676 1.584 . . . . 0.0 109.272 161.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.836 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 64.6 mttm -44.42 -34.0 1.88 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.582 169.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 41' ' ' THR . 98.7 m-85 -127.16 2.15 6.45 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -173.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 mp -98.12 130.47 46.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.811 0.338 . . . . 0.0 110.46 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 p -124.27 -7.2 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.492 0.663 . . . . 0.0 110.199 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.02 156.9 26.5 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.803 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.901 ' HB3' HD12 ' A' ' 63' ' ' LEU . 1.9 t80 -140.7 138.08 33.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.256 0.551 . . . . 0.0 110.769 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.6 m -143.59 105.26 4.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.697 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.566 ' NE ' ' H ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -77.68 115.6 17.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.394 0.616 . . . . 0.0 111.117 -178.739 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.662 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 1.1 tt0 -86.18 117.12 24.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.247 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.2 mt -103.85 145.95 29.36 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -167.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.88 50.29 1.94 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.42 176.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -127.23 -64.42 1.0 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.201 -175.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -85.55 53.4 2.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.653 0.739 . . . . 0.0 111.902 -174.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.55 -61.5 0.51 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.809 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -55.06 152.13 8.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.842 -0.679 . . . . 0.0 111.63 175.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -120.35 -5.86 9.86 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 34' ' ' ILE . 26.1 pt -127.85 115.75 40.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 CA-C-O 121.911 0.862 . . . . 0.0 111.069 176.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -83.55 118.2 23.64 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 121.475 -0.766 . . . . 0.0 111.442 -172.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.1 139.06 53.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.767 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.573 HG12 ' HG3' ' A' ' 51' ' ' PRO . 43.5 mm -85.48 109.89 18.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.249 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.3 mm -90.4 100.17 10.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.989 0.423 . . . . 0.0 110.814 -177.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.582 ' HE2' HG22 ' A' ' 56' ' ' VAL . 11.7 m-85 -92.22 118.53 30.96 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.882 173.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -89.03 115.19 26.4 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.419 ' C ' ' H ' ' A' ' 43' ' ' LYS . 33.1 p -82.21 162.24 22.45 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.468 0.652 . . . . 0.0 112.249 -172.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -60.32 -4.43 0.84 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.313 170.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 41' ' ' THR . 75.2 mmtt -109.74 16.56 22.0 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.944 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 59.7 mttp 75.17 -21.44 0.3 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.87 0.868 . . . . 0.0 112.525 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.3 mt -68.5 118.29 11.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.868 0.366 . . . . 0.0 111.159 -173.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.2 p -79.24 101.64 8.11 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 175.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 76.3 t -83.16 132.63 30.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.456 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.0 m -85.41 74.38 10.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.863 0.839 . . . . 0.0 109.094 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.437 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -69.71 142.45 53.32 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.657 -175.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.66 ' HB2' ' CG ' ' A' ' 53' ' ' GLN . 1.7 m-20 -84.02 127.8 65.41 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.197 -177.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.573 ' HG3' HG12 ' A' ' 37' ' ' ILE . 24.1 Cg_exo -64.75 3.18 0.97 Allowed 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.728 2.285 . . . . 0.0 111.824 174.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 50' ' ' ASN . 57.7 mtpt -92.67 -22.7 19.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.627 -176.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.66 ' CG ' ' HB2' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -93.27 134.31 35.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.536 -169.585 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 p -64.34 -32.42 74.02 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.577 ' CD1' HD13 ' A' ' 14' ' ' ILE . 47.3 p-90 -61.94 -33.32 74.05 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.582 HG22 ' HE2' ' A' ' 39' ' ' PHE . 14.0 t -70.34 -49.77 51.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.99 173.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 96.4 mttt -56.72 -35.05 68.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.26 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -66.09 -56.43 11.52 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.012 175.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.426 HD11 ' HA ' ' A' ' 16' ' ' HIS . 86.6 mt -60.84 -48.07 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.121 -176.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.649 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 14.4 p -62.55 -31.68 52.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -177.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -62.45 -47.78 82.51 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.066 0.46 . . . . 0.0 110.039 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 66' ' ' LYS . 11.0 mp -69.86 -40.54 75.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.304 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.901 HD12 ' HB3' ' A' ' 23' ' ' PHE . 3.6 mm? -70.11 -7.62 42.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.55 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -90.03 -63.03 1.34 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.95 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -134.5 25.75 3.76 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -171.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 62' ' ' LEU . 16.5 tppt? -120.1 114.79 22.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.207 0.527 . . . . 0.0 110.476 176.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.01 126.37 75.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.12 -174.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -139.24 -63.45 0.52 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.204 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -106.49 148.22 28.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.393 0.616 . . . . 0.0 112.334 -171.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.013 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.315 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.714 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 13.7 p . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.0 t -52.15 118.72 3.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.787 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.419 ' HA ' HD11 ' A' ' 34' ' ' ILE . 80.2 mt -84.61 -15.75 44.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.217 -177.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -120.88 108.8 1.43 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.754 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 17.8 m-85 -79.92 -167.49 1.29 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.263 0.554 . . . . 0.0 111.177 -173.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.5 t -125.03 170.74 10.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.973 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -133.98 77.53 1.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.516 0.674 . . . . 0.0 110.311 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.526 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 94.7 mtt180 -133.23 179.09 6.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.743 176.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.566 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.0 mm -118.29 83.46 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 164.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.591 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.5 mm? -79.42 158.88 27.26 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.661 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 54.7 m170 -131.81 175.71 3.47 Favored Pre-proline 0 C--N 1.312 -1.052 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.151 -174.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.653 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 32.5 Cg_exo -56.4 -25.51 57.84 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.747 1.631 . . . . 0.0 109.282 164.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.661 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 64.0 mttm -49.38 -31.55 9.72 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.282 175.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 41' ' ' THR . 91.0 m-85 -124.1 0.32 8.45 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.443 ' CG1' ' HB3' ' A' ' 39' ' ' PHE . 1.4 mp -105.88 130.08 57.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.077 0.465 . . . . 0.0 112.105 -173.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.1 m -123.95 -5.76 7.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.468 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.12 162.6 30.21 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.409 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.679 ' CB ' HD13 ' A' ' 63' ' ' LEU . 1.1 t80 -158.04 133.65 9.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.981 0.42 . . . . 0.0 110.413 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.6 m -135.91 120.37 18.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.938 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -93.0 137.2 32.57 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.131 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.714 ' NE2' ' HB2' ' A' ' 6' ' ' CYS . 12.9 mt-30 -120.72 121.01 37.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.749 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.4 mp -102.45 165.91 10.84 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.026 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.27 18.36 11.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.401 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -139.61 1.98 1.97 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.781 0.324 . . . . 0.0 111.62 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -99.99 -21.73 15.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.107 0.479 . . . . 0.0 110.33 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.21 -53.95 0.1 OUTLIER Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.5 t -69.03 156.89 37.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -89.63 -20.07 24.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.455 0.645 . . . . 0.0 109.788 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.452 HG12 ' SG ' ' A' ' 6' ' ' CYS . 4.6 pt -116.26 -178.68 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.4 ' OD1' ' HG2' ' A' ' 51' ' ' PRO . 4.7 p30 -129.7 129.08 43.77 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.115 0.483 . . . . 0.0 110.557 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . -141.95 132.82 25.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.118 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 46.7 mm -82.34 125.17 39.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.9 mm -98.8 101.68 12.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 O-C-N 121.969 -0.457 . . . . 0.0 110.757 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.521 ' HE2' HG22 ' A' ' 56' ' ' VAL . 18.6 m-85 -87.99 123.49 32.75 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 173.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -92.88 112.75 24.81 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 36.7 p -75.22 160.52 30.29 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.663 -176.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -71.93 5.62 2.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.476 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 41' ' ' THR . 0.5 OUTLIER -106.57 12.28 29.62 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.335 176.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 68.14 19.39 9.2 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.079 174.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.8 mt -112.7 136.19 52.57 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.991 0.424 . . . . 0.0 110.925 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.6 p -84.88 115.79 22.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.623 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 83.0 t -89.12 126.6 42.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.625 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 16.5 m -83.09 81.24 8.77 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.616 0.722 . . . . 0.0 109.238 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.524 ' HB1' HG22 ' A' ' 56' ' ' VAL . . . -71.85 134.48 46.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.671 -175.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.754 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -80.64 124.29 82.04 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.4 ' HG2' ' OD1' ' A' ' 35' ' ' ASN . 25.6 Cg_exo -65.62 -0.44 3.73 Favored 'Trans proline' 0 C--N 1.328 -0.537 0 C-N-CA 121.862 1.708 . . . . 0.0 111.933 174.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.418 ' H ' ' C ' ' A' ' 50' ' ' ASN . 51.0 mtpt -85.0 -25.46 27.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.874 -175.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.542 HE21 HG21 ' A' ' 56' ' ' VAL . 5.4 pt20 -103.37 145.95 29.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.7 -167.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.41 -32.59 68.58 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -171.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.591 ' CZ3' ' HB2' ' A' ' 15' ' ' LEU . 48.3 p-90 -63.48 -32.91 74.49 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.859 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.542 HG21 HE21 ' A' ' 53' ' ' GLN . 4.5 t -69.75 -46.95 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.314 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.754 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 65.0 mttm -58.04 -40.6 81.29 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.098 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -62.93 -53.11 59.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.188 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.456 HG22 ' CD1' ' A' ' 63' ' ' LEU . 85.0 mt -63.79 -41.06 91.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.314 -177.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.1 p -68.44 -25.62 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.132 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.754 ' HG2' ' O ' ' A' ' 57' ' ' LYS . 1.3 mmp_? -66.43 -45.19 80.71 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 122.007 -0.433 . . . . 0.0 109.999 174.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.9 mt -68.72 -36.42 78.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.821 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.679 HD13 ' CB ' ' A' ' 23' ' ' PHE . 81.3 mt -72.3 -18.54 61.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.92 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 C--N 1.327 -0.38 0 CA-C-O 120.816 0.341 . . . . 0.0 110.969 173.68 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.754 ' SG ' HG12 ' A' ' 34' ' ' ILE . 20.8 p . . . . . 0 N--CA 1.449 -0.476 0 CA-C-O 120.949 0.404 . . . . 0.0 110.999 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 55.8 m -61.36 117.65 5.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.684 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.3 mt -68.82 -16.55 63.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.292 0.568 . . . . 0.0 110.242 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.1 88.17 0.19 Allowed Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.121 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.483 ' HA ' ' HB2' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -74.39 157.31 35.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.111 0.482 . . . . 0.0 110.533 174.583 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 48' ' ' CYS . 15.1 t -82.3 159.34 23.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -164.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -118.54 74.23 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.52 ' HB2' HD22 ' A' ' 15' ' ' LEU . 1.8 mmp_? -131.65 178.53 6.67 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.586 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.539 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.9 mm -121.6 84.46 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.237 161.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.541 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 1.9 mm? -84.59 167.58 16.15 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 175.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.694 ' ND1' ' HD2' ' A' ' 18' ' ' LYS . 63.5 m170 -133.04 168.14 19.45 Favored Pre-proline 0 C--N 1.311 -1.088 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.689 -175.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 17.3 Cg_endo -59.49 -23.05 69.1 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.316 2.011 . . . . 0.0 109.207 165.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.694 ' HD2' ' ND1' ' A' ' 16' ' ' HIS . 65.1 mttm -49.53 -27.68 4.67 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 113.846 -1.525 . . . . 0.0 111.628 170.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -124.99 -1.46 7.8 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -172.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.529 HD12 HD13 ' A' ' 59' ' ' ILE . 27.7 mt -105.99 124.64 61.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.838 0.351 . . . . 0.0 111.544 -173.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.2 m -121.13 0.69 7.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.002 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.99 158.7 30.0 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.587 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.586 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 2.1 t80 -153.24 134.31 14.05 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.346 0.593 . . . . 0.0 110.93 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.9 m -141.95 112.56 7.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.495 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -80.29 103.08 9.91 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.961 0.41 . . . . 0.0 110.381 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.581 ' NE2' ' HA ' ' A' ' 6' ' ' CYS . 8.5 tt0 -74.27 126.11 29.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.045 -177.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.529 ' HB3' HD22 ' A' ' 29' ' ' ASN . 87.8 mt -100.59 156.39 17.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.499 0.666 . . . . 0.0 112.606 -170.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.57 -30.65 36.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.909 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.529 HD22 ' HB3' ' A' ' 27' ' ' LEU . 44.3 m-80 -49.94 -34.06 19.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.534 -1.212 . . . . 0.0 113.069 -175.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -99.83 27.3 5.55 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -172.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.13 -44.82 1.03 Allowed Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.722 172.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -80.56 -167.1 1.23 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.008 0.432 . . . . 0.0 111.955 -174.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -122.54 -28.54 4.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.718 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.754 HG12 ' SG ' ' A' ' 6' ' ' CYS . 1.4 pt -111.69 169.51 4.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.409 ' OD1' ' HA ' ' A' ' 27' ' ' LEU . 34.1 m-80 -116.2 123.35 47.55 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.01 121.62 43.69 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.715 0.293 . . . . 0.0 110.847 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.721 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 48.6 mm -69.74 104.94 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.371 176.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.431 HD11 ' NE2' ' A' ' 26' ' ' GLN . 33.4 mm -85.89 97.64 6.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 O-C-N 122.059 -0.401 . . . . 0.0 110.113 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.487 ' HB3' HG12 ' A' ' 20' ' ' ILE . 9.6 m-85 -85.77 122.88 30.48 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -93.45 106.76 18.69 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.8 p -78.09 162.92 26.31 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.073 -173.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -65.9 -7.8 18.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.326 173.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -91.16 2.82 56.06 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.282 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 68.41 17.73 9.12 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.936 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.6 mt -106.69 125.98 51.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.517 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.4 p -76.72 108.35 9.67 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.652 177.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 99.6 t -91.63 131.35 38.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.662 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 62.8 m -88.7 90.97 8.63 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.721 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -77.95 141.15 39.18 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.958 -176.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.582 HD22 ' N ' ' A' ' 50' ' ' ASN . 0.7 OUTLIER -82.38 130.34 59.66 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.82 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -71.48 2.93 4.01 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.099 1.866 . . . . 0.0 112.041 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -90.32 -21.62 21.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.918 -176.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.58 HE21 HG21 ' A' ' 56' ' ' VAL . 5.0 pt20 -103.14 142.27 34.43 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.437 -168.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 p -74.3 -28.79 61.34 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -171.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.616 ' O ' HG13 ' A' ' 59' ' ' ILE . 47.2 p-90 -62.57 -33.73 75.54 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.387 176.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.58 HG21 HE21 ' A' ' 53' ' ' GLN . 4.5 t -70.99 -47.92 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.413 174.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -56.98 -36.71 70.65 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 123.761 0.663 . . . . 0.0 110.85 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -65.77 -49.47 68.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.838 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.616 HG13 ' O ' ' A' ' 55' ' ' TRP . 60.0 mt -67.76 -47.86 78.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.039 -175.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.586 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 11.7 p -62.69 -29.84 47.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 120.803 0.335 . . . . 0.0 110.762 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -64.47 -45.26 88.17 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 34.8 mt -70.26 -30.81 67.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.934 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.592 HD23 HG22 ' A' ' 59' ' ' ILE . 2.0 mm? -68.45 -36.65 79.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.539 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.694 -178.777 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.818 ' SG ' HG12 ' A' ' 34' ' ' ILE . 26.2 p . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.665 ' O ' HD11 ' A' ' 34' ' ' ILE . 58.3 m -60.2 130.25 45.72 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.136 174.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.3 mt -84.5 0.13 50.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.209 0.528 . . . . 0.0 110.108 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.54 136.44 6.94 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 174.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.825 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 29.0 m-85 -97.3 176.65 5.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.798 0.332 . . . . 0.0 110.226 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.479 HG21 ' CG1' ' A' ' 47' ' ' VAL . 2.7 t -112.91 137.85 50.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.168 0.509 . . . . 0.0 111.015 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -108.02 68.9 0.72 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.564 0.697 . . . . 0.0 109.363 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.483 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 4.3 mmp_? -129.19 -173.21 2.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.586 -177.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.556 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.4 mm -124.98 89.65 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.208 165.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.59 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.7 mm? -89.12 162.83 15.75 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 58.3 m170 -132.05 166.65 26.92 Favored Pre-proline 0 C--N 1.312 -1.051 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.994 -172.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 12.2 Cg_endo -57.57 -27.14 75.53 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.176 1.917 . . . . 0.0 109.149 166.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 65.6 mttm -45.0 -35.47 2.93 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.384 171.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -116.89 -13.48 10.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.903 -172.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.673 HG12 ' HB3' ' A' ' 39' ' ' PHE . 21.8 mt -92.39 127.18 44.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.768 0.318 . . . . 0.0 111.327 -172.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 m -122.33 -7.6 8.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.157 0.503 . . . . 0.0 110.995 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -152.21 163.1 30.1 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.683 ' HB2' HD13 ' A' ' 63' ' ' LEU . 2.4 t80 -156.6 134.28 10.91 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 117.325 0.563 . . . . 0.0 110.897 -175.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.562 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 83.5 m -140.41 107.8 5.55 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.112 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.52 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 14.8 ptp180 -86.5 102.78 14.42 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.756 HE21 ' HB3' ' A' ' 36' ' ' ALA . 19.9 pt20 -93.25 136.04 33.88 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.421 ' HA ' ' HB3' ' A' ' 35' ' ' ASN . 86.7 mt -119.64 163.72 16.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.214 0.53 . . . . 0.0 111.882 -170.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.58 35.03 0.49 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.824 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -132.73 -52.62 0.93 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.396 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -60.97 -43.21 99.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.799 -173.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -157.16 -65.03 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.279 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.8 t -71.42 169.3 15.64 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.378 0.609 . . . . 0.0 112.384 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -90.1 -24.67 21.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.653 -173.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.818 HG12 ' SG ' ' A' ' 6' ' ' CYS . 2.1 pt -120.41 170.16 10.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.421 ' HB3' ' HA ' ' A' ' 27' ' ' LEU . 6.1 p30 -118.86 128.18 54.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.778 0.323 . . . . 0.0 111.178 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.756 ' HB3' HE21 ' A' ' 26' ' ' GLN . . . -131.9 143.6 50.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.958 0.409 . . . . 0.0 110.928 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.603 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 49.9 mm -90.2 101.34 12.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.229 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.562 ' HB ' ' HB ' ' A' ' 24' ' ' THR . 63.9 mt -79.49 104.75 7.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.019 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.673 ' HB3' HG12 ' A' ' 20' ' ' ILE . 12.5 m-85 -95.26 111.35 23.21 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 172.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -82.67 110.25 17.57 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.0 p -85.06 163.13 19.01 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.412 0.625 . . . . 0.0 112.008 -174.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -68.75 -2.53 9.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.032 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -90.58 3.04 55.2 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.769 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt 69.47 22.86 6.24 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.015 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 97.3 mt -114.75 139.6 49.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.144 0.497 . . . . 0.0 110.712 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.422 ' HB2' HG23 ' A' ' 38' ' ' ILE . 12.0 p -90.07 95.41 10.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.694 174.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.479 ' CG1' HG21 ' A' ' 11' ' ' THR . 59.0 t -76.33 130.2 36.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.834 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.0 m -92.64 81.74 4.78 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.018 0.913 . . . . 0.0 109.591 -175.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.603 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -69.87 144.63 52.46 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.794 -176.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.825 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -83.8 129.39 59.49 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.758 -179.126 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -72.01 21.33 0.27 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.406 2.071 . . . . 0.0 111.988 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 50' ' ' ASN . 35.3 mtmm -119.42 -4.93 10.36 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.99 -173.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.536 HE21 HG21 ' A' ' 56' ' ' VAL . 4.7 pt20 -117.26 146.37 43.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.027 0.441 . . . . 0.0 111.555 -172.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 p -69.86 -36.32 75.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -171.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.59 ' CZ3' ' HB2' ' A' ' 15' ' ' LEU . 47.9 p-90 -61.05 -30.75 70.51 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.554 ' O ' HG12 ' A' ' 60' ' ' VAL . 12.6 t -74.21 -49.04 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.244 174.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 84.1 mttt -57.0 -34.05 67.76 Favored 'General case' 0 C--N 1.334 -0.089 0 O-C-N 123.457 0.473 . . . . 0.0 110.506 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -66.1 -54.73 22.06 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.527 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.668 HG21 HD13 ' A' ' 20' ' ' ILE . 72.7 mt -65.57 -43.82 94.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.477 -174.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.573 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 13.8 p -66.71 -33.83 66.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.092 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -62.89 -43.14 99.59 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.37 0.605 . . . . 0.0 109.494 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.3 tp -66.2 -41.06 90.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.041 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 23' ' ' PHE . 75.3 mt -76.28 -7.44 54.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.355 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 C--N 1.327 -0.391 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.864 178.092 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.701 ' HA ' ' HB3' ' A' ' 26' ' ' GLN . 7.9 p . . . . . 0 N--CA 1.44 -0.932 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.498 ' O ' HD11 ' A' ' 34' ' ' ILE . 94.8 m -105.91 122.75 46.76 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 166.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.6 mt -67.7 -26.69 66.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.345 0.593 . . . . 0.0 109.536 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -129.06 135.38 8.43 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.206 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.766 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 6.9 m-85 -100.58 -160.12 0.78 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.414 ' H ' HD21 ' A' ' 50' ' ' ASN . 5.1 t -129.12 158.7 38.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.214 176.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.498 ' O ' ' HD2' ' A' ' 13' ' ' ARG . 1.5 m-20 -118.55 69.23 0.79 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.858 0.361 . . . . 0.0 110.087 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.498 ' HD2' ' O ' ' A' ' 12' ' ' ASP . 8.4 mmm180 -131.36 175.89 8.75 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.411 0.624 . . . . 0.0 112.122 -177.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.529 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.1 mm -120.18 90.05 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.001 164.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.495 ' CD2' ' HB2' ' A' ' 13' ' ' ARG . 1.9 mm? -92.35 163.26 13.94 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.78 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 34.9 m170 -131.24 176.39 2.93 Favored Pre-proline 0 C--N 1.313 -1.013 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.277 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.78 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 13.2 Cg_endo -58.68 -21.28 54.99 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.631 1.554 . . . . 0.0 109.353 167.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.729 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 28.5 mtpp -45.17 -32.77 1.97 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.844 171.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 41' ' ' THR . 77.9 m-85 -124.27 -5.08 7.82 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -174.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.615 HG12 ' HB3' ' A' ' 39' ' ' PHE . 18.3 mt -100.26 128.45 52.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.777 0.323 . . . . 0.0 111.666 -173.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.6 m -120.68 -11.48 9.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.195 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.3 165.74 31.42 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.736 ' HB2' HD13 ' A' ' 63' ' ' LEU . 2.7 t80 -155.01 133.44 11.87 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.23 0.538 . . . . 0.0 111.666 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.7 m -142.1 121.42 13.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.603 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -98.11 119.16 36.26 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.512 -0.475 . . . . 0.0 112.112 -176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.701 ' HB3' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -76.17 130.09 37.72 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 170.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.6 mt -97.9 152.52 19.13 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -169.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 32' ' ' CYS . . . -100.87 5.48 43.39 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.059 173.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -100.26 -64.61 1.03 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.146 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -116.98 86.41 2.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.63 0.728 . . . . 0.0 110.079 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.56 -77.37 0.16 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.444 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 47.1 t -117.9 176.51 5.17 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -87.38 -23.28 24.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.351 0.596 . . . . 0.0 109.405 171.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.691 HG12 ' SG ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -113.33 162.97 11.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 26' ' ' GLN . 7.0 p30 -129.11 138.35 51.77 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.286 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.88 148.56 52.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.017 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.776 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 47.8 mm -95.48 116.81 38.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.715 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.436 HD11 HE22 ' A' ' 26' ' ' GLN . 44.4 mm -90.31 98.38 8.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.085 0.469 . . . . 0.0 110.047 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.615 ' HB3' HG12 ' A' ' 20' ' ' ILE . 8.8 m-85 -87.94 115.01 25.11 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -82.03 108.14 15.28 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 42.0 p -82.55 159.15 22.85 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.195 0.521 . . . . 0.0 111.471 -175.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -67.28 -2.42 5.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.358 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -95.15 3.71 54.42 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.842 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt 70.33 11.92 7.5 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.451 0.7 . . . . 0.0 111.176 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.3 mt -92.85 125.82 37.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.098 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 p -86.06 93.79 9.08 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.3 t -85.64 130.92 35.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.687 -174.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 82.3 m -86.29 84.73 7.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 122.016 0.912 . . . . 0.0 109.506 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.776 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -69.51 143.03 53.58 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.6 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.766 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -88.14 122.52 69.83 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -178.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.494 ' HG3' ' OD1' ' A' ' 35' ' ' ASN . 9.5 Cg_endo -57.33 -8.19 3.49 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.889 2.393 . . . . 0.0 112.471 172.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -77.2 -34.54 56.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.961 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.698 ' CG ' ' HB2' ' A' ' 50' ' ' ASN . 0.4 OUTLIER -85.43 140.53 30.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.719 -169.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.64 -27.68 61.39 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -176.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.529 ' CD1' HD13 ' A' ' 14' ' ' ILE . 47.8 p-90 -62.74 -32.4 73.53 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.653 HG21 HE21 ' A' ' 53' ' ' GLN . 7.4 t -73.03 -48.78 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.494 174.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 66.7 mttm -53.93 -36.5 62.83 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.584 0.552 . . . . 0.0 110.575 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -66.52 -57.28 7.64 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.691 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.577 HG21 HD13 ' A' ' 20' ' ' ILE . 75.2 mt -62.67 -43.3 98.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.201 -175.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.632 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 12.6 p -63.5 -33.42 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 121.309 -0.156 . . . . 0.0 111.328 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -63.75 -41.99 97.91 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.268 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.4 mt -81.48 4.81 19.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.023 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.736 HD13 ' HB2' ' A' ' 23' ' ' PHE . 55.9 mt -117.7 -14.86 10.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.321 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--N 1.325 -0.466 0 CA-C-O 120.761 0.315 . . . . 0.0 110.185 179.064 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.719 ' SG ' HG12 ' A' ' 34' ' ' ILE . 19.3 p . . . . . 0 N--CA 1.451 -0.421 0 CA-C-O 120.963 0.411 . . . . 0.0 111.985 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.9 m -61.6 134.68 57.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.808 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt -86.72 6.62 30.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.592 0.711 . . . . 0.0 109.885 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.67 119.79 0.95 Allowed Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.676 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.49 ' HD1' ' H ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -118.62 161.38 20.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.944 0.402 . . . . 0.0 110.833 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 49' ' ' ALA . 14.4 t -73.38 -171.52 0.99 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -167.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -147.27 14.19 1.12 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.634 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -88.81 170.43 10.75 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.408 -171.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.569 HD13 ' CD1' ' A' ' 55' ' ' TRP . 8.7 mm -105.3 84.57 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 163.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.588 HD12 ' CH2' ' A' ' 55' ' ' TRP . 1.1 mt -92.14 160.49 15.17 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.739 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 52.1 m170 -132.51 171.5 9.03 Favored Pre-proline 0 C--N 1.313 -1.014 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.005 -173.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.575 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 32.1 Cg_exo -55.83 -24.24 46.09 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.181 1.921 . . . . 0.0 109.255 165.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.739 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 64.9 mttm -44.51 -32.65 1.47 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 114.24 -1.346 . . . . 0.0 112.082 171.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -126.81 -3.48 6.52 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 122.243 -0.286 . . . . 0.0 111.449 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.62 HG13 ' HB3' ' A' ' 39' ' ' PHE . 1.2 mp -92.88 120.12 41.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.02 0.438 . . . . 0.0 110.344 -175.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.3 m -113.63 -5.87 11.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.735 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.19 158.37 29.13 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.36 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.665 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -146.97 137.39 23.58 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.139 0.495 . . . . 0.0 110.258 -179.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.2 m -144.38 109.45 5.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.518 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 25' ' ' ARG . 8.6 ptp180 -75.9 118.14 18.37 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.429 ' NE2' HD11 ' A' ' 38' ' ' ILE . 8.4 tt0 -101.88 106.35 17.29 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -177.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.499 ' HA ' HD22 ' A' ' 35' ' ' ASN . 6.6 mp -81.7 164.5 21.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.457 0.646 . . . . 0.0 111.984 -173.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.24 -57.8 3.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.862 175.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -74.62 19.67 0.13 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -170.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -115.19 23.86 12.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.281 0.562 . . . . 0.0 110.494 173.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.25 -12.86 4.36 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.647 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.4 t -120.06 -153.69 0.55 Allowed 'General case' 0 C--N 1.319 -0.742 0 O-C-N 122.454 -0.439 . . . . 0.0 111.563 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -129.61 -27.95 2.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.576 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.719 HG12 ' SG ' ' A' ' 6' ' ' CYS . 2.8 pt -118.61 169.51 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.499 HD22 ' HA ' ' A' ' 27' ' ' LEU . 14.9 m120 -103.39 131.06 50.78 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 174.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.14 126.14 36.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.28 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.67 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 46.7 mm -88.72 98.08 7.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.34 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.429 HD11 ' NE2' ' A' ' 26' ' ' GLN . 70.2 mt -75.49 105.95 4.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.867 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.62 ' HB3' HG13 ' A' ' 20' ' ' ILE . 13.6 m-85 -97.73 116.94 30.93 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 171.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -86.88 106.46 17.77 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 43' ' ' LYS . 42.7 p -74.75 164.1 26.94 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.642 -176.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -74.26 4.79 5.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.963 0.887 . . . . 0.0 108.912 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.483 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 14.5 tppt? -87.87 -1.36 57.93 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.004 176.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt 70.6 12.26 7.32 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.828 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.6 mt -109.44 129.2 55.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.598 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.411 ' HB2' HG23 ' A' ' 38' ' ' ILE . 11.8 p -79.84 107.07 12.33 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.821 176.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 73.0 t -93.23 127.25 45.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.437 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 57.4 m -88.94 100.5 13.24 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.703 0.763 . . . . 0.0 109.493 -174.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.67 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -78.66 143.38 36.38 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.934 -177.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.625 HD22 ' N ' ' A' ' 50' ' ' ASN . 0.7 OUTLIER -80.41 130.98 63.13 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.59 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.53 -10.63 28.54 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.678 2.252 . . . . 0.0 112.044 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -74.93 -27.76 60.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.231 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.616 HE21 HG21 ' A' ' 56' ' ' VAL . 5.1 mt-30 -84.64 139.29 32.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.036 -168.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 p -76.33 -31.1 57.93 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.856 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.588 ' CH2' HD12 ' A' ' 15' ' ' LEU . 51.9 p-90 -60.35 -33.8 72.94 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 174.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.616 HG21 HE21 ' A' ' 53' ' ' GLN . 25.7 t -68.54 -52.06 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.252 173.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 67.6 mttm -54.2 -38.21 65.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.683 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -63.46 -52.45 61.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.787 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 55' ' ' TRP . 72.6 mt -63.52 -47.65 90.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.296 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.665 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 7.5 p -63.99 -36.19 75.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -175.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -68.7 -31.67 70.92 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.303 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 30.2 tp -74.28 -41.88 60.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.828 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.482 HD12 ' HB3' ' A' ' 23' ' ' PHE . 2.4 mm? -66.25 -29.09 69.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.039 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.0 -176.924 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.685 ' SG ' ' HG2' ' A' ' 26' ' ' GLN . 93.8 m . . . . . 0 N--CA 1.452 -0.352 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 67.1 m -49.3 122.29 5.92 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.284 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.7 mt -65.24 -24.82 67.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.087 0.47 . . . . 0.0 110.406 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.72 134.77 7.43 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.11 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.84 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 28.9 m-85 -92.66 178.41 5.8 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.566 0.222 . . . . 0.0 110.445 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.657 HG21 HG13 ' A' ' 47' ' ' VAL . 3.4 t -127.08 130.58 50.18 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.371 0.605 . . . . 0.0 111.758 -177.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.66 72.57 2.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 122.007 0.908 . . . . 0.0 108.6 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.44 ' HB2' HD12 ' A' ' 15' ' ' LEU . 18.2 mmt180 -104.42 -178.9 3.79 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.925 177.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.471 HD13 ' CD1' ' A' ' 55' ' ' TRP . 9.1 mm -126.74 87.68 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 162.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.714 HD13 HG11 ' A' ' 47' ' ' VAL . 1.2 mt -99.82 162.27 13.1 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.273 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.577 ' O ' HD13 ' A' ' 20' ' ' ILE . 63.1 m170 -132.59 167.08 24.41 Favored Pre-proline 0 C--N 1.316 -0.889 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.087 -172.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.624 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 18.3 Cg_endo -61.3 -22.53 74.86 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.315 2.01 . . . . 0.0 108.925 166.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.557 ' HD2' ' ND1' ' A' ' 16' ' ' HIS . 66.4 mttm -52.46 -28.31 19.68 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.718 172.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -124.0 -2.71 8.17 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.426 -175.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.624 ' HB ' ' HA ' ' A' ' 17' ' ' PRO . 0.9 OUTLIER -94.19 124.18 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 120.995 0.426 . . . . 0.0 110.891 -174.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.4 m -120.32 -1.96 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.547 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.3 160.22 31.95 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.432 -0.889 . . . . 0.0 111.962 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.54 ' CB ' ' HG ' ' A' ' 63' ' ' LEU . 1.7 t80 -149.3 134.5 18.23 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.5 m -140.95 107.18 5.23 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.381 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.515 ' HD3' HD21 ' A' ' 27' ' ' LEU . 32.4 ttm180 -82.37 107.52 15.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.168 0.509 . . . . 0.0 110.013 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.685 ' HG2' ' SG ' ' A' ' 6' ' ' CYS . 4.1 tt0 -80.14 115.56 19.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.906 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.515 HD21 ' HD3' ' A' ' 25' ' ' ARG . 65.2 mt -103.39 148.18 26.2 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -166.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.62 15.88 0.44 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.272 176.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 27' ' ' LEU . 34.3 m-80 -116.04 -6.99 11.96 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.783 -177.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.426 ' HG2' ' HB2' ' A' ' 27' ' ' LEU . 34.2 mm-40 -103.69 -1.06 28.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.474 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.99 -48.65 0.68 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.496 -0.859 . . . . 0.0 113.311 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 34' ' ' ILE . 13.4 p -68.16 171.04 7.52 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -112.52 6.76 18.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.553 0.692 . . . . 0.0 111.035 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.415 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 25.0 pt -131.34 -171.81 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 8.9 p30 -142.62 124.08 14.83 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.874 174.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.99 137.89 51.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.729 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.504 HG23 ' HE1' ' A' ' 23' ' ' PHE . 50.0 mm -89.04 98.23 7.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.089 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.678 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 2.6 mp -85.46 99.7 7.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.346 -0.541 . . . . 0.0 110.541 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.527 ' HE2' HG22 ' A' ' 56' ' ' VAL . 20.1 m-85 -86.89 125.93 34.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 171.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -93.32 112.32 24.22 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.4 p -79.13 155.39 28.72 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -65.62 -6.72 11.97 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.283 175.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -99.21 12.32 36.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.989 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.9 mttm 70.68 19.89 5.87 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.372 172.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.8 mt -104.48 124.72 49.77 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.416 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.8 p -80.85 109.56 15.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.302 0.572 . . . . 0.0 109.769 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.714 HG11 HD13 ' A' ' 15' ' ' LEU . 70.0 t -87.1 132.14 33.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.025 -176.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 65.0 m -93.34 76.97 4.51 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.863 0.84 . . . . 0.0 108.832 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.595 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -70.71 141.13 51.56 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.898 -175.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.84 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -79.0 129.63 72.52 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.3 -179.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.54 -3.08 8.44 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 121.794 1.663 . . . . 0.0 111.122 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 50' ' ' ASN . 53.8 mtmt -88.58 -18.85 27.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.048 -173.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.634 HE21 HG21 ' A' ' 56' ' ' VAL . 5.5 pt20 -104.54 145.21 30.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.953 0.406 . . . . 0.0 111.05 -170.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 p -69.72 -36.06 75.56 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -172.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.639 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 36.1 p-90 -60.14 -30.93 69.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.453 0.644 . . . . 0.0 109.466 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.634 HG21 HE21 ' A' ' 53' ' ' GLN . 15.1 t -75.27 -49.54 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.198 175.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -56.09 -33.61 65.22 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 123.454 0.471 . . . . 0.0 110.401 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -66.48 -56.96 8.44 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.872 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.446 HG12 ' HD3' ' A' ' 17' ' ' PRO . 72.4 mt -64.65 -43.94 96.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.142 -176.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 56' ' ' VAL . 7.1 p -67.07 -24.46 32.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.586 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 61' ' ' ARG . 8.4 ttp180 -69.61 -33.28 72.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.154 0.502 . . . . 0.0 110.114 174.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.6 mt -73.22 -44.45 59.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.872 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.54 ' HG ' ' CB ' ' A' ' 23' ' ' PHE . 3.7 mm? -61.96 -49.81 74.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.776 176.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.1 t . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 121.479 0.657 . . . . 0.0 109.8 178.882 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.813 ' HA ' ' HG3' ' A' ' 26' ' ' GLN . 82.8 m . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 110.94 -0.022 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.0 t -56.76 118.58 5.04 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 123.396 0.435 . . . . 0.0 110.062 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.33 -24.98 66.83 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.167 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.25 142.41 10.48 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.998 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.834 ' HB2' ' ND2' ' A' ' 50' ' ' ASN . 0.3 OUTLIER -105.24 171.32 7.38 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.027 0.441 . . . . 0.0 111.973 -178.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 t -93.12 154.11 18.27 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -169.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -95.19 59.53 2.25 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.419 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.632 ' HB3' HD22 ' A' ' 15' ' ' LEU . 6.7 mtm180 -129.34 173.66 10.32 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.511 HD13 ' CD1' ' A' ' 55' ' ' TRP . 14.5 mm -120.71 79.74 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 113.979 -1.464 . . . . 0.0 108.528 168.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 13' ' ' ARG . 2.8 mm? -79.31 159.12 27.33 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.655 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 52.3 m170 -134.24 172.05 7.99 Favored Pre-proline 0 C--N 1.309 -1.19 0 O-C-N 122.028 -0.42 . . . . 0.0 111.064 -176.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.575 ' HD3' HG12 ' A' ' 59' ' ' ILE . 14.4 Cg_endo -59.56 -21.64 63.08 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.732 1.622 . . . . 0.0 109.177 165.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.655 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 67.6 mttm -49.01 -34.28 12.88 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.151 174.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 41' ' ' THR . 12.0 m-85 -122.83 1.79 9.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.745 0.307 . . . . 0.0 111.135 -173.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.486 HD13 ' O ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -95.63 129.57 45.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.666 -174.27 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.35 -8.3 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.061 0.458 . . . . 0.0 110.389 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.02 159.43 30.34 Favored Glycine 0 N--CA 1.453 -0.193 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.56 ' CB ' HD13 ' A' ' 63' ' ' LEU . 1.6 t80 -147.04 131.0 17.16 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.617 0.722 . . . . 0.0 111.281 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.711 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 38.2 m -129.42 144.17 51.14 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.341 -1.3 . . . . 0.0 107.82 174.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -127.73 121.62 30.79 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.434 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.813 ' HG3' ' HA ' ' A' ' 6' ' ' CYS . 1.2 pm0 -97.75 123.92 41.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.301 177.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.432 ' C ' ' H ' ' A' ' 29' ' ' ASN . 82.8 mt -103.72 159.54 15.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.507 -176.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.513 ' C ' HD22 ' A' ' 29' ' ' ASN . . . -78.04 32.82 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.445 0.64 . . . . 0.0 110.662 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.513 HD22 ' C ' ' A' ' 28' ' ' ALA . 0.9 OUTLIER -116.86 -30.37 5.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.167 -174.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -104.24 30.91 4.92 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -170.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.81 -60.06 0.67 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.741 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 0.5 OUTLIER -70.3 139.14 52.02 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 122.198 0.199 . . . . 0.0 111.058 178.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.36 -18.98 47.47 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.362 0.601 . . . . 0.0 109.419 176.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.3 pt -97.53 174.25 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.039 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -143.02 145.62 33.08 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.482 ' H ' ' HG2' ' A' ' 26' ' ' GLN . . . -142.55 177.11 8.51 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.078 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.962 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 42.6 mm -122.31 133.26 69.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.711 ' HB ' ' HB ' ' A' ' 24' ' ' THR . 72.9 mt -101.78 99.13 7.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.844 0.354 . . . . 0.0 110.091 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -91.76 114.06 26.49 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -86.56 113.49 22.51 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -176.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 41.5 p -79.75 162.08 25.36 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.142 0.496 . . . . 0.0 111.314 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -69.87 -2.66 12.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.829 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -93.67 7.26 45.44 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.777 176.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm 72.63 8.62 5.64 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.444 0.698 . . . . 0.0 111.002 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.77 120.74 36.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.03 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 p -79.94 105.57 11.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.358 0.599 . . . . 0.0 109.769 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 96.5 t -86.01 130.43 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.805 -176.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.9 m -82.1 92.22 6.8 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.855 0.835 . . . . 0.0 109.09 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.962 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -70.38 142.7 52.07 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.315 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.834 ' ND2' ' HB2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -81.79 151.79 68.23 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -174.178 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -89.76 39.16 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.562 2.174 . . . . 0.0 112.835 168.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.609 ' O ' ' HE2' ' A' ' 57' ' ' LYS . 64.9 mttm -131.97 -80.79 0.51 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.046 0.451 . . . . 0.0 111.234 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.673 HE22 ' CG2' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -40.1 139.31 0.71 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.664 1.186 . . . . 0.0 113.543 177.387 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.474 HG22 ' HD2' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -75.1 -16.93 60.53 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -172.395 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.594 ' CD1' ' HB2' ' A' ' 53' ' ' GLN . 60.7 p-90 -65.01 -30.82 71.82 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.586 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.673 ' CG2' HE22 ' A' ' 53' ' ' GLN . 0.9 OUTLIER -71.39 -47.94 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.914 174.019 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.609 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 68.3 mttm -54.41 -34.98 62.4 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 123.779 0.674 . . . . 0.0 110.386 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -68.33 -56.27 9.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.128 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.575 HG12 ' HD3' ' A' ' 17' ' ' PRO . 63.5 mt -64.57 -46.59 92.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.641 0.258 . . . . 0.0 111.486 -175.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.638 HG12 ' O ' ' A' ' 56' ' ' VAL . 12.7 p -71.4 -28.5 32.14 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.016 -174.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -68.9 -35.02 76.37 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.4 tp -72.1 -37.53 69.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.323 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.56 HD13 ' CB ' ' A' ' 23' ' ' PHE . 95.9 mt -82.4 -37.62 25.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.819 -177.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 C--N 1.324 -0.519 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.808 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.564 ' SG ' HG12 ' A' ' 34' ' ' ILE . 25.1 p . . . . . 0 N--CA 1.447 -0.578 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 46.8 t -61.7 126.29 26.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.624 177.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.451 HD23 ' H ' ' A' ' 8' ' ' LEU . 2.3 pt? -64.21 -24.91 67.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.929 -176.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.27 122.57 1.74 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.565 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.712 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 3.2 m-85 -79.15 -178.42 6.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.561 0.696 . . . . 0.0 110.306 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.2 t -107.38 -166.26 1.14 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.065 175.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -160.22 81.42 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 170.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.459 ' HB2' HD22 ' A' ' 15' ' ' LEU . 23.1 mmm180 -131.59 -173.99 3.28 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.479 -168.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.504 HD13 ' CD1' ' A' ' 55' ' ' TRP . 7.6 mm -126.89 86.3 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 113.647 -1.615 . . . . 0.0 107.872 160.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.63 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 1.9 mm? -91.2 169.92 10.44 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.694 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 63.1 m170 -134.25 170.21 11.88 Favored Pre-proline 0 C--N 1.311 -1.073 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.879 -175.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 31.6 Cg_exo -55.73 -26.89 58.76 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 121.951 1.767 . . . . 0.0 109.251 164.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.694 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 62.6 mttm -45.5 -38.25 6.07 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 113.95 -1.477 . . . . 0.0 112.085 172.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 41' ' ' THR . 14.0 m-85 -118.14 2.59 12.02 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -170.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.681 HG12 ' HB3' ' A' ' 39' ' ' PHE . 17.2 mt -106.45 122.53 60.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.874 0.369 . . . . 0.0 111.058 -175.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.57 -0.52 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.822 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -157.42 158.32 28.87 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.548 ' CB ' HD13 ' A' ' 63' ' ' LEU . 2.8 t80 -155.29 133.29 11.49 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.514 0.673 . . . . 0.0 110.545 -176.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.3 m -136.87 108.82 7.12 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.07 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 25' ' ' ARG . 0.4 OUTLIER -80.15 105.28 11.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.967 0.889 . . . . 0.0 110.464 -177.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.652 ' HB3' ' O ' ' A' ' 36' ' ' ALA . 0.7 OUTLIER -84.67 120.15 26.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.449 178.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.462 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 2.8 mm? -114.89 155.12 27.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.494 0.664 . . . . 0.0 112.036 -170.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.2 22.27 1.25 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.909 -175.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.462 ' ND2' ' HB3' ' A' ' 27' ' ' LEU . 7.8 p30 -127.08 -3.17 6.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -103.8 25.19 10.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.029 0.443 . . . . 0.0 110.974 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.14 -64.83 0.6 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.634 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.56 152.8 41.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.772 0.32 . . . . 0.0 111.288 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -90.97 -14.46 31.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.012 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.564 HG12 ' SG ' ' A' ' 6' ' ' CYS . 3.6 pt -111.71 140.31 31.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.409 ' HB2' ' HA ' ' A' ' 27' ' ' LEU . 9.6 p30 -110.43 126.97 54.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.314 0.578 . . . . 0.0 110.519 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.652 ' O ' ' HB3' ' A' ' 26' ' ' GLN . . . -127.11 132.01 50.69 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.683 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.44 HG23 ' HE1' ' A' ' 23' ' ' PHE . 47.0 mm -77.61 112.28 15.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.1 mm -90.21 97.79 7.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 122.044 -0.41 . . . . 0.0 111.087 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.681 ' HB3' HG12 ' A' ' 20' ' ' ILE . 16.7 m-85 -90.52 119.07 30.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 6.6 m-70 -89.31 115.1 26.54 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 15.0 p -84.86 159.47 20.37 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.774 0.797 . . . . 0.0 112.509 -171.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -67.9 -0.7 4.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.055 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -98.61 20.62 12.57 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.68 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt 67.9 22.64 8.6 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.58 175.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.32 173.65 8.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.724 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 40' ' ' HIS . 49.1 m -127.75 122.3 32.47 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 173.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.4 t -92.01 131.51 38.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.439 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.455 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 20.6 m -82.87 82.18 8.27 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.486 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -72.16 141.28 49.08 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.155 -173.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.712 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -82.41 131.42 55.68 Favored Pre-proline 0 CA--C 1.508 -0.671 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.733 -175.379 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 50' ' ' ASN . 5.8 Cg_exo -76.69 15.3 1.09 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.025 1.817 . . . . 0.0 111.632 169.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 50' ' ' ASN . 1.1 ttpp -89.82 -28.66 19.15 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.664 176.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.598 HE21 HG21 ' A' ' 56' ' ' VAL . 5.3 pt20 -105.95 138.8 41.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.746 -163.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.29 -29.81 66.65 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -173.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.63 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 46.0 p-90 -63.19 -33.76 76.17 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.421 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.598 HG21 HE21 ' A' ' 53' ' ' GLN . 2.7 t -70.17 -46.99 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.918 174.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.474 ' HA ' HG12 ' A' ' 60' ' ' VAL . 91.1 mttt -62.19 -29.06 70.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.855 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -68.19 -51.01 50.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.79 0.329 . . . . 0.0 110.419 173.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 55' ' ' TRP . 58.1 mt -68.53 -43.91 83.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.322 -175.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.544 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 14.9 p -68.22 -33.29 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.08 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -66.04 -40.19 90.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.103 0.478 . . . . 0.0 109.78 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.0 tp -66.69 -47.64 71.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.992 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.548 HD13 ' CB ' ' A' ' 23' ' ' PHE . 83.0 mt -65.5 -36.37 83.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.377 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.5 m . . . . . 0 C--N 1.32 -0.691 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.453 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.708 ' HA ' ' NE2' ' A' ' 26' ' ' GLN . 1.8 p . . . . . 0 CA--C 1.52 -0.18 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.479 ' C ' ' H ' ' A' ' 9' ' ' GLY . 73.4 m -62.84 155.39 27.1 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.609 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 1.2 pp -77.34 25.7 0.17 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.428 0.632 . . . . 0.0 110.638 173.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 7' ' ' CYS . . . 131.15 156.98 8.69 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -175.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.718 ' HB2' HD22 ' A' ' 50' ' ' ASN . 0.1 OUTLIER -105.96 172.03 7.03 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.53 178.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 t -84.66 -174.96 5.56 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.032 -172.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -135.66 70.99 1.42 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 173.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -131.65 178.51 6.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.541 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.576 HD13 ' CD1' ' A' ' 55' ' ' TRP . 5.2 mm -124.51 94.79 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.374 167.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.513 HD12 ' CH2' ' A' ' 55' ' ' TRP . 1.1 mt -106.75 158.08 17.24 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.877 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.77 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 26.4 m170 -132.19 178.81 1.58 Allowed Pre-proline 0 C--N 1.314 -0.969 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.716 -173.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.77 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 9.4 Cg_endo -55.42 -20.32 25.64 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.281 1.987 . . . . 0.0 110.046 164.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.634 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 22.0 mtpp -47.16 -27.03 1.29 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.308 172.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 41' ' ' THR . 55.2 m-85 -126.15 -10.85 6.47 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.427 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 16' ' ' HIS . 1.5 mp -95.13 128.42 46.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.046 0.45 . . . . 0.0 111.649 -170.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -122.53 -16.96 5.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.591 172.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -145.07 162.37 28.13 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.603 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -155.16 136.03 13.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.002 0.429 . . . . 0.0 111.006 -175.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.2 m -134.47 123.25 23.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.501 174.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 25' ' ' ARG . 6.6 ptp85 -91.18 91.89 8.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.612 0.72 . . . . 0.0 110.298 176.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.708 ' NE2' ' HA ' ' A' ' 6' ' ' CYS . 0.9 OUTLIER -68.76 121.61 16.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.95 179.2 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.7 mt -113.82 147.8 37.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.899 -168.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.83 46.84 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.159 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -139.32 -29.49 0.75 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.244 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -90.56 28.62 1.45 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -168.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.32 -37.99 2.7 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.74 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.7 m -91.14 158.56 16.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.856 0.36 . . . . 0.0 110.735 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -110.45 -12.39 14.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.539 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.555 HG13 ' HB2' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -105.93 133.42 50.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 174.119 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -108.54 136.84 47.48 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.929 0.395 . . . . 0.0 110.872 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 26' ' ' GLN . . . -140.19 140.19 35.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.94 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 45.8 mm -79.94 101.95 5.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -87.03 98.33 7.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 O-C-N 121.87 -0.519 . . . . 0.0 110.747 -176.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.492 ' HE2' HG22 ' A' ' 56' ' ' VAL . 11.3 m-85 -86.23 135.15 33.67 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -105.96 116.91 32.75 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 41.7 p -79.85 163.63 24.23 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.34 -172.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -63.57 -12.19 30.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.551 170.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -84.04 0.16 49.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.278 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 67.9 mttm 71.27 12.4 6.74 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.778 0.831 . . . . 0.0 111.368 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.7 mt -107.86 141.68 39.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.423 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.8 p -92.47 124.16 36.31 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.102 0.477 . . . . 0.0 110.721 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.4 t -105.16 134.1 47.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.43 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 69.6 m -85.32 86.2 7.39 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.582 0.706 . . . . 0.0 109.634 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.628 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -72.78 149.12 43.92 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.451 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.718 HD22 ' HB2' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -83.48 151.76 62.74 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.865 -172.295 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -88.91 32.16 0.39 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.263 1.975 . . . . 0.0 113.771 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.675 ' O ' ' HE3' ' A' ' 57' ' ' LYS . 50.9 mtpt -132.25 -61.43 0.87 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -174.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.64 HE22 ' CG2' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -56.49 143.14 36.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.55 0.691 . . . . 0.0 112.272 -179.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p -74.94 -20.49 59.67 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -172.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.576 ' CD1' HD13 ' A' ' 14' ' ' ILE . 60.4 p-90 -63.22 -32.47 73.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.068 176.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.64 ' CG2' HE22 ' A' ' 53' ' ' GLN . 1.0 OUTLIER -68.92 -46.31 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.922 174.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.675 ' HE3' ' O ' ' A' ' 52' ' ' LYS . 92.6 mttt -63.81 -24.55 67.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.573 -178.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -74.12 -49.83 22.09 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.547 174.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.47 HD11 ' O ' ' A' ' 15' ' ' LEU . 76.8 mt -65.66 -48.15 83.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.06 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.603 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 14.1 p -65.37 -29.14 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 120.579 0.228 . . . . 0.0 110.743 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 28.3 ttm180 -63.79 -43.92 94.89 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.4 mt -64.75 -43.33 93.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.69 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.491 ' HG ' ' CB ' ' A' ' 23' ' ' PHE . 3.9 mm? -57.48 -49.95 74.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.951 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.8 m . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.989 -176.461 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.836 ' HA ' ' CD ' ' A' ' 26' ' ' GLN . 30.2 p . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 121.452 0.644 . . . . 0.0 112.056 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.428 ' O ' HD11 ' A' ' 34' ' ' ILE . 74.1 m -57.0 143.2 39.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.209 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.3 mt -82.56 10.27 7.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.91 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.22 162.89 34.29 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.172 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.74 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 39.1 m-85 -116.19 -178.89 3.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.913 0.387 . . . . 0.0 110.304 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 49' ' ' ALA . 13.8 t -96.0 -178.68 4.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.135 176.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -144.83 23.37 1.56 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.073 0.463 . . . . 0.0 110.717 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.534 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 40.6 mtt180 -109.65 -174.08 2.41 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.76 0.791 . . . . 0.0 113.001 -173.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.553 HD13 ' CD1' ' A' ' 55' ' ' TRP . 6.2 mm -117.71 77.69 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 113.598 -1.637 . . . . 0.0 107.912 167.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.534 ' CD2' ' HB2' ' A' ' 13' ' ' ARG . 2.8 mm? -75.45 158.33 32.81 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.693 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 42.1 m170 -132.1 174.59 4.52 Favored Pre-proline 0 C--N 1.306 -1.285 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.857 -176.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.693 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 9.4 Cg_endo -54.52 -26.56 45.85 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.807 1.671 . . . . 0.0 108.954 166.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.657 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 67.4 mttm -46.27 -34.8 4.71 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 113.676 -1.602 . . . . 0.0 111.726 173.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -124.93 -4.6 7.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.632 0.253 . . . . 0.0 111.626 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.797 HG12 ' HB3' ' A' ' 39' ' ' PHE . 11.6 mt -102.83 114.86 43.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.071 0.462 . . . . 0.0 110.86 -173.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.9 -5.36 11.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.63 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -150.8 159.94 28.38 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.476 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 2.3 t80 -154.66 137.07 14.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.222 0.534 . . . . 0.0 110.483 -176.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.2 m -143.82 104.01 4.12 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.674 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -73.77 104.13 4.56 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.898 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.836 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 11.0 tt0 -90.14 125.88 35.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.216 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.9 mp -105.93 173.97 6.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.46 0.647 . . . . 0.0 112.156 -170.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.43 16.82 21.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.286 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -118.11 7.55 12.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.287 -173.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -119.63 37.49 4.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.174 0.511 . . . . 0.0 110.751 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.68 -62.31 0.29 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.052 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -71.64 143.75 49.66 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -97.27 9.78 41.3 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -170.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.768 HG12 ' SG ' ' A' ' 6' ' ' CYS . 4.5 pt -128.23 156.83 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 172.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -120.23 122.25 40.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.194 0.521 . . . . 0.0 111.524 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.535 ' O ' ' HB3' ' A' ' 26' ' ' GLN . . . -121.2 137.11 54.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.809 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.637 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 48.0 mm -82.6 98.56 4.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.158 0.504 . . . . 0.0 109.905 178.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.49 HG23 ' HB2' ' A' ' 46' ' ' SER . 67.0 mt -76.91 105.83 6.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.036 0.446 . . . . 0.0 111.273 -176.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.797 ' HB3' HG12 ' A' ' 20' ' ' ILE . 19.8 m-85 -96.29 119.42 34.75 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -89.01 106.09 18.2 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.9 p -72.57 164.0 27.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.645 -175.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -71.47 6.54 1.77 Allowed 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.421 0.629 . . . . 0.0 110.55 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -101.81 9.41 40.8 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.126 173.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 68.41 14.07 9.09 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.663 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.5 mt -103.05 131.48 50.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.051 0.453 . . . . 0.0 110.699 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.49 ' HB2' HG23 ' A' ' 38' ' ' ILE . 5.7 p -80.58 102.54 9.85 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.541 177.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 77.8 t -84.93 124.03 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.743 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 25.8 m -88.82 90.58 8.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.739 0.781 . . . . 0.0 109.496 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.637 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -70.87 134.82 47.62 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.818 -174.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.74 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -70.26 129.15 90.8 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.22 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 50' ' ' ASN . 21.8 Cg_exo -65.39 -6.5 13.58 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.387 2.058 . . . . 0.0 112.676 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -76.43 -37.56 56.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.777 0.799 . . . . 0.0 111.254 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.617 HE21 HG21 ' A' ' 56' ' ' VAL . 7.0 mt-30 -72.79 134.96 45.16 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.862 -164.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.22 -26.62 60.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.861 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.553 ' CD1' HD13 ' A' ' 14' ' ' ILE . 55.8 p-90 -65.31 -32.45 74.1 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 173.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.617 HG21 HE21 ' A' ' 53' ' ' GLN . 43.2 t -70.04 -50.5 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.829 173.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.549 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 96.5 mttt -59.3 -28.08 66.46 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.696 0.622 . . . . 0.0 111.281 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -71.06 -56.86 5.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.7 0.286 . . . . 0.0 110.309 173.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.673 HG22 HD22 ' A' ' 63' ' ' LEU . 81.9 mt -60.19 -45.95 95.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 -177.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.539 HG12 ' O ' ' A' ' 56' ' ' VAL . 9.8 p -70.3 -26.42 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.362 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -60.55 -43.11 97.6 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 174.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.2 mt -72.78 -41.2 65.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.489 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.673 HD22 HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -62.31 -46.4 88.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.348 -0.387 . . . . 0.0 112.043 -179.017 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 p . . . . . 0 C--N 1.323 -0.586 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -173.21 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.579 ' HB3' ' HG2' ' A' ' 26' ' ' GLN . 30.1 p . . . . . 0 N--CA 1.444 -0.754 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.8 t -50.74 114.14 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.607 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.1 mt -90.45 17.92 6.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.662 -176.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.54 113.39 0.7 Allowed Glycine 0 C--O 1.225 -0.415 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.772 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 33.6 m-85 -85.27 168.68 14.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.126 0.489 . . . . 0.0 111.239 -173.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 49' ' ' ALA . 11.1 t -86.75 -177.48 6.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.938 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -141.23 16.57 2.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.935 -177.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.592 ' HB3' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -104.76 175.16 5.58 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.213 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.549 HD13 ' CD1' ' A' ' 55' ' ' TRP . 2.8 mm -110.34 90.07 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 113.813 -1.539 . . . . 0.0 108.173 161.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.592 HD22 ' HB3' ' A' ' 13' ' ' ARG . 2.5 mm? -88.97 167.2 13.39 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.599 ' O ' HD13 ' A' ' 20' ' ' ILE . 63.2 m170 -133.07 167.83 21.01 Favored Pre-proline 0 C--N 1.314 -0.947 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.0 -175.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.661 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 22.8 Cg_endo -63.42 -19.07 67.29 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.121 1.881 . . . . 0.0 109.214 165.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 85.6 mttt -55.35 -24.66 30.47 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.417 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' A' ' 41' ' ' THR . 50.2 m-85 -128.29 2.53 5.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.946 -175.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.661 ' HB ' ' HA ' ' A' ' 17' ' ' PRO . 1.0 OUTLIER -100.85 122.78 53.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.098 0.475 . . . . 0.0 110.587 -175.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.03 -9.96 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.67 175.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -148.43 161.28 28.6 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.41 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.542 ' CE2' HG23 ' A' ' 60' ' ' VAL . 1.8 t80 -156.05 134.01 11.25 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -176.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.545 HG22 ' OE1' ' A' ' 26' ' ' GLN . 22.9 m -141.02 112.69 7.58 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.399 176.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 11.7 ttp180 -101.73 117.65 35.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.936 0.398 . . . . 0.0 111.202 -176.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.579 ' HG2' ' HB3' ' A' ' 6' ' ' CYS . 1.2 mp0 -97.75 139.01 34.26 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.806 174.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.536 HD13 ' HG3' ' A' ' 30' ' ' GLU . 5.2 mp -124.64 159.54 30.53 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 123.628 0.58 . . . . 0.0 109.767 -177.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.739 ' HA ' ' O ' ' A' ' 32' ' ' CYS . . . -77.01 1.08 18.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.818 0.818 . . . . 0.0 110.722 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -116.44 2.77 13.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.619 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.536 ' HG3' HD13 ' A' ' 27' ' ' LEU . 7.1 mm-40 -107.48 -8.75 16.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.849 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.12 -56.74 0.47 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.154 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.739 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 9.5 t -57.99 151.07 19.24 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 122.88 0.472 . . . . 0.0 109.98 174.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -84.39 -21.74 30.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.092 0.472 . . . . 0.0 109.911 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.428 HG13 ' SG ' ' A' ' 6' ' ' CYS . 46.9 pt -110.41 -171.46 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 173.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -138.86 119.29 13.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.445 0.64 . . . . 0.0 110.477 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.74 137.53 53.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.055 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.525 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 15.5 mm -96.47 92.32 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.217 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.443 HD12 HE22 ' A' ' 26' ' ' GLN . 40.5 mt -79.63 101.16 4.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.852 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.472 ' CE1' ' HD2' ' A' ' 23' ' ' PHE . 20.8 m-85 -85.13 131.2 34.48 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 171.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -100.02 107.89 19.94 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 41.1 p -71.14 159.21 35.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.762 -174.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -3.08 12.28 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.576 0.703 . . . . 0.0 109.642 171.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -90.97 1.22 57.22 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.112 174.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 70.42 16.32 7.13 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.638 -1.164 . . . . 0.0 112.057 173.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.8 mt -107.2 136.56 46.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.825 175.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.8 p -84.47 120.82 26.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.062 0.458 . . . . 0.0 110.477 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 91.0 t -104.2 124.36 58.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.962 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.5 m -85.53 82.79 8.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.661 0.743 . . . . 0.0 109.385 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.601 ' HA ' HG22 ' A' ' 11' ' ' THR . . . -69.64 143.55 53.19 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.034 -173.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.772 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -81.29 128.33 70.72 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.924 -176.046 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -71.19 13.49 0.4 Allowed 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.761 2.308 . . . . 0.0 112.303 173.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 50' ' ' ASN . 55.6 mtpt -99.47 -23.94 14.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.172 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.581 HE21 HG21 ' A' ' 56' ' ' VAL . 5.0 pt20 -102.63 145.77 29.16 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.737 -167.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.3 -30.83 63.66 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.638 -171.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.578 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 42.6 p-90 -63.34 -32.87 74.41 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.368 177.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.589 ' CG2' ' HB1' ' A' ' 49' ' ' ALA . 8.6 t -72.09 -46.14 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.38 174.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.511 ' HA ' HG12 ' A' ' 60' ' ' VAL . 88.6 mttt -60.5 -34.65 74.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.903 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -64.37 -50.07 69.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.395 174.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 55' ' ' TRP . 68.0 mt -68.88 -45.96 79.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.481 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.542 HG23 ' CE2' ' A' ' 23' ' ' PHE . 12.8 p -65.65 -35.35 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.89 -0.141 . . . . 0.0 111.297 -178.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -65.39 -33.84 76.89 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 30.6 tp -74.64 -38.1 62.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.236 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.443 ' HG ' ' CB ' ' A' ' 23' ' ' PHE . 2.8 mm? -69.52 -26.17 64.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.55 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.1 p . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 121.322 0.582 . . . . 0.0 110.25 175.948 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.703 ' SG ' HG12 ' A' ' 34' ' ' ILE . 19.6 p . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.0 t -62.63 152.69 34.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.328 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.9 mt -74.97 2.14 11.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.45 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.13 -153.92 12.31 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.825 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 64.0 m-85 -137.37 -171.47 2.98 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.525 HG21 ' CG1' ' A' ' 47' ' ' VAL . 11.2 t -127.19 136.88 52.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.075 0.464 . . . . 0.0 111.045 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -101.97 56.65 0.81 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.822 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.543 ' NE ' ' HA ' ' A' ' 13' ' ' ARG . 3.3 mmp_? -122.65 -177.16 3.57 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.517 0.675 . . . . 0.0 112.088 -177.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.599 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.5 mm -125.4 87.2 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 114.228 -1.351 . . . . 0.0 107.789 167.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.585 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.8 mm? -88.14 161.0 17.53 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.705 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 48.4 m170 -131.77 174.8 4.28 Favored Pre-proline 0 C--N 1.31 -1.115 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.275 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.705 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 10.1 Cg_endo -56.05 -23.22 42.83 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.8 1.667 . . . . 0.0 108.99 167.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.666 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 9.5 mmmt -47.35 -26.59 1.32 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 113.541 -1.663 . . . . 0.0 112.245 173.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 41' ' ' THR . 86.4 m-85 -126.86 -11.35 6.03 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 122.195 -0.316 . . . . 0.0 111.682 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.555 HG13 ' HB3' ' A' ' 39' ' ' PHE . 1.4 mp -89.65 122.59 41.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.062 0.458 . . . . 0.0 110.988 -171.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.53 -8.07 8.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.769 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -154.19 155.59 26.28 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.737 ' HB2' HD13 ' A' ' 63' ' ' LEU . 2.4 t80 -147.67 137.54 22.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.908 0.385 . . . . 0.0 110.278 -177.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 50.3 m -145.22 110.58 5.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.577 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -83.9 139.3 32.7 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.658 ' NE2' ' HA ' ' A' ' 6' ' ' CYS . 1.9 pt20 -119.26 108.41 14.6 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.784 0.802 . . . . 0.0 110.704 177.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 86.2 mt -98.24 165.04 12.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.958 -175.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.791 ' HA ' ' O ' ' A' ' 32' ' ' CYS . . . -82.7 11.31 6.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.586 -177.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -108.58 -19.87 13.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.839 0.352 . . . . 0.0 111.73 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -134.39 30.77 3.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.118 0.485 . . . . 0.0 111.769 -170.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.72 -86.83 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 119.933 -1.127 . . . . 0.0 113.119 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.791 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 42.2 t -105.64 170.11 8.08 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.572 -0.314 . . . . 0.0 110.904 -175.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.402 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 9.5 m-20 -83.59 -21.87 32.47 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.096 0.247 . . . . 0.0 111.618 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.703 HG12 ' SG ' ' A' ' 6' ' ' CYS . 2.0 pt -100.0 157.33 3.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 17.6 p30 -115.26 130.54 56.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.367 0.603 . . . . 0.0 111.246 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.565 ' HB3' ' OE1' ' A' ' 26' ' ' GLN . . . -139.08 166.46 24.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.597 175.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.536 HG23 ' HE1' ' A' ' 23' ' ' PHE . 43.5 mm -113.88 106.19 20.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.161 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 66.0 mt -83.64 105.08 12.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 O-C-N 121.734 -0.603 . . . . 0.0 111.238 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.555 ' HB3' HG13 ' A' ' 20' ' ' ILE . 14.0 m-85 -94.96 111.85 23.61 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 171.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -84.45 112.98 20.86 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 28.2 p -76.33 166.01 24.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.128 0.49 . . . . 0.0 111.123 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -71.14 2.97 3.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.617 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.0 mmtp -98.82 5.64 47.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.568 176.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 67.2 mttm 68.42 12.58 8.77 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.805 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.5 mt -97.82 130.65 44.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.022 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.4 p -86.66 106.64 17.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.298 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.525 ' CG1' HG21 ' A' ' 11' ' ' THR . 66.4 t -86.82 124.93 40.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.9 m -88.61 83.89 6.76 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.718 0.771 . . . . 0.0 109.985 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.572 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -69.82 141.59 53.27 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.397 -175.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.825 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -80.53 130.21 65.72 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.083 -179.075 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -73.2 23.47 0.31 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.831 1.688 . . . . 0.0 111.666 171.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 50' ' ' ASN . 32.2 mtmm -115.24 -17.21 11.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.547 -176.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.554 HE21 HG21 ' A' ' 56' ' ' VAL . 5.8 pt20 -109.5 145.23 36.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 -170.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.69 ' HA ' ' HG2' ' A' ' 57' ' ' LYS . 1.3 p -81.5 -23.1 37.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -170.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.599 ' CD1' HD13 ' A' ' 14' ' ' ILE . 54.9 p-90 -63.19 -32.83 74.33 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 173.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.572 ' CG2' ' HB1' ' A' ' 49' ' ' ALA . 25.3 t -69.16 -46.98 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.792 172.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.69 ' HG2' ' HA ' ' A' ' 54' ' ' THR . 6.9 mmtp -55.89 -38.47 70.22 Favored 'General case' 0 C--O 1.222 -0.383 0 O-C-N 123.426 0.454 . . . . 0.0 110.737 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -65.22 -53.81 38.93 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.707 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.499 HG22 HD12 ' A' ' 63' ' ' LEU . 78.9 mt -62.74 -45.71 98.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.874 -177.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.554 HG12 ' O ' ' A' ' 56' ' ' VAL . 12.5 p -70.02 -24.9 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 120.911 -0.315 . . . . 0.0 110.903 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 49.8 ttp180 -64.45 -35.14 79.95 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.16 0.505 . . . . 0.0 110.256 176.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.6 mt -84.42 -25.22 29.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.968 177.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.737 HD13 ' HB2' ' A' ' 23' ' ' PHE . 77.5 mt -87.68 -31.28 19.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.307 -176.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 121.215 0.531 . . . . 0.0 109.74 178.074 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.824 ' HA ' ' CD ' ' A' ' 26' ' ' GLN . 26.6 p . . . . . 0 C--O 1.231 0.118 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.479 ' O ' HD11 ' A' ' 34' ' ' ILE . 43.1 t -73.03 127.75 33.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.088 171.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.7 mt -81.93 45.34 0.9 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.146 0.498 . . . . 0.0 110.742 -174.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 166.26 157.65 10.37 Favored Glycine 0 N--CA 1.44 -1.048 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.833 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 25.2 m-85 -123.87 162.33 23.5 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 117.159 0.479 . . . . 0.0 110.488 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.5 t -90.18 -175.58 4.58 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.404 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -144.78 31.18 1.17 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.553 0.692 . . . . 0.0 109.813 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.595 ' HB2' HD22 ' A' ' 15' ' ' LEU . 35.2 mmt180 -87.68 -176.6 5.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.714 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.494 HD13 ' CD1' ' A' ' 55' ' ' TRP . 16.4 mm -124.93 77.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.654 165.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.741 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.2 mm? -74.76 153.7 38.68 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.057 -178.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.692 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 42.9 m170 -132.66 173.63 5.66 Favored Pre-proline 0 C--N 1.317 -0.847 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.622 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.692 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 13.0 Cg_endo -58.86 -23.84 69.33 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 121.718 1.612 . . . . 0.0 108.825 167.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.674 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 8.7 mmmt -47.22 -34.4 6.38 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 113.434 -1.712 . . . . 0.0 111.931 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.687 ' HA ' ' HE3' ' A' ' 42' ' ' LYS . 27.0 m-85 -125.44 -0.2 7.59 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.655 0.264 . . . . 0.0 111.338 -175.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.507 HD13 ' O ' ' A' ' 16' ' ' HIS . 1.3 mp -96.46 126.75 49.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.0 0.428 . . . . 0.0 110.635 -175.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.12 -6.8 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.999 174.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -157.73 154.27 25.38 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.542 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.606 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -145.02 132.99 21.29 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.477 0.656 . . . . 0.0 110.386 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.7 m -132.93 121.06 22.27 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.469 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -86.68 114.03 23.04 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.508 0.671 . . . . 0.0 110.412 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.824 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 21.6 tt0 -104.27 121.91 44.31 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.876 177.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.5 mp -109.31 178.65 4.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.946 -170.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -111.52 26.58 10.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.922 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -130.7 -12.82 3.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.489 -175.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -115.05 23.51 12.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.462 -174.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.42 -91.79 0.11 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.358 177.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 6' ' ' CYS . 18.5 m -66.16 169.56 6.89 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.997 0.427 . . . . 0.0 111.976 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -99.22 -6.02 28.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.089 176.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.479 HD11 ' O ' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -108.61 153.41 10.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 174.561 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.497 ' OD1' ' HG2' ' A' ' 51' ' ' PRO . 4.8 p30 -127.09 129.64 48.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.801 -0.181 . . . . 0.0 111.28 -173.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.762 ' O ' ' HB3' ' A' ' 26' ' ' GLN . . . -134.68 127.37 30.93 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.244 0.545 . . . . 0.0 111.962 176.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.408 HG23 ' HE1' ' A' ' 23' ' ' PHE . 48.3 mm -70.05 117.61 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 170.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 55.8 mt -94.42 104.41 15.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 120.834 0.349 . . . . 0.0 111.117 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.703 ' CE2' HG12 ' A' ' 56' ' ' VAL . 12.1 m-85 -93.98 127.73 39.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 173.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -98.03 108.81 21.6 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.1 p -74.0 160.15 31.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.068 -174.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.687 ' HE3' ' HA ' ' A' ' 19' ' ' PHE . 18.0 ptpt -66.07 -3.03 4.71 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.317 172.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -89.66 0.54 56.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.633 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.546 ' NZ ' ' HB2' ' A' ' 44' ' ' LYS . 8.3 mtmp? 71.89 15.6 5.69 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.981 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.0 mt -107.88 136.66 47.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.904 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.1 p -87.16 118.57 26.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.301 0.572 . . . . 0.0 110.007 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 76.5 t -97.24 134.05 36.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.083 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.3 m -89.12 87.44 7.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.424 ' HB1' ' CG1' ' A' ' 56' ' ' VAL . . . -79.49 143.07 35.25 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.409 -174.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.833 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -82.53 122.19 78.6 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.524 -174.2 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HG2' ' OD1' ' A' ' 35' ' ' ASN . 19.8 Cg_exo -70.18 9.8 0.62 Allowed 'Trans proline' 0 C--N 1.329 -0.479 0 C-N-CA 122.279 1.986 . . . . 0.0 112.368 175.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 50' ' ' ASN . 51.3 mttm -104.33 -14.27 15.83 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.406 -176.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.749 ' CG ' ' HB2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -89.53 168.13 12.42 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -176.454 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.23 -33.51 14.65 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.741 ' CZ3' ' HB2' ' A' ' 15' ' ' LEU . 59.3 p-90 -62.19 -28.58 69.77 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.823 -177.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.718 HG21 ' O ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -71.04 -49.91 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 174.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 93.9 mttt -55.03 -33.85 63.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.687 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -64.37 -52.67 57.12 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.211 0.529 . . . . 0.0 110.486 174.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.536 HG12 ' HD3' ' A' ' 17' ' ' PRO . 87.7 mt -65.85 -48.96 80.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.74 -176.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.606 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 7.8 p -65.53 -28.37 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.836 0.35 . . . . 0.0 110.754 -176.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -69.03 -35.43 76.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.212 0.53 . . . . 0.0 109.672 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.4 tp -79.02 -32.63 45.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.995 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 1.9 mm? -67.63 -42.5 82.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.275 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.7 p . . . . . 0 C--N 1.323 -0.545 0 CA-C-O 120.894 0.378 . . . . 0.0 110.901 -179.969 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.767 ' HB2' HG12 ' A' ' 34' ' ' ILE . 18.7 p . . . . . 0 N--CA 1.441 -0.892 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.1 t -106.54 158.37 16.97 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.927 -0.483 . . . . 0.0 110.425 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.7 mt -77.73 -27.94 50.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.933 0.397 . . . . 0.0 110.828 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.83 136.3 4.08 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.784 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 20.1 m-85 -78.47 173.63 12.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.486 0.66 . . . . 0.0 111.047 -177.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.8 t -89.02 -178.55 5.72 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.94 174.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -140.63 1.86 1.76 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.011 0.434 . . . . 0.0 110.169 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.603 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 32.7 mtt180 -94.23 -172.42 2.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.641 -166.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.614 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.3 mm -117.64 88.79 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.599 -1.182 . . . . 0.0 107.982 167.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.603 ' CD2' ' HB2' ' A' ' 13' ' ' ARG . 2.9 mm? -88.34 164.77 15.39 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.732 ' ND1' ' HD2' ' A' ' 18' ' ' LYS . 63.2 m170 -132.97 163.63 49.66 Favored Pre-proline 0 C--N 1.311 -1.105 0 C-N-CA 119.831 -0.748 . . . . 0.0 112.151 -174.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.612 ' HD3' HG12 ' A' ' 59' ' ' ILE . 26.7 Cg_endo -64.28 -17.18 58.75 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.213 1.942 . . . . 0.0 109.174 167.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.732 ' HD2' ' ND1' ' A' ' 16' ' ' HIS . 60.8 mttm -51.66 -29.23 17.14 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.361 172.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -128.01 11.37 6.55 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.62 -174.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.641 HG12 ' O ' ' A' ' 16' ' ' HIS . 7.5 mm -106.69 127.64 62.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -173.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.3 m -118.56 -3.49 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.146 0.498 . . . . 0.0 110.934 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -155.29 158.91 28.76 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.004 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.739 ' HB2' HD13 ' A' ' 63' ' ' LEU . 1.4 t80 -155.47 134.68 12.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.239 0.542 . . . . 0.0 110.183 -177.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.449 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 25.5 m -142.06 107.08 4.93 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.867 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 14.1 ptp180 -77.02 109.03 10.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.827 0.822 . . . . 0.0 110.112 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.589 ' OE1' ' HB3' ' A' ' 36' ' ' ALA . 2.4 tt0 -99.05 133.11 43.79 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.218 -175.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.0 mt -122.18 158.9 28.36 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -159.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.72 31.24 4.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.737 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -99.41 -73.42 0.63 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.745 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -110.9 23.12 14.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.574 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -129.53 -71.93 0.13 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.345 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 47.3 t -128.63 -172.08 2.62 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.441 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 0.9 OUTLIER -96.85 -23.55 16.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.957 0.408 . . . . 0.0 109.923 178.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.767 HG12 ' HB2' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -109.03 159.75 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 175.352 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -132.56 132.13 42.24 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.915 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.589 ' HB3' ' OE1' ' A' ' 26' ' ' GLN . . . -129.1 145.13 51.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.415 0.626 . . . . 0.0 111.63 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.691 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 47.9 mm -88.79 104.77 15.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.861 177.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.449 ' HB ' ' HB ' ' A' ' 24' ' ' THR . 58.1 mt -79.65 103.05 6.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 O-C-N 122.108 -0.37 . . . . 0.0 111.386 -176.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -91.65 123.82 35.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 171.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -97.66 108.93 21.76 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.2 p -75.84 157.49 33.29 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.116 0.484 . . . . 0.0 111.37 -175.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -68.17 -10.33 53.44 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 43' ' ' LYS . 23.0 ttmm -89.92 14.18 12.77 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.702 -177.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp 71.0 13.55 6.94 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.046 173.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.5 mt -112.66 142.15 45.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.968 0.413 . . . . 0.0 111.042 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.0 p -99.13 112.64 24.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.222 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.2 t -92.48 120.31 41.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.354 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.9 m -83.44 89.21 7.02 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.808 0.813 . . . . 0.0 109.269 177.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.691 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -71.18 140.33 50.47 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.387 -174.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.784 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -79.97 126.06 80.6 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.175 -179.213 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.1 13.98 0.48 Allowed 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.321 2.014 . . . . 0.0 111.613 174.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 50' ' ' ASN . 74.8 mttt -100.5 -21.51 15.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.136 -175.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.616 HE21 HG21 ' A' ' 56' ' ' VAL . 5.8 pt20 -109.57 148.46 31.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.646 -167.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p -75.03 -33.65 61.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -170.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.614 ' CD1' HD13 ' A' ' 14' ' ' ILE . 49.7 p-90 -61.34 -32.58 72.47 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.352 0.596 . . . . 0.0 109.491 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.626 HG22 ' HB1' ' A' ' 49' ' ' ALA . 14.7 t -70.51 -51.29 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.171 174.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 95.2 mttt -58.05 -32.12 67.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.968 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -68.04 -56.37 9.15 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.395 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.612 HG12 ' HD3' ' A' ' 17' ' ' PRO . 72.5 mt -61.02 -43.34 95.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.222 -176.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.641 HG23 ' CE1' ' A' ' 23' ' ' PHE . 13.8 p -65.45 -35.03 74.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.374 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -68.63 -33.08 73.41 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.989 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 29.8 mt -77.66 -33.44 53.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.094 0.473 . . . . 0.0 110.701 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.739 HD13 ' HB2' ' A' ' 23' ' ' PHE . 78.7 mt -79.24 -12.49 59.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.989 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--N 1.32 -0.691 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.526 173.079 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.642 ' HB3' ' HG2' ' A' ' 26' ' ' GLN . 18.5 p . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.2 m -41.26 98.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 -169.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.1 mt -63.65 -37.28 86.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.548 173.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.38 85.58 0.42 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.775 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.5 ' HB2' ' ND2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -88.11 155.03 20.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.994 0.426 . . . . 0.0 111.254 177.504 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.454 HG21 HG13 ' A' ' 47' ' ' VAL . 14.9 t -91.11 141.94 28.28 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -166.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -104.58 74.57 1.16 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.68 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.407 ' HD2' HD21 ' A' ' 15' ' ' LEU . 99.5 mtt180 -123.44 -171.8 2.38 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.055 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.537 HD13 ' CD1' ' A' ' 55' ' ' TRP . 8.2 mm -126.54 91.78 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.147 165.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.623 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 1.7 mm? -98.15 162.77 13.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.77 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 34.2 m170 -132.63 175.46 3.69 Favored Pre-proline 0 C--N 1.317 -0.841 0 O-C-N 122.054 -0.404 . . . . 0.0 110.757 -178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.77 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 18.9 Cg_endo -60.25 -16.95 43.68 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.106 1.871 . . . . 0.0 109.453 166.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.608 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 9.1 mtmt -45.91 -35.54 4.69 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 114.111 -1.404 . . . . 0.0 111.779 172.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -126.68 2.22 6.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.024 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.626 ' HB ' ' HA ' ' A' ' 17' ' ' PRO . 1.2 mp -92.44 124.32 44.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.81 0.338 . . . . 0.0 110.116 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.3 m -121.34 -1.18 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.977 0.418 . . . . 0.0 110.333 176.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.92 157.94 29.48 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.676 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.751 ' HB2' HD13 ' A' ' 63' ' ' LEU . 2.8 t80 -151.01 134.29 16.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.193 0.521 . . . . 0.0 110.564 -177.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.42 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 32.2 m -146.15 102.32 3.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.265 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -74.58 126.7 31.37 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.711 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.642 ' HG2' ' HB3' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -101.35 126.87 48.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.689 -177.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.3 mp -125.17 153.42 43.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.335 0.588 . . . . 0.0 111.712 -171.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.41 ' HA ' ' C ' ' A' ' 32' ' ' CYS . . . -64.57 -23.58 67.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.328 174.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.418 ' N ' HD22 ' A' ' 29' ' ' ASN . 0.9 OUTLIER -67.38 -24.87 65.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.366 -176.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -102.72 -32.62 9.76 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.866 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.38 41.24 0.02 OUTLIER Glycine 0 C--O 1.221 -0.682 0 C-N-CA 119.998 -1.096 . . . . 0.0 112.306 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.576 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 53.8 t -133.8 -179.71 5.71 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 173.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -118.23 -32.18 4.77 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.974 169.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.5 pt -95.75 -156.58 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 169.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -150.93 137.36 18.63 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.115 0.483 . . . . 0.0 110.132 174.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.49 145.11 33.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.071 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.809 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 46.4 mm -93.57 108.25 20.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.42 ' HB ' ' O ' ' A' ' 24' ' ' THR . 33.6 mm -85.91 99.03 7.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 O-C-N 121.982 -0.449 . . . . 0.0 110.636 -177.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.434 ' HB3' HG13 ' A' ' 20' ' ' ILE . 17.1 m-85 -90.59 122.9 33.8 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 174.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -93.6 107.35 19.22 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.5 p -79.36 164.58 23.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.119 0.485 . . . . 0.0 111.698 -174.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -72.86 -1.63 17.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 122.151 0.976 . . . . 0.0 108.59 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.42 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 12.6 tptt -86.14 9.0 18.71 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.505 173.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.8 pttm 46.89 34.04 2.48 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.455 1.102 . . . . 0.0 111.686 -173.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 43' ' ' LYS . 94.0 mt -119.47 131.13 55.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.072 175.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.9 p -84.9 105.69 15.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.382 0.611 . . . . 0.0 110.651 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.454 HG13 HG21 ' A' ' 11' ' ' THR . 54.3 t -79.62 126.28 39.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.601 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 58.8 m -84.67 88.86 7.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.809 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -76.72 134.67 39.14 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.629 -176.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.594 HD22 ' N ' ' A' ' 50' ' ' ASN . 0.7 OUTLIER -77.35 134.99 66.01 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.106 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -74.25 7.29 2.62 Favored 'Trans proline' 0 C--N 1.33 -0.398 0 C-N-CA 122.502 2.135 . . . . 0.0 110.614 168.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -90.3 -17.48 27.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.265 -177.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.527 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 6.2 pt20 -118.83 150.72 39.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.859 -168.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.766 ' HA ' ' HG2' ' A' ' 57' ' ' LYS . 1.7 p -91.45 -17.75 25.27 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -170.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.623 ' CZ3' ' HB2' ' A' ' 15' ' ' LEU . 58.1 p-90 -63.62 -32.8 74.38 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 172.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.544 ' O ' HG12 ' A' ' 60' ' ' VAL . 38.9 t -66.52 -47.28 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.839 171.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.766 ' HG2' ' HA ' ' A' ' 54' ' ' THR . 13.4 mmtp -54.45 -39.0 66.98 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.168 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.52 ' HD1' HH21 ' A' ' 61' ' ' ARG . 5.8 t80 -67.41 -53.69 26.94 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.087 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.568 HG22 HD12 ' A' ' 63' ' ' LEU . 71.0 mt -61.34 -45.16 99.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.954 -176.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 56' ' ' VAL . 12.0 p -70.15 -23.47 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 120.784 0.326 . . . . 0.0 110.688 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.52 HH21 ' HD1' ' A' ' 58' ' ' TYR . 43.5 ttp180 -66.46 -29.64 69.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.136 0.493 . . . . 0.0 110.113 175.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.3 mp -87.58 -36.74 17.37 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.599 174.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.751 HD13 ' HB2' ' A' ' 23' ' ' PHE . 91.0 mt -81.8 2.12 31.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.646 -176.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 120.701 0.286 . . . . 0.0 111.054 175.045 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.646 ' HA ' ' CD ' ' A' ' 26' ' ' GLN . 22.0 p . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 37.7 m -74.96 148.26 40.14 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.211 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.6 mt -70.69 -9.26 56.75 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.153 0.501 . . . . 0.0 110.681 176.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.62 160.27 28.53 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.942 ' HB2' HD22 ' A' ' 50' ' ' ASN . 0.3 OUTLIER -113.65 158.62 20.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.716 0.258 . . . . 0.0 110.846 177.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 t -88.94 145.56 25.45 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -168.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -95.12 66.2 2.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.662 0.744 . . . . 0.0 109.46 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.492 ' C ' HD12 ' A' ' 14' ' ' ILE . 36.2 mtp180 -130.85 -178.08 4.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.523 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.559 HG22 ' CD2' ' A' ' 16' ' ' HIS . 2.4 mp -121.89 91.39 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 163.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.511 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 3.5 mm? -72.14 155.87 39.79 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.031 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.763 ' HB2' ' HG2' ' A' ' 18' ' ' LYS . 65.5 m170 -131.64 159.22 72.83 Favored Pre-proline 0 C--N 1.315 -0.898 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.905 -168.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.51 -30.47 74.12 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.553 2.169 . . . . 0.0 109.882 167.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.763 ' HG2' ' HB2' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -62.95 -18.32 63.02 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.226 178.353 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -118.84 -13.3 9.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.582 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.501 HG12 ' HB3' ' A' ' 39' ' ' PHE . 23.4 mt -97.83 127.43 50.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.025 0.44 . . . . 0.0 111.249 -172.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.9 p -111.61 -16.81 8.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.419 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.48 150.89 21.85 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.584 -0.607 . . . . 0.0 111.584 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.546 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -134.15 134.79 42.58 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.253 0.549 . . . . 0.0 110.637 -178.461 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.425 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 20.6 m -139.86 112.61 7.99 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.099 175.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 25' ' ' ARG . 9.0 ptp180 -75.78 130.27 38.36 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.014 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.646 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -101.03 127.02 47.74 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.898 179.161 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.2 mp -117.86 169.13 9.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.854 0.359 . . . . 0.0 111.125 -170.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.7 29.72 1.12 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.615 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -127.25 -53.9 1.38 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.251 -174.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -83.82 36.38 0.55 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.189 0.518 . . . . 0.0 111.707 -172.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.88 -96.28 0.16 Allowed Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.312 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 42.2 t -70.77 160.83 31.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.496 -0.352 . . . . 0.0 110.772 -178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -92.36 0.39 57.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.597 -177.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.457 HG12 ' SG ' ' A' ' 6' ' ' CYS . 3.4 pt -116.2 167.91 8.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -132.79 136.94 46.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.973 0.416 . . . . 0.0 111.556 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.502 ' HA ' ' HG3' ' A' ' 51' ' ' PRO . . . -138.56 164.78 28.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.634 172.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.671 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 49.9 mm -96.9 112.06 28.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.483 HD11 HE21 ' A' ' 26' ' ' GLN . 60.2 mt -88.78 102.39 12.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 O-C-N 121.707 -0.62 . . . . 0.0 111.152 -178.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.566 ' HE2' HG22 ' A' ' 56' ' ' VAL . 6.9 m-85 -95.58 119.81 34.73 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -94.27 111.56 23.3 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.2 p -78.77 153.18 30.98 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.299 0.571 . . . . 0.0 111.41 -175.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -58.17 -17.83 21.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.742 173.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -83.94 10.45 9.78 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.214 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 74.62 7.34 4.46 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.416 0.686 . . . . 0.0 111.911 173.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.7 mt -102.9 135.74 44.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.866 0.365 . . . . 0.0 110.524 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.8 p -92.61 110.54 21.97 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.404 HG11 ' HG ' ' A' ' 15' ' ' LEU . 49.0 t -94.67 132.15 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.971 -176.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.8 m -85.85 91.26 8.29 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.759 0.79 . . . . 0.0 108.982 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.671 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -74.47 143.31 44.71 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.473 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.942 HD22 ' HB2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -81.38 142.3 50.27 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -174.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.502 ' HG3' ' HA ' ' A' ' 36' ' ' ALA . 5.1 Cg_exo -82.5 1.5 9.11 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.125 1.883 . . . . 0.0 112.714 176.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -98.03 -48.81 4.99 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -175.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.806 ' OE1' ' HB ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -65.14 166.99 8.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.122 0.487 . . . . 0.0 112.17 -174.647 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.97 -25.59 16.45 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -175.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.687 ' O ' HG13 ' A' ' 59' ' ' ILE . 58.7 p-90 -58.25 -34.75 70.82 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.73 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.806 ' HB ' ' OE1' ' A' ' 53' ' ' GLN . 1.1 t -69.59 -46.21 76.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.959 175.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -58.77 -31.7 68.61 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.482 0.489 . . . . 0.0 110.67 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -64.75 -51.79 60.45 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.918 172.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.687 HG13 ' O ' ' A' ' 55' ' ' TRP . 23.8 mt -61.64 -56.86 15.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.268 -176.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 56' ' ' VAL . 4.4 p -62.1 -25.45 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.337 -175.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -63.43 -47.29 82.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.764 0.316 . . . . 0.0 110.187 172.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.3 mt -78.0 -1.44 32.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.044 0.45 . . . . 0.0 110.872 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 3.4 mm? -96.84 -58.28 2.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.64 176.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.5 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.426 -170.578 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.625 ' SG ' HG12 ' A' ' 34' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 t -43.62 118.54 1.41 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.941 170.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.0 mt -68.25 -26.67 65.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.249 -174.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.87 140.12 12.19 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.738 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 42.6 m-85 -91.79 179.85 5.51 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.071 0.462 . . . . 0.0 110.708 -176.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.588 ' OG1' ' HG2' ' A' ' 13' ' ' ARG . 14.4 t -97.78 -172.02 2.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.931 177.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -147.6 17.38 1.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.005 0.431 . . . . 0.0 110.609 177.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.617 ' HB2' HD22 ' A' ' 15' ' ' LEU . 18.0 mmm180 -88.1 -173.61 4.32 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.379 0.609 . . . . 0.0 112.462 -171.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.552 HD13 ' CD1' ' A' ' 55' ' ' TRP . 5.2 mm -125.31 90.35 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 114.176 -1.374 . . . . 0.0 108.423 167.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.617 HD22 ' HB2' ' A' ' 13' ' ' ARG . 2.8 mm? -93.31 165.07 12.97 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.687 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 63.2 m170 -133.29 168.28 18.71 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.569 -175.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.464 ' HD3' HG12 ' A' ' 59' ' ' ILE . 14.0 Cg_endo -59.02 -24.3 72.78 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.055 1.836 . . . . 0.0 108.94 166.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.687 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 60.7 mttm -49.26 -33.3 12.56 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 114.011 -1.449 . . . . 0.0 111.04 171.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 41' ' ' THR . 76.5 m-85 -120.51 -0.98 10.19 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.744 -171.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.649 HG12 ' HB3' ' A' ' 39' ' ' PHE . 19.5 mt -104.68 118.86 52.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.061 0.457 . . . . 0.0 111.211 -173.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.86 -5.96 11.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.779 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -152.05 151.58 23.44 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.497 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 1.1 t80 -148.99 129.8 14.2 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.137 0.494 . . . . 0.0 110.495 -177.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.5 m -131.4 126.28 34.74 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.033 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.456 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 10.3 ptp180 -98.41 103.63 15.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.307 0.575 . . . . 0.0 111.09 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.598 ' OE1' ' HA ' ' A' ' 6' ' ' CYS . 13.9 mt-30 -77.77 126.65 31.18 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.254 176.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.757 ' HB3' HD22 ' A' ' 29' ' ' ASN . 34.2 mt -119.94 145.07 47.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.925 -171.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.709 ' HA ' ' O ' ' A' ' 32' ' ' CYS . . . -76.47 63.97 2.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.971 172.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.757 HD22 ' HB3' ' A' ' 27' ' ' LEU . 32.2 m-80 -135.42 -66.13 0.58 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.504 -174.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -105.9 51.48 0.75 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.249 0.547 . . . . 0.0 111.889 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.79 -58.31 0.71 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.9 173.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.709 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 1.1 t -60.7 136.46 58.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.716 0.293 . . . . 0.0 110.733 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -87.67 -30.16 20.61 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.238 -175.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.625 HG12 ' SG ' ' A' ' 6' ' ' CYS . 37.3 pt -105.55 -152.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -153.41 121.67 6.2 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 171.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . -132.9 129.11 37.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.581 -177.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.444 HG23 ' HE1' ' A' ' 23' ' ' PHE . 47.1 mm -81.71 113.14 20.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.771 177.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 42.8 mt -91.47 103.66 14.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.558 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.649 ' HB3' HG12 ' A' ' 20' ' ' ILE . 16.5 m-85 -87.81 113.69 23.71 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 172.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -87.95 105.71 17.63 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 58.2 p -75.51 158.49 32.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.462 0.648 . . . . 0.0 111.826 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.551 ' HD3' ' O ' ' A' ' 42' ' ' LYS . 1.9 tmtp? -60.21 -20.99 61.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.423 172.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 82.5 tttt -84.03 11.91 7.15 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.486 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 75.4 mmtt 77.87 -20.92 0.35 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.831 0.852 . . . . 0.0 112.285 174.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.6 mt -73.46 126.57 30.5 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.971 0.415 . . . . 0.0 111.192 -177.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 p -87.18 105.34 17.13 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.843 175.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 62.1 t -82.65 130.54 35.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.804 -174.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.4 m -85.62 76.46 9.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.538 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -69.43 138.12 53.27 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.032 -173.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.738 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -80.44 127.46 75.86 Favored Pre-proline 0 CA--C 1.507 -0.678 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -177.433 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.24 14.52 0.22 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.221 1.947 . . . . 0.0 111.811 172.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 50' ' ' ASN . 0.4 OUTLIER -106.44 -19.07 13.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.875 -174.239 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.619 HE21 HG21 ' A' ' 56' ' ' VAL . 5.6 pt20 -105.05 140.65 37.92 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.032 -168.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 p -64.83 -36.24 83.7 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -172.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.578 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 43.9 p-90 -60.83 -32.62 72.0 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.726 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.619 HG21 HE21 ' A' ' 53' ' ' GLN . 4.8 t -73.58 -50.42 30.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.324 174.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 94.8 mttt -54.92 -36.95 65.78 Favored 'General case' 0 CA--C 1.522 -0.126 0 O-C-N 123.602 0.564 . . . . 0.0 110.421 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.404 ' O ' HD23 ' A' ' 62' ' ' LEU . 22.8 t80 -65.95 -58.64 5.08 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.642 176.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 55' ' ' TRP . 78.6 mt -59.1 -48.0 88.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -175.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.591 HG12 ' O ' ' A' ' 56' ' ' VAL . 11.9 p -65.45 -31.62 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.992 -177.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.0 ttp85 -63.83 -41.57 97.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.847 0.356 . . . . 0.0 110.517 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.404 HD23 ' O ' ' A' ' 58' ' ' TYR . 4.4 mm? -79.37 -29.86 42.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.138 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.459 HD13 ' CB ' ' A' ' 23' ' ' PHE . 28.5 mt -72.4 -46.46 55.13 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.558 177.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.7 t . . . . . 0 C--N 1.323 -0.576 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.373 -174.709 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.686 ' SG ' HG12 ' A' ' 34' ' ' ILE . 3.7 p . . . . . 0 N--CA 1.437 -1.105 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.432 ' O ' HD11 ' A' ' 34' ' ' ILE . 19.3 t -125.99 135.33 51.69 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 166.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 pp -65.87 -13.6 59.91 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.48 0.487 . . . . 0.0 111.873 -176.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.72 166.9 28.75 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.853 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 81.0 m-85 -119.39 -168.56 1.6 Allowed 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 176.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.511 ' H ' ' ND2' ' A' ' 50' ' ' ASN . 14.9 t -129.03 148.29 50.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.493 -178.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -107.15 62.69 0.62 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.542 ' HB3' HD22 ' A' ' 15' ' ' LEU . 15.9 mtm180 -131.25 173.18 11.31 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.1 mm -122.4 91.13 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.428 165.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.542 HD22 ' HB3' ' A' ' 13' ' ' ARG . 2.9 mm? -88.9 167.19 13.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 63.6 m170 -132.56 166.78 26.44 Favored Pre-proline 0 C--N 1.313 -0.994 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.894 -174.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 19.5 Cg_endo -60.39 -21.96 69.52 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.852 1.701 . . . . 0.0 109.213 166.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 83.7 mttt -52.94 -27.34 18.4 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 113.938 -1.483 . . . . 0.0 111.01 172.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -125.5 2.0 7.64 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.987 -174.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.677 HG12 ' HB3' ' A' ' 39' ' ' PHE . 13.3 mt -106.93 123.66 62.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.997 0.427 . . . . 0.0 111.275 -174.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.3 m -117.09 -16.19 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.02 177.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.66 160.17 26.51 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.539 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 2.0 t80 -155.7 134.03 11.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.533 0.682 . . . . 0.0 110.606 -175.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.9 m -138.02 135.65 36.11 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.801 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -116.2 117.81 31.08 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.09 0.471 . . . . 0.0 111.847 -175.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.608 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 1.1 mp0 -94.32 135.96 35.14 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 174.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.9 156.07 18.35 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.1 0.476 . . . . 0.0 111.516 -170.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.17 11.93 26.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.278 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -126.83 -58.33 1.31 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.781 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -103.12 89.31 3.38 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.918 177.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.57 -63.11 0.52 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.973 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.557 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 49.1 t -130.76 171.28 13.3 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -86.25 -20.19 28.83 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.686 HG12 ' SG ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -111.35 169.75 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 171.052 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -127.03 144.89 50.91 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 121.961 -0.462 . . . . 0.0 111.39 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.45 146.72 35.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.431 174.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.571 HG12 ' HG3' ' A' ' 51' ' ' PRO . 49.5 mm -106.96 102.4 13.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.882 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.594 HG13 HE22 ' A' ' 26' ' ' GLN . 70.0 mt -78.96 104.99 7.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.978 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.677 ' HB3' HG12 ' A' ' 20' ' ' ILE . 19.5 m-85 -88.91 120.15 30.07 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 170.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -90.25 104.85 17.38 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.4 p -74.38 161.79 29.5 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.779 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -68.18 -3.47 10.68 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.353 172.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 21.6 ttmm -95.47 8.39 43.41 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.245 176.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 31.3 mmmt 76.53 -24.17 0.23 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.244 1.018 . . . . 0.0 112.446 176.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.94 130.55 41.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.066 0.46 . . . . 0.0 111.38 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 p -86.51 108.84 18.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.185 176.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 60.9 t -91.97 128.96 43.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.434 -175.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 79.4 m -85.18 82.21 8.49 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.676 0.75 . . . . 0.0 109.143 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.503 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -72.45 136.79 46.08 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.091 -177.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.853 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -77.59 126.88 83.88 Favored Pre-proline 0 CA--C 1.51 -0.565 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.677 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.571 ' HG3' HG12 ' A' ' 37' ' ' ILE . 27.0 Cg_exo -63.99 -5.95 10.23 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 122.425 2.083 . . . . 0.0 111.903 177.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.487 ' O ' ' HE3' ' A' ' 57' ' ' LYS . 83.2 mttt -82.61 -29.8 29.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.634 -176.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.558 HE21 HG21 ' A' ' 56' ' ' VAL . 12.1 mt-30 -72.71 134.16 44.9 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.289 -175.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.5 -33.18 75.32 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.537 ' O ' HG13 ' A' ' 59' ' ' ILE . 49.0 p-90 -63.42 -33.11 74.83 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 175.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.558 HG21 HE21 ' A' ' 53' ' ' GLN . 8.7 t -72.67 -47.14 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.308 174.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 82.0 mttt -60.65 -28.07 68.29 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -70.1 -52.66 22.02 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.166 173.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.642 HG21 HD13 ' A' ' 20' ' ' ILE . 70.4 mt -68.03 -40.19 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.627 -176.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 56' ' ' VAL . 15.0 p -70.44 -30.3 42.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 O-C-N 122.122 -0.361 . . . . 0.0 110.555 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -66.0 -30.66 71.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.789 0.804 . . . . 0.0 108.999 173.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.1 tp -84.12 -20.66 32.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.435 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 23' ' ' PHE . 65.4 mt -108.89 4.27 23.24 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -175.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.3 t . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.457 -177.993 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.733 ' SG ' HG12 ' A' ' 34' ' ' ILE . 31.8 p . . . . . 0 N--CA 1.442 -0.833 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.442 ' O ' HD11 ' A' ' 34' ' ' ILE . 61.0 m -54.97 128.82 35.29 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.931 -176.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.432 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 2.0 pp -81.57 -14.53 56.71 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.275 0.56 . . . . 0.0 110.121 174.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.61 140.65 11.99 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.667 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.839 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 5.7 m-85 -107.07 -163.12 0.88 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.59 0.233 . . . . 0.0 110.415 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.482 HG21 ' CG1' ' A' ' 47' ' ' VAL . 4.7 t -137.46 149.99 47.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.974 0.416 . . . . 0.0 111.354 177.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -116.6 73.51 0.86 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.228 0.537 . . . . 0.0 109.783 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.527 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 57.5 mtt180 -129.23 -171.39 2.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.294 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.586 HD13 ' CD1' ' A' ' 55' ' ' TRP . 13.7 mm -125.59 78.58 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.344 168.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.552 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.6 mm? -81.7 161.86 23.21 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.771 ' ND1' ' HD3' ' A' ' 18' ' ' LYS . 65.5 m170 -133.82 162.17 59.31 Favored Pre-proline 0 C--N 1.31 -1.125 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.938 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.825 ' HD3' HG12 ' A' ' 59' ' ' ILE . 27.7 Cg_endo -64.55 -16.87 57.48 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.341 2.027 . . . . 0.0 108.746 166.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.771 ' HD3' ' ND1' ' A' ' 16' ' ' HIS . 28.8 mtpp -53.43 -21.58 6.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 113.38 -1.736 . . . . 0.0 110.966 170.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -130.31 3.74 4.72 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.675 ' HB ' ' HA ' ' A' ' 17' ' ' PRO . 3.9 mm -100.37 122.9 52.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -170.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.3 m -114.49 -10.13 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.483 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.52 158.46 27.67 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.681 ' HB2' HD13 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -156.52 134.7 11.29 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.065 0.46 . . . . 0.0 109.867 -175.686 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.436 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 30.7 m -138.4 103.23 4.84 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.495 178.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.435 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 11.5 ptm180 -78.36 89.76 4.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.785 0.802 . . . . 0.0 109.787 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.647 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 4.0 tt0 -72.46 114.92 11.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.842 -175.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 25' ' ' ARG . 97.7 mt -116.71 164.07 15.18 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.225 -171.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.62 -37.44 65.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.826 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -62.14 -19.96 63.58 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -174.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -94.1 13.89 21.67 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.76 -30.17 2.79 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.092 -1.051 . . . . 0.0 113.658 174.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 3.7 t -86.08 -168.6 2.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.18 0.514 . . . . 0.0 111.659 -177.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -120.12 -36.2 3.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.216 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.733 HG12 ' SG ' ' A' ' 6' ' ' CYS . 6.8 pt -104.75 -175.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -138.16 112.16 8.46 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.345 0.593 . . . . 0.0 111.922 -173.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.5 119.88 39.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.527 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.485 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 41.3 mm -80.38 98.05 3.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.051 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.508 ' CG2' ' HB3' ' A' ' 46' ' ' SER . 23.7 mt -80.37 111.74 17.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 O-C-N 121.832 -0.542 . . . . 0.0 111.495 -174.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.445 ' HE2' HG22 ' A' ' 56' ' ' VAL . 30.3 m-85 -97.28 122.45 40.32 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 9.2 m-70 -97.66 111.36 23.67 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -176.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.5 p -71.17 163.63 27.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.099 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -66.92 -3.08 6.13 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.846 171.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -94.36 0.5 55.54 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.691 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm 78.64 -1.31 2.43 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.25 1.02 . . . . 0.0 111.496 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.4 mt -83.78 119.81 25.27 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.508 ' HB3' ' CG2' ' A' ' 38' ' ' ILE . 3.4 m -88.87 106.99 18.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.19 0.519 . . . . 0.0 109.901 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.482 ' CG1' HG21 ' A' ' 11' ' ' THR . 24.4 t -91.08 132.9 34.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.597 -175.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.8 m -88.19 91.6 8.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.749 0.785 . . . . 0.0 109.515 -178.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.641 ' HB1' HG22 ' A' ' 56' ' ' VAL . . . -76.52 146.0 38.73 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.077 -174.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.839 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -84.16 128.68 61.39 Favored Pre-proline 0 CA--C 1.512 -0.495 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.293 -177.578 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.79 6.55 1.28 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.248 1.965 . . . . 0.0 112.65 176.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -92.34 -24.7 18.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.863 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.53 HE21 HG21 ' A' ' 56' ' ' VAL . 4.8 pt20 -103.61 142.7 33.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.056 -165.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 p -65.6 -37.2 85.95 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -172.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.586 ' CD1' HD13 ' A' ' 14' ' ' ILE . 49.9 p-90 -60.49 -33.84 73.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.221 0.534 . . . . 0.0 109.752 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.641 HG22 ' HB1' ' A' ' 49' ' ' ALA . 14.2 t -70.72 -50.62 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.154 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 95.7 mttt -54.82 -37.38 66.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.378 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -67.77 -54.39 19.61 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.836 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.825 HG12 ' HD3' ' A' ' 17' ' ' PRO . 75.0 mt -62.82 -45.52 98.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.634 0.254 . . . . 0.0 111.038 -176.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.564 HG23 ' CE1' ' A' ' 23' ' ' PHE . 10.2 p -64.4 -29.22 46.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.807 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -67.59 -43.95 79.29 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.988 0.423 . . . . 0.0 110.194 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.6 mt -75.07 -32.36 61.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.816 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.681 HD13 ' HB2' ' A' ' 23' ' ' PHE . 82.7 mt -71.73 -35.95 70.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.858 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 C--N 1.326 -0.44 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 172.897 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.509 ' HA ' ' NE2' ' A' ' 26' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.4 t -66.35 128.63 36.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.467 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.6 mt -75.21 -17.94 60.25 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.196 0.31 . . . . 0.0 111.436 -176.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.31 117.58 1.39 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.285 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.753 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 1.6 m-85 -75.63 168.51 19.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.274 0.559 . . . . 0.0 109.709 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.45 ' OG1' ' HG3' ' A' ' 13' ' ' ARG . 4.8 t -94.7 -176.42 3.88 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.762 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -150.3 72.63 1.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.519 ' HB2' HD22 ' A' ' 15' ' ' LEU . 2.2 mtp180 -132.68 -179.56 5.54 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.121 -175.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.577 HD13 ' CD1' ' A' ' 55' ' ' TRP . 19.1 mm -126.4 84.33 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.014 167.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.534 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.3 mm? -89.32 161.57 16.29 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.836 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 55.3 m170 -133.95 177.96 2.0 Allowed Pre-proline 0 C--N 1.312 -1.053 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.185 -177.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.643 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 51.8 Cg_exo -53.26 -30.7 52.73 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.676 1.584 . . . . 0.0 109.272 161.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.836 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 64.6 mttm -44.42 -34.0 1.88 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.582 169.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 41' ' ' THR . 98.7 m-85 -127.16 2.15 6.45 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -173.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 mp -98.12 130.47 46.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.811 0.338 . . . . 0.0 110.46 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 p -124.27 -7.2 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.492 0.663 . . . . 0.0 110.199 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.02 156.9 26.5 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.803 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.901 ' HB3' HD12 ' A' ' 63' ' ' LEU . 1.9 t80 -140.7 138.08 33.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.256 0.551 . . . . 0.0 110.769 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.6 m -143.59 105.26 4.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.697 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.566 ' NE ' ' H ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -77.68 115.6 17.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.394 0.616 . . . . 0.0 111.117 -178.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.531 ' NE2' HD11 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -86.18 117.12 24.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.247 -179.174 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.838 ' HB3' HD22 ' A' ' 29' ' ' ASN . 98.2 mt -103.85 145.95 29.36 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -167.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.88 50.29 1.94 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.42 176.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.838 HD22 ' HB3' ' A' ' 27' ' ' LEU . 52.9 m-80 -127.23 -64.42 1.0 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.201 -175.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -85.55 53.4 2.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.653 0.739 . . . . 0.0 111.902 -174.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.55 -61.5 0.51 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.809 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -55.06 152.13 8.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.842 -0.679 . . . . 0.0 111.63 175.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -120.35 -5.86 9.86 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 34' ' ' ILE . 26.1 pt -127.85 115.75 40.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 CA-C-O 121.911 0.862 . . . . 0.0 111.069 176.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -83.55 118.2 23.64 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 121.475 -0.766 . . . . 0.0 111.442 -172.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.1 139.06 53.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.767 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.573 HG12 ' HG3' ' A' ' 51' ' ' PRO . 43.5 mm -85.48 109.89 18.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.249 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.531 HD11 ' NE2' ' A' ' 26' ' ' GLN . 42.3 mm -90.4 100.17 10.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.989 0.423 . . . . 0.0 110.814 -177.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.582 ' HE2' HG22 ' A' ' 56' ' ' VAL . 11.7 m-85 -92.22 118.53 30.96 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.882 173.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -89.03 115.19 26.4 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.419 ' C ' ' H ' ' A' ' 43' ' ' LYS . 33.1 p -82.21 162.24 22.45 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.468 0.652 . . . . 0.0 112.249 -172.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -60.32 -4.43 0.84 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.313 170.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 41' ' ' THR . 75.2 mmtt -109.74 16.56 22.0 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.944 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 59.7 mttp 75.17 -21.44 0.3 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.87 0.868 . . . . 0.0 112.525 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.3 mt -68.5 118.29 11.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.868 0.366 . . . . 0.0 111.159 -173.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.2 p -79.24 101.64 8.11 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 175.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 76.3 t -83.16 132.63 30.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.456 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.0 m -85.41 74.38 10.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.863 0.839 . . . . 0.0 109.094 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.437 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -69.71 142.45 53.32 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.657 -175.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.753 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -84.02 127.8 65.41 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.197 -177.114 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.573 ' HG3' HG12 ' A' ' 37' ' ' ILE . 24.1 Cg_exo -64.75 3.18 0.97 Allowed 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.728 2.285 . . . . 0.0 111.824 174.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 50' ' ' ASN . 57.7 mtpt -92.67 -22.7 19.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.627 -176.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.66 ' CG ' ' HB2' ' A' ' 50' ' ' ASN . 0.6 OUTLIER -93.27 134.31 35.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.536 -169.585 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 p -64.34 -32.42 74.02 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.577 ' CD1' HD13 ' A' ' 14' ' ' ILE . 47.3 p-90 -61.94 -33.32 74.05 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.649 HG21 HE21 ' A' ' 53' ' ' GLN . 14.0 t -70.34 -49.77 51.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.99 173.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 96.4 mttt -56.72 -35.05 68.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.26 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -66.09 -56.43 11.52 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.012 175.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.426 HD11 ' HA ' ' A' ' 16' ' ' HIS . 86.6 mt -60.84 -48.07 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.121 -176.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.649 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 14.4 p -62.55 -31.68 52.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -177.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -62.45 -47.78 82.51 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.066 0.46 . . . . 0.0 110.039 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.86 -40.54 75.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.304 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.901 HD12 ' HB3' ' A' ' 23' ' ' PHE . 3.6 mm? -70.11 -7.62 42.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.55 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.95 178.451 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.895 0 CA-C-O 120.589 0.233 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.3 m -80.0 129.25 34.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.918 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -62.26 -55.06 32.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.072 0.463 . . . . 0.0 110.353 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.653 ' CE2' ' HG2' ' A' ' 26' ' ' GLN . 48.7 p90 -131.68 175.52 9.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.699 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -131.92 103.92 6.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.593 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.714 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 13.7 p -50.86 157.58 0.79 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 123.983 0.913 . . . . 0.0 113.379 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.0 t -52.15 118.72 3.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.787 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.419 ' HA ' HD11 ' A' ' 34' ' ' ILE . 80.2 mt -84.61 -15.75 44.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.217 -177.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -120.88 108.8 1.43 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.754 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 17.8 m-85 -79.92 -167.49 1.29 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.263 0.554 . . . . 0.0 111.177 -173.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.5 t -125.03 170.74 10.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.973 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -133.98 77.53 1.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.516 0.674 . . . . 0.0 110.311 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.526 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 94.7 mtt180 -133.23 179.09 6.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.743 176.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.566 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.0 mm -118.29 83.46 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 164.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.591 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.5 mm? -79.42 158.88 27.26 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.661 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 54.7 m170 -131.81 175.71 3.47 Favored Pre-proline 0 C--N 1.312 -1.052 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.151 -174.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.653 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 32.5 Cg_exo -56.4 -25.51 57.84 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.747 1.631 . . . . 0.0 109.282 164.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.661 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 64.0 mttm -49.38 -31.55 9.72 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.282 175.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 41' ' ' THR . 91.0 m-85 -124.1 0.32 8.45 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.443 ' CG1' ' HB3' ' A' ' 39' ' ' PHE . 1.4 mp -105.88 130.08 57.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.077 0.465 . . . . 0.0 112.105 -173.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.1 m -123.95 -5.76 7.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.468 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.12 162.6 30.21 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.409 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.679 ' CB ' HD13 ' A' ' 63' ' ' LEU . 1.1 t80 -158.04 133.65 9.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.981 0.42 . . . . 0.0 110.413 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.6 m -135.91 120.37 18.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.938 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -93.0 137.2 32.57 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.131 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.714 ' NE2' ' HB2' ' A' ' 6' ' ' CYS . 12.9 mt-30 -120.72 121.01 37.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.749 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.4 mp -102.45 165.91 10.84 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.026 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.27 18.36 11.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.401 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -139.61 1.98 1.97 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.781 0.324 . . . . 0.0 111.62 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -99.99 -21.73 15.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.107 0.479 . . . . 0.0 110.33 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.21 -53.95 0.1 OUTLIER Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.416 ' HB2' ' H ' ' A' ' 6' ' ' CYS . 8.5 t -69.03 156.89 37.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 177.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -89.63 -20.07 24.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.455 0.645 . . . . 0.0 109.788 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.452 HG12 ' SG ' ' A' ' 6' ' ' CYS . 4.6 pt -116.26 -178.68 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.4 ' OD1' ' HG2' ' A' ' 51' ' ' PRO . 4.7 p30 -129.7 129.08 43.77 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.115 0.483 . . . . 0.0 110.557 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . -141.95 132.82 25.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.118 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 46.7 mm -82.34 125.17 39.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.9 mm -98.8 101.68 12.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 O-C-N 121.969 -0.457 . . . . 0.0 110.757 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.521 ' HE2' HG22 ' A' ' 56' ' ' VAL . 18.6 m-85 -87.99 123.49 32.75 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 173.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -92.88 112.75 24.81 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 36.7 p -75.22 160.52 30.29 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.663 -176.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -71.93 5.62 2.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.476 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 41' ' ' THR . 0.5 OUTLIER -106.57 12.28 29.62 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.335 176.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 68.14 19.39 9.2 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.079 174.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.8 mt -112.7 136.19 52.57 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.991 0.424 . . . . 0.0 110.925 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.6 p -84.88 115.79 22.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.623 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 83.0 t -89.12 126.6 42.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.625 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 16.5 m -83.09 81.24 8.77 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.616 0.722 . . . . 0.0 109.238 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.524 ' HB1' HG22 ' A' ' 56' ' ' VAL . . . -71.85 134.48 46.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.671 -175.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.754 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -80.64 124.29 82.04 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.4 ' HG2' ' OD1' ' A' ' 35' ' ' ASN . 25.6 Cg_exo -65.62 -0.44 3.73 Favored 'Trans proline' 0 C--N 1.328 -0.537 0 C-N-CA 121.862 1.708 . . . . 0.0 111.933 174.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.418 ' H ' ' C ' ' A' ' 50' ' ' ASN . 51.0 mtpt -85.0 -25.46 27.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.874 -175.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.542 HE21 HG21 ' A' ' 56' ' ' VAL . 5.4 pt20 -103.37 145.95 29.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.7 -167.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.41 -32.59 68.58 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -171.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.591 ' CZ3' ' HB2' ' A' ' 15' ' ' LEU . 48.3 p-90 -63.48 -32.91 74.49 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.859 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.542 HG21 HE21 ' A' ' 53' ' ' GLN . 4.5 t -69.75 -46.95 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.314 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.754 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 65.0 mttm -58.04 -40.6 81.29 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.098 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -62.93 -53.11 59.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.188 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.456 HG22 ' CD1' ' A' ' 63' ' ' LEU . 85.0 mt -63.79 -41.06 91.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.314 -177.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.1 p -68.44 -25.62 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.132 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.754 ' HG2' ' O ' ' A' ' 57' ' ' LYS . 1.3 mmp_? -66.43 -45.19 80.71 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 122.007 -0.433 . . . . 0.0 109.999 174.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.9 mt -68.72 -36.42 78.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.821 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.679 HD13 ' CB ' ' A' ' 23' ' ' PHE . 81.3 mt -72.3 -18.54 61.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.92 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 m -94.47 -11.37 29.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.816 0.341 . . . . 0.0 110.969 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -119.91 47.07 1.81 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.764 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 66' ' ' LYS . 39.9 mtpt -75.98 77.92 2.85 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.705 173.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.6 p -87.37 133.59 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.421 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -79.86 88.42 5.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.395 0.617 . . . . 0.0 111.295 -175.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -95.93 -43.81 7.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.436 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 52.9 ttm . . . . . 0 C--O 1.248 1.011 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.861 -177.866 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.96 0.409 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 m -114.13 106.35 14.28 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -61.25 -52.17 65.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.29 0.567 . . . . 0.0 109.941 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -132.23 -174.21 3.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.591 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -133.57 115.31 14.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.147 171.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.754 ' SG ' HG12 ' A' ' 34' ' ' ILE . 20.8 p -46.37 150.8 0.6 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.999 172.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 55.8 m -61.36 117.65 5.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.684 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.3 mt -68.82 -16.55 63.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.292 0.568 . . . . 0.0 110.242 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.1 88.17 0.19 Allowed Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.121 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.483 ' HA ' ' HB2' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -74.39 157.31 35.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.111 0.482 . . . . 0.0 110.533 174.583 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 48' ' ' CYS . 15.1 t -82.3 159.34 23.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -164.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -118.54 74.23 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.52 ' HB2' HD22 ' A' ' 15' ' ' LEU . 1.8 mmp_? -131.65 178.53 6.67 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.586 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.539 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.9 mm -121.6 84.46 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.237 161.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.541 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 1.9 mm? -84.59 167.58 16.15 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 175.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.694 ' ND1' ' HD2' ' A' ' 18' ' ' LYS . 63.5 m170 -133.04 168.14 19.45 Favored Pre-proline 0 C--N 1.311 -1.088 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.689 -175.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 17.3 Cg_endo -59.49 -23.05 69.1 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.316 2.011 . . . . 0.0 109.207 165.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.694 ' HD2' ' ND1' ' A' ' 16' ' ' HIS . 65.1 mttm -49.53 -27.68 4.67 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 113.846 -1.525 . . . . 0.0 111.628 170.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -124.99 -1.46 7.8 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -172.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.529 HD12 HD13 ' A' ' 59' ' ' ILE . 27.7 mt -105.99 124.64 61.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.838 0.351 . . . . 0.0 111.544 -173.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.2 m -121.13 0.69 7.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.002 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.99 158.7 30.0 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.587 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.586 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 2.1 t80 -153.24 134.31 14.05 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.346 0.593 . . . . 0.0 110.93 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.9 m -141.95 112.56 7.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.495 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -80.29 103.08 9.91 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.961 0.41 . . . . 0.0 110.381 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.581 ' NE2' ' HA ' ' A' ' 6' ' ' CYS . 8.5 tt0 -74.27 126.11 29.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.045 -177.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.529 ' HB3' HD22 ' A' ' 29' ' ' ASN . 87.8 mt -100.59 156.39 17.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.499 0.666 . . . . 0.0 112.606 -170.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.57 -30.65 36.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.909 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.529 HD22 ' HB3' ' A' ' 27' ' ' LEU . 44.3 m-80 -49.94 -34.06 19.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.534 -1.212 . . . . 0.0 113.069 -175.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -99.83 27.3 5.55 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -172.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.13 -44.82 1.03 Allowed Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.722 172.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -80.56 -167.1 1.23 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.008 0.432 . . . . 0.0 111.955 -174.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -122.54 -28.54 4.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.718 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.754 HG12 ' SG ' ' A' ' 6' ' ' CYS . 1.4 pt -111.69 169.51 4.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.409 ' OD1' ' HA ' ' A' ' 27' ' ' LEU . 34.1 m-80 -116.2 123.35 47.55 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.01 121.62 43.69 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.715 0.293 . . . . 0.0 110.847 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.721 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 48.6 mm -69.74 104.94 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.371 176.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.431 HD11 ' NE2' ' A' ' 26' ' ' GLN . 33.4 mm -85.89 97.64 6.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 O-C-N 122.059 -0.401 . . . . 0.0 110.113 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.487 ' HB3' HG12 ' A' ' 20' ' ' ILE . 9.6 m-85 -85.77 122.88 30.48 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -93.45 106.76 18.69 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.8 p -78.09 162.92 26.31 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.073 -173.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -65.9 -7.8 18.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.326 173.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -91.16 2.82 56.06 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.282 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 68.41 17.73 9.12 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.936 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.6 mt -106.69 125.98 51.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.517 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.4 p -76.72 108.35 9.67 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.652 177.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 99.6 t -91.63 131.35 38.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.662 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 62.8 m -88.7 90.97 8.63 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.721 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -77.95 141.15 39.18 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.958 -176.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.582 HD22 ' N ' ' A' ' 50' ' ' ASN . 0.7 OUTLIER -82.38 130.34 59.66 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.82 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -71.48 2.93 4.01 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.099 1.866 . . . . 0.0 112.041 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -90.32 -21.62 21.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.918 -176.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.58 HE21 HG21 ' A' ' 56' ' ' VAL . 5.0 pt20 -103.14 142.27 34.43 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.437 -168.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 p -74.3 -28.79 61.34 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -171.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.616 ' O ' HG13 ' A' ' 59' ' ' ILE . 47.2 p-90 -62.57 -33.73 75.54 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.387 176.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.58 HG21 HE21 ' A' ' 53' ' ' GLN . 4.5 t -70.99 -47.92 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.413 174.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -56.98 -36.71 70.65 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 123.761 0.663 . . . . 0.0 110.85 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -65.77 -49.47 68.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.838 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.616 HG13 ' O ' ' A' ' 55' ' ' TRP . 60.0 mt -67.76 -47.86 78.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.039 -175.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.586 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 11.7 p -62.69 -29.84 47.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 120.803 0.335 . . . . 0.0 110.762 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -64.47 -45.26 88.17 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 34.8 mt -70.26 -30.81 67.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.934 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.592 HD23 HG22 ' A' ' 59' ' ' ILE . 2.0 mm? -68.45 -36.65 79.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.539 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 m -74.87 -42.96 56.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.694 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -109.03 86.22 2.24 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.17 0.51 . . . . 0.0 110.503 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -92.71 112.86 24.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.18 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.9 m -98.49 160.68 3.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.011 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -104.33 114.07 28.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.138 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -74.53 -38.87 62.65 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.1 ttt . . . . . 0 C--O 1.246 0.905 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.678 178.732 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 120.804 0.335 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.479 ' HA ' ' HA3' ' A' ' 31' ' ' GLY . 23.5 m -76.54 91.08 3.34 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.441 0.638 . . . . 0.0 111.103 -175.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -69.43 -41.76 75.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.674 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.745 ' CE1' ' HB2' ' A' ' 26' ' ' GLN . 29.2 p90 -121.04 -176.61 3.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.008 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -140.51 103.43 4.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.255 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.818 ' SG ' HG12 ' A' ' 34' ' ' ILE . 26.2 p -49.72 146.88 4.01 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.687 1.195 . . . . 0.0 112.918 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.665 ' O ' HD11 ' A' ' 34' ' ' ILE . 58.3 m -60.2 130.25 45.72 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.136 174.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.3 mt -84.5 0.13 50.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.209 0.528 . . . . 0.0 110.108 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.54 136.44 6.94 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 174.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.825 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 29.0 m-85 -97.3 176.65 5.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.798 0.332 . . . . 0.0 110.226 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.479 HG21 ' CG1' ' A' ' 47' ' ' VAL . 2.7 t -112.91 137.85 50.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.168 0.509 . . . . 0.0 111.015 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -108.02 68.9 0.72 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.564 0.697 . . . . 0.0 109.363 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.483 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 4.3 mmp_? -129.19 -173.21 2.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.586 -177.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.556 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.4 mm -124.98 89.65 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.208 165.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.59 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.7 mm? -89.12 162.83 15.75 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 58.3 m170 -132.05 166.65 26.92 Favored Pre-proline 0 C--N 1.312 -1.051 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.994 -172.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 12.2 Cg_endo -57.57 -27.14 75.53 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.176 1.917 . . . . 0.0 109.149 166.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 65.6 mttm -45.0 -35.47 2.93 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.384 171.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -116.89 -13.48 10.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.903 -172.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.673 HG12 ' HB3' ' A' ' 39' ' ' PHE . 21.8 mt -92.39 127.18 44.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.768 0.318 . . . . 0.0 111.327 -172.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 m -122.33 -7.6 8.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.157 0.503 . . . . 0.0 110.995 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -152.21 163.1 30.1 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.683 ' HB2' HD13 ' A' ' 63' ' ' LEU . 2.4 t80 -156.6 134.28 10.91 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 117.325 0.563 . . . . 0.0 110.897 -175.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.562 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 83.5 m -140.41 107.8 5.55 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.112 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.52 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 14.8 ptp180 -86.5 102.78 14.42 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.756 HE21 ' HB3' ' A' ' 36' ' ' ALA . 19.9 pt20 -93.25 136.04 33.88 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.421 ' HA ' ' HB3' ' A' ' 35' ' ' ASN . 86.7 mt -119.64 163.72 16.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.214 0.53 . . . . 0.0 111.882 -170.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.58 35.03 0.49 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.824 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -132.73 -52.62 0.93 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.396 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -60.97 -43.21 99.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.799 -173.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 2' ' ' SER . . . -157.16 -65.03 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.279 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.457 ' CB ' ' H ' ' A' ' 6' ' ' CYS . 2.8 t -71.42 169.3 15.64 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.378 0.609 . . . . 0.0 112.384 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -90.1 -24.67 21.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.653 -173.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.818 HG12 ' SG ' ' A' ' 6' ' ' CYS . 2.1 pt -120.41 170.16 10.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.421 ' HB3' ' HA ' ' A' ' 27' ' ' LEU . 6.1 p30 -118.86 128.18 54.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.778 0.323 . . . . 0.0 111.178 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.756 ' HB3' HE21 ' A' ' 26' ' ' GLN . . . -131.9 143.6 50.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.958 0.409 . . . . 0.0 110.928 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.603 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 49.9 mm -90.2 101.34 12.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.229 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.562 ' HB ' ' HB ' ' A' ' 24' ' ' THR . 63.9 mt -79.49 104.75 7.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.019 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.673 ' HB3' HG12 ' A' ' 20' ' ' ILE . 12.5 m-85 -95.26 111.35 23.21 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 172.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -82.67 110.25 17.57 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.0 p -85.06 163.13 19.01 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.412 0.625 . . . . 0.0 112.008 -174.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -68.75 -2.53 9.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.032 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -90.58 3.04 55.2 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.769 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt 69.47 22.86 6.24 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.015 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 97.3 mt -114.75 139.6 49.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.144 0.497 . . . . 0.0 110.712 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.422 ' HB2' HG23 ' A' ' 38' ' ' ILE . 12.0 p -90.07 95.41 10.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.694 174.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.479 ' CG1' HG21 ' A' ' 11' ' ' THR . 59.0 t -76.33 130.2 36.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.834 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.0 m -92.64 81.74 4.78 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.018 0.913 . . . . 0.0 109.591 -175.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.603 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -69.87 144.63 52.46 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.794 -176.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.825 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -83.8 129.39 59.49 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.758 -179.126 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -72.01 21.33 0.27 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.406 2.071 . . . . 0.0 111.988 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 50' ' ' ASN . 35.3 mtmm -119.42 -4.93 10.36 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.99 -173.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.536 HE21 HG21 ' A' ' 56' ' ' VAL . 4.7 pt20 -117.26 146.37 43.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.027 0.441 . . . . 0.0 111.555 -172.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 p -69.86 -36.32 75.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -171.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.59 ' CZ3' ' HB2' ' A' ' 15' ' ' LEU . 47.9 p-90 -61.05 -30.75 70.51 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.554 ' O ' HG12 ' A' ' 60' ' ' VAL . 12.6 t -74.21 -49.04 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.244 174.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 84.1 mttt -57.0 -34.05 67.76 Favored 'General case' 0 C--N 1.334 -0.089 0 O-C-N 123.457 0.473 . . . . 0.0 110.506 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -66.1 -54.73 22.06 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.527 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.668 HG21 HD13 ' A' ' 20' ' ' ILE . 72.7 mt -65.57 -43.82 94.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.477 -174.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.573 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 13.8 p -66.71 -33.83 66.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.092 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -62.89 -43.14 99.59 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.37 0.605 . . . . 0.0 109.494 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.3 tp -66.2 -41.06 90.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.041 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 23' ' ' PHE . 75.3 mt -76.28 -7.44 54.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.355 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 77.7 p -100.22 -4.61 29.09 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.864 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -132.25 8.08 4.3 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.326 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -119.8 16.31 12.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.618 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.4 m -110.48 142.26 23.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.721 176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -76.19 109.1 9.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.05 0.452 . . . . 0.0 110.466 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -97.87 -9.86 25.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.056 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 54.1 ttm . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.509 -0.758 . . . . 0.0 109.487 -179.156 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.725 ' HB3' ' HA2' ' A' ' 31' ' ' GLY . 1.2 m -76.0 88.24 2.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.911 0.386 . . . . 0.0 110.841 -176.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -77.06 -36.22 56.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.642 0.734 . . . . 0.0 109.023 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.458 ' CE1' ' HA ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -130.68 -166.84 1.74 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.107 173.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.571 ' C ' ' HB2' ' A' ' 32' ' ' CYS . 5.5 m-20 -112.03 -104.44 0.39 Allowed 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 122.04 0.924 . . . . 0.0 109.81 171.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.701 ' HA ' ' HB3' ' A' ' 26' ' ' GLN . 7.9 p -144.98 -160.33 1.12 Allowed 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 113.932 -1.485 . . . . 0.0 109.302 -176.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.498 ' O ' HD11 ' A' ' 34' ' ' ILE . 94.8 m -105.91 122.75 46.76 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 166.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.6 mt -67.7 -26.69 66.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.345 0.593 . . . . 0.0 109.536 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -129.06 135.38 8.43 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.206 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.766 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 6.9 m-85 -100.58 -160.12 0.78 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.414 ' H ' HD21 ' A' ' 50' ' ' ASN . 5.1 t -129.12 158.7 38.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.214 176.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.498 ' O ' ' HD2' ' A' ' 13' ' ' ARG . 1.5 m-20 -118.55 69.23 0.79 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.858 0.361 . . . . 0.0 110.087 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.498 ' HD2' ' O ' ' A' ' 12' ' ' ASP . 8.4 mmm180 -131.36 175.89 8.75 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.411 0.624 . . . . 0.0 112.122 -177.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.529 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.1 mm -120.18 90.05 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.001 164.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.495 ' CD2' ' HB2' ' A' ' 13' ' ' ARG . 1.9 mm? -92.35 163.26 13.94 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.78 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 34.9 m170 -131.24 176.39 2.93 Favored Pre-proline 0 C--N 1.313 -1.013 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.277 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.78 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 13.2 Cg_endo -58.68 -21.28 54.99 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.631 1.554 . . . . 0.0 109.353 167.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.729 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 28.5 mtpp -45.17 -32.77 1.97 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.844 171.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 41' ' ' THR . 77.9 m-85 -124.27 -5.08 7.82 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -174.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.615 HG12 ' HB3' ' A' ' 39' ' ' PHE . 18.3 mt -100.26 128.45 52.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.777 0.323 . . . . 0.0 111.666 -173.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.6 m -120.68 -11.48 9.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.195 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.3 165.74 31.42 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.736 ' HB2' HD13 ' A' ' 63' ' ' LEU . 2.7 t80 -155.01 133.44 11.87 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.23 0.538 . . . . 0.0 111.666 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.7 m -142.1 121.42 13.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.603 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -98.11 119.16 36.26 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.512 -0.475 . . . . 0.0 112.112 -176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.701 ' HB3' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -76.17 130.09 37.72 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 170.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.6 mt -97.9 152.52 19.13 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -169.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 32' ' ' CYS . . . -100.87 5.48 43.39 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.059 173.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -100.26 -64.61 1.03 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.146 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -116.98 86.41 2.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.63 0.728 . . . . 0.0 110.079 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.725 ' HA2' ' HB3' ' A' ' 2' ' ' SER . . . 162.56 -77.37 0.16 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.444 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.571 ' HB2' ' C ' ' A' ' 5' ' ' ASP . 47.1 t -117.9 176.51 5.17 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -87.38 -23.28 24.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.351 0.596 . . . . 0.0 109.405 171.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.691 HG12 ' SG ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -113.33 162.97 11.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 26' ' ' GLN . 7.0 p30 -129.11 138.35 51.77 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.286 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.88 148.56 52.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.017 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.776 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 47.8 mm -95.48 116.81 38.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.715 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.436 HD11 HE22 ' A' ' 26' ' ' GLN . 44.4 mm -90.31 98.38 8.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.085 0.469 . . . . 0.0 110.047 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.615 ' HB3' HG12 ' A' ' 20' ' ' ILE . 8.8 m-85 -87.94 115.01 25.11 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -82.03 108.14 15.28 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 42.0 p -82.55 159.15 22.85 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.195 0.521 . . . . 0.0 111.471 -175.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -67.28 -2.42 5.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.358 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -95.15 3.71 54.42 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.842 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt 70.33 11.92 7.5 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.451 0.7 . . . . 0.0 111.176 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.3 mt -92.85 125.82 37.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.098 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 p -86.06 93.79 9.08 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.3 t -85.64 130.92 35.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.687 -174.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 82.3 m -86.29 84.73 7.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 122.016 0.912 . . . . 0.0 109.506 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.776 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -69.51 143.03 53.58 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.6 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.766 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -88.14 122.52 69.83 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -178.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.494 ' HG3' ' OD1' ' A' ' 35' ' ' ASN . 9.5 Cg_endo -57.33 -8.19 3.49 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.889 2.393 . . . . 0.0 112.471 172.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -77.2 -34.54 56.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.961 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.698 ' CG ' ' HB2' ' A' ' 50' ' ' ASN . 0.4 OUTLIER -85.43 140.53 30.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.719 -169.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.64 -27.68 61.39 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -176.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.529 ' CD1' HD13 ' A' ' 14' ' ' ILE . 47.8 p-90 -62.74 -32.4 73.53 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.653 HG21 HE21 ' A' ' 53' ' ' GLN . 7.4 t -73.03 -48.78 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.494 174.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 66.7 mttm -53.93 -36.5 62.83 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.584 0.552 . . . . 0.0 110.575 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -66.52 -57.28 7.64 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.691 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.577 HG21 HD13 ' A' ' 20' ' ' ILE . 75.2 mt -62.67 -43.3 98.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.201 -175.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.632 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 12.6 p -63.5 -33.42 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 121.309 -0.156 . . . . 0.0 111.328 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -63.75 -41.99 97.91 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.268 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.4 mt -81.48 4.81 19.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.023 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.736 HD13 ' HB2' ' A' ' 23' ' ' PHE . 55.9 mt -117.7 -14.86 10.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.321 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -108.35 -63.38 1.34 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.761 0.315 . . . . 0.0 110.185 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.72 78.33 1.82 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.277 0.56 . . . . 0.0 109.667 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.403 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . 15.9 ptmt -119.67 142.55 48.36 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.558 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.49 105.63 17.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.71 -175.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -100.01 102.47 13.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.971 0.415 . . . . 0.0 110.325 176.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -112.65 -80.97 0.59 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 174.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.152 176.036 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 m -55.94 128.04 33.29 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.493 0.496 . . . . 0.0 111.346 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -80.99 -53.28 6.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.135 0.493 . . . . 0.0 110.469 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -131.03 -170.64 2.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.77 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -140.38 110.44 6.54 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.474 0.654 . . . . 0.0 110.485 172.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.719 ' SG ' HG12 ' A' ' 34' ' ' ILE . 19.3 p -40.76 147.55 0.12 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.985 173.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.9 m -61.6 134.68 57.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.808 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt -86.72 6.62 30.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.592 0.711 . . . . 0.0 109.885 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.67 119.79 0.95 Allowed Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.676 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.49 ' HD1' ' H ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -118.62 161.38 20.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.944 0.402 . . . . 0.0 110.833 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 49' ' ' ALA . 14.4 t -73.38 -171.52 0.99 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -167.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -147.27 14.19 1.12 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.634 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -88.81 170.43 10.75 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.408 -171.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.569 HD13 ' CD1' ' A' ' 55' ' ' TRP . 8.7 mm -105.3 84.57 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 163.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.588 HD12 ' CH2' ' A' ' 55' ' ' TRP . 1.1 mt -92.14 160.49 15.17 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.739 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 52.1 m170 -132.51 171.5 9.03 Favored Pre-proline 0 C--N 1.313 -1.014 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.005 -173.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.575 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 32.1 Cg_exo -55.83 -24.24 46.09 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.181 1.921 . . . . 0.0 109.255 165.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.739 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 64.9 mttm -44.51 -32.65 1.47 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 114.24 -1.346 . . . . 0.0 112.082 171.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -126.81 -3.48 6.52 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 122.243 -0.286 . . . . 0.0 111.449 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.62 HG13 ' HB3' ' A' ' 39' ' ' PHE . 1.2 mp -92.88 120.12 41.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.02 0.438 . . . . 0.0 110.344 -175.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.3 m -113.63 -5.87 11.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.735 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.19 158.37 29.13 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.36 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.665 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -146.97 137.39 23.58 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.139 0.495 . . . . 0.0 110.258 -179.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.2 m -144.38 109.45 5.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.518 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 25' ' ' ARG . 8.6 ptp180 -75.9 118.14 18.37 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.429 ' NE2' HD11 ' A' ' 38' ' ' ILE . 8.4 tt0 -101.88 106.35 17.29 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -177.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.499 ' HA ' HD22 ' A' ' 35' ' ' ASN . 6.6 mp -81.7 164.5 21.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.457 0.646 . . . . 0.0 111.984 -173.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.24 -57.8 3.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.862 175.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -74.62 19.67 0.13 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -170.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -115.19 23.86 12.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.281 0.562 . . . . 0.0 110.494 173.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.25 -12.86 4.36 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.647 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.479 ' HB2' ' H ' ' A' ' 6' ' ' CYS . 2.4 t -120.06 -153.69 0.55 Allowed 'General case' 0 C--N 1.319 -0.742 0 O-C-N 122.454 -0.439 . . . . 0.0 111.563 -177.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -129.61 -27.95 2.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.576 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.719 HG12 ' SG ' ' A' ' 6' ' ' CYS . 2.8 pt -118.61 169.51 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.499 HD22 ' HA ' ' A' ' 27' ' ' LEU . 14.9 m120 -103.39 131.06 50.78 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 174.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.14 126.14 36.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.28 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.67 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 46.7 mm -88.72 98.08 7.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.34 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.429 HD11 ' NE2' ' A' ' 26' ' ' GLN . 70.2 mt -75.49 105.95 4.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.867 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.62 ' HB3' HG13 ' A' ' 20' ' ' ILE . 13.6 m-85 -97.73 116.94 30.93 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 171.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -86.88 106.46 17.77 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 43' ' ' LYS . 42.7 p -74.75 164.1 26.94 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.642 -176.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -74.26 4.79 5.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.963 0.887 . . . . 0.0 108.912 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.483 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 14.5 tppt? -87.87 -1.36 57.93 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.004 176.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt 70.6 12.26 7.32 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.828 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.6 mt -109.44 129.2 55.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.598 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.411 ' HB2' HG23 ' A' ' 38' ' ' ILE . 11.8 p -79.84 107.07 12.33 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.821 176.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 73.0 t -93.23 127.25 45.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.437 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 57.4 m -88.94 100.5 13.24 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.703 0.763 . . . . 0.0 109.493 -174.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.67 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -78.66 143.38 36.38 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.934 -177.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.625 HD22 ' N ' ' A' ' 50' ' ' ASN . 0.7 OUTLIER -80.41 130.98 63.13 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.59 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.53 -10.63 28.54 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.678 2.252 . . . . 0.0 112.044 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -74.93 -27.76 60.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.231 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.616 HE21 HG21 ' A' ' 56' ' ' VAL . 5.1 mt-30 -84.64 139.29 32.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.036 -168.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 p -76.33 -31.1 57.93 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.856 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.588 ' CH2' HD12 ' A' ' 15' ' ' LEU . 51.9 p-90 -60.35 -33.8 72.94 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 174.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.616 HG21 HE21 ' A' ' 53' ' ' GLN . 25.7 t -68.54 -52.06 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.252 173.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 67.6 mttm -54.2 -38.21 65.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.683 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -63.46 -52.45 61.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.787 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 55' ' ' TRP . 72.6 mt -63.52 -47.65 90.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.296 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.665 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 7.5 p -63.99 -36.19 75.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -175.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -68.7 -31.67 70.92 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.303 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 30.2 tp -74.28 -41.88 60.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.828 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.482 HD12 ' HB3' ' A' ' 23' ' ' PHE . 2.4 mm? -66.25 -29.09 69.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.039 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.9 t -73.11 -28.91 62.54 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.0 -176.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -135.98 48.73 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.111 0.482 . . . . 0.0 110.92 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 66' ' ' LYS . 18.6 ttpp -74.87 88.68 2.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.942 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.9 m -116.15 -177.28 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.799 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -103.56 -43.62 5.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.846 0.355 . . . . 0.0 111.35 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -107.86 136.74 47.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.373 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 66.5 mtm . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.691 -177.131 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.51 0.195 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.764 ' HA ' ' HA3' ' A' ' 31' ' ' GLY . 2.3 p -114.51 110.48 19.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.483 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -83.66 -44.46 14.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.92 177.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.574 ' CZ ' ' HB2' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -131.13 -171.92 2.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.189 178.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -138.29 104.17 5.11 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.438 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.685 ' SG ' ' HG2' ' A' ' 26' ' ' GLN . 93.8 m -47.99 146.99 2.25 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.137 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 67.1 m -49.3 122.29 5.92 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.284 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.7 mt -65.24 -24.82 67.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.087 0.47 . . . . 0.0 110.406 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.72 134.77 7.43 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.11 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.84 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 28.9 m-85 -92.66 178.41 5.8 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.566 0.222 . . . . 0.0 110.445 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.657 HG21 HG13 ' A' ' 47' ' ' VAL . 3.4 t -127.08 130.58 50.18 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.371 0.605 . . . . 0.0 111.758 -177.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.66 72.57 2.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 122.007 0.908 . . . . 0.0 108.6 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.44 ' HB2' HD12 ' A' ' 15' ' ' LEU . 18.2 mmt180 -104.42 -178.9 3.79 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.925 177.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.471 HD13 ' CD1' ' A' ' 55' ' ' TRP . 9.1 mm -126.74 87.68 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 162.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.714 HD13 HG11 ' A' ' 47' ' ' VAL . 1.2 mt -99.82 162.27 13.1 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.273 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.577 ' O ' HD13 ' A' ' 20' ' ' ILE . 63.1 m170 -132.59 167.08 24.41 Favored Pre-proline 0 C--N 1.316 -0.889 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.087 -172.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.624 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 18.3 Cg_endo -61.3 -22.53 74.86 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.315 2.01 . . . . 0.0 108.925 166.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.557 ' HD2' ' ND1' ' A' ' 16' ' ' HIS . 66.4 mttm -52.46 -28.31 19.68 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.718 172.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -124.0 -2.71 8.17 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.426 -175.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.624 ' HB ' ' HA ' ' A' ' 17' ' ' PRO . 0.9 OUTLIER -94.19 124.18 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 120.995 0.426 . . . . 0.0 110.891 -174.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.4 m -120.32 -1.96 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.547 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.3 160.22 31.95 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.432 -0.889 . . . . 0.0 111.962 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.54 ' CB ' ' HG ' ' A' ' 63' ' ' LEU . 1.7 t80 -149.3 134.5 18.23 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.5 m -140.95 107.18 5.23 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.381 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.515 ' HD3' HD21 ' A' ' 27' ' ' LEU . 32.4 ttm180 -82.37 107.52 15.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.168 0.509 . . . . 0.0 110.013 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.685 ' HG2' ' SG ' ' A' ' 6' ' ' CYS . 4.1 tt0 -80.14 115.56 19.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.906 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.515 HD21 ' HD3' ' A' ' 25' ' ' ARG . 65.2 mt -103.39 148.18 26.2 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -166.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.62 15.88 0.44 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.272 176.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 27' ' ' LEU . 34.3 m-80 -116.04 -6.99 11.96 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.783 -177.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . 34.2 mm-40 -103.69 -1.06 28.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.474 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.764 ' HA3' ' HA ' ' A' ' 2' ' ' SER . . . 145.99 -48.65 0.68 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.496 -0.859 . . . . 0.0 113.311 177.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.468 ' HB3' ' H ' ' A' ' 6' ' ' CYS . 13.4 p -68.16 171.04 7.52 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -112.52 6.76 18.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.553 0.692 . . . . 0.0 111.035 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.415 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 25.0 pt -131.34 -171.81 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 8.9 p30 -142.62 124.08 14.83 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.874 174.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.99 137.89 51.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.729 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.504 HG23 ' HE1' ' A' ' 23' ' ' PHE . 50.0 mm -89.04 98.23 7.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.089 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.678 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 2.6 mp -85.46 99.7 7.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.346 -0.541 . . . . 0.0 110.541 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.527 ' HE2' HG22 ' A' ' 56' ' ' VAL . 20.1 m-85 -86.89 125.93 34.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 171.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -93.32 112.32 24.22 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.4 p -79.13 155.39 28.72 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -65.62 -6.72 11.97 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.283 175.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -99.21 12.32 36.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.989 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.9 mttm 70.68 19.89 5.87 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.372 172.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.8 mt -104.48 124.72 49.77 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.416 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.8 p -80.85 109.56 15.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.302 0.572 . . . . 0.0 109.769 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.714 HG11 HD13 ' A' ' 15' ' ' LEU . 70.0 t -87.1 132.14 33.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.025 -176.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 65.0 m -93.34 76.97 4.51 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.863 0.84 . . . . 0.0 108.832 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.595 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -70.71 141.13 51.56 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.898 -175.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.84 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -79.0 129.63 72.52 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.3 -179.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.54 -3.08 8.44 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 121.794 1.663 . . . . 0.0 111.122 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 50' ' ' ASN . 53.8 mtmt -88.58 -18.85 27.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.048 -173.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.634 HE21 HG21 ' A' ' 56' ' ' VAL . 5.5 pt20 -104.54 145.21 30.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.953 0.406 . . . . 0.0 111.05 -170.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 p -69.72 -36.06 75.56 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -172.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.639 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 36.1 p-90 -60.14 -30.93 69.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.453 0.644 . . . . 0.0 109.466 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.634 HG21 HE21 ' A' ' 53' ' ' GLN . 15.1 t -75.27 -49.54 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.198 175.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -56.09 -33.61 65.22 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 123.454 0.471 . . . . 0.0 110.401 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -66.48 -56.96 8.44 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.872 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.446 HG12 ' HD3' ' A' ' 17' ' ' PRO . 72.4 mt -64.65 -43.94 96.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.142 -176.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 56' ' ' VAL . 7.1 p -67.07 -24.46 32.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.586 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 61' ' ' ARG . 8.4 ttp180 -69.61 -33.28 72.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.154 0.502 . . . . 0.0 110.114 174.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.6 mt -73.22 -44.45 59.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.872 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.54 ' HG ' ' CB ' ' A' ' 23' ' ' PHE . 3.7 mm? -61.96 -49.81 74.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.776 176.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.1 t -87.15 60.8 6.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.479 0.657 . . . . 0.0 109.8 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -66.27 103.53 1.02 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.762 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -91.1 -17.42 26.21 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.916 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.5 p -81.4 101.53 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.514 0.673 . . . . 0.0 110.123 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -86.71 77.21 9.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.381 0.61 . . . . 0.0 110.246 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -132.01 -82.95 0.5 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.558 177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 17.8 tpt . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.192 -0.908 . . . . 0.0 109.28 178.906 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 121.067 0.461 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -117.42 118.74 33.04 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.815 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -63.13 -48.7 77.4 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.464 ' CE1' ' HB2' ' A' ' 26' ' ' GLN . 2.2 p90 -132.01 -178.84 5.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.616 173.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -122.53 111.85 17.31 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.36 0.6 . . . . 0.0 109.618 169.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.813 ' HA ' ' HG3' ' A' ' 26' ' ' GLN . 82.8 m -50.48 138.13 17.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.94 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.0 t -56.76 118.58 5.04 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 123.396 0.435 . . . . 0.0 110.062 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.33 -24.98 66.83 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.167 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.25 142.41 10.48 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.998 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.834 ' HB2' ' ND2' ' A' ' 50' ' ' ASN . 0.3 OUTLIER -105.24 171.32 7.38 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.027 0.441 . . . . 0.0 111.973 -178.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 t -93.12 154.11 18.27 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -169.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -95.19 59.53 2.25 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.419 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.632 ' HB3' HD22 ' A' ' 15' ' ' LEU . 6.7 mtm180 -129.34 173.66 10.32 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.511 HD13 ' CD1' ' A' ' 55' ' ' TRP . 14.5 mm -120.71 79.74 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 113.979 -1.464 . . . . 0.0 108.528 168.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 13' ' ' ARG . 2.8 mm? -79.31 159.12 27.33 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.655 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 52.3 m170 -134.24 172.05 7.99 Favored Pre-proline 0 C--N 1.309 -1.19 0 O-C-N 122.028 -0.42 . . . . 0.0 111.064 -176.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.575 ' HD3' HG12 ' A' ' 59' ' ' ILE . 14.4 Cg_endo -59.56 -21.64 63.08 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.732 1.622 . . . . 0.0 109.177 165.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.655 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 67.6 mttm -49.01 -34.28 12.88 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.151 174.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 41' ' ' THR . 12.0 m-85 -122.83 1.79 9.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.745 0.307 . . . . 0.0 111.135 -173.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.486 HD13 ' O ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -95.63 129.57 45.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.666 -174.27 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.35 -8.3 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.061 0.458 . . . . 0.0 110.389 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.02 159.43 30.34 Favored Glycine 0 N--CA 1.453 -0.193 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.56 ' CB ' HD13 ' A' ' 63' ' ' LEU . 1.6 t80 -147.04 131.0 17.16 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.617 0.722 . . . . 0.0 111.281 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.711 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 38.2 m -129.42 144.17 51.14 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.341 -1.3 . . . . 0.0 107.82 174.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -127.73 121.62 30.79 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.434 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.813 ' HG3' ' HA ' ' A' ' 6' ' ' CYS . 1.2 pm0 -97.75 123.92 41.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.301 177.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.432 ' C ' ' H ' ' A' ' 29' ' ' ASN . 82.8 mt -103.72 159.54 15.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.507 -176.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.513 ' C ' HD22 ' A' ' 29' ' ' ASN . . . -78.04 32.82 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.445 0.64 . . . . 0.0 110.662 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.513 HD22 ' C ' ' A' ' 28' ' ' ALA . 0.9 OUTLIER -116.86 -30.37 5.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.167 -174.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -104.24 30.91 4.92 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -170.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.81 -60.06 0.67 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.741 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 0.5 OUTLIER -70.3 139.14 52.02 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 122.198 0.199 . . . . 0.0 111.058 178.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.36 -18.98 47.47 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.362 0.601 . . . . 0.0 109.419 176.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.3 pt -97.53 174.25 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.039 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -143.02 145.62 33.08 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.482 ' H ' ' HG2' ' A' ' 26' ' ' GLN . . . -142.55 177.11 8.51 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.078 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.962 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 42.6 mm -122.31 133.26 69.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.711 ' HB ' ' HB ' ' A' ' 24' ' ' THR . 72.9 mt -101.78 99.13 7.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.844 0.354 . . . . 0.0 110.091 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -91.76 114.06 26.49 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -86.56 113.49 22.51 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -176.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 41.5 p -79.75 162.08 25.36 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.142 0.496 . . . . 0.0 111.314 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -69.87 -2.66 12.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.829 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -93.67 7.26 45.44 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.777 176.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm 72.63 8.62 5.64 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.444 0.698 . . . . 0.0 111.002 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.77 120.74 36.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.03 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 p -79.94 105.57 11.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.358 0.599 . . . . 0.0 109.769 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 96.5 t -86.01 130.43 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.805 -176.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.9 m -82.1 92.22 6.8 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.855 0.835 . . . . 0.0 109.09 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.962 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -70.38 142.7 52.07 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.315 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.834 ' ND2' ' HB2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -81.79 151.79 68.23 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -174.178 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -89.76 39.16 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.562 2.174 . . . . 0.0 112.835 168.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.609 ' O ' ' HE2' ' A' ' 57' ' ' LYS . 64.9 mttm -131.97 -80.79 0.51 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.046 0.451 . . . . 0.0 111.234 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.673 HE22 ' CG2' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -40.1 139.31 0.71 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.664 1.186 . . . . 0.0 113.543 177.387 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.474 HG22 ' HD2' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -75.1 -16.93 60.53 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -172.395 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.594 ' CD1' ' HB2' ' A' ' 53' ' ' GLN . 60.7 p-90 -65.01 -30.82 71.82 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.586 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.673 ' CG2' HE22 ' A' ' 53' ' ' GLN . 0.9 OUTLIER -71.39 -47.94 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.914 174.019 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.609 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 68.3 mttm -54.41 -34.98 62.4 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 123.779 0.674 . . . . 0.0 110.386 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -68.33 -56.27 9.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.128 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.575 HG12 ' HD3' ' A' ' 17' ' ' PRO . 63.5 mt -64.57 -46.59 92.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.641 0.258 . . . . 0.0 111.486 -175.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.638 HG12 ' O ' ' A' ' 56' ' ' VAL . 12.7 p -71.4 -28.5 32.14 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.016 -174.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -68.9 -35.02 76.37 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.4 tp -72.1 -37.53 69.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.323 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.56 HD13 ' CB ' ' A' ' 23' ' ' PHE . 95.9 mt -82.4 -37.62 25.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.819 -177.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.4 t -96.23 52.43 1.27 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -56.18 103.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.836 -174.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -86.32 -4.29 59.14 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.912 174.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.9 p -96.75 -10.44 8.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.235 0.541 . . . . 0.0 111.765 -173.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -133.34 107.69 8.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.406 0.622 . . . . 0.0 111.892 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -130.92 -51.62 1.04 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.854 169.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 39.5 tpp . . . . . 0 C--O 1.245 0.854 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.693 177.299 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 120.671 0.272 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -59.96 133.98 56.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.875 173.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -58.53 -53.15 61.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.507 0.67 . . . . 0.0 109.412 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.712 ' HZ ' ' H ' ' A' ' 27' ' ' LEU . 1.4 p90 -131.83 178.08 7.04 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.543 173.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -121.39 117.38 26.79 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.629 0.728 . . . . 0.0 110.199 169.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.564 ' SG ' HG12 ' A' ' 34' ' ' ILE . 25.1 p -36.35 142.09 0.09 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 113.87 -1.514 . . . . 0.0 113.683 170.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 46.8 t -61.7 126.29 26.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.624 177.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.451 HD23 ' H ' ' A' ' 8' ' ' LEU . 2.3 pt? -64.21 -24.91 67.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.929 -176.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.27 122.57 1.74 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.565 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.712 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 3.2 m-85 -79.15 -178.42 6.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.561 0.696 . . . . 0.0 110.306 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.2 t -107.38 -166.26 1.14 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.065 175.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -160.22 81.42 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 170.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.459 ' HB2' HD22 ' A' ' 15' ' ' LEU . 23.1 mmm180 -131.59 -173.99 3.28 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.479 -168.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.504 HD13 ' CD1' ' A' ' 55' ' ' TRP . 7.6 mm -126.89 86.3 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 113.647 -1.615 . . . . 0.0 107.872 160.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.63 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 1.9 mm? -91.2 169.92 10.44 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.694 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 63.1 m170 -134.25 170.21 11.88 Favored Pre-proline 0 C--N 1.311 -1.073 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.879 -175.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 31.6 Cg_exo -55.73 -26.89 58.76 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 121.951 1.767 . . . . 0.0 109.251 164.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.694 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 62.6 mttm -45.5 -38.25 6.07 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 113.95 -1.477 . . . . 0.0 112.085 172.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 41' ' ' THR . 14.0 m-85 -118.14 2.59 12.02 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -170.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.681 HG12 ' HB3' ' A' ' 39' ' ' PHE . 17.2 mt -106.45 122.53 60.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.874 0.369 . . . . 0.0 111.058 -175.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.57 -0.52 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.822 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -157.42 158.32 28.87 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.548 ' CB ' HD13 ' A' ' 63' ' ' LEU . 2.8 t80 -155.29 133.29 11.49 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.514 0.673 . . . . 0.0 110.545 -176.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.3 m -136.87 108.82 7.12 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.07 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 25' ' ' ARG . 0.4 OUTLIER -80.15 105.28 11.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.967 0.889 . . . . 0.0 110.464 -177.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.686 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.7 OUTLIER -84.67 120.15 26.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.449 178.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.712 ' H ' ' HZ ' ' A' ' 4' ' ' PHE . 2.8 mm? -114.89 155.12 27.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.494 0.664 . . . . 0.0 112.036 -170.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.2 22.27 1.25 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.909 -175.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.462 ' ND2' ' HB3' ' A' ' 27' ' ' LEU . 7.8 p30 -127.08 -3.17 6.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -103.8 25.19 10.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.029 0.443 . . . . 0.0 110.974 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.14 -64.83 0.6 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.634 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.56 152.8 41.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.772 0.32 . . . . 0.0 111.288 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -90.97 -14.46 31.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.012 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.564 HG12 ' SG ' ' A' ' 6' ' ' CYS . 3.6 pt -111.71 140.31 31.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.409 ' HB2' ' HA ' ' A' ' 27' ' ' LEU . 9.6 p30 -110.43 126.97 54.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.314 0.578 . . . . 0.0 110.519 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.652 ' O ' ' HB3' ' A' ' 26' ' ' GLN . . . -127.11 132.01 50.69 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.683 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.44 HG23 ' HE1' ' A' ' 23' ' ' PHE . 47.0 mm -77.61 112.28 15.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.1 mm -90.21 97.79 7.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 122.044 -0.41 . . . . 0.0 111.087 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.681 ' HB3' HG12 ' A' ' 20' ' ' ILE . 16.7 m-85 -90.52 119.07 30.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 6.6 m-70 -89.31 115.1 26.54 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 15.0 p -84.86 159.47 20.37 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.774 0.797 . . . . 0.0 112.509 -171.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -67.9 -0.7 4.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.055 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -98.61 20.62 12.57 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.68 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt 67.9 22.64 8.6 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.58 175.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.32 173.65 8.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.724 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 40' ' ' HIS . 49.1 m -127.75 122.3 32.47 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 173.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.4 t -92.01 131.51 38.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.439 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.455 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 20.6 m -82.87 82.18 8.27 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.486 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -72.16 141.28 49.08 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.155 -173.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.712 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -82.41 131.42 55.68 Favored Pre-proline 0 CA--C 1.508 -0.671 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.733 -175.379 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 50' ' ' ASN . 5.8 Cg_exo -76.69 15.3 1.09 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.025 1.817 . . . . 0.0 111.632 169.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 50' ' ' ASN . 1.1 ttpp -89.82 -28.66 19.15 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.664 176.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.598 HE21 HG21 ' A' ' 56' ' ' VAL . 5.3 pt20 -105.95 138.8 41.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.746 -163.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.29 -29.81 66.65 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -173.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.63 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 46.0 p-90 -63.19 -33.76 76.17 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.421 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.598 HG21 HE21 ' A' ' 53' ' ' GLN . 2.7 t -70.17 -46.99 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.918 174.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.474 ' HA ' HG12 ' A' ' 60' ' ' VAL . 91.1 mttt -62.19 -29.06 70.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.855 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -68.19 -51.01 50.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.79 0.329 . . . . 0.0 110.419 173.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 55' ' ' TRP . 58.1 mt -68.53 -43.91 83.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.322 -175.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.544 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 14.9 p -68.22 -33.29 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.08 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.458 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 5.9 tmm_? -66.04 -40.19 90.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.103 0.478 . . . . 0.0 109.78 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.0 tp -66.69 -47.64 71.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.992 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.548 HD13 ' CB ' ' A' ' 23' ' ' PHE . 83.0 mt -65.5 -36.37 83.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.377 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.5 m -81.84 -1.23 46.79 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 61' ' ' ARG . 33.8 mmtp -108.62 -13.19 14.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.021 0.439 . . . . 0.0 111.423 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -114.01 -37.34 4.49 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.194 -175.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.7 t -90.57 13.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 122.125 0.964 . . . . 0.0 109.483 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -93.6 -14.38 26.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.38 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -105.47 145.9 30.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.569 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 13.1 tpt . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.415 -179.577 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 120.778 0.323 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.883 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . 24.2 m -95.28 -168.73 1.84 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.175 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.619 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 8.0 t30 -74.46 -72.14 0.3 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.666 0.269 . . . . 0.0 110.814 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.612 ' CD2' ' HB2' ' A' ' 5' ' ' ASP . 6.1 p90 -130.77 -42.85 1.12 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -176.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.612 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 0.8 OUTLIER -141.05 -34.91 0.48 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -169.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.883 ' SG ' ' HB3' ' A' ' 2' ' ' SER . 1.8 p -40.0 117.39 0.76 Allowed 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.852 0.72 . . . . 0.0 112.709 177.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.479 ' C ' ' H ' ' A' ' 9' ' ' GLY . 73.4 m -62.84 155.39 27.1 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.609 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 1.2 pp -77.34 25.7 0.17 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.428 0.632 . . . . 0.0 110.638 173.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 7' ' ' CYS . . . 131.15 156.98 8.69 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -175.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.718 ' HB2' HD22 ' A' ' 50' ' ' ASN . 0.1 OUTLIER -105.96 172.03 7.03 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.53 178.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 t -84.66 -174.96 5.56 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.032 -172.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -135.66 70.99 1.42 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 173.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -131.65 178.51 6.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.541 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.576 HD13 ' CD1' ' A' ' 55' ' ' TRP . 5.2 mm -124.51 94.79 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.374 167.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.513 HD12 ' CH2' ' A' ' 55' ' ' TRP . 1.1 mt -106.75 158.08 17.24 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.877 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.77 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 26.4 m170 -132.19 178.81 1.58 Allowed Pre-proline 0 C--N 1.314 -0.969 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.716 -173.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.77 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 9.4 Cg_endo -55.42 -20.32 25.64 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.281 1.987 . . . . 0.0 110.046 164.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.634 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 22.0 mtpp -47.16 -27.03 1.29 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.308 172.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 41' ' ' THR . 55.2 m-85 -126.15 -10.85 6.47 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.427 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 16' ' ' HIS . 1.5 mp -95.13 128.42 46.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.046 0.45 . . . . 0.0 111.649 -170.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -122.53 -16.96 5.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.591 172.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -145.07 162.37 28.13 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.603 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -155.16 136.03 13.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.002 0.429 . . . . 0.0 111.006 -175.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.2 m -134.47 123.25 23.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.501 174.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 25' ' ' ARG . 6.6 ptp85 -91.18 91.89 8.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.612 0.72 . . . . 0.0 110.298 176.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.708 ' NE2' ' HA ' ' A' ' 6' ' ' CYS . 0.9 OUTLIER -68.76 121.61 16.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.95 179.2 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.7 mt -113.82 147.8 37.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.899 -168.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.83 46.84 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.159 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -139.32 -29.49 0.75 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.244 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -90.56 28.62 1.45 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -168.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.32 -37.99 2.7 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.74 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.619 ' SG ' ' HB3' ' A' ' 3' ' ' ASN . 57.7 m -91.14 158.56 16.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.856 0.36 . . . . 0.0 110.735 175.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -110.45 -12.39 14.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.539 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.555 HG13 ' HB2' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -105.93 133.42 50.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 174.119 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -108.54 136.84 47.48 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.929 0.395 . . . . 0.0 110.872 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 26' ' ' GLN . . . -140.19 140.19 35.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.94 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 45.8 mm -79.94 101.95 5.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -87.03 98.33 7.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 O-C-N 121.87 -0.519 . . . . 0.0 110.747 -176.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.492 ' HE2' HG22 ' A' ' 56' ' ' VAL . 11.3 m-85 -86.23 135.15 33.67 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -105.96 116.91 32.75 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 41.7 p -79.85 163.63 24.23 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.34 -172.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -63.57 -12.19 30.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.551 170.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -84.04 0.16 49.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.278 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 67.9 mttm 71.27 12.4 6.74 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.778 0.831 . . . . 0.0 111.368 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.7 mt -107.86 141.68 39.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.423 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.8 p -92.47 124.16 36.31 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.102 0.477 . . . . 0.0 110.721 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.4 t -105.16 134.1 47.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.43 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 69.6 m -85.32 86.2 7.39 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.582 0.706 . . . . 0.0 109.634 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.628 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -72.78 149.12 43.92 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.451 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.718 HD22 ' HB2' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -83.48 151.76 62.74 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.865 -172.295 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -88.91 32.16 0.39 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.263 1.975 . . . . 0.0 113.771 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.675 ' O ' ' HE3' ' A' ' 57' ' ' LYS . 50.9 mtpt -132.25 -61.43 0.87 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -174.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.64 HE22 ' CG2' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -56.49 143.14 36.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.55 0.691 . . . . 0.0 112.272 -179.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p -74.94 -20.49 59.67 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -172.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.576 ' CD1' HD13 ' A' ' 14' ' ' ILE . 60.4 p-90 -63.22 -32.47 73.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.068 176.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.64 ' CG2' HE22 ' A' ' 53' ' ' GLN . 1.0 OUTLIER -68.92 -46.31 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.922 174.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.675 ' HE3' ' O ' ' A' ' 52' ' ' LYS . 92.6 mttt -63.81 -24.55 67.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.573 -178.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -74.12 -49.83 22.09 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.547 174.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.47 HD11 ' O ' ' A' ' 15' ' ' LEU . 76.8 mt -65.66 -48.15 83.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.06 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.603 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 14.1 p -65.37 -29.14 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 120.579 0.228 . . . . 0.0 110.743 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 28.3 ttm180 -63.79 -43.92 94.89 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.4 mt -64.75 -43.33 93.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.69 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.611 ' O ' HG13 ' A' ' 67' ' ' VAL . 3.9 mm? -57.48 -49.95 74.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.951 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.8 m -67.32 -17.23 64.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.989 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -108.32 1.02 21.6 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -118.36 -3.98 10.93 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.06 0.457 . . . . 0.0 110.506 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 63' ' ' LEU . 9.3 m -69.73 136.63 25.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.862 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -85.73 94.15 9.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.625 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -89.98 -2.26 58.11 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 171.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 66.2 mtm . . . . . 0 C--O 1.248 1.016 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.96 176.329 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 120.459 0.171 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.6 m -72.57 107.15 4.93 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.568 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -60.98 -53.99 50.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.004 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.583 ' CE1' ' HG3' ' A' ' 26' ' ' GLN . 0.4 OUTLIER -132.01 -178.5 4.92 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.384 177.201 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -120.34 112.36 18.92 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.164 0.507 . . . . 0.0 110.303 172.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.836 ' HA ' ' CD ' ' A' ' 26' ' ' GLN . 30.2 p -38.6 142.31 0.2 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.056 167.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.428 ' O ' HD11 ' A' ' 34' ' ' ILE . 74.1 m -57.0 143.2 39.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.209 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.3 mt -82.56 10.27 7.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.91 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.22 162.89 34.29 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.172 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.74 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 39.1 m-85 -116.19 -178.89 3.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.913 0.387 . . . . 0.0 110.304 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 49' ' ' ALA . 13.8 t -96.0 -178.68 4.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.135 176.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -144.83 23.37 1.56 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.073 0.463 . . . . 0.0 110.717 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.534 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 40.6 mtt180 -109.65 -174.08 2.41 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.76 0.791 . . . . 0.0 113.001 -173.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.553 HD13 ' CD1' ' A' ' 55' ' ' TRP . 6.2 mm -117.71 77.69 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 113.598 -1.637 . . . . 0.0 107.912 167.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.534 ' CD2' ' HB2' ' A' ' 13' ' ' ARG . 2.8 mm? -75.45 158.33 32.81 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.693 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 42.1 m170 -132.1 174.59 4.52 Favored Pre-proline 0 C--N 1.306 -1.285 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.857 -176.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.693 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 9.4 Cg_endo -54.52 -26.56 45.85 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.807 1.671 . . . . 0.0 108.954 166.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.657 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 67.4 mttm -46.27 -34.8 4.71 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 113.676 -1.602 . . . . 0.0 111.726 173.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -124.93 -4.6 7.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.632 0.253 . . . . 0.0 111.626 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.797 HG12 ' HB3' ' A' ' 39' ' ' PHE . 11.6 mt -102.83 114.86 43.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.071 0.462 . . . . 0.0 110.86 -173.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.9 -5.36 11.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.63 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -150.8 159.94 28.38 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.476 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 2.3 t80 -154.66 137.07 14.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.222 0.534 . . . . 0.0 110.483 -176.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.2 m -143.82 104.01 4.12 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.674 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -73.77 104.13 4.56 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.898 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.836 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 11.0 tt0 -90.14 125.88 35.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.216 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.582 ' H ' ' HZ ' ' A' ' 4' ' ' PHE . 7.9 mp -105.93 173.97 6.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.46 0.647 . . . . 0.0 112.156 -170.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.43 16.82 21.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.286 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -118.11 7.55 12.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.287 -173.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -119.63 37.49 4.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.174 0.511 . . . . 0.0 110.751 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.68 -62.31 0.29 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.052 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -71.64 143.75 49.66 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -97.27 9.78 41.3 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -170.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.768 HG12 ' SG ' ' A' ' 6' ' ' CYS . 4.5 pt -128.23 156.83 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 172.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -120.23 122.25 40.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.194 0.521 . . . . 0.0 111.524 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.535 ' O ' ' HB3' ' A' ' 26' ' ' GLN . . . -121.2 137.11 54.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.809 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.637 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 48.0 mm -82.6 98.56 4.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.158 0.504 . . . . 0.0 109.905 178.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.49 HG23 ' HB2' ' A' ' 46' ' ' SER . 67.0 mt -76.91 105.83 6.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.036 0.446 . . . . 0.0 111.273 -176.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.797 ' HB3' HG12 ' A' ' 20' ' ' ILE . 19.8 m-85 -96.29 119.42 34.75 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -89.01 106.09 18.2 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.9 p -72.57 164.0 27.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.645 -175.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -71.47 6.54 1.77 Allowed 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.421 0.629 . . . . 0.0 110.55 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -101.81 9.41 40.8 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.126 173.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 68.41 14.07 9.09 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.663 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.5 mt -103.05 131.48 50.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.051 0.453 . . . . 0.0 110.699 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.49 ' HB2' HG23 ' A' ' 38' ' ' ILE . 5.7 p -80.58 102.54 9.85 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.541 177.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 77.8 t -84.93 124.03 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.743 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 25.8 m -88.82 90.58 8.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.739 0.781 . . . . 0.0 109.496 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.637 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -70.87 134.82 47.62 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.818 -174.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.74 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -70.26 129.15 90.8 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.22 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 50' ' ' ASN . 21.8 Cg_exo -65.39 -6.5 13.58 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.387 2.058 . . . . 0.0 112.676 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -76.43 -37.56 56.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.777 0.799 . . . . 0.0 111.254 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.617 HE21 HG21 ' A' ' 56' ' ' VAL . 7.0 mt-30 -72.79 134.96 45.16 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.862 -164.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.22 -26.62 60.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.861 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.553 ' CD1' HD13 ' A' ' 14' ' ' ILE . 55.8 p-90 -65.31 -32.45 74.1 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 173.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.617 HG21 HE21 ' A' ' 53' ' ' GLN . 43.2 t -70.04 -50.5 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.829 173.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.549 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 96.5 mttt -59.3 -28.08 66.46 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.696 0.622 . . . . 0.0 111.281 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -71.06 -56.86 5.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.7 0.286 . . . . 0.0 110.309 173.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.673 HG22 HD22 ' A' ' 63' ' ' LEU . 81.9 mt -60.19 -45.95 95.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 -177.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.539 HG12 ' O ' ' A' ' 56' ' ' VAL . 9.8 p -70.3 -26.42 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.362 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -60.55 -43.11 97.6 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 174.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.2 mt -72.78 -41.2 65.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.489 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.673 HD22 HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -62.31 -46.4 88.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.348 -0.387 . . . . 0.0 112.043 -179.017 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 p -64.34 -25.18 67.92 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -173.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 11.5 mptt -101.41 -7.79 22.6 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -112.17 -31.79 6.76 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.984 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 48.1 t -82.72 119.38 32.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.046 0.451 . . . . 0.0 111.029 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -85.72 105.52 16.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.82 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -93.76 -6.23 46.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.273 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 51.1 tpp . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.936 179.26 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.46 148.95 47.97 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -68.5 -66.01 0.63 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 171.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.54 ' HE2' ' HG2' ' A' ' 26' ' ' GLN . 17.2 p90 -131.03 162.82 28.96 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.584 -1.189 . . . . 0.0 107.953 172.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -118.73 111.5 18.57 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.008 0.909 . . . . 0.0 110.323 173.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.579 ' HB3' ' HG2' ' A' ' 26' ' ' GLN . 30.1 p -60.43 -179.85 0.13 Allowed 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 113.779 -1.555 . . . . 0.0 113.125 -179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.8 t -50.74 114.14 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.607 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.1 mt -90.45 17.92 6.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.662 -176.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.54 113.39 0.7 Allowed Glycine 0 C--O 1.225 -0.415 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.772 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 33.6 m-85 -85.27 168.68 14.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.126 0.489 . . . . 0.0 111.239 -173.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 49' ' ' ALA . 11.1 t -86.75 -177.48 6.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.938 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -141.23 16.57 2.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.935 -177.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.592 ' HB3' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -104.76 175.16 5.58 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.213 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.549 HD13 ' CD1' ' A' ' 55' ' ' TRP . 2.8 mm -110.34 90.07 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 113.813 -1.539 . . . . 0.0 108.173 161.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.592 HD22 ' HB3' ' A' ' 13' ' ' ARG . 2.5 mm? -88.97 167.2 13.39 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.599 ' O ' HD13 ' A' ' 20' ' ' ILE . 63.2 m170 -133.07 167.83 21.01 Favored Pre-proline 0 C--N 1.314 -0.947 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.0 -175.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.661 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 22.8 Cg_endo -63.42 -19.07 67.29 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.121 1.881 . . . . 0.0 109.214 165.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 85.6 mttt -55.35 -24.66 30.47 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.417 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' A' ' 41' ' ' THR . 50.2 m-85 -128.29 2.53 5.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.946 -175.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.661 ' HB ' ' HA ' ' A' ' 17' ' ' PRO . 1.0 OUTLIER -100.85 122.78 53.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.098 0.475 . . . . 0.0 110.587 -175.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.03 -9.96 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.67 175.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -148.43 161.28 28.6 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.41 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.542 ' CE2' HG23 ' A' ' 60' ' ' VAL . 1.8 t80 -156.05 134.01 11.25 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -176.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.545 HG22 ' OE1' ' A' ' 26' ' ' GLN . 22.9 m -141.02 112.69 7.58 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.399 176.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 11.7 ttp180 -101.73 117.65 35.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.936 0.398 . . . . 0.0 111.202 -176.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.579 ' HG2' ' HB3' ' A' ' 6' ' ' CYS . 1.2 mp0 -97.75 139.01 34.26 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.806 174.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.536 HD13 ' HG3' ' A' ' 30' ' ' GLU . 5.2 mp -124.64 159.54 30.53 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 123.628 0.58 . . . . 0.0 109.767 -177.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.739 ' HA ' ' O ' ' A' ' 32' ' ' CYS . . . -77.01 1.08 18.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.818 0.818 . . . . 0.0 110.722 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -116.44 2.77 13.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.619 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.536 ' HG3' HD13 ' A' ' 27' ' ' LEU . 7.1 mm-40 -107.48 -8.75 16.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.849 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.12 -56.74 0.47 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.154 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.739 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 9.5 t -57.99 151.07 19.24 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 122.88 0.472 . . . . 0.0 109.98 174.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -84.39 -21.74 30.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.092 0.472 . . . . 0.0 109.911 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.428 HG13 ' SG ' ' A' ' 6' ' ' CYS . 46.9 pt -110.41 -171.46 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 173.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -138.86 119.29 13.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.445 0.64 . . . . 0.0 110.477 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.74 137.53 53.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.055 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.525 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 15.5 mm -96.47 92.32 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.217 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.443 HD12 HE22 ' A' ' 26' ' ' GLN . 40.5 mt -79.63 101.16 4.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.852 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.472 ' CE1' ' HD2' ' A' ' 23' ' ' PHE . 20.8 m-85 -85.13 131.2 34.48 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 171.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -100.02 107.89 19.94 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 41.1 p -71.14 159.21 35.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.762 -174.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -3.08 12.28 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.576 0.703 . . . . 0.0 109.642 171.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -90.97 1.22 57.22 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.112 174.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 70.42 16.32 7.13 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.638 -1.164 . . . . 0.0 112.057 173.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.8 mt -107.2 136.56 46.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.825 175.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.8 p -84.47 120.82 26.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.062 0.458 . . . . 0.0 110.477 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 91.0 t -104.2 124.36 58.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.962 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.5 m -85.53 82.79 8.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.661 0.743 . . . . 0.0 109.385 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.601 ' HA ' HG22 ' A' ' 11' ' ' THR . . . -69.64 143.55 53.19 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.034 -173.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.772 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -81.29 128.33 70.72 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.924 -176.046 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -71.19 13.49 0.4 Allowed 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.761 2.308 . . . . 0.0 112.303 173.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 50' ' ' ASN . 55.6 mtpt -99.47 -23.94 14.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.172 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.581 HE21 HG21 ' A' ' 56' ' ' VAL . 5.0 pt20 -102.63 145.77 29.16 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.737 -167.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.3 -30.83 63.66 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.638 -171.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.578 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 42.6 p-90 -63.34 -32.87 74.41 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.368 177.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.589 ' CG2' ' HB1' ' A' ' 49' ' ' ALA . 8.6 t -72.09 -46.14 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.38 174.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.511 ' HA ' HG12 ' A' ' 60' ' ' VAL . 88.6 mttt -60.5 -34.65 74.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.903 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -64.37 -50.07 69.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.395 174.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 55' ' ' TRP . 68.0 mt -68.88 -45.96 79.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.481 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.542 HG23 ' CE2' ' A' ' 23' ' ' PHE . 12.8 p -65.65 -35.35 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.89 -0.141 . . . . 0.0 111.297 -178.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 36.9 ttm180 -65.39 -33.84 76.89 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 30.6 tp -74.64 -38.1 62.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.236 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.443 ' HG ' ' CB ' ' A' ' 23' ' ' PHE . 2.8 mm? -69.52 -26.17 64.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.55 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.1 p -98.38 12.56 34.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.322 0.582 . . . . 0.0 110.25 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 59.8 tttp -102.17 8.47 40.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.946 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -79.28 58.01 2.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.916 0.865 . . . . 0.0 109.885 176.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -104.23 178.0 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.165 -176.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -78.23 91.88 4.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -98.3 -57.82 2.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.318 -175.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 17.1 tpt . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.139 -0.934 . . . . 0.0 109.261 -179.676 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 120.926 0.393 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.479 ' HB3' ' HA2' ' A' ' 31' ' ' GLY . 17.1 m -68.96 125.99 28.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.609 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -69.27 -45.85 68.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.298 0.571 . . . . 0.0 109.642 175.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.505 ' HZ ' ' H ' ' A' ' 27' ' ' LEU . 2.1 p90 -130.06 -172.64 2.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.804 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -135.09 116.45 14.59 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.821 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.703 ' SG ' HG12 ' A' ' 34' ' ' ILE . 19.6 p -38.08 150.84 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.321 170.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.0 t -62.63 152.69 34.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.328 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.9 mt -74.97 2.14 11.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.45 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.13 -153.92 12.31 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.825 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 64.0 m-85 -137.37 -171.47 2.98 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.525 HG21 ' CG1' ' A' ' 47' ' ' VAL . 11.2 t -127.19 136.88 52.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.075 0.464 . . . . 0.0 111.045 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -101.97 56.65 0.81 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.822 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.543 ' NE ' ' HA ' ' A' ' 13' ' ' ARG . 3.3 mmp_? -122.65 -177.16 3.57 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.517 0.675 . . . . 0.0 112.088 -177.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.599 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.5 mm -125.4 87.2 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 114.228 -1.351 . . . . 0.0 107.789 167.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.585 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.8 mm? -88.14 161.0 17.53 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.705 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 48.4 m170 -131.77 174.8 4.28 Favored Pre-proline 0 C--N 1.31 -1.115 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.275 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.705 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 10.1 Cg_endo -56.05 -23.22 42.83 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.8 1.667 . . . . 0.0 108.99 167.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.666 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 9.5 mmmt -47.35 -26.59 1.32 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 113.541 -1.663 . . . . 0.0 112.245 173.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 41' ' ' THR . 86.4 m-85 -126.86 -11.35 6.03 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 122.195 -0.316 . . . . 0.0 111.682 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.555 HG13 ' HB3' ' A' ' 39' ' ' PHE . 1.4 mp -89.65 122.59 41.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.062 0.458 . . . . 0.0 110.988 -171.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.53 -8.07 8.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.769 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -154.19 155.59 26.28 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.737 ' HB2' HD13 ' A' ' 63' ' ' LEU . 2.4 t80 -147.67 137.54 22.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.908 0.385 . . . . 0.0 110.278 -177.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 50.3 m -145.22 110.58 5.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.577 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -83.9 139.3 32.7 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.658 ' NE2' ' HA ' ' A' ' 6' ' ' CYS . 1.9 pt20 -119.26 108.41 14.6 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.784 0.802 . . . . 0.0 110.704 177.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.505 ' H ' ' HZ ' ' A' ' 4' ' ' PHE . 86.2 mt -98.24 165.04 12.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.958 -175.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.791 ' HA ' ' O ' ' A' ' 32' ' ' CYS . . . -82.7 11.31 6.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.586 -177.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -108.58 -19.87 13.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.839 0.352 . . . . 0.0 111.73 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.419 ' HG3' ' CE2' ' A' ' 4' ' ' PHE . 2.7 pt-20 -134.39 30.77 3.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.118 0.485 . . . . 0.0 111.769 -170.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.479 ' HA2' ' HB3' ' A' ' 2' ' ' SER . . . 176.72 -86.83 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 119.933 -1.127 . . . . 0.0 113.119 177.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.791 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 42.2 t -105.64 170.11 8.08 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.572 -0.314 . . . . 0.0 110.904 -175.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.402 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 9.5 m-20 -83.59 -21.87 32.47 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.096 0.247 . . . . 0.0 111.618 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.703 HG12 ' SG ' ' A' ' 6' ' ' CYS . 2.0 pt -100.0 157.33 3.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 17.6 p30 -115.26 130.54 56.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.367 0.603 . . . . 0.0 111.246 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.565 ' HB3' ' OE1' ' A' ' 26' ' ' GLN . . . -139.08 166.46 24.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.597 175.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.536 HG23 ' HE1' ' A' ' 23' ' ' PHE . 43.5 mm -113.88 106.19 20.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.161 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 66.0 mt -83.64 105.08 12.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 O-C-N 121.734 -0.603 . . . . 0.0 111.238 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.555 ' HB3' HG13 ' A' ' 20' ' ' ILE . 14.0 m-85 -94.96 111.85 23.61 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 171.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -84.45 112.98 20.86 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 28.2 p -76.33 166.01 24.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.128 0.49 . . . . 0.0 111.123 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -71.14 2.97 3.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.617 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.0 mmtp -98.82 5.64 47.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.568 176.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 67.2 mttm 68.42 12.58 8.77 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.805 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.5 mt -97.82 130.65 44.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.022 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.4 p -86.66 106.64 17.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.298 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.525 ' CG1' HG21 ' A' ' 11' ' ' THR . 66.4 t -86.82 124.93 40.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.9 m -88.61 83.89 6.76 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.718 0.771 . . . . 0.0 109.985 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.572 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -69.82 141.59 53.27 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.397 -175.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.825 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -80.53 130.21 65.72 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.083 -179.075 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -73.2 23.47 0.31 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.831 1.688 . . . . 0.0 111.666 171.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 50' ' ' ASN . 32.2 mtmm -115.24 -17.21 11.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.547 -176.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.554 HE21 HG21 ' A' ' 56' ' ' VAL . 5.8 pt20 -109.5 145.23 36.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 -170.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.69 ' HA ' ' HG2' ' A' ' 57' ' ' LYS . 1.3 p -81.5 -23.1 37.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -170.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.599 ' CD1' HD13 ' A' ' 14' ' ' ILE . 54.9 p-90 -63.19 -32.83 74.33 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 173.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.572 ' CG2' ' HB1' ' A' ' 49' ' ' ALA . 25.3 t -69.16 -46.98 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.792 172.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.69 ' HG2' ' HA ' ' A' ' 54' ' ' THR . 6.9 mmtp -55.89 -38.47 70.22 Favored 'General case' 0 C--O 1.222 -0.383 0 O-C-N 123.426 0.454 . . . . 0.0 110.737 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -65.22 -53.81 38.93 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.707 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.499 HG22 HD12 ' A' ' 63' ' ' LEU . 78.9 mt -62.74 -45.71 98.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.874 -177.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.554 HG12 ' O ' ' A' ' 56' ' ' VAL . 12.5 p -70.02 -24.9 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 120.911 -0.315 . . . . 0.0 110.903 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 49.8 ttp180 -64.45 -35.14 79.95 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.16 0.505 . . . . 0.0 110.256 176.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.6 mt -84.42 -25.22 29.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.968 177.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.737 HD13 ' HB2' ' A' ' 23' ' ' PHE . 77.5 mt -87.68 -31.28 19.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.307 -176.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t -79.84 -34.51 39.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.215 0.531 . . . . 0.0 109.74 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.572 ' HB3' ' NZ ' ' A' ' 65' ' ' LYS . 4.5 ttpm? -127.8 86.81 2.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.299 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -96.96 108.08 20.73 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.9 m -93.11 124.35 45.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.53 0.681 . . . . 0.0 111.759 -174.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.887 ' HE2' ' HA ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -106.7 0.81 24.56 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -117.29 146.62 43.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.934 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 81.1 mtp . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.152 177.762 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 120.726 0.298 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.524 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 14.2 m -127.81 116.53 20.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.565 -0.288 . . . . 0.0 110.227 178.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -75.1 -44.94 44.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.178 0.513 . . . . 0.0 110.012 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.789 ' HZ ' ' H ' ' A' ' 27' ' ' LEU . 0.9 OUTLIER -130.65 -172.92 2.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.493 176.518 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -131.02 106.04 8.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.328 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.824 ' HA ' ' CD ' ' A' ' 26' ' ' GLN . 26.6 p -35.62 142.55 0.07 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 114.878 -1.055 . . . . 0.0 113.678 170.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.479 ' O ' HD11 ' A' ' 34' ' ' ILE . 43.1 t -73.03 127.75 33.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.088 171.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.7 mt -81.93 45.34 0.9 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.146 0.498 . . . . 0.0 110.742 -174.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 166.26 157.65 10.37 Favored Glycine 0 N--CA 1.44 -1.048 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.833 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 25.2 m-85 -123.87 162.33 23.5 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 117.159 0.479 . . . . 0.0 110.488 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.5 t -90.18 -175.58 4.58 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.404 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -144.78 31.18 1.17 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.553 0.692 . . . . 0.0 109.813 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.595 ' HB2' HD22 ' A' ' 15' ' ' LEU . 35.2 mmt180 -87.68 -176.6 5.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.714 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.494 HD13 ' CD1' ' A' ' 55' ' ' TRP . 16.4 mm -124.93 77.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.654 165.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.741 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.2 mm? -74.76 153.7 38.68 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.057 -178.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.692 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 42.9 m170 -132.66 173.63 5.66 Favored Pre-proline 0 C--N 1.317 -0.847 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.622 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.692 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 13.0 Cg_endo -58.86 -23.84 69.33 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 121.718 1.612 . . . . 0.0 108.825 167.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.674 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 8.7 mmmt -47.22 -34.4 6.38 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 113.434 -1.712 . . . . 0.0 111.931 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.687 ' HA ' ' HE3' ' A' ' 42' ' ' LYS . 27.0 m-85 -125.44 -0.2 7.59 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.655 0.264 . . . . 0.0 111.338 -175.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.507 HD13 ' O ' ' A' ' 16' ' ' HIS . 1.3 mp -96.46 126.75 49.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.0 0.428 . . . . 0.0 110.635 -175.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.12 -6.8 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.999 174.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -157.73 154.27 25.38 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.542 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.606 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -145.02 132.99 21.29 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.477 0.656 . . . . 0.0 110.386 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.7 m -132.93 121.06 22.27 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.469 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -86.68 114.03 23.04 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.508 0.671 . . . . 0.0 110.412 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.824 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 21.6 tt0 -104.27 121.91 44.31 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.876 177.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.789 ' H ' ' HZ ' ' A' ' 4' ' ' PHE . 6.5 mp -109.31 178.65 4.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.946 -170.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -111.52 26.58 10.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.922 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -130.7 -12.82 3.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.489 -175.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -115.05 23.51 12.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.462 -174.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 2' ' ' SER . . . 164.42 -91.79 0.11 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.358 177.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 6' ' ' CYS . 18.5 m -66.16 169.56 6.89 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.997 0.427 . . . . 0.0 111.976 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -99.22 -6.02 28.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.089 176.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.479 HD11 ' O ' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -108.61 153.41 10.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 174.561 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.497 ' OD1' ' HG2' ' A' ' 51' ' ' PRO . 4.8 p30 -127.09 129.64 48.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.801 -0.181 . . . . 0.0 111.28 -173.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.762 ' O ' ' HB3' ' A' ' 26' ' ' GLN . . . -134.68 127.37 30.93 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.244 0.545 . . . . 0.0 111.962 176.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.408 HG23 ' HE1' ' A' ' 23' ' ' PHE . 48.3 mm -70.05 117.61 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 170.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 55.8 mt -94.42 104.41 15.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 120.834 0.349 . . . . 0.0 111.117 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.703 ' CE2' HG12 ' A' ' 56' ' ' VAL . 12.1 m-85 -93.98 127.73 39.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 173.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -98.03 108.81 21.6 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.1 p -74.0 160.15 31.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.068 -174.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.687 ' HE3' ' HA ' ' A' ' 19' ' ' PHE . 18.0 ptpt -66.07 -3.03 4.71 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.317 172.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -89.66 0.54 56.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.633 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.546 ' NZ ' ' HB2' ' A' ' 44' ' ' LYS . 8.3 mtmp? 71.89 15.6 5.69 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.981 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.0 mt -107.88 136.66 47.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.904 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.1 p -87.16 118.57 26.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.301 0.572 . . . . 0.0 110.007 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 76.5 t -97.24 134.05 36.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.083 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.3 m -89.12 87.44 7.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.424 ' HB1' ' CG1' ' A' ' 56' ' ' VAL . . . -79.49 143.07 35.25 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.409 -174.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.833 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -82.53 122.19 78.6 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.524 -174.2 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HG2' ' OD1' ' A' ' 35' ' ' ASN . 19.8 Cg_exo -70.18 9.8 0.62 Allowed 'Trans proline' 0 C--N 1.329 -0.479 0 C-N-CA 122.279 1.986 . . . . 0.0 112.368 175.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 50' ' ' ASN . 51.3 mttm -104.33 -14.27 15.83 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.406 -176.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.749 ' CG ' ' HB2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -89.53 168.13 12.42 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -176.454 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.23 -33.51 14.65 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.741 ' CZ3' ' HB2' ' A' ' 15' ' ' LEU . 59.3 p-90 -62.19 -28.58 69.77 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.823 -177.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.718 HG21 ' O ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -71.04 -49.91 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 174.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 93.9 mttt -55.03 -33.85 63.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.687 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -64.37 -52.67 57.12 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.211 0.529 . . . . 0.0 110.486 174.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.536 HG12 ' HD3' ' A' ' 17' ' ' PRO . 87.7 mt -65.85 -48.96 80.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.74 -176.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.606 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 7.8 p -65.53 -28.37 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.836 0.35 . . . . 0.0 110.754 -176.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -69.03 -35.43 76.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.212 0.53 . . . . 0.0 109.672 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.4 tp -79.02 -32.63 45.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.995 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 1.9 mm? -67.63 -42.5 82.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.275 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.7 p -77.09 -49.98 14.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.894 0.378 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -94.59 69.94 3.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.159 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -68.77 97.89 0.86 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.328 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.1 p -100.54 -16.82 7.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.504 0.669 . . . . 0.0 110.118 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 68' ' ' LYS . 21.7 tptm -77.65 108.6 10.97 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.889 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -119.77 129.48 54.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.356 176.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 60.0 ttp . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.77 178.769 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p -83.1 93.76 7.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.086 0.469 . . . . 0.0 111.783 -175.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -66.25 -41.83 89.41 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 167.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.609 ' CZ ' ' HA ' ' A' ' 26' ' ' GLN . 44.5 p90 -131.1 -168.01 1.93 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.77 -1.559 . . . . 0.0 107.511 168.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.696 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 4.3 p-10 -128.79 -93.1 0.45 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.764 0.793 . . . . 0.0 111.573 173.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.767 ' HB2' HG12 ' A' ' 34' ' ' ILE . 18.7 p -146.88 -168.78 3.13 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 125.146 1.378 . . . . 0.0 108.7 -177.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.1 t -106.54 158.37 16.97 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.927 -0.483 . . . . 0.0 110.425 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.7 mt -77.73 -27.94 50.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.933 0.397 . . . . 0.0 110.828 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.83 136.3 4.08 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.784 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 20.1 m-85 -78.47 173.63 12.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.486 0.66 . . . . 0.0 111.047 -177.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.8 t -89.02 -178.55 5.72 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.94 174.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -140.63 1.86 1.76 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.011 0.434 . . . . 0.0 110.169 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.603 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 32.7 mtt180 -94.23 -172.42 2.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.641 -166.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.614 HD13 ' CD1' ' A' ' 55' ' ' TRP . 3.3 mm -117.64 88.79 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.599 -1.182 . . . . 0.0 107.982 167.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.603 ' CD2' ' HB2' ' A' ' 13' ' ' ARG . 2.9 mm? -88.34 164.77 15.39 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.732 ' ND1' ' HD2' ' A' ' 18' ' ' LYS . 63.2 m170 -132.97 163.63 49.66 Favored Pre-proline 0 C--N 1.311 -1.105 0 C-N-CA 119.831 -0.748 . . . . 0.0 112.151 -174.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.612 ' HD3' HG12 ' A' ' 59' ' ' ILE . 26.7 Cg_endo -64.28 -17.18 58.75 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.213 1.942 . . . . 0.0 109.174 167.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.732 ' HD2' ' ND1' ' A' ' 16' ' ' HIS . 60.8 mttm -51.66 -29.23 17.14 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.361 172.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -128.01 11.37 6.55 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.62 -174.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.641 HG12 ' O ' ' A' ' 16' ' ' HIS . 7.5 mm -106.69 127.64 62.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -173.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.3 m -118.56 -3.49 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.146 0.498 . . . . 0.0 110.934 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -155.29 158.91 28.76 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.004 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.739 ' HB2' HD13 ' A' ' 63' ' ' LEU . 1.4 t80 -155.47 134.68 12.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.239 0.542 . . . . 0.0 110.183 -177.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.449 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 25.5 m -142.06 107.08 4.93 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.867 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 14.1 ptp180 -77.02 109.03 10.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.827 0.822 . . . . 0.0 110.112 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.609 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 2.4 tt0 -99.05 133.11 43.79 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.218 -175.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.488 ' H ' ' HE1' ' A' ' 4' ' ' PHE . 96.0 mt -122.18 158.9 28.36 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -159.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.72 31.24 4.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.737 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -99.41 -73.42 0.63 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.745 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -110.9 23.12 14.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.574 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -129.53 -71.93 0.13 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.345 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.696 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 47.3 t -128.63 -172.08 2.62 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.441 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 0.9 OUTLIER -96.85 -23.55 16.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.957 0.408 . . . . 0.0 109.923 178.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.767 HG12 ' HB2' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -109.03 159.75 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 175.352 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -132.56 132.13 42.24 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.915 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.589 ' HB3' ' OE1' ' A' ' 26' ' ' GLN . . . -129.1 145.13 51.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.415 0.626 . . . . 0.0 111.63 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.691 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 47.9 mm -88.79 104.77 15.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.861 177.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.449 ' HB ' ' HB ' ' A' ' 24' ' ' THR . 58.1 mt -79.65 103.05 6.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 O-C-N 122.108 -0.37 . . . . 0.0 111.386 -176.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -91.65 123.82 35.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 171.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -97.66 108.93 21.76 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.2 p -75.84 157.49 33.29 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.116 0.484 . . . . 0.0 111.37 -175.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -68.17 -10.33 53.44 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 43' ' ' LYS . 23.0 ttmm -89.92 14.18 12.77 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.702 -177.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp 71.0 13.55 6.94 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.046 173.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.5 mt -112.66 142.15 45.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.968 0.413 . . . . 0.0 111.042 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.0 p -99.13 112.64 24.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.222 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.2 t -92.48 120.31 41.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.354 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.9 m -83.44 89.21 7.02 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.808 0.813 . . . . 0.0 109.269 177.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.691 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -71.18 140.33 50.47 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.387 -174.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.784 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -79.97 126.06 80.6 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.175 -179.213 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.1 13.98 0.48 Allowed 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.321 2.014 . . . . 0.0 111.613 174.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 50' ' ' ASN . 74.8 mttt -100.5 -21.51 15.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.136 -175.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.616 HE21 HG21 ' A' ' 56' ' ' VAL . 5.8 pt20 -109.57 148.46 31.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.646 -167.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p -75.03 -33.65 61.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -170.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.614 ' CD1' HD13 ' A' ' 14' ' ' ILE . 49.7 p-90 -61.34 -32.58 72.47 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.352 0.596 . . . . 0.0 109.491 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.626 HG22 ' HB1' ' A' ' 49' ' ' ALA . 14.7 t -70.51 -51.29 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.171 174.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 95.2 mttt -58.05 -32.12 67.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.968 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -68.04 -56.37 9.15 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.395 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.612 HG12 ' HD3' ' A' ' 17' ' ' PRO . 72.5 mt -61.02 -43.34 95.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.222 -176.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.641 HG23 ' CE1' ' A' ' 23' ' ' PHE . 13.8 p -65.45 -35.03 74.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.374 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -68.63 -33.08 73.41 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.989 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 29.8 mt -77.66 -33.44 53.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.094 0.473 . . . . 0.0 110.701 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.739 HD13 ' HB2' ' A' ' 23' ' ' PHE . 78.7 mt -79.24 -12.49 59.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.989 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 m -121.18 67.37 0.87 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.526 173.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -60.12 86.67 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.532 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -101.46 14.28 32.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.263 0.554 . . . . 0.0 110.172 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.9 m -85.07 14.24 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.999 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -103.59 -19.91 14.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.488 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.561 ' C ' HD22 ' A' ' 69' ' ' ASN . 0.3 OUTLIER -110.08 176.15 5.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.662 -178.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 45.9 tpp . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.537 -0.744 . . . . 0.0 109.573 176.482 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -86.99 131.43 34.09 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 173.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.809 HD22 ' HD1' ' A' ' 4' ' ' PHE . 6.4 t30 -57.21 -57.72 11.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.027 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.809 ' HD1' HD22 ' A' ' 3' ' ' ASN . 38.0 p90 -133.75 -169.51 2.31 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.144 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 30.0 t0 -141.6 112.18 7.09 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 163.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.642 ' HB3' ' HG2' ' A' ' 26' ' ' GLN . 18.5 p -58.36 174.65 0.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.788 -169.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.2 m -41.26 98.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 -169.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.1 mt -63.65 -37.28 86.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.548 173.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.38 85.58 0.42 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.775 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.5 ' HB2' ' ND2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -88.11 155.03 20.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.994 0.426 . . . . 0.0 111.254 177.504 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.454 HG21 HG13 ' A' ' 47' ' ' VAL . 14.9 t -91.11 141.94 28.28 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -166.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -104.58 74.57 1.16 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.68 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.407 ' HD2' HD21 ' A' ' 15' ' ' LEU . 99.5 mtt180 -123.44 -171.8 2.38 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.055 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.537 HD13 ' CD1' ' A' ' 55' ' ' TRP . 8.2 mm -126.54 91.78 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.147 165.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.623 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 1.7 mm? -98.15 162.77 13.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.77 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 34.2 m170 -132.63 175.46 3.69 Favored Pre-proline 0 C--N 1.317 -0.841 0 O-C-N 122.054 -0.404 . . . . 0.0 110.757 -178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.77 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 18.9 Cg_endo -60.25 -16.95 43.68 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.106 1.871 . . . . 0.0 109.453 166.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.608 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 9.1 mtmt -45.91 -35.54 4.69 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 114.111 -1.404 . . . . 0.0 111.779 172.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -126.68 2.22 6.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.024 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.626 ' HB ' ' HA ' ' A' ' 17' ' ' PRO . 1.2 mp -92.44 124.32 44.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.81 0.338 . . . . 0.0 110.116 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.3 m -121.34 -1.18 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.977 0.418 . . . . 0.0 110.333 176.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.92 157.94 29.48 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.676 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.751 ' HB2' HD13 ' A' ' 63' ' ' LEU . 2.8 t80 -151.01 134.29 16.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.193 0.521 . . . . 0.0 110.564 -177.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.42 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 32.2 m -146.15 102.32 3.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.265 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -74.58 126.7 31.37 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.711 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.642 ' HG2' ' HB3' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -101.35 126.87 48.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.689 -177.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.3 mp -125.17 153.42 43.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.335 0.588 . . . . 0.0 111.712 -171.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.41 ' HA ' ' C ' ' A' ' 32' ' ' CYS . . . -64.57 -23.58 67.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.328 174.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.418 ' N ' HD22 ' A' ' 29' ' ' ASN . 0.9 OUTLIER -67.38 -24.87 65.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.366 -176.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -102.72 -32.62 9.76 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.866 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.38 41.24 0.02 OUTLIER Glycine 0 C--O 1.221 -0.682 0 C-N-CA 119.998 -1.096 . . . . 0.0 112.306 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 53.8 t -133.8 -179.71 5.71 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 173.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -118.23 -32.18 4.77 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.974 169.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.5 pt -95.75 -156.58 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 169.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -150.93 137.36 18.63 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.115 0.483 . . . . 0.0 110.132 174.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.49 145.11 33.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.071 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.809 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 46.4 mm -93.57 108.25 20.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.42 ' HB ' ' O ' ' A' ' 24' ' ' THR . 33.6 mm -85.91 99.03 7.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 O-C-N 121.982 -0.449 . . . . 0.0 110.636 -177.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.434 ' HB3' HG13 ' A' ' 20' ' ' ILE . 17.1 m-85 -90.59 122.9 33.8 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 174.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -93.6 107.35 19.22 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.5 p -79.36 164.58 23.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.119 0.485 . . . . 0.0 111.698 -174.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -72.86 -1.63 17.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 122.151 0.976 . . . . 0.0 108.59 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.42 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 12.6 tptt -86.14 9.0 18.71 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.505 173.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.8 pttm 46.89 34.04 2.48 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.455 1.102 . . . . 0.0 111.686 -173.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 43' ' ' LYS . 94.0 mt -119.47 131.13 55.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.072 175.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.9 p -84.9 105.69 15.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.382 0.611 . . . . 0.0 110.651 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.454 HG13 HG21 ' A' ' 11' ' ' THR . 54.3 t -79.62 126.28 39.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.601 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 58.8 m -84.67 88.86 7.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.809 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -76.72 134.67 39.14 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.629 -176.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.594 HD22 ' N ' ' A' ' 50' ' ' ASN . 0.7 OUTLIER -77.35 134.99 66.01 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.106 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -74.25 7.29 2.62 Favored 'Trans proline' 0 C--N 1.33 -0.398 0 C-N-CA 122.502 2.135 . . . . 0.0 110.614 168.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -90.3 -17.48 27.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.265 -177.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.527 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 6.2 pt20 -118.83 150.72 39.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.859 -168.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.766 ' HA ' ' HG2' ' A' ' 57' ' ' LYS . 1.7 p -91.45 -17.75 25.27 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -170.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.623 ' CZ3' ' HB2' ' A' ' 15' ' ' LEU . 58.1 p-90 -63.62 -32.8 74.38 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 172.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.544 ' O ' HG12 ' A' ' 60' ' ' VAL . 38.9 t -66.52 -47.28 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.839 171.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.766 ' HG2' ' HA ' ' A' ' 54' ' ' THR . 13.4 mmtp -54.45 -39.0 66.98 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.168 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.52 ' HD1' HH21 ' A' ' 61' ' ' ARG . 5.8 t80 -67.41 -53.69 26.94 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.087 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.568 HG22 HD12 ' A' ' 63' ' ' LEU . 71.0 mt -61.34 -45.16 99.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.954 -176.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 56' ' ' VAL . 12.0 p -70.15 -23.47 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 120.784 0.326 . . . . 0.0 110.688 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.52 HH21 ' HD1' ' A' ' 58' ' ' TYR . 43.5 ttp180 -66.46 -29.64 69.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.136 0.493 . . . . 0.0 110.113 175.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.3 mp -87.58 -36.74 17.37 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.599 174.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.751 HD13 ' HB2' ' A' ' 23' ' ' PHE . 91.0 mt -81.8 2.12 31.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.646 -176.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.3 p -95.41 -38.55 10.43 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.701 0.286 . . . . 0.0 111.054 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -105.2 54.41 0.71 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.774 0.797 . . . . 0.0 110.691 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -58.22 108.58 0.63 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.922 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.0 m -102.65 140.62 20.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.426 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -106.62 4.34 27.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.734 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.713 HD22 ' HG2' ' A' ' 70' ' ' MET . 13.5 t30 -96.07 -65.23 0.98 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.279 -175.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.713 ' HG2' HD22 ' A' ' 69' ' ' ASN . 26.0 mmt . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.744 -0.646 . . . . 0.0 109.552 177.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 121.025 0.44 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.405 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 24.9 m -148.6 132.33 16.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.314 176.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -82.79 -45.03 14.85 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.628 ' HZ ' ' H ' ' A' ' 27' ' ' LEU . 15.8 p90 -130.69 -169.63 2.19 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.221 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -137.59 107.16 6.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.239 175.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.646 ' HA ' ' CD ' ' A' ' 26' ' ' GLN . 22.0 p -37.48 146.43 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 171.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 37.7 m -74.96 148.26 40.14 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.211 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.6 mt -70.69 -9.26 56.75 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.153 0.501 . . . . 0.0 110.681 176.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.62 160.27 28.53 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.942 ' HB2' HD22 ' A' ' 50' ' ' ASN . 0.3 OUTLIER -113.65 158.62 20.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.716 0.258 . . . . 0.0 110.846 177.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 t -88.94 145.56 25.45 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -168.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -95.12 66.2 2.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.662 0.744 . . . . 0.0 109.46 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.492 ' C ' HD12 ' A' ' 14' ' ' ILE . 36.2 mtp180 -130.85 -178.08 4.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.523 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.559 HG22 ' CD2' ' A' ' 16' ' ' HIS . 2.4 mp -121.89 91.39 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 163.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.511 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 3.5 mm? -72.14 155.87 39.79 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.031 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.763 ' HB2' ' HG2' ' A' ' 18' ' ' LYS . 65.5 m170 -131.64 159.22 72.83 Favored Pre-proline 0 C--N 1.315 -0.898 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.905 -168.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.51 -30.47 74.12 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.553 2.169 . . . . 0.0 109.882 167.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.763 ' HG2' ' HB2' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -62.95 -18.32 63.02 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.226 178.353 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -118.84 -13.3 9.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.582 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.501 HG12 ' HB3' ' A' ' 39' ' ' PHE . 23.4 mt -97.83 127.43 50.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.025 0.44 . . . . 0.0 111.249 -172.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.9 p -111.61 -16.81 8.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.419 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.48 150.89 21.85 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.584 -0.607 . . . . 0.0 111.584 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.546 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -134.15 134.79 42.58 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.253 0.549 . . . . 0.0 110.637 -178.461 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.425 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 20.6 m -139.86 112.61 7.99 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.099 175.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 25' ' ' ARG . 9.0 ptp180 -75.78 130.27 38.36 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.014 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.646 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -101.03 127.02 47.74 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.898 179.161 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.628 ' H ' ' HZ ' ' A' ' 4' ' ' PHE . 4.2 mp -117.86 169.13 9.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.854 0.359 . . . . 0.0 111.125 -170.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.7 29.72 1.12 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.615 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -127.25 -53.9 1.38 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.251 -174.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -83.82 36.38 0.55 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.189 0.518 . . . . 0.0 111.707 -172.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 2' ' ' SER . . . 151.88 -96.28 0.16 Allowed Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.312 177.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 42.2 t -70.77 160.83 31.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.496 -0.352 . . . . 0.0 110.772 -178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -92.36 0.39 57.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.597 -177.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.457 HG12 ' SG ' ' A' ' 6' ' ' CYS . 3.4 pt -116.2 167.91 8.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -132.79 136.94 46.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.973 0.416 . . . . 0.0 111.556 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.502 ' HA ' ' HG3' ' A' ' 51' ' ' PRO . . . -138.56 164.78 28.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.634 172.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.671 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 49.9 mm -96.9 112.06 28.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.483 HD11 HE21 ' A' ' 26' ' ' GLN . 60.2 mt -88.78 102.39 12.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 O-C-N 121.707 -0.62 . . . . 0.0 111.152 -178.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.566 ' HE2' HG22 ' A' ' 56' ' ' VAL . 6.9 m-85 -95.58 119.81 34.73 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -94.27 111.56 23.3 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.2 p -78.77 153.18 30.98 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.299 0.571 . . . . 0.0 111.41 -175.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -58.17 -17.83 21.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.742 173.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -83.94 10.45 9.78 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.214 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 74.62 7.34 4.46 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.416 0.686 . . . . 0.0 111.911 173.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.7 mt -102.9 135.74 44.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.866 0.365 . . . . 0.0 110.524 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.8 p -92.61 110.54 21.97 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.404 HG11 ' HG ' ' A' ' 15' ' ' LEU . 49.0 t -94.67 132.15 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.971 -176.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.8 m -85.85 91.26 8.29 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.759 0.79 . . . . 0.0 108.982 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.671 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -74.47 143.31 44.71 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.473 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.942 HD22 ' HB2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -81.38 142.3 50.27 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -174.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.502 ' HG3' ' HA ' ' A' ' 36' ' ' ALA . 5.1 Cg_exo -82.5 1.5 9.11 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.125 1.883 . . . . 0.0 112.714 176.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -98.03 -48.81 4.99 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -175.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.806 ' OE1' ' HB ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -65.14 166.99 8.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.122 0.487 . . . . 0.0 112.17 -174.647 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.97 -25.59 16.45 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -175.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.687 ' O ' HG13 ' A' ' 59' ' ' ILE . 58.7 p-90 -58.25 -34.75 70.82 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.73 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.806 ' HB ' ' OE1' ' A' ' 53' ' ' GLN . 1.1 t -69.59 -46.21 76.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.959 175.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -58.77 -31.7 68.61 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.482 0.489 . . . . 0.0 110.67 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -64.75 -51.79 60.45 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.918 172.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.687 HG13 ' O ' ' A' ' 55' ' ' TRP . 23.8 mt -61.64 -56.86 15.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.268 -176.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 56' ' ' VAL . 4.4 p -62.1 -25.45 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.337 -175.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -63.43 -47.29 82.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.764 0.316 . . . . 0.0 110.187 172.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.3 mt -78.0 -1.44 32.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.044 0.45 . . . . 0.0 110.872 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 3.4 mm? -96.84 -58.28 2.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.64 176.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.5 m -65.02 -40.0 94.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.426 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -92.58 3.91 54.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.845 0.355 . . . . 0.0 111.722 -175.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 66' ' ' LYS . 35.1 ttmt -101.18 -56.73 2.24 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.841 0.353 . . . . 0.0 110.724 -177.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 63' ' ' LEU . 14.5 m -82.66 90.31 2.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.965 0.888 . . . . 0.0 110.361 -178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -119.02 108.62 14.96 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.893 -175.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -115.21 172.19 7.23 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.532 174.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.8 tmm? . . . . . 0 C--O 1.246 0.894 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.465 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.819 0.342 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.708 ' HA ' ' HA3' ' A' ' 31' ' ' GLY . 5.9 m -92.68 108.1 19.72 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.918 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -59.35 -52.23 66.54 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 171.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.57 ' CE2' ' HG2' ' A' ' 26' ' ' GLN . 48.3 p90 -131.62 165.0 24.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.019 173.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -122.49 114.75 21.12 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.383 0.611 . . . . 0.0 109.621 168.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.625 ' SG ' HG12 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -50.4 149.12 3.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.107 -0.951 . . . . 0.0 113.504 177.458 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 t -43.62 118.54 1.41 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.941 170.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.0 mt -68.25 -26.67 65.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.249 -174.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.87 140.12 12.19 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.738 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 42.6 m-85 -91.79 179.85 5.51 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.071 0.462 . . . . 0.0 110.708 -176.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.588 ' OG1' ' HG2' ' A' ' 13' ' ' ARG . 14.4 t -97.78 -172.02 2.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.931 177.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -147.6 17.38 1.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.005 0.431 . . . . 0.0 110.609 177.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.617 ' HB2' HD22 ' A' ' 15' ' ' LEU . 18.0 mmm180 -88.1 -173.61 4.32 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.379 0.609 . . . . 0.0 112.462 -171.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.552 HD13 ' CD1' ' A' ' 55' ' ' TRP . 5.2 mm -125.31 90.35 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 114.176 -1.374 . . . . 0.0 108.423 167.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.617 HD22 ' HB2' ' A' ' 13' ' ' ARG . 2.8 mm? -93.31 165.07 12.97 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.687 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 63.2 m170 -133.29 168.28 18.71 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.569 -175.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.464 ' HD3' HG12 ' A' ' 59' ' ' ILE . 14.0 Cg_endo -59.02 -24.3 72.78 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.055 1.836 . . . . 0.0 108.94 166.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.687 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 60.7 mttm -49.26 -33.3 12.56 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 114.011 -1.449 . . . . 0.0 111.04 171.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 41' ' ' THR . 76.5 m-85 -120.51 -0.98 10.19 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.744 -171.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.649 HG12 ' HB3' ' A' ' 39' ' ' PHE . 19.5 mt -104.68 118.86 52.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.061 0.457 . . . . 0.0 111.211 -173.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.86 -5.96 11.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.779 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -152.05 151.58 23.44 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.497 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 1.1 t80 -148.99 129.8 14.2 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.137 0.494 . . . . 0.0 110.495 -177.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.5 m -131.4 126.28 34.74 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.033 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.456 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 10.3 ptp180 -98.41 103.63 15.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.307 0.575 . . . . 0.0 111.09 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.598 ' OE1' ' HA ' ' A' ' 6' ' ' CYS . 13.9 mt-30 -77.77 126.65 31.18 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.254 176.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.757 ' HB3' HD22 ' A' ' 29' ' ' ASN . 34.2 mt -119.94 145.07 47.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.925 -171.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.709 ' HA ' ' O ' ' A' ' 32' ' ' CYS . . . -76.47 63.97 2.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.971 172.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.757 HD22 ' HB3' ' A' ' 27' ' ' LEU . 32.2 m-80 -135.42 -66.13 0.58 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.504 -174.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -105.9 51.48 0.75 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.249 0.547 . . . . 0.0 111.889 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.708 ' HA3' ' HA ' ' A' ' 2' ' ' SER . . . 130.79 -58.31 0.71 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.9 173.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.709 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 1.1 t -60.7 136.46 58.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.716 0.293 . . . . 0.0 110.733 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -87.67 -30.16 20.61 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.238 -175.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.625 HG12 ' SG ' ' A' ' 6' ' ' CYS . 37.3 pt -105.55 -152.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -153.41 121.67 6.2 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 171.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . -132.9 129.11 37.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.581 -177.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.444 HG23 ' HE1' ' A' ' 23' ' ' PHE . 47.1 mm -81.71 113.14 20.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.771 177.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 42.8 mt -91.47 103.66 14.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.558 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.649 ' HB3' HG12 ' A' ' 20' ' ' ILE . 16.5 m-85 -87.81 113.69 23.71 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 172.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -87.95 105.71 17.63 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 58.2 p -75.51 158.49 32.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.462 0.648 . . . . 0.0 111.826 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.551 ' HD3' ' O ' ' A' ' 42' ' ' LYS . 1.9 tmtp? -60.21 -20.99 61.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.423 172.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 82.5 tttt -84.03 11.91 7.15 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.486 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 75.4 mmtt 77.87 -20.92 0.35 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.831 0.852 . . . . 0.0 112.285 174.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.6 mt -73.46 126.57 30.5 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.971 0.415 . . . . 0.0 111.192 -177.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 p -87.18 105.34 17.13 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.843 175.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 62.1 t -82.65 130.54 35.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.804 -174.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.4 m -85.62 76.46 9.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.538 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -69.43 138.12 53.27 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.032 -173.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.738 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -80.44 127.46 75.86 Favored Pre-proline 0 CA--C 1.507 -0.678 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -177.433 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.24 14.52 0.22 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.221 1.947 . . . . 0.0 111.811 172.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 50' ' ' ASN . 0.4 OUTLIER -106.44 -19.07 13.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.875 -174.239 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.619 HE21 HG21 ' A' ' 56' ' ' VAL . 5.6 pt20 -105.05 140.65 37.92 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.032 -168.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 p -64.83 -36.24 83.7 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -172.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.578 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 43.9 p-90 -60.83 -32.62 72.0 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.726 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.619 HG21 HE21 ' A' ' 53' ' ' GLN . 4.8 t -73.58 -50.42 30.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.324 174.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 94.8 mttt -54.92 -36.95 65.78 Favored 'General case' 0 CA--C 1.522 -0.126 0 O-C-N 123.602 0.564 . . . . 0.0 110.421 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.404 ' O ' HD23 ' A' ' 62' ' ' LEU . 22.8 t80 -65.95 -58.64 5.08 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.642 176.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 55' ' ' TRP . 78.6 mt -59.1 -48.0 88.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -175.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.591 HG12 ' O ' ' A' ' 56' ' ' VAL . 11.9 p -65.45 -31.62 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.992 -177.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.0 ttp85 -63.83 -41.57 97.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.847 0.356 . . . . 0.0 110.517 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.404 HD23 ' O ' ' A' ' 58' ' ' TYR . 4.4 mm? -79.37 -29.86 42.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.138 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.459 HD13 ' CB ' ' A' ' 23' ' ' PHE . 28.5 mt -72.4 -46.46 55.13 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.558 177.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.7 t -81.13 -43.31 19.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.373 -174.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -98.9 93.01 5.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.458 0.646 . . . . 0.0 110.064 -179.539 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -83.93 82.8 8.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.961 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.5 t -87.25 1.96 5.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 122.181 0.991 . . . . 0.0 108.871 174.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.439 ' HD3' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -95.33 21.99 7.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.301 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -68.88 -22.95 64.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.301 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 49.9 ttm . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.922 177.481 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 120.866 0.365 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 m -85.19 97.18 9.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.232 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -61.26 -47.09 87.62 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.543 0.687 . . . . 0.0 109.247 175.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.66 -167.76 1.92 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.675 169.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.675 ' C ' ' HB2' ' A' ' 32' ' ' CYS . 3.1 p-10 -114.29 -99.42 0.43 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.89 0.852 . . . . 0.0 110.394 170.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.686 ' SG ' HG12 ' A' ' 34' ' ' ILE . 3.7 p -142.26 -142.71 0.14 Allowed 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 125.353 1.461 . . . . 0.0 107.843 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.432 ' O ' HD11 ' A' ' 34' ' ' ILE . 19.3 t -125.99 135.33 51.69 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 166.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 pp -65.87 -13.6 59.91 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.48 0.487 . . . . 0.0 111.873 -176.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.72 166.9 28.75 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.853 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 81.0 m-85 -119.39 -168.56 1.6 Allowed 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 176.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.511 ' H ' ' ND2' ' A' ' 50' ' ' ASN . 14.9 t -129.03 148.29 50.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.493 -178.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -107.15 62.69 0.62 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.542 ' HB3' HD22 ' A' ' 15' ' ' LEU . 15.9 mtm180 -131.25 173.18 11.31 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.1 mm -122.4 91.13 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.428 165.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.542 HD22 ' HB3' ' A' ' 13' ' ' ARG . 2.9 mm? -88.9 167.19 13.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 63.6 m170 -132.56 166.78 26.44 Favored Pre-proline 0 C--N 1.313 -0.994 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.894 -174.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 19.5 Cg_endo -60.39 -21.96 69.52 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.852 1.701 . . . . 0.0 109.213 166.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 83.7 mttt -52.94 -27.34 18.4 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 113.938 -1.483 . . . . 0.0 111.01 172.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -125.5 2.0 7.64 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.987 -174.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.677 HG12 ' HB3' ' A' ' 39' ' ' PHE . 13.3 mt -106.93 123.66 62.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.997 0.427 . . . . 0.0 111.275 -174.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.3 m -117.09 -16.19 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.02 177.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.66 160.17 26.51 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.539 ' CZ ' HG23 ' A' ' 60' ' ' VAL . 2.0 t80 -155.7 134.03 11.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.533 0.682 . . . . 0.0 110.606 -175.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.9 m -138.02 135.65 36.11 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.801 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -116.2 117.81 31.08 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.09 0.471 . . . . 0.0 111.847 -175.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.608 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 1.1 mp0 -94.32 135.96 35.14 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 174.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.9 156.07 18.35 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.1 0.476 . . . . 0.0 111.516 -170.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.17 11.93 26.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.278 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -126.83 -58.33 1.31 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.781 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -103.12 89.31 3.38 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.918 177.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.57 -63.11 0.52 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.973 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.675 ' HB2' ' C ' ' A' ' 5' ' ' ASP . 49.1 t -130.76 171.28 13.3 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -86.25 -20.19 28.83 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.686 HG12 ' SG ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -111.35 169.75 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 171.052 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -127.03 144.89 50.91 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 121.961 -0.462 . . . . 0.0 111.39 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.45 146.72 35.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.431 174.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.571 HG12 ' HG3' ' A' ' 51' ' ' PRO . 49.5 mm -106.96 102.4 13.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.882 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.594 HG13 HE22 ' A' ' 26' ' ' GLN . 70.0 mt -78.96 104.99 7.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.978 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.677 ' HB3' HG12 ' A' ' 20' ' ' ILE . 19.5 m-85 -88.91 120.15 30.07 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 170.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -90.25 104.85 17.38 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.4 p -74.38 161.79 29.5 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.779 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -68.18 -3.47 10.68 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.353 172.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 21.6 ttmm -95.47 8.39 43.41 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.245 176.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 31.3 mmmt 76.53 -24.17 0.23 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.244 1.018 . . . . 0.0 112.446 176.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.94 130.55 41.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.066 0.46 . . . . 0.0 111.38 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 p -86.51 108.84 18.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.185 176.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 60.9 t -91.97 128.96 43.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.434 -175.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 79.4 m -85.18 82.21 8.49 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.676 0.75 . . . . 0.0 109.143 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.503 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -72.45 136.79 46.08 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.091 -177.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.853 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -77.59 126.88 83.88 Favored Pre-proline 0 CA--C 1.51 -0.565 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.677 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.571 ' HG3' HG12 ' A' ' 37' ' ' ILE . 27.0 Cg_exo -63.99 -5.95 10.23 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 122.425 2.083 . . . . 0.0 111.903 177.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.487 ' O ' ' HE3' ' A' ' 57' ' ' LYS . 83.2 mttt -82.61 -29.8 29.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.634 -176.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.558 HE21 HG21 ' A' ' 56' ' ' VAL . 12.1 mt-30 -72.71 134.16 44.9 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.289 -175.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.5 -33.18 75.32 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.537 ' O ' HG13 ' A' ' 59' ' ' ILE . 49.0 p-90 -63.42 -33.11 74.83 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 175.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.558 HG21 HE21 ' A' ' 53' ' ' GLN . 8.7 t -72.67 -47.14 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.308 174.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 82.0 mttt -60.65 -28.07 68.29 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -70.1 -52.66 22.02 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.166 173.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.642 HG21 HD13 ' A' ' 20' ' ' ILE . 70.4 mt -68.03 -40.19 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.627 -176.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 56' ' ' VAL . 15.0 p -70.44 -30.3 42.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 O-C-N 122.122 -0.361 . . . . 0.0 110.555 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -66.0 -30.66 71.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.789 0.804 . . . . 0.0 108.999 173.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 28.1 tp -84.12 -20.66 32.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.435 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 23' ' ' PHE . 65.4 mt -108.89 4.27 23.24 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -175.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.3 t -63.69 -54.3 37.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.457 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -132.19 12.88 4.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 2.7 mmmp? -105.84 2.82 28.06 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.551 -176.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 69.8 t -87.27 115.9 28.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.182 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -86.11 88.0 7.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.022 0.439 . . . . 0.0 110.11 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -105.26 109.89 22.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.132 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 56.6 ttp . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.214 177.403 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.92 0 CA-C-O 120.808 0.337 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 m -125.86 135.76 52.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -65.44 -57.1 9.12 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 172.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -133.9 165.89 23.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.456 173.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -112.89 114.42 26.92 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 162.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.733 ' SG ' HG12 ' A' ' 34' ' ' ILE . 31.8 p -56.19 164.44 1.29 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.49 -172.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.442 ' O ' HD11 ' A' ' 34' ' ' ILE . 61.0 m -54.97 128.82 35.29 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.931 -176.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.432 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 2.0 pp -81.57 -14.53 56.71 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.275 0.56 . . . . 0.0 110.121 174.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.61 140.65 11.99 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.667 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.839 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 5.7 m-85 -107.07 -163.12 0.88 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.59 0.233 . . . . 0.0 110.415 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.482 HG21 ' CG1' ' A' ' 47' ' ' VAL . 4.7 t -137.46 149.99 47.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.974 0.416 . . . . 0.0 111.354 177.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -116.6 73.51 0.86 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.228 0.537 . . . . 0.0 109.783 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.527 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 57.5 mtt180 -129.23 -171.39 2.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.294 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.586 HD13 ' CD1' ' A' ' 55' ' ' TRP . 13.7 mm -125.59 78.58 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.344 168.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.552 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.6 mm? -81.7 161.86 23.21 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.771 ' ND1' ' HD3' ' A' ' 18' ' ' LYS . 65.5 m170 -133.82 162.17 59.31 Favored Pre-proline 0 C--N 1.31 -1.125 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.938 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.825 ' HD3' HG12 ' A' ' 59' ' ' ILE . 27.7 Cg_endo -64.55 -16.87 57.48 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.341 2.027 . . . . 0.0 108.746 166.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.771 ' HD3' ' ND1' ' A' ' 16' ' ' HIS . 28.8 mtpp -53.43 -21.58 6.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 113.38 -1.736 . . . . 0.0 110.966 170.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -130.31 3.74 4.72 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.675 ' HB ' ' HA ' ' A' ' 17' ' ' PRO . 3.9 mm -100.37 122.9 52.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -170.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.3 m -114.49 -10.13 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.483 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.52 158.46 27.67 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.681 ' HB2' HD13 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -156.52 134.7 11.29 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.065 0.46 . . . . 0.0 109.867 -175.686 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.436 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 30.7 m -138.4 103.23 4.84 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.495 178.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.435 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 11.5 ptm180 -78.36 89.76 4.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.785 0.802 . . . . 0.0 109.787 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.647 ' CD ' ' HA ' ' A' ' 6' ' ' CYS . 4.0 tt0 -72.46 114.92 11.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.842 -175.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 25' ' ' ARG . 97.7 mt -116.71 164.07 15.18 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.225 -171.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.62 -37.44 65.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.826 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -62.14 -19.96 63.58 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -174.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -94.1 13.89 21.67 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.76 -30.17 2.79 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.092 -1.051 . . . . 0.0 113.658 174.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 3.7 t -86.08 -168.6 2.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.18 0.514 . . . . 0.0 111.659 -177.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -120.12 -36.2 3.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.216 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.733 HG12 ' SG ' ' A' ' 6' ' ' CYS . 6.8 pt -104.75 -175.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -138.16 112.16 8.46 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.345 0.593 . . . . 0.0 111.922 -173.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.5 119.88 39.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.527 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.485 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 41.3 mm -80.38 98.05 3.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.051 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.508 ' CG2' ' HB3' ' A' ' 46' ' ' SER . 23.7 mt -80.37 111.74 17.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 O-C-N 121.832 -0.542 . . . . 0.0 111.495 -174.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.445 ' HE2' HG22 ' A' ' 56' ' ' VAL . 30.3 m-85 -97.28 122.45 40.32 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 9.2 m-70 -97.66 111.36 23.67 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -176.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.5 p -71.17 163.63 27.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.099 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -66.92 -3.08 6.13 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.846 171.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -94.36 0.5 55.54 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.691 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm 78.64 -1.31 2.43 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.25 1.02 . . . . 0.0 111.496 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.4 mt -83.78 119.81 25.27 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.508 ' HB3' ' CG2' ' A' ' 38' ' ' ILE . 3.4 m -88.87 106.99 18.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.19 0.519 . . . . 0.0 109.901 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.482 ' CG1' HG21 ' A' ' 11' ' ' THR . 24.4 t -91.08 132.9 34.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.597 -175.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.8 m -88.19 91.6 8.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.749 0.785 . . . . 0.0 109.515 -178.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.641 ' HB1' HG22 ' A' ' 56' ' ' VAL . . . -76.52 146.0 38.73 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.077 -174.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.839 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -84.16 128.68 61.39 Favored Pre-proline 0 CA--C 1.512 -0.495 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.293 -177.578 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.79 6.55 1.28 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.248 1.965 . . . . 0.0 112.65 176.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -92.34 -24.7 18.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.863 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.53 HE21 HG21 ' A' ' 56' ' ' VAL . 4.8 pt20 -103.61 142.7 33.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.056 -165.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 p -65.6 -37.2 85.95 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -172.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.586 ' CD1' HD13 ' A' ' 14' ' ' ILE . 49.9 p-90 -60.49 -33.84 73.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.221 0.534 . . . . 0.0 109.752 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.641 HG22 ' HB1' ' A' ' 49' ' ' ALA . 14.2 t -70.72 -50.62 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.154 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 95.7 mttt -54.82 -37.38 66.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.378 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -67.77 -54.39 19.61 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.836 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.825 HG12 ' HD3' ' A' ' 17' ' ' PRO . 75.0 mt -62.82 -45.52 98.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.634 0.254 . . . . 0.0 111.038 -176.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.564 HG23 ' CE1' ' A' ' 23' ' ' PHE . 10.2 p -64.4 -29.22 46.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.807 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -67.59 -43.95 79.29 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.988 0.423 . . . . 0.0 110.194 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.6 mt -75.07 -32.36 61.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.816 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.681 HD13 ' HB2' ' A' ' 23' ' ' PHE . 82.7 mt -71.73 -35.95 70.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.858 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.3 m -94.08 57.9 2.46 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 172.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.02 69.94 1.49 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.897 0.856 . . . . 0.0 110.745 -178.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -82.14 37.62 0.5 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.347 -173.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.5 m -129.95 12.13 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.415 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -138.08 146.99 43.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.111 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -80.59 119.49 23.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.099 0.476 . . . . 0.0 111.001 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 21.8 ptm . . . . . 0 C--O 1.246 0.883 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.118 174.804 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.6 m -76.96 126.29 30.72 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.811 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -71.3 -48.87 48.0 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.662 ' CE1' ' HG2' ' A' ' 26' ' ' GLN . 51.9 p90 -132.08 170.39 15.03 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.366 177.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -123.46 116.73 23.7 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.945 168.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.509 ' HA ' ' NE2' ' A' ' 26' ' ' GLN . 0.6 OUTLIER -54.37 165.8 0.5 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 179.444 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.4 t -66.35 128.63 36.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.467 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.6 mt -75.21 -17.94 60.25 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.196 0.31 . . . . 0.0 111.436 -176.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.31 117.58 1.39 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.285 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.753 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 1.6 m-85 -75.63 168.51 19.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.274 0.559 . . . . 0.0 109.709 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.45 ' OG1' ' HG3' ' A' ' 13' ' ' ARG . 4.8 t -94.7 -176.42 3.88 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.762 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -150.3 72.63 1.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.519 ' HB2' HD22 ' A' ' 15' ' ' LEU . 2.2 mtp180 -132.68 -179.56 5.54 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.121 -175.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.577 HD13 ' CD1' ' A' ' 55' ' ' TRP . 19.1 mm -126.4 84.33 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.014 167.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.534 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 2.3 mm? -89.32 161.57 16.29 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.836 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 55.3 m170 -133.95 177.96 2.0 Allowed Pre-proline 0 C--N 1.312 -1.053 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.185 -177.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.643 ' HD2' ' HB3' ' A' ' 16' ' ' HIS . 51.8 Cg_exo -53.26 -30.7 52.73 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.676 1.584 . . . . 0.0 109.272 161.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.836 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 64.6 mttm -44.42 -34.0 1.88 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.582 169.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 41' ' ' THR . 98.7 m-85 -127.16 2.15 6.45 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -173.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 mp -98.12 130.47 46.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.811 0.338 . . . . 0.0 110.46 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 p -124.27 -7.2 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.492 0.663 . . . . 0.0 110.199 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.02 156.9 26.5 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.803 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.901 ' HB3' HD12 ' A' ' 63' ' ' LEU . 1.9 t80 -140.7 138.08 33.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.256 0.551 . . . . 0.0 110.769 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.6 m -143.59 105.26 4.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.697 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.566 ' NE ' ' H ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -77.68 115.6 17.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.394 0.616 . . . . 0.0 111.117 -178.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.662 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.6 OUTLIER -86.18 117.12 24.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.247 -179.174 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.838 ' HB3' HD22 ' A' ' 29' ' ' ASN . 98.2 mt -103.85 145.95 29.36 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -167.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.88 50.29 1.94 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.42 176.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.838 HD22 ' HB3' ' A' ' 27' ' ' LEU . 52.9 m-80 -127.23 -64.42 1.0 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.201 -175.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -85.55 53.4 2.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.653 0.739 . . . . 0.0 111.902 -174.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.55 -61.5 0.51 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.809 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -55.06 152.13 8.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.842 -0.679 . . . . 0.0 111.63 175.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -120.35 -5.86 9.86 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 34' ' ' ILE . 26.1 pt -127.85 115.75 40.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 CA-C-O 121.911 0.862 . . . . 0.0 111.069 176.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -83.55 118.2 23.64 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 121.475 -0.766 . . . . 0.0 111.442 -172.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.1 139.06 53.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.767 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.573 HG12 ' HG3' ' A' ' 51' ' ' PRO . 43.5 mm -85.48 109.89 18.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.249 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.531 HD11 ' NE2' ' A' ' 26' ' ' GLN . 42.3 mm -90.4 100.17 10.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.989 0.423 . . . . 0.0 110.814 -177.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.582 ' HE2' HG22 ' A' ' 56' ' ' VAL . 11.7 m-85 -92.22 118.53 30.96 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.882 173.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -89.03 115.19 26.4 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.419 ' C ' ' H ' ' A' ' 43' ' ' LYS . 33.1 p -82.21 162.24 22.45 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.468 0.652 . . . . 0.0 112.249 -172.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -60.32 -4.43 0.84 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.313 170.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 41' ' ' THR . 75.2 mmtt -109.74 16.56 22.0 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.944 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 59.7 mttp 75.17 -21.44 0.3 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.87 0.868 . . . . 0.0 112.525 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.3 mt -68.5 118.29 11.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.868 0.366 . . . . 0.0 111.159 -173.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.2 p -79.24 101.64 8.11 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 175.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 76.3 t -83.16 132.63 30.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.456 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.0 m -85.41 74.38 10.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.863 0.839 . . . . 0.0 109.094 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.437 ' HB1' ' CG2' ' A' ' 56' ' ' VAL . . . -69.71 142.45 53.32 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.657 -175.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.753 ' ND2' ' HB3' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -84.02 127.8 65.41 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.197 -177.114 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.573 ' HG3' HG12 ' A' ' 37' ' ' ILE . 24.1 Cg_exo -64.75 3.18 0.97 Allowed 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.728 2.285 . . . . 0.0 111.824 174.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 50' ' ' ASN . 57.7 mtpt -92.67 -22.7 19.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.627 -176.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.66 ' CG ' ' HB2' ' A' ' 50' ' ' ASN . 0.6 OUTLIER -93.27 134.31 35.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.536 -169.585 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 p -64.34 -32.42 74.02 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.577 ' CD1' HD13 ' A' ' 14' ' ' ILE . 47.3 p-90 -61.94 -33.32 74.05 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.649 HG21 HE21 ' A' ' 53' ' ' GLN . 14.0 t -70.34 -49.77 51.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.99 173.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 53' ' ' GLN . 96.4 mttt -56.72 -35.05 68.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.26 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -66.09 -56.43 11.52 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.012 175.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.426 HD11 ' HA ' ' A' ' 16' ' ' HIS . 86.6 mt -60.84 -48.07 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.121 -176.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.649 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 14.4 p -62.55 -31.68 52.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -177.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -62.45 -47.78 82.51 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.066 0.46 . . . . 0.0 110.039 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 66' ' ' LYS . 11.0 mp -69.86 -40.54 75.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.304 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.901 HD12 ' HB3' ' A' ' 23' ' ' PHE . 3.6 mm? -70.11 -7.62 42.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.55 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -90.03 -63.03 1.34 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.95 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -134.5 25.75 3.76 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -171.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 62' ' ' LEU . 16.5 tppt? -120.1 114.79 22.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.207 0.527 . . . . 0.0 110.476 176.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.01 126.37 75.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.12 -174.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -139.24 -63.45 0.52 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.204 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -106.49 148.22 28.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.393 0.616 . . . . 0.0 112.334 -171.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.013 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.315 176.271 . . . . . . . . 1 1 . 1 stop_ save_